Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFGE8,Lactadherin,42120,-0.12412386497986,0.00436024741694339,-0.132669949917069,-0.115577780042651,6.08932743549756e-173
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCG,Pro-glucagon,41861,-0.332930186780533,0.0126806376054369,-0.357784236487189,-0.308076137073877,5.48785757513273e-148
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS15,Enteropeptidase,42094,-0.237300513610302,0.00915546029453589,-0.255245215787592,-0.219355811433012,1.95760954459386e-144
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,42273,0.312567185142064,0.0121349180459813,0.28878274577194,0.336351624512187,9.29336839182562e-143
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRAP1,Proline-rich acidic protein 1,40097,-0.0950718342937562,0.00415512058109702,-0.103215870632706,-0.086927797954806,3.2735591976243e-113
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOF,Apolipoprotein F,40102,0.0540819559135091,0.00240041760829806,0.0493771374012449,0.0587867744257733,6.6018258016935e-110
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF9,Protein turtle homolog A,40080,-0.182040029488552,0.00838189480305762,-0.198468543302545,-0.165611515674559,2.02226950163611e-102
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PYY,Peptide YY,39706,-0.219098154188485,0.0103704939873328,-0.239424322403658,-0.198771985973313,4.59325361016012e-97
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C9,Complement component C9,40102,0.109067068666185,0.00539872739232045,0.0984855629772365,0.119648574355133,3.9419316007522e-89
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIP,Gastric inhibitory polypeptide,39804,-0.119481975029543,0.00592794786118638,-0.131100752837468,-0.107863197221617,1.08392733686414e-88
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON3,Serum paraoxonase/lactonase 3,42184,0.0561796924314878,0.00280196578576051,0.0506878394913972,0.0616715453715784,4.308174125674e-88
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES1,Liver carboxylesterase 1,42170,-0.156310614301649,0.00828783849333241,-0.17255477774858,-0.140066450854717,2.68930786054289e-78
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACY1,Aminoacylase-1,42144,-0.113818135155479,0.00620016934324722,-0.125970467068244,-0.101665803242715,2.52394797684603e-74
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPM,Carboxypeptidase M,42158,-0.0625404980036578,0.00343886649050604,-0.0692806763250497,-0.055800319682266,5.33409764248021e-73
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGRP,Agouti-related protein,42256,-0.0942736976128346,0.0051955257377949,-0.104456928058913,-0.0840904671667566,1.0923380179664e-72
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPY,Pro-neuropeptide Y,42223,-0.115375093750136,0.00649270167059944,-0.128100789024511,-0.102649398475761,8.03261684715888e-70
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS8,Prostasin,42078,-0.075849316419389,0.00429265301891381,-0.0842629163364601,-0.0674357165023179,4.6840230961178e-69
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,41876,-0.143271516787017,0.00829265638529593,-0.159525123302197,-0.127017910271837,4.00340635905844e-66
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,42186,0.0573949006212277,0.00338423039177487,0.050761809053349,0.0640279921891065,7.94510543638431e-64
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPY,Pancreatic prohormone,42110,-0.179152717865153,0.0105947272797306,-0.199918383333425,-0.158387052396881,1.83806101885465e-63
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,42223,-0.0616901649785907,0.00372401352657542,-0.0689892314906785,-0.0543910984665028,5.19838664721212e-61
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADIPOQ,Adiponectin,40113,0.116208165612581,0.00700994701131609,0.102468669470402,0.129947661754761,5.61137242714068e-61
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,42197,0.0626488907064077,0.00382884745295262,0.0551443496986206,0.0701534317141948,1.39745157934724e-59
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,42274,0.103571508669777,0.00636098818491193,0.0911039718273492,0.116039045512204,5.01178820068335e-59
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17RB,Interleukin-17 receptor B,41931,0.0890362040819009,0.00547976695481061,0.0782958608504721,0.0997765473133297,8.96264347185875e-59
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFASC,Neurofascin,42256,-0.047877258641921,0.00298035409027264,-0.0537187526588554,-0.0420357646249866,1.61335562210377e-57
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPA,Apolipoprotein(a),39902,0.298718696928301,0.018593612595612,0.262275216240901,0.3351621776157,2.07708889382722e-57
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,42094,-0.0585618827570298,0.00371217155859107,-0.0658377390118683,-0.0512860265021913,1.51160604566793e-55
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPL,Lipoprotein lipase,42144,0.0748444954094651,0.00476232862953603,0.0655103312955745,0.0841786595233557,3.7984632339447e-55
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPB1,Beta-ureidopropionase,40080,-0.143171000426668,0.00912376878486165,-0.161053587244996,-0.125288413608339,6.83037449373904e-55
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FURIN,Furin,42186,-0.0516673230094324,0.00333019389225139,-0.0581945030382451,-0.0451401429806197,8.3624935605722e-54
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEP1A,Meprin A subunit alpha,40021,-0.114262987122906,0.00737751401244329,-0.128722914587295,-0.099803059658517,1.56539744416122e-53
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACE2,Angiotensin-converting enzyme 2,41876,-0.0849369830973337,0.00551613191890159,-0.0957486016583808,-0.0741253645362866,5.09647569324934e-53
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHBG,Sex hormone-binding globulin,40102,0.0777335731024373,0.00514715525015693,0.0676451488121297,0.0878219973927449,5.12554296483589e-51
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCG2,Secretogranin-2,42140,-0.0528582404423714,0.00351642123606745,-0.0597504260650636,-0.0459660548196792,1.21438200037278e-50
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGR3,Anterior gradient protein 3,41841,-0.090906196544929,0.00615178512238234,-0.102963695384798,-0.0788486977050596,5.26336784546838e-49
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,40035,-0.127168615622457,0.0087003400855118,-0.14422128219006,-0.110115949054854,6.29014286045124e-48
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKB,Creatine kinase B-type,40097,0.0895527156330929,0.0061495301057081,0.0774996366259051,0.101605794640281,1.35877569923697e-47
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INHBC,Inhibin beta C chain,42120,-0.0607064130042322,0.00418379669685365,-0.0689066545300653,-0.052506171478399,2.46933453098452e-47
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF21,Fibroblast growth factor 21,42193,-0.17392604245771,0.0120064282605758,-0.197458641848439,-0.150393443066982,3.45728667539767e-47
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTA1,Glutathione S-transferase A1,42121,-0.120829827492941,0.00844801603085654,-0.13738793891342,-0.104271716072462,4.72223844463891e-46
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,39863,0.0454115052970604,0.00318088493883134,0.039176970816951,0.0516460397771698,8.10792251448408e-46
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,41985,-0.105487154606505,0.00751302001795479,-0.120212673841696,-0.0907616353713133,1.88052714872517e-44
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,41772,-0.0791085387449352,0.00566470797298049,-0.0902113663719769,-0.0680057111178934,5.41647074132375e-44
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,42120,-0.0762979565935694,0.00549046096500919,-0.0870592600849874,-0.0655366531021514,1.36945113156159e-43
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSD,Cathepsin D,41291,-0.0593963299171217,0.00433191514076974,-0.0678868835930304,-0.050905776241213,1.80332314941779e-42
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC13,Mucin-13,41829,-0.073336107401326,0.00535347367528951,-0.0838289158048935,-0.0628432989977586,2.07323130628122e-42
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC39A5,Zinc transporter ZIP5,42103,-0.0756910726979801,0.00552941494834496,-0.0865287259967362,-0.064853419399224,2.33952871739617e-42
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GH1,Somatotropin,42122,0.240045059044663,0.0176087514705529,0.205531906162379,0.274558211926946,5.03273494504709e-42
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MET,Hepatocyte growth factor receptor,42161,0.0277374092406663,0.00204054724017178,0.0237379366499296,0.031736881831403,8.50354159347015e-42
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OXT,Oxytocin-neurophysin 1,42213,-0.191835796728314,0.0141845439583952,-0.219637502886769,-0.16403409056986,2.13959136490378e-41
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUSB,Beta-glucuronidase,42217,-0.0840983285092933,0.00623248514087235,-0.0963139993854031,-0.0718826576331835,3.22884940332994e-41
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,41887,-0.0762178794979614,0.00567998842107765,-0.0873506568032736,-0.0650851021926492,8.91175122535887e-41
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAMDC4,Apical endosomal glycoprotein,40020,-0.0745912821603873,0.00562898900435345,-0.0856241006089201,-0.0635584637118546,9.04497108623508e-40
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,40097,-0.0454859226977357,0.00349913900740406,-0.0523442351522476,-0.0386276102432237,2.38248115613661e-38
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,42094,-0.108925862598577,0.00840533150165581,-0.125400312341822,-0.0924514128553316,3.60909806499439e-38
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHR,Growth hormone receptor,39863,-0.0368999748261663,0.0028871261465089,-0.0425587420733237,-0.0312412075790088,3.92403031104292e-37
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",42094,-0.105783399463551,0.00829156040578531,-0.122034857858891,-0.0895319410682121,4.71273286761389e-37
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG2,Desmoglein-2,42120,0.0354063576044121,0.00278468693082071,0.0299483712200035,0.0408643439888207,8.14304013635836e-37
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN1,CCN family member 1,42076,-0.0943501496708209,0.00743023370820542,-0.108913407738904,-0.0797868916027383,1.00493219576284e-36
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTA3,Glutathione S-transferase A3,41861,-0.0990787868017061,0.00785411385953719,-0.114472849966399,-0.0836847236370132,2.88739612658876e-36
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MVK,Mevalonate kinase,41887,-0.102778597753311,0.00818335974770119,-0.118817982858805,-0.0867392126478162,5.77025118721398e-36
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",39804,-0.072709479959477,0.00582369720114756,-0.0841239264737262,-0.0612950334452278,1.59861848391209e-35
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO3,Beta-enolase,39804,-0.0746148010676802,0.00600256848175782,-0.0863798352919255,-0.0628497668434349,3.13972454136479e-35
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,42094,-0.0498456318415214,0.00408090956841818,-0.057844214595621,-0.0418470490874217,4.02122386532677e-34
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3B,Protein FAM3B,42094,-0.043933025850785,0.00362436486676112,-0.0510367809896368,-0.0368292707119332,1.23662297909578e-33
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFM,Afamin,40113,-0.0246667297100118,0.00204181947314338,-0.0286686958773728,-0.0206647635426508,2.17882256975336e-33
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,39784,-0.155602625578935,0.0128822064033913,-0.180851750129582,-0.130353501028288,2.26237317649197e-33
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,42193,-0.050946131272326,0.00422477096985288,-0.0592266823732377,-0.0426655801714144,2.62091932136719e-33
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,39858,-0.0572977600084706,0.0047666645995283,-0.0666404226235461,-0.0479550973933952,4.53352364308051e-33
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA14,Carbonic anhydrase 14,42223,0.0443122786917754,0.0037072007952028,0.0370461651331779,0.0515783922503729,9.28577094708198e-33
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSO,Cathepsin O,42256,-0.0376654658711426,0.00315922220998298,-0.0438575414027093,-0.031473390339576,1.33546019887545e-32
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR37,Prosaposin receptor GPR37,41876,-0.0834398267148812,0.00701356723266505,-0.0971864184909047,-0.0696932349388577,1.82743061346429e-32
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,41861,-0.0785627994197161,0.00663150384039015,-0.0915605469468807,-0.0655650518925514,3.30251433965538e-32
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,39863,-0.0599883875092473,0.00508427605040642,-0.0699535685680439,-0.0500232064504507,6.25028434482358e-32
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MME,Neprilysin,42094,-0.098058042960308,0.00834164928237842,-0.11440767555377,-0.0817084103668463,9.63598739220829e-32
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA2,Apolipoprotein A-II,40102,0.0586547461539215,0.00503605265962997,0.0487840829410468,0.0685254093667963,3.63481781344576e-31
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,42186,-0.0281623331509289,0.00242965763446956,-0.0329244621144893,-0.0234002041873686,6.4911244609649e-31
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTH,Parathyroid hormone,39768,-0.0969530901450717,0.00839499571089843,-0.113407281738433,-0.0804988985517108,1.14159823770164e-30
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KHK,Ketohexokinase,39804,-0.0729570001712018,0.00639573877524905,-0.0854926481706899,-0.0604213521717137,5.75756997665761e-30
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSZ,Cathepsin Z,42159,-0.0378618047671322,0.00332274918486391,-0.0443743931694655,-0.031349216364799,6.16622352866457e-30
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,39784,-0.0518683377403951,0.00456020580261449,-0.0608063411135195,-0.0429303343672707,8.37688255758202e-30
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP5,Retinol-binding protein 5,42094,-0.0651979204192684,0.00574527774147689,-0.0764586647925632,-0.0539371760459737,1.04830264727383e-29
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSE,Cathepsin E,39863,-0.059621725886855,0.00526368264437617,-0.0699385438698323,-0.0493049079038778,1.42262550081247e-29
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELE,E-selectin,42296,-0.0588614864897359,0.00520251550794236,-0.0690584168853029,-0.0486645560941689,1.53289753008898e-29
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,42239,-0.036134330879775,0.00322369692002869,-0.0424527768430312,-0.0298158849165187,5.00025937007922e-29
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCLY,Selenocysteine lyase,42178,-0.0538610161759715,0.00480925200140056,-0.0632871500987165,-0.0444348822532264,5.56961973674962e-29
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,39863,-0.0851591268562821,0.00762180437961478,-0.100097863440327,-0.0702203902722372,7.98021045159895e-29
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISM1,Isthmin-1,42103,-0.044111997887657,0.00395518948117262,-0.0518641692707553,-0.0363598265045586,9.37497254167628e-29
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,41861,-0.0676138888443737,0.00607488796046105,-0.0795206692468773,-0.05570710844187,1.21607252445219e-28
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LDLR,Low-density lipoprotein receptor,42151,-0.0580527572906229,0.00521645461979906,-0.068277008345429,-0.0478285062358167,1.22522881895879e-28
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTN4R,Reticulon-4 receptor,42223,-0.0393991417008721,0.0035421264785472,-0.0463417095988246,-0.0324565738029196,1.30400476666875e-28
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDUA,Alpha-L-iduronidase,42223,-0.0529361308343972,0.00476073744188853,-0.0622671762204987,-0.0436050854482957,1.35879039755855e-28
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1R2,Interleukin-1 receptor type 2,42108,-0.0227424241915679,0.00204536422867463,-0.0267513380797702,-0.0187335103033657,1.36695844252576e-28
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,42099,-0.0572821429844557,0.00517027767178883,-0.0674158872211618,-0.0471483987477496,2.1272150191635e-28
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA2,Carboxypeptidase A2,42173,-0.0750538043835884,0.00679286146684889,-0.0883678128586122,-0.0617397959085646,2.96481908486208e-28
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOD,Apolipoprotein D,39633,0.0489056366403343,0.00443083731302701,0.0402211955068014,0.0575900777738673,3.60329625375955e-28
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,42094,-0.0898926096737249,0.00815733806613271,-0.105880992283345,-0.0739042270641048,4.09185087627095e-28
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGR2,Anterior gradient protein 2 homolog,41739,-0.114807261055676,0.0104420652425692,-0.135273708931112,-0.0943408131802405,5.43903730486549e-28
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBKS,Ribokinase,41830,-0.0558751989091372,0.00510265199788393,-0.0658763968249897,-0.0458740009932847,8.83479683506449e-28
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,42103,0.0394438966122621,0.00361887724813948,0.0323508972059087,0.0465368960186154,1.52787576166951e-27
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBS2,Thrombospondin-2,42120,-0.0430947071486746,0.00400832072744661,-0.05095101577447,-0.0352383985228792,7.58726431927255e-27
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINF1,Pigment epithelium-derived factor,39933,-0.0293496340493606,0.00273078762717418,-0.034701977798622,-0.0239972903000992,8.31664269271935e-27
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREG1,Protein CREG1,41961,-0.0424799855337968,0.00395877904948673,-0.0502391924707908,-0.0347207785968028,9.50959775485503e-27
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRP1,Neuropilin-1,42211,0.0305744130841015,0.00285254139601293,0.0249834319479162,0.0361653942202869,1.07924930665394e-26
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORD,Sorbitol dehydrogenase,42162,-0.0736988805494496,0.0068773594991517,-0.0871785051677869,-0.0602192559311122,1.10542895406024e-26
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,42186,-0.0246889728062731,0.00230644473558685,-0.0292096044880233,-0.0201683411245229,1.25394932870229e-26
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,42004,-0.0336172488670956,0.00314380238790837,-0.0397791015473961,-0.0274553961867952,1.41803188285174e-26
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,41876,-0.0606381988033238,0.00568054939715478,-0.0717720756217472,-0.0495043219849005,1.73180555622044e-26
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSP1,Lymphocyte-specific protein 1,42103,-0.043582134109248,0.00408409515036316,-0.0515869606039598,-0.0355773076145362,1.79000855682894e-26
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,42103,-0.0300580508354528,0.00282119024635537,-0.0355875837183093,-0.0245285179525963,2.14107939627565e-26
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH15,Cadherin-15,42194,-0.0687830023539041,0.00646403818507492,-0.081452517196651,-0.0561134875111573,2.46808483283926e-26
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLA,Alpha-galactosidase A,39847,-0.0404866519856509,0.00383072965412564,-0.0479948821077371,-0.0329784218635646,5.58312125613035e-26
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,39706,-0.0684182894996818,0.00649350133607185,-0.0811455521183826,-0.055691026880981,7.89267620626589e-26
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,42094,0.0213248244646916,0.00203159056377565,0.0173429069596914,0.0253067419696919,1.13610010101652e-25
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THOP1,Thimet oligopeptidase,42081,-0.0330888732191515,0.00317664254782178,-0.0393150926128822,-0.0268626538254208,2.63275836647019e-25
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EZR,Ezrin,42213,-0.025559057847424,0.00245762373496546,-0.0303760003679563,-0.0207421153268917,3.11579954886254e-25
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLB1,Beta-galactosidase,42004,-0.0440369928392575,0.00425968032337094,-0.0523859662730646,-0.0356880194054505,5.93901559355246e-25
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,42144,-0.0373398994235649,0.00361870908688072,-0.0444325692338511,-0.0302472296132787,7.25007153024976e-25
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEPH,Hephaestin,40080,-0.027921327456542,0.0027195828546068,-0.0332517098515713,-0.0225909450615126,1.28803460633437e-24
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS4,Galectin-4,42126,-0.0594342750499357,0.00584102873898826,-0.0708826913783527,-0.0479858587215187,3.15344425698564e-24
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD2AP,CD2-associated protein,42144,-0.0666663082691793,0.00656145361338661,-0.079526757351417,-0.0538058591869415,3.67330366176953e-24
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNGR2,Interferon gamma receptor 2,42004,-0.0543575368948497,0.00536845961820191,-0.0648797177465255,-0.043835356043174,5.25052477922773e-24
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,41954,-0.0499235275145658,0.00497443626826401,-0.0596734226003633,-0.0401736324287684,1.29512670400446e-23
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,41987,-0.153917812875637,0.0153908398766638,-0.184083859033898,-0.123751766717376,1.84683293070743e-23
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCXR,L-xylulose reductase,42186,-0.0540385648759212,0.00541236102436903,-0.0646467924836845,-0.0434303372681579,2.16825115337012e-23
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRP2,Neuropilin-2,42120,0.0293697543559114,0.00295910936551684,0.0235698999994984,0.0351696087123244,3.91335496933782e-23
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,42094,-0.0878332650403912,0.00885931091324903,-0.105197514430359,-0.0704690156504231,4.36594373802739e-23
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FEN1,Flap endonuclease 1,41861,-0.0648543614644988,0.00655582587902639,-0.0777037801873906,-0.0520049427416071,5.42883104478983e-23
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,40113,0.0270160653283288,0.00273168270285701,0.0216619672307291,0.0323701634259285,5.75061856109081e-23
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN3,Contactin-3,42120,-0.0316280215495317,0.00319944053113504,-0.0378989249905564,-0.025357118108507,5.80506048133833e-23
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,40054,0.0373314936818224,0.00378412374614885,0.0299146111393707,0.0447483762242742,7.34337219523906e-23
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,42296,0.0252504173144573,0.00256266156596992,0.0202276006451563,0.0302732339837583,7.97001249790964e-23
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADM,Pro-adrenomedullin,42223,-0.0272630684064842,0.00276748061487694,-0.032687330411643,-0.0218388064013254,8.13548869045556e-23
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18R1,Interleukin-18 receptor 1,42256,-0.0333095089963249,0.00339492475096912,-0.0399635615082243,-0.0266554564844254,1.20224250359868e-22
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL16,C-C motif chemokine 16,42296,-0.0521966403817675,0.00535857835464045,-0.0626994539568628,-0.0416938268066722,2.40560841259954e-22
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,42296,0.0290234920058242,0.00298282470782114,0.0231771555784948,0.0348698284331537,2.66690059796114e-22
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSME1,Proteasome activator complex subunit 1,41989,-0.0370985672819822,0.00381495663849316,-0.0445758822934288,-0.0296212522705356,2.83107578116096e-22
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300LG,CMRF35-like molecule 9,42120,0.038356605985053,0.00394906380414477,0.0306164409289292,0.0460967710411767,3.16651677733701e-22
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM20A,Pseudokinase FAM20A,40080,-0.027989751648297,0.00289194111786083,-0.0336579562393042,-0.0223215470572897,4.56483398957909e-22
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHI3L1,Chitinase-3-like protein 1,41936,-0.0818080066761943,0.00850713731563648,-0.0984819958148418,-0.0651340175375468,8.08578634216288e-22
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA1,Ephrin type-A receptor 1,42167,-0.0325308884973958,0.00339397035356304,-0.0391830703903794,-0.0258787066044123,1.09185917709572e-21
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL15,Interleukin-15,42103,-0.0326972124482597,0.00343298355864475,-0.0394258602232035,-0.025968564673316,1.95155072945233e-21
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,42094,-0.042760351086295,0.00449119541891865,-0.0515630941073756,-0.0339576080652145,2.01820049910113e-21
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,41861,-0.079442681477242,0.0083854439529747,-0.0958781516250724,-0.0630072113294116,3.16982500199548e-21
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,39784,-0.0668508670217077,0.00706038115837803,-0.0806892140921286,-0.0530125199512867,3.44445852477078e-21
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD4,T-cell surface glycoprotein CD4,42081,-0.0295655329198639,0.00313030266026963,-0.0357009261339924,-0.0234301397057355,4.16086342271288e-21
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,42120,0.0320345222286638,0.00341347894502068,0.0253441034964233,0.0387249409609043,7.34972938305973e-21
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,42094,-0.0673236509160527,0.00717423155289652,-0.0813851447597298,-0.0532621570723755,7.39515694691676e-21
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,42223,-0.0333412003417429,0.00355369782154748,-0.0403064480719759,-0.0263759526115098,7.5229173444673e-21
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCS1,Neuronal calcium sensor 1,42223,-0.0278634226624612,0.00297775433304176,-0.033699821155223,-0.0220270241696993,9.51130204686359e-21
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREH,Trehalase,40097,-0.0710371611160526,0.00760407776852785,-0.0859411535423672,-0.056133168689738,1.12931147094395e-20
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,42095,-0.0520998054636328,0.00558548679823215,-0.0630473595881678,-0.0411522513390978,1.25612100533719e-20
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HJV,Hemojuvelin,40054,-0.042182531257201,0.00452941414311584,-0.0510601829777081,-0.033304879536694,1.48187345274315e-20
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STC1,Stanniocalcin-1,42213,-0.0432525626392813,0.00466705860239293,-0.0523999974999715,-0.0341051277785912,2.19878322035198e-20
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FMNL1,Formin-like protein 1,41829,-0.0584007939181711,0.00635539740014422,-0.0708573728224537,-0.0459442150138884,4.57116434885125e-20
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NHLRC3,NHL repeat-containing protein 3,39604,-0.030479080241885,0.00331922262452976,-0.0369847565859633,-0.0239734038978067,5.00722012481419e-20
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,40020,-0.048863805908873,0.00532845725402531,-0.0593075821267626,-0.0384200296909834,5.56812039341254e-20
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PXN,Paxillin,41829,-0.0481186089793069,0.00525442743105684,-0.0584172867441783,-0.0378199312144355,6.10791344474272e-20
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,42172,0.0284680275327386,0.00310948863841012,0.0223734298014548,0.0345626252640224,6.22762607604025e-20
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,42094,-0.0556516631440111,0.00609694273933342,-0.0676016709131046,-0.0437016553749176,8.01830584747715e-20
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPO,Erythropoietin,42103,-0.0694272028419735,0.00763321090310888,-0.0843882962120669,-0.0544661094718801,1.07863544932579e-19
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLTP,Phospholipid transfer protein,42255,0.0335900755136438,0.00369760890599128,0.0263427620579009,0.0408373889693868,1.19240696138211e-19
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOM,Apolipoprotein M,42172,0.0262606073385049,0.00291418425741198,0.0205488061939774,0.0319724084830323,2.31790527876051e-19
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPPC,C-type natriuretic peptide,42103,-0.0465751466645889,0.00517712946742743,-0.0567223204207467,-0.0364279729084312,2.65648489173222e-19
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,42122,-0.104943166941271,0.0117458234400267,-0.127964980883723,-0.0819213529988184,4.6380700048865e-19
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KYNU,Kynureninase,42256,-0.0406792076161372,0.0045765817448876,-0.0496493078361169,-0.0317091073961575,6.99395152245877e-19
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,42004,-0.0657264305732171,0.00739814754511062,-0.080226799761634,-0.0512260613848003,7.29087572854419e-19
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEP,Leptin,42144,-0.0603105222849252,0.00682214605755735,-0.0736819285577376,-0.0469391160121128,1.07579917264823e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,41757,-0.0180565722999533,0.00204325031939425,-0.0220613429259661,-0.0140518016739406,1.11117663207358e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL2,C-C motif chemokine 2,41984,-0.0483783237394088,0.0054844321337072,-0.0591278107214749,-0.0376288367573427,1.27987432375077e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCTN3,Tectonic-3,40080,-0.0271644809620755,0.00307870972676473,-0.0331987520265344,-0.0211302098976166,1.28063020290242e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,39863,-0.0347380504648989,0.00395175441645179,-0.0424834891211445,-0.0269926118086534,1.71697849549751e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF23,Fibroblast growth factor 23,42214,-0.0492245426162018,0.0056324650053056,-0.0602641740266008,-0.0381849112058029,2.62703421295153e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",41829,-0.0490411535420759,0.00562295557175866,-0.0600621464627228,-0.0380201606214289,3.08354514711267e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMG3,Proteasome assembly chaperone 3,42103,-0.0459056654106328,0.00526768058145211,-0.056230319350279,-0.0355810114709867,3.27112993955927e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POSTN,Periostin,40097,0.0344296575828631,0.0039541566982361,0.0266795104543203,0.0421798047114058,3.56342874494156e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES3,Carboxylesterase 3,42094,-0.0631863326183896,0.00726026911558634,-0.0774164600849388,-0.0489562051518404,3.62037380275343e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,42186,-0.0331509509427343,0.00381179959582169,-0.0406220781505448,-0.0256798237349237,3.81605249326993e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AREG,Amphiregulin,42094,-0.0382001455669998,0.00439533050133943,-0.0468149933496251,-0.0295852977843745,4.01995620305229e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMPD3,AMP deaminase 3,40054,-0.0628477346827274,0.00726111983058175,-0.0770795295506677,-0.0486159398147872,5.60618869688909e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCAM,Cell surface glycoprotein MUC18,42197,0.0299377323170199,0.00346667690176013,0.0231430455895701,0.0367324190444697,6.50240159495562e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UMOD,Uromodulin,42267,0.04925878026963,0.0057084034187497,0.0380703095688806,0.0604472509703794,6.88784426175737e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTSS1,Protein MTSS 1,40021,-0.0984980291277355,0.0114195166517708,-0.120880281765206,-0.0761157764902648,7.27741998984439e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,40076,0.0437034908170007,0.00506822678783681,0.0337697663128406,0.0536372153211609,7.42425189021105e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR2,Cadherin-related family member 2,42094,-0.0624714464602067,0.00725669982267456,-0.0766945781126488,-0.0482483148077645,8.23252482570793e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PVR,Poliovirus receptor,42213,-0.0326906058019065,0.00379976412972095,-0.0401381434961596,-0.0252430681076534,8.6238547081287e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSME2,Proteasome activator complex subunit 2,41952,-0.0319317807643707,0.00371728955478409,-0.0392176682917475,-0.0246458932369939,9.6939773201113e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,42103,-0.0570222393182064,0.00664283457250865,-0.0700421950803233,-0.0440022835560894,1.02017653652197e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,42121,-0.0860825747456995,0.0100379730906444,-0.105757002003363,-0.0664081474880363,1.09617434182865e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,42004,-0.064010593805418,0.00750222773886781,-0.0787149601735989,-0.049306227437237,1.59607835393697e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,40080,-0.0587648542034186,0.00688726867022589,-0.0722639007970613,-0.0452658076097759,1.62361121966136e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,42144,-0.0380933449046214,0.00448329033011764,-0.046880593951652,-0.0293060958575908,2.16149166987677e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,42296,0.0298105841451066,0.00351400346460835,0.0229231373544742,0.036698030935739,2.4206305370761e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK14,Kallikrein-14,42223,0.0412931618982475,0.00486775882289296,0.0317523546053773,0.0508339691911177,2.42978366990897e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,40113,0.0222139913015111,0.00261989941922477,0.0170789884398306,0.0273489941631917,2.56488564730552e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAO1,Hydroxyacid oxidase 1,42223,-0.109028852812793,0.0128658628104211,-0.134245943921218,-0.0838117617043679,2.61773624528025e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGBL1,Integrin beta-like protein 1,40097,-0.033940391648223,0.00401103376187073,-0.0418020178214897,-0.0260787654749564,2.9704696323627e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SBSN,Suprabasin,40084,0.0304346953757133,0.00359706122893983,0.0233844553669913,0.0374849353844354,2.99039088479789e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,42004,-0.0297519744626255,0.0035180863601406,-0.0366474237285011,-0.0228565251967499,3.04227344668776e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,41957,-0.02534429951616,0.0030056569626159,-0.0312353871628872,-0.0194532118694329,3.75437374655641e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KITLG,Kit ligand,42144,0.0326988073082023,0.0038861492051023,0.0250819548662018,0.0403156597502028,4.36834188193302e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA1,Apolipoprotein A-I,40113,0.0236807085604548,0.00282714772008394,0.0181394990290903,0.0292219180918193,6.13594982640027e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUOM,Fucose mutarotase,39863,-0.0544184742067034,0.00651433707638283,-0.0671865748764137,-0.041650373536993,7.43909110043912e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLK1,Protein delta homolog 1,42296,-0.0472836873806001,0.0056755042076554,-0.0584076756276047,-0.0361596991335955,8.79438678872996e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAST,Gastrin,40054,-0.124209263421182,0.0149752831469701,-0.153560818389244,-0.0948577084531207,1.22141457198313e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRP,Gastrin-releasing peptide,39804,-0.047563933495184,0.00573718608455991,-0.0588088182209214,-0.0363190487694465,1.26434631187839e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRIP2,Cysteine-rich protein 2,42004,-0.0311402935258247,0.00376436737860534,-0.0385184535878911,-0.0237621334637582,1.44206759493014e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAN,Neurocan core protein,42213,0.0324866552951894,0.00392725779052613,0.0247892300257582,0.0401840805646206,1.44337011217258e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTRK3,NT-3 growth factor receptor,42213,0.018568037466383,0.00224655822627398,0.0141647833428859,0.02297129158988,1.53007146231919e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELN,Elastin,40080,-0.0311451451706709,0.00377363040462071,-0.0385414607637275,-0.0237488295776143,1.71768979977397e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,41861,-0.0489453247786076,0.00596780280604281,-0.0606422182784515,-0.0372484312787637,2.60042077039453e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,39863,-0.0315974672976291,0.00388416033419037,-0.0392104215526422,-0.023984513042616,4.57839893921162e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,40054,-0.0626530112698675,0.00770359579694989,-0.0777520590318893,-0.0475539635078457,4.64547365825531e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,42156,-0.0487609333048544,0.00600157632801099,-0.0605240229077559,-0.0369978437019529,4.8893225916434e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF19,Fibroblast growth factor 19,42184,-0.0647869725503893,0.00798094794326644,-0.0804296305191916,-0.0491443145815871,5.17650237107871e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,42094,-0.0287182708548676,0.00353983108077027,-0.0356563397731773,-0.0217802019365578,5.38783172210426e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH2,Cadherin-2,42144,-0.0297949685737532,0.00367338474615854,-0.0369948026762239,-0.0225951344712825,5.4684340180894e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,40020,-0.0317602044373686,0.00391639533777965,-0.0394363392994167,-0.0240840695753205,5.62904284647455e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,39706,-0.0464722686079326,0.00574877295201909,-0.0577398635938901,-0.0352046736219752,6.96416455596283e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MENT,Protein MENT,39863,0.0193132504845087,0.00239482441313488,0.0146193946347643,0.024007106334253,8.13584444378092e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,42103,0.0328452265707933,0.00407730760844205,0.0248537036582469,0.0408367494833398,8.59891302293506e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,42186,-0.0255597479330622,0.00317459528813435,-0.0317819546978055,-0.0193375411683189,8.8984803385063e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,42213,0.039122430477177,0.00486230429851455,0.0295923140520885,0.0486525469022655,9.286578921625e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTG,Protogenin,42223,-0.0206483591360017,0.00256825259182979,-0.0256821342159881,-0.0156145840560153,9.7672757773172e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAT,Tissue-type plasminogen activator,42262,-0.0415395005009637,0.0051832070513442,-0.0516985863215983,-0.031380414680329,1.20174989114099e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,40021,-0.0487644153827384,0.00609441767064352,-0.0607094740171997,-0.036819356748277,1.3547245245873e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFC1,Cryptic protein,41861,-0.0391994971431653,0.00490954365547809,-0.0488222027079024,-0.0295767915784283,1.53407555902005e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL11,Eotaxin,42256,-0.0301560318058771,0.00378314361205522,-0.0375709932855053,-0.0227410703262488,1.70191027824399e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",41876,-0.0757555768978875,0.00951298374685988,-0.0944010250417329,-0.0571101287540422,1.81603956502664e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,40080,-0.06049440924283,0.00759819560228252,-0.0753868726233037,-0.0456019458623562,1.86594613837152e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEPR,Leptin receptor,42144,0.0254485032560154,0.00320684480729534,0.0191630874337166,0.0317339190783143,2.26486108528272e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAPIN,SNARE-associated protein Snapin,40054,-0.0465951083038973,0.00588993730998899,-0.0581393854314757,-0.0350508311763189,2.80193164681783e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,42094,-0.0849507569522065,0.0107495852245331,-0.106019943992291,-0.0638815699121217,2.9498826180626e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,42094,0.0335545797875078,0.00425227507615082,0.0252201206382522,0.0418890389367634,3.23938042390607e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,42211,-0.0381829581275609,0.00483955144825104,-0.0476684789661329,-0.0286974372889888,3.26824021298802e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL6,C-X-C motif chemokine 6,42256,-0.0620639516488847,0.00786689817567539,-0.0774830720732085,-0.046644831224561,3.28092996516675e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,42223,-0.0265341005483599,0.00336340306506651,-0.0331263705558903,-0.0199418305408296,3.28652815367886e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,40020,-0.0458761171385444,0.00582450840066266,-0.0572921536038433,-0.0344600806732456,3.69207810195394e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH17,Cadherin-17,42144,-0.0563974792994764,0.0071864844226888,-0.0704829887679465,-0.0423119698310064,4.56843312718093e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN1,Dynactin subunit 1,42223,-0.0522326228530207,0.00666025211050359,-0.0652867169896077,-0.0391785287164336,4.76146368983867e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA4,Carbonic anhydrase 4,42296,0.0194822066037851,0.0024923983190771,0.014597105898394,0.0243673073091762,5.83744473812616e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTBS,Di-N-acetylchitobiase,39958,-0.0214392525550236,0.00274803177232379,-0.0268253948287782,-0.016053110281269,6.67447518385563e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CENPF,Centromere protein F,39881,-0.0436008185356061,0.00560208029200173,-0.0545808959079295,-0.0326207411632827,7.73830523718038e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACHE,Acetylcholinesterase,39863,-0.0267669773274271,0.00344226798204426,-0.0335138225722338,-0.0200201320826203,8.17704251468165e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BECN1,Beclin-1,39804,-0.0477059770251213,0.00613891665588015,-0.0597382536706464,-0.0356737003795962,8.50180562496733e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,41887,-0.0553893551620277,0.00713528625910265,-0.0693745162298688,-0.0414041940941865,8.9467638677582e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C19orf12,Protein C19orf12,41829,-0.0509469863434729,0.00657636413966968,-0.0638366600572255,-0.0380573126297203,1.01267293584723e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,42162,0.0357680821856028,0.00461947995308019,0.0267139014775657,0.04482226289364,1.04378875431435e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFB1,BPI fold-containing family B member 1,42083,0.0497974254018729,0.00644636464383411,0.037162550699958,0.0624323001037877,1.20210151608251e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELOA,Elongin-A,42094,-0.0426067447174735,0.00551890814845574,-0.0534238046884467,-0.0317896847465002,1.24741852071551e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS2,Trypsin-2,42197,-0.044456033777926,0.00577328168327538,-0.0557716658771457,-0.0331404016787062,1.45532542969259e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMPER,BMP-binding endothelial regulator protein,39863,-0.0183427047005648,0.00239075835343861,-0.0230285910733045,-0.0136568183278251,1.83621260977654e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",40054,-0.0486850209084207,0.0063689304452653,-0.0611681245811407,-0.0362019172357007,2.28082648828859e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,42103,-0.0407810428877795,0.00534107876971105,-0.0512495572764131,-0.0303125284991458,2.4100772581647e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL15,C-C motif chemokine 15,42296,-0.0352906009874825,0.00462555353387322,-0.044356685913874,-0.026224516061091,2.51936350088562e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL32,Interleukin-32,42103,0.0348162126556034,0.00457652863011173,0.0258462165405844,0.0437862087706224,2.98644543578735e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGR1,Prostaglandin reductase 1,40080,-0.0655640948516415,0.00861908126955394,-0.0824574941399673,-0.0486706955633158,3.04011577396589e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,42144,-0.0495881401225367,0.00652114696320532,-0.0623695881704191,-0.0368066920746543,3.06391664330364e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,41829,-0.022484996061489,0.00296084974748409,-0.0282882615665578,-0.0166817305564202,3.31697705017427e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,42197,0.0347579697105038,0.00457977288823364,0.0257816148495659,0.0437343245714417,3.43107053791652e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,41718,-0.067054762693921,0.00883663471525106,-0.0843745667358131,-0.0497349586520289,3.47110126565408e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,42177,0.0239072271228822,0.00315723320697565,0.01771905003721,0.0300954042085545,3.91696346004825e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATG4A,Cysteine protease ATG4A,41861,-0.0458557688853963,0.00606754605478433,-0.0577481591527736,-0.033963378618019,4.38949264323225e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA1,Carboxypeptidase A1,42296,-0.0486852593900578,0.00644504623224388,-0.0613175500052558,-0.0360529687748598,4.50366749887352e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",42120,0.0184790092191075,0.00245066447550074,0.0136757068471261,0.023282311591089,4.99728897291145e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA2,Carbonic anhydrase 2,42082,-0.0538375880984377,0.00715170455342783,-0.0678549290231563,-0.0398202471737192,5.49707664419419e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP85,Centrosomal protein of 85 kDa,41861,-0.0496419185761085,0.00659512098603603,-0.0625683557087391,-0.0367154814434778,5.53987468979993e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,42181,0.025244595406819,0.00335752005723893,0.0186638560946307,0.0318253347190073,5.88955508693422e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,42184,0.01604651457197,0.00214342412476282,0.0118454032874349,0.0202476258565051,7.53517915442604e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMBS,Porphobilinogen deaminase,42223,-0.0333050811133114,0.00445604796880544,-0.0420389351321701,-0.0245712270944528,8.26732740793402e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL4,Myosin light chain 4,39804,-0.0399313582704341,0.00534650162097152,-0.0504105014475383,-0.02945221509333,8.73639046476638e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLUL1,Clusterin-like protein 1,42129,0.0344867940402015,0.00463027189722994,0.0254114611216309,0.0435621269587722,1.00682787456661e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IKBKG,NF-kappa-B essential modulator,42103,-0.069605430543404,0.0093579890836311,-0.087947089147321,-0.0512637719394871,1.08613468287067e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAT,Catalase,39940,-0.0414036862885398,0.00556686486486278,-0.0523147414236708,-0.0304926311534088,1.10414109452292e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BACH1,Transcription regulator protein BACH1,42103,-0.0557857486151182,0.00751825080980742,-0.0705215202023407,-0.0410499770278957,1.24402507167985e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGLN1,Egl nine homolog 1,42103,-0.0424212701248419,0.00572293315767817,-0.0536382191138911,-0.0312043211357927,1.3165332656406e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGF,Hepatocyte growth factor,42256,-0.0265372767984993,0.00358317572071867,-0.0335603012111079,-0.0195142523858907,1.38065078748755e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSN,Gelsolin,40058,0.0148063680946252,0.00200981070048148,0.0108671391216815,0.0187455970675689,1.87104871114651e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASAH2,Neutral ceramidase,42004,-0.0403918467554452,0.0055014698869733,-0.0511747277339129,-0.0296089657769776,2.23115493701056e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA3F,Semaphorin-3F,42144,-0.0206023760609597,0.00280627836476354,-0.0261026816558962,-0.0151020704660231,2.23772850760776e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH9,Myosin-9,40097,-0.0857925135925095,0.0117416596802224,-0.108806166565745,-0.0627788606192736,2.92970298533985e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,40054,-0.0530887726458626,0.00727588971984248,-0.0673495164967539,-0.0388280287949713,3.15883749393699e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPB1,Carboxypeptidase B,42296,-0.0455992331864791,0.00626394372946289,-0.0578765628962264,-0.0333219034767319,3.53802734253884e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM2,Paralemmin-2,40054,-0.0280863318801823,0.00386104993378497,-0.0356539897504009,-0.0205186740099638,3.72298409553798e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACAN,Aggrecan core protein,42003,0.0208843626803733,0.00287294476154685,0.0152533909477415,0.0265153344130051,3.82254045388408e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,42099,-0.0624455521185686,0.00859554100088929,-0.0792928124803116,-0.0455982917568256,3.94819071764867e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEG1,Protein HEG homolog 1,39863,-0.0201311296675873,0.00277293154469855,-0.0255660754951964,-0.0146961838399781,4.14437781498857e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL27,C-C motif chemokine 27,42144,-0.0439756824654472,0.00607173291829476,-0.055876278985305,-0.0320750859455895,4.64732460488623e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PQBP1,Polyglutamine-binding protein 1,41861,-0.0424478477719088,0.00586802059838348,-0.0539491681447404,-0.0309465273990772,4.9683279305392e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G15,Phospholipase A2 group XV,42186,-0.019879543814174,0.00274840489974117,-0.0252664174176667,-0.0144926702106813,4.98470316178932e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,42103,-0.0430672314998109,0.00596193907394369,-0.0547526320847406,-0.0313818309148813,5.34323174225938e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,41829,-0.038730357194362,0.00536568663997531,-0.0492471030087136,-0.0282136113800104,5.57109334485693e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,42197,-0.0318240356471017,0.00441456350566318,-0.0404765801182015,-0.0231714911760019,5.95322438396208e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,42094,-0.0407087207089724,0.0056589096018914,-0.0518001835286796,-0.0296172578892653,6.65214214621092e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,40080,-0.0218112370698156,0.00303299477619588,-0.0277559068311595,-0.0158665673084717,6.83796864443531e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGR,Tyrosine-protein kinase Fgr,41829,-0.0423259996954322,0.00588792320704626,-0.0538663291812428,-0.0307856702096215,6.91341785683483e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F9,Coagulation factor IX,42172,-0.013404379369394,0.00186797857160755,-0.0170656173697448,-0.00974314136904317,7.57500437774079e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL16,Pro-interleukin-16,42256,-0.030525295257062,0.00425953769255903,-0.0388739891344777,-0.0221766013796463,8.11646670599749e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARSA,Arylsulfatase A,42120,-0.0328935925980111,0.00459063989576742,-0.0418912467937152,-0.0238959384023069,8.17893157092825e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,42256,-0.0296348122733436,0.00413638828320947,-0.0377421333084342,-0.0215274912382531,8.23072869349867e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F11R,Junctional adhesion molecule A,42120,-0.0409896496604528,0.00572483812545995,-0.0522103323863543,-0.0297689669345513,8.50599597228246e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,39863,-0.0158507983065387,0.00222268533328731,-0.0202072615597819,-0.0114943350532956,1.05810188217685e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C4BPB,C4b-binding protein beta chain,42186,0.0295178485132612,0.00414678309218851,0.0213901536525717,0.0376455433739507,1.15046802843005e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA9,Serpin A9,42045,-0.0526917171968111,0.00740372933297145,-0.0672030266894352,-0.0381804077041871,1.1622830412848e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLVRB,Flavin reductase,42120,-0.0482085084983196,0.00677626764463441,-0.061489993081803,-0.0349270239148361,1.18395963104002e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFX1,Transcriptional repressor NF-X1,39706,-0.0498165663458569,0.00700992356743413,-0.0635560165380278,-0.036077116153686,1.26670959207143e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOMO1,Nodal modulator 1,42120,-0.0169279301842233,0.00238545451756801,-0.0216034210386566,-0.01225243932979,1.3481324855314e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,42076,-0.0186495346434461,0.00263204550400936,-0.0238083438313044,-0.0134907254555877,1.45680571425879e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",42103,-0.0703655566983177,0.00993844347756185,-0.0898449059143389,-0.0508862074822964,1.51463689610441e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,39784,-0.0388480981939905,0.0054920187628688,-0.0496124549692133,-0.0280837414187676,1.6055280444904e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,40076,0.0110136471066411,0.0015641906904786,0.00794783335330301,0.0140794608599791,2.02206150761043e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,42197,-0.030596924566756,0.00435310390693129,-0.0391290082243414,-0.0220648409091707,2.18772578514575e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESM1,Endothelial cell-specific molecule 1,42126,0.0248859912021268,0.00354166579045596,0.0179443262528331,0.0318276561514205,2.22176673483952e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,41861,-0.0523250134592375,0.00744853918862902,-0.0669241502689503,-0.0377258766495246,2.25222549737262e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGXT,Serine--pyruvate aminotransferase,42144,-0.0546196130171931,0.00778859269474999,-0.0698852546989031,-0.0393539713354831,2.45243655561607e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGF,Placenta growth factor,42256,-0.0192932898522478,0.00275409619985662,-0.0246913184039668,-0.0138952613005288,2.58520205898408e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD209,CD209 antigen,42176,0.0280154353235278,0.00400117597521969,0.0201731304120972,0.0358577402349584,2.65128849656117e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OCLN,Occludin,40054,-0.0323844428153991,0.00462594741499353,-0.0414512997487864,-0.0233175858820118,2.6989967634031e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,42144,-0.0221857423663779,0.00317002661008363,-0.0283989945221418,-0.015972490210614,2.71267266260113e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNB2,Plexin-B2,42246,-0.0174497506078803,0.00249444633803909,-0.0223388654304369,-0.0125606357853237,2.77320852843296e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPP1,Tripeptidyl-peptidase 1,42053,-0.0323442870983859,0.00463689301203987,-0.0414325974019841,-0.0232559767947878,3.19878674144766e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F7,Coagulation factor VII,42179,-0.0222960485058395,0.00319852318467862,-0.0285651539478096,-0.0160269430638695,3.30533156763055e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAN,Brevican core protein,42004,0.0249086714502253,0.00357648006807036,0.0178987705168074,0.0319185723836432,3.45475281237539e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDT,D-dopachrome decarboxylase,40097,-0.0295960967469347,0.00425944945919659,-0.03794461768696,-0.0212475758069094,3.90698341439121e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,39706,-0.048389256238637,0.00697260860888722,-0.0620555691120559,-0.0347229433652181,4.15481098567326e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",42094,-0.0692280693260624,0.00998561817686686,-0.0887998809527214,-0.0496562576994033,4.3229908002509e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS3BP,Galectin-3-binding protein,40113,-0.0218147617855038,0.00315130180277988,-0.0279913133189523,-0.0156382102520552,4.68772159013879e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD6,T-cell differentiation antigen CD6,42248,-0.0375612082778149,0.00543399234548143,-0.0482118332749586,-0.0269105832806713,4.99132870190745e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP2,Retinol-binding protein 2,42094,0.0551736023428663,0.00798583272535318,0.0395213702011741,0.0708258344845586,5.11228545862359e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFRP4,Secreted frizzled-related protein 4,39863,-0.0286519291024472,0.00414971221390648,-0.0367853650417039,-0.0205184931631905,5.32236061744976e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN3,Ataxin-3,40054,-0.0438556863132747,0.00637748803132459,-0.0563555628546709,-0.0313558097718785,6.46475010271747e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN8,Tetraspanin-8,40021,-0.0721796671317475,0.0105133590355295,-0.0927858508413853,-0.0515734834221096,6.98771625379789e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,39706,-0.0254789524644246,0.00372246843263602,-0.0327749905923912,-0.018182914336458,8.09429134525109e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAM2,Neural cell adhesion molecule 2,42120,0.0191857256991611,0.00280556193870857,0.0136868242992923,0.0246846270990299,8.36479540052382e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,41861,-0.0359655508493621,0.00526088382759905,-0.0462768831514562,-0.025654218547268,8.49262622320649e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,42103,-0.0744554843092264,0.0108981580839056,-0.0958158741536813,-0.0530950944647714,8.75359028160684e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,41861,-0.0476793420901606,0.0069944252624406,-0.0613884156045442,-0.0339702685757771,9.73347340713758e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,40080,-0.0421128238375429,0.00619335055092932,-0.0542517909173643,-0.0299738567577214,1.10341263215036e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSB,Cathepsin B,42164,0.0376744800671212,0.00554365764328926,0.0268089110862743,0.0485400490479682,1.12295601103657e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VNN1,Pantetheinase,40102,-0.0509224527902254,0.00749488401073172,-0.0656124254512595,-0.0362324801291912,1.14514928510749e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,41861,-0.046124443658682,0.00679628353139726,-0.0594451593802206,-0.0328037279371434,1.19823252873412e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLIN1,Perilipin-1,41829,-0.0244229604404227,0.00360253821880455,-0.0314839353492796,-0.0173619855315658,1.26061402268112e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,39804,-0.0583604301801635,0.00861667302105303,-0.0752491093014274,-0.0414717510588995,1.32847285225538e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPL,N-acetylneuraminate lyase,40080,-0.0317855720503289,0.00469638965148149,-0.0409904957672327,-0.0225806483334252,1.37205538467444e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSNAX,Translin-associated protein X,39706,-0.0274904344729211,0.00407480072630566,-0.0354770438964802,-0.0195038250493621,1.59477091700883e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASN,Vasorin,41967,0.0191896140030407,0.00284664976442223,0.0136101804647732,0.0247690475413083,1.63922923364085e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C9orf40,Uncharacterized protein C9orf40,40021,-0.0562827181577702,0.00836704318801747,-0.0726821228062845,-0.039883313509256,1.82289132891504e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,42144,-0.0191899167108284,0.00285425179288696,-0.0247842502248868,-0.0135955831967699,1.85137302666361e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KEL,Kell blood group glycoprotein,41829,-0.0250805704647644,0.00374367131196626,-0.0324181662362182,-0.0177429746933105,2.18062031752482e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRDL2,Chordin-like protein 2,42144,-0.0326402105279537,0.00487333199851022,-0.0421919412450338,-0.0230884798108737,2.20440732786505e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,42004,-0.0368320889418275,0.00550289217747214,-0.0476177576096729,-0.0260464202739821,2.27399342914773e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA4,Kallistatin,39921,-0.0165937365769281,0.0024845512549035,-0.0214634570365389,-0.0117240161173172,2.52886081050267e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADD1,Alpha-adducin,39863,-0.0489147879370224,0.00732452942474085,-0.0632708656095144,-0.0345587102645303,2.53899725031005e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",42144,0.0544176681337649,0.00819228207378862,0.0383607952691392,0.0704745409983906,3.20615694502572e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,41876,-0.0395840015706397,0.00596003576893395,-0.0512656716777503,-0.0279023314635292,3.23018559232887e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH1,Cadherin-1,41716,-0.0274000837969552,0.00412800299078661,-0.0354909696588969,-0.0193091979350134,3.31949071310818e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",42146,0.0234108992876953,0.00352965999030506,0.0164927657066974,0.0303290328686932,3.42874314166513e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCHE,Cholinesterase,39922,-0.0189645451053254,0.00286337062664131,-0.0245767515335424,-0.0133523386771085,3.68438633303221e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHMP6,Charged multivesicular body protein 6,40080,-0.0380828247120248,0.00575007787190095,-0.0493529773409506,-0.0268126720830989,3.68546781862535e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3GLB2,Endophilin-B2,40054,-0.0451495838539978,0.00683460246562279,-0.0585454046866184,-0.0317537630213771,4.13227880274911e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA1,Carbonic anhydrase 1,41879,-0.0409128529791542,0.00620488938603063,-0.0530744361757742,-0.0287512697825341,4.46155859637586e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCF2,Neutrophil cytosol factor 2,42087,-0.0563559459377622,0.00856111753853092,-0.0731357363132828,-0.0395761555622416,4.79613631679947e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAXX,Protein PAXX,39863,-0.0307965874885692,0.00468246272053754,-0.0399742144208228,-0.0216189605563156,5.02475249751756e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASS1,Argininosuccinate synthase,39706,-0.0525255033910631,0.00799094050755769,-0.0681877467858762,-0.03686325999625,5.16029053779302e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKLR,Pyruvate kinase PKLR,42145,-0.0441243296062305,0.00674263029711731,-0.0573398849885804,-0.0309087742238805,6.211551860268e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXLNA,Alpha-taxilin,42004,-0.0590564818886532,0.00902614862269704,-0.0767477331891394,-0.041365230588167,6.26653257964756e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEMIP2,Cell surface hyaluronidase,39784,-0.0231987484487243,0.00355118625878944,-0.0301590735159516,-0.016238423381497,6.75697379177588e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",41861,-0.0547462000236497,0.00840150265268511,-0.0712131452229125,-0.0382792548243869,7.48214684919533e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,41876,-0.0255856499281136,0.00393188813524028,-0.0332921506731845,-0.0178791491830426,7.94347365025765e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PODXL2,Podocalyxin-like protein 2,42186,0.019038918606102,0.00292957593018404,0.0132969497829413,0.0247808874292627,8.38827733926307e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,41861,-0.0332035833210379,0.00511150961009007,-0.0432221421568144,-0.0231850244852613,8.56549462847355e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMPR,GMP reductase 1,42256,-0.0329579980859169,0.00507686237775198,-0.0429086483463108,-0.023007347825523,8.78805590101509e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SULT2A1,Bile salt sulfotransferase,42103,-0.0376776736600907,0.00580755418719845,-0.0490604798669997,-0.0262948674531818,9.03370548318907e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX2,Peroxiredoxin-2,39911,-0.0416303792467803,0.00643137332959229,-0.0542358709727811,-0.0290248875207794,1.00264849344644e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",39784,-0.0241985602414219,0.00374905557672559,-0.031546709171804,-0.0168504113110397,1.13269897789098e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR4,Complement factor H-related protein 4,40083,0.0495972700731741,0.00768559405119669,0.0345335057328286,0.0646610344135196,1.14106838946051e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAT2,Linker for activation of T-cells family member 2,42094,-0.0818945962152814,0.0127006253116417,-0.106787821826099,-0.0570013706044636,1.17316675601853e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCA,Calcitonin,41985,-0.0419451094683818,0.00650773740462201,-0.0547002747814409,-0.0291899441553227,1.19417460824793e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA5,Plasma serine protease inhibitor,39965,-0.0209099053193195,0.00324369744839269,-0.0272675523181691,-0.0145522583204698,1.19501839172045e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",39719,-0.0543881691187718,0.00844937448546771,-0.0709489431102885,-0.0378273951272551,1.27208450607863e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,39863,-0.035600399681599,0.00554282594339119,-0.0464643385306457,-0.0247364608325522,1.39495301635556e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3D,Protein FAM3D,40021,-0.0566761363677449,0.00882851719165435,-0.0739800300633874,-0.0393722426721023,1.42288869562912e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORT1,Sortilin,42122,-0.0244700662736922,0.00381393433676918,-0.0319453775737598,-0.0169947549736246,1.44813328448602e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSC,Dipeptidyl peptidase 1,42125,-0.0292208133197115,0.00455575847326295,-0.0381500999273069,-0.0202915267121161,1.46647785525063e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIT,Citron Rho-interacting kinase,39768,-0.0299430950376216,0.00466999014783299,-0.0390962757273743,-0.020789914347869,1.49935700332174e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNC,Tenascin,42197,0.0319399291423514,0.00499741342924302,0.022144998821035,0.0417348594636677,1.70104823495902e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LBR,Delta(14)-sterol reductase LBR,42213,-0.0437216892354815,0.00685214921483671,-0.0571519016965614,-0.0302914767744015,1.82219628512414e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM3,Intercellular adhesion molecule 3,42296,0.0177714066996026,0.00278796854140083,0.012306988358457,0.0232358250407483,1.89935121768318e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,39872,-0.028869119013728,0.00453359980014723,-0.0377549746220166,-0.0199832634054395,1.99621403295957e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPL14,60S ribosomal protein L14,39804,-0.0262195367682963,0.00412608885350285,-0.0343066709211619,-0.0181324026154308,2.17579037121901e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,40054,-0.0536944866272439,0.00845006641884187,-0.070256616808174,-0.0371323564463139,2.17726196359651e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,39804,0.0395105180456358,0.00622284948482477,0.0273137330553793,0.0517073030358924,2.25192265057272e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,39863,0.028339413070917,0.00446510733690733,0.0195878026905786,0.0370910234512553,2.28674245958195e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,41984,-0.0580676005717097,0.00915318260003843,-0.0760078384677851,-0.0401273626756344,2.31451539511369e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",41887,-0.0389533108230354,0.0061420250542759,-0.0509916799294161,-0.0269149417166546,2.34349998224541e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,42004,-0.0283914364063113,0.00448881244286735,-0.0371895087943313,-0.0195933640182913,2.61767173898506e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,39881,-0.0293856441385699,0.00464631166965771,-0.0384924150110991,-0.0202788732660408,2.64189081581616e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,39804,-0.0153624209661032,0.0024343560254898,-0.0201337587760632,-0.0105910831561432,2.8891461092401e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FYB1,FYN-binding protein 1,42099,-0.0596392020715418,0.00945820054901791,-0.0781772751476169,-0.0411011289954666,2.965261352899e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR5,Complement factor H-related protein 5,39959,0.0275376822642397,0.00436996880763248,0.0189725434012801,0.0361028211271994,3.06157357649171e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YES1,Tyrosine-protein kinase Yes,42094,-0.0735176001116477,0.0116731985448244,-0.0963970692595036,-0.0506381309637919,3.1133336369461e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,42122,-0.0528903907938401,0.00840188086066129,-0.0693580772807363,-0.036422704306944,3.17204482331487e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,40054,-0.0200666273151753,0.00319401718441357,-0.0263269009966259,-0.0138063536337247,3.45778029082e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,39772,-0.0174375302774238,0.00277576356639099,-0.0228780268675502,-0.0119970336872975,3.47237055154962e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLRX,Glutaredoxin-1,42057,-0.0362618459104346,0.00578004121406547,-0.0475907266900029,-0.0249329651308662,3.64032436318303e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,42208,-0.0429770005432965,0.00685085590292804,-0.0564046781130355,-0.0295493229735576,3.6483355190882e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",42094,-0.0284857315061866,0.00454253819098667,-0.0373891063605205,-0.0195823566518528,3.70459846137131e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NME3,Nucleoside diphosphate kinase 3,42146,0.0155862507248487,0.00248556955416443,0.0107145343986864,0.020457967051011,3.70860494201931e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REN,Renin,42144,-0.0554974201349203,0.00887888958084789,-0.0729000437133822,-0.0380947965564584,4.22003546357428e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPEP2,Dipeptidase 2,42094,0.019107261239052,0.00305771956762438,0.0131141308865082,0.0251003915915958,4.26471276048021e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,41829,-0.0329084449519557,0.00527171521639884,-0.0432410067760974,-0.0225758831278139,4.44543939149469e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUS,RNA-binding protein FUS,41852,-0.0256397972385208,0.00410756102900265,-0.033690616855366,-0.0175889776216756,4.45532270171934e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMN,Protein amnionless,41887,-0.0302249525637187,0.00484712807873949,-0.0397253235980481,-0.0207245815293893,4.64204061206929e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,40021,-0.019524188072519,0.00313079156597712,-0.0256605395418341,-0.0133878366032038,4.65098141702673e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,42256,0.0180750131329202,0.00290303418894743,0.0123850661225833,0.0237649601432572,4.92369211013871e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSF,Cathepsin F,42186,-0.0254611261651072,0.00408987124840228,-0.0334772738119756,-0.0174449785182387,4.95082638225284e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMD,Osteomodulin,42184,0.0271321863550459,0.00435905093356207,0.0185884465252643,0.0356759261848276,4.9848663994036e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPT2,Angiopoietin-2,42223,-0.0242658539402327,0.00390020178478872,-0.0319102494384186,-0.0166214584420468,5.06882506292677e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTYMK,Thymidylate kinase,40080,-0.0432692999673672,0.00696670799161526,-0.0569240476309331,-0.0296145523038013,5.4615773722435e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFC,Platelet-derived growth factor C,41861,-0.018136904653973,0.00292412829041712,-0.0238681961031905,-0.0124056132047554,5.73030674828771e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPY30,Protein dpy-30 homolog,42156,-0.0385944505820183,0.00623285137888946,-0.0508108392846416,-0.0263780618793949,6.11604549780941e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,39804,-0.0235733940536105,0.00381210283133497,-0.031045115603027,-0.016101672504194,6.48681590998163e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CILP,Cartilage intermediate layer protein 1,40097,-0.034892437152967,0.00565970518240478,-0.0459854593104804,-0.0237994149954537,7.29479260648285e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,42004,-0.0150833680811138,0.0024473686141516,-0.019880210564851,-0.0102865255973767,7.34767586027936e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDC4,Syndecan-4,42144,0.0298099416044922,0.0048572994327338,0.020289634716334,0.0393302484926504,8.6471004472271e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WDR46,WD repeat-containing protein 46,40020,-0.0227368839058902,0.00370652975379725,-0.0300016822233329,-0.0154720855884476,8.85353951619696e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELL,L-selectin,40113,0.014986154552928,0.00244854785158022,0.0101870007638308,0.0197853083420252,9.65291813548527e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLO1,Lactoylglutathione lyase,41876,-0.0365568329234395,0.00597461677597893,-0.0482670818043582,-0.0248465840425208,9.71266527494368e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,41829,-0.0419774353768732,0.00686312849454145,-0.0554291672261744,-0.028525703527572,9.85572683665703e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NSFL1C,NSFL1 cofactor p47,42213,-0.0405991775697686,0.00668047865268064,-0.0536929157290227,-0.0275054394105146,1.25647604852473e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MERTK,Tyrosine-protein kinase Mer,42256,0.0159830022410799,0.00263113668913953,0.0108259743303664,0.0211400301517934,1.27781321844244e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OLFM4,Olfactomedin-4,39466,-0.0774007531383643,0.0127412933827254,-0.102373688168506,-0.0524278181082225,1.28547007273073e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,40102,-0.0408818490835768,0.00673589993819308,-0.0540842129624352,-0.0276794852047183,1.32781452766924e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL12,Stromal cell-derived factor 1,41887,0.0251802740041403,0.00415119795641572,0.0170439260095655,0.0333166219987152,1.35045298632458e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,40054,-0.0202514391553439,0.0033392142888017,-0.0267962991613952,-0.0137065791492925,1.36573585506475e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPACT,Protein IMPACT,40054,-0.0348340494125816,0.00574705771861913,-0.0460982825410751,-0.0235698162840881,1.39599173202929e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIGR,Polymeric immunoglobulin receptor,41977,-0.0224042441401792,0.00369764904406711,-0.0296516362665507,-0.0151568520138076,1.40776579725648e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,39784,-0.0312923548226886,0.00516443564489493,-0.0414146486866827,-0.0211700609586946,1.41453637239842e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3C,Protein FAM3C,42122,-0.0195386884707781,0.00322582997888633,-0.0258613152293953,-0.0132160617121609,1.4257800745253e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCS,Copper chaperone for superoxide dismutase,42004,-0.0296844732368228,0.00490619223463214,-0.0393006100167018,-0.0200683364569438,1.48508350615888e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDF15,Growth/differentiation factor 15,42296,-0.0290145956778105,0.00480182482538762,-0.0384261723355703,-0.0196030190200508,1.55947239744793e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLB,Beta-klotho,41829,0.0464001190291626,0.00769316736784493,0.0313215109881865,0.0614787270701386,1.67146960517696e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCOF1,Treacle protein,40080,-0.0199784257916816,0.00332395823409213,-0.0264933839305022,-0.013463467652861,1.90958551769386e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA1,GDNF family receptor alpha-1,42193,-0.0184224926059394,0.00306844075198332,-0.0244366364798268,-0.0124083487320521,1.97816408346865e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LBP,Lipopolysaccharide-binding protein,42197,0.0363902962789529,0.00606448115289798,0.0245039132192729,0.048276679338633,2.01865083927532e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,39784,0.0202994760701901,0.00338822347308323,0.0136585580629469,0.0269403940774332,2.15094724748448e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,42103,-0.0638877156132434,0.0106703345188393,-0.0848015712701685,-0.0429738599563183,2.18865679089787e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPME1,Protein phosphatase methylesterase 1,42094,-0.036642987072344,0.0061421655685102,-0.048681631586624,-0.024604342558064,2.49803206612187e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,39650,-0.032545562370444,0.00547355651861456,-0.0432737331469286,-0.0218173915939595,2.83628305808867e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A4,Protein S100-A4,42186,-0.0347724264456506,0.00585813550722673,-0.046254372039815,-0.0232904808514862,2.99965246384429e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLNS1A,Methylosome subunit pICln,39768,-0.0204012428004385,0.00343893904897416,-0.0271415633364278,-0.0136609222644491,3.07851067062812e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,42162,-0.062863210366768,0.0105983477454215,-0.0836359719477943,-0.0420904487857418,3.07984520585036e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGN,Secretagogin,41887,-0.0276438137579101,0.00467053287574941,-0.0367980581943789,-0.0184895693214412,3.32730356233538e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,42004,-0.0359336769073381,0.00607525306923241,-0.0478411729230336,-0.0240261808916426,3.40833945260635e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,42094,-0.0332336463732893,0.00562599085403565,-0.0442605884471992,-0.0222067042993794,3.56820469439447e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLF4,Krueppel-like factor 4,39719,-0.0243739106810681,0.00413667691277555,-0.0324817974301082,-0.0162660239320281,3.92894286228541e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF2,TNF receptor-associated factor 2,42103,-0.0420479866441501,0.00714197926772967,-0.0560462660089002,-0.0280497072793999,4.01968069856572e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA11,Integrin alpha-11,42103,0.020644345164129,0.0035152699076686,0.0137544161450986,0.0275342741831595,4.3914088266624e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFR,Epidermal growth factor receptor,42296,0.00987761978835912,0.00168500319589925,0.00657501352439659,0.0131802260523217,4.68114635247016e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMB1,Laminin subunit beta-1,39804,-0.0182219448854758,0.00311914332477131,-0.0243354658020276,-0.012108423968924,5.31032663699519e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",40080,-0.0441887394375421,0.00756726852124129,-0.059020585739175,-0.0293568931359092,5.38687114165677e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,40021,-0.0310976589070301,0.00532808528113902,-0.0415407060580625,-0.0206546117559976,5.48206178150238e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASSF2,Ras association domain-containing protein 2,41861,-0.0342592591275126,0.00587125352278257,-0.0457669160321665,-0.0227516022228588,5.50784143341018e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,42296,0.0198285026052255,0.00340059911646233,0.0131633283369593,0.0264936768734916,5.64338030570842e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA12,Serpin A12,41774,-0.0620809055100523,0.0106674063121211,-0.0829890218818096,-0.041172789138295,6.03971109787231e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,40020,-0.0415466376493617,0.00713894336444837,-0.0555389666436805,-0.0275543086550429,6.0619473827781e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL17,C-X-C motif chemokine 17,42256,-0.0243324791393107,0.00418717179420276,-0.0325393358559481,-0.0161256224226732,6.3475104880646e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TJAP1,Tight junction-associated protein 1,42186,-0.0491612363532863,0.00849103776112525,-0.0658036703650918,-0.0325188023414808,7.2108489292323e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,40020,-0.0401095442208249,0.00693565580439347,-0.0537034295974361,-0.0265156588442137,7.53691203987792e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,42094,-0.0317249366987675,0.0054873925964819,-0.0424802261878721,-0.020969647209663,7.57867068529072e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRB1,Chymotrypsinogen B,42120,-0.0345590210181913,0.00597772022266679,-0.0462753526546182,-0.0228426893817644,7.5836391968699e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,42248,-0.0226889141704039,0.00392661334129417,-0.0303850763193404,-0.0149927520214673,7.7209534187681e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PADI4,Protein-arginine deiminase type-4,41813,-0.0429106238053589,0.00742901862759018,-0.0574715003154357,-0.0283497472952822,7.82637378737501e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM5,Tripartite motif-containing protein 5,42103,-0.0508346785951044,0.00880961999963894,-0.0681015337943967,-0.033567823395812,8.09190935442289e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD207,C-type lectin domain family 4 member K,41880,-0.0236787023132332,0.00411335880573714,-0.031740885572478,-0.0156165190539884,8.78449771344545e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,41887,-0.0355498569308996,0.00618378100902905,-0.0476700677085965,-0.0234296461532026,9.19010383364105e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPR,Nucleoprotein TPR,39706,-0.0288646726828183,0.00503283409505195,-0.0387290275091202,-0.0190003178565165,1.0004250944661e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,42103,-0.0362087147162997,0.00631707314786617,-0.0485901780861174,-0.023827251346482,1.01544589085314e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR2,Folate receptor beta,42213,0.0175513152741627,0.00306413803146493,0.0115456047324915,0.023557025815834,1.03882979460676e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,39804,-0.0317205649301004,0.00554212796295955,-0.0425831357375012,-0.0208579941226997,1.07159091594814e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,42094,-0.0394150258267136,0.00689822362108574,-0.0529355441240416,-0.0258945075293855,1.129278858718e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GET3,ATPase GET3,40080,-0.0316571771433635,0.00554040579981083,-0.0425163725109927,-0.0207979817757343,1.13331802363453e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",42071,-0.0398053043860751,0.00701574778529649,-0.0535561700452562,-0.026054438726894,1.42750149505856e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC27,Cell division cycle protein 27 homolog,41861,-0.0353139274325875,0.00623175885111674,-0.0475281747807763,-0.0230996800843987,1.48689307260684e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAX1BP1,Tax1-binding protein 1,40054,-0.0366334119890232,0.00648499581731442,-0.0493440037909595,-0.023922820187087,1.65492395407688e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,42223,0.0341185916549393,0.00604357680463693,0.022273181117851,0.0459640021920277,1.68208941494794e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUMB,Protein numb homolog,39784,-0.0477158271909657,0.00845258323917844,-0.0642828903397554,-0.0311487640421759,1.69316295350567e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMOT,Angiomotin,39863,-0.0224958217092354,0.00398543073838349,-0.030307265956467,-0.0146843774620037,1.69877239327684e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL5A1,Collagen alpha-1(V) chain,39863,-0.0240277913677071,0.00426010483608192,-0.0323775968464277,-0.0156779858889866,1.74188643606355e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,42094,-0.0161269255891691,0.00286420852220744,-0.0217407742926957,-0.0105130768856425,1.8343866972175e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,39881,-0.0327451923824232,0.00581566790738835,-0.0441439014809044,-0.021346483283942,1.84209730820341e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RILP,Rab-interacting lysosomal protein,42178,-0.0345159171873078,0.00613420581382034,-0.0465389605823957,-0.0224928737922199,1.87386086713536e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,40054,-0.0274884319934843,0.00490020123813363,-0.0370928264202263,-0.0178840375667424,2.07693732508463e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSTN,Growth/differentiation factor 8,41876,-0.030876246497078,0.00550517765319859,-0.0416663946973473,-0.0200860982968088,2.08255607364936e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,40054,-0.0365591985774771,0.0065212537751036,-0.0493408559766802,-0.0237775411782741,2.11914160947655e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,42146,-0.0149493814252807,0.00266708804101109,-0.0201768739856625,-0.00972188886489898,2.12345909816165e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,42256,0.0147081259305335,0.00262791439312269,0.00955741372001302,0.0198588381410539,2.22635459276751e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NBN,Nibrin,41887,-0.030939484563725,0.00553450405189593,-0.041787112505441,-0.020091856622009,2.31366450088451e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSNL1,Visinin-like protein 1,40054,-0.021939751632064,0.00392536953967963,-0.0296334759298361,-0.0142460273342919,2.33595751486391e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCR,Breakpoint cluster region protein,42103,-0.0522314911527913,0.00938196269759037,-0.0706201380400685,-0.0338428442655142,2.63993809813369e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNCG,Gamma-synuclein,42004,-0.0395951685319515,0.00711538271448386,-0.0535413186523398,-0.0256490184115631,2.67832607724844e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,42120,0.0237005616229493,0.00426451271939282,0.0153421166929394,0.0320590065529593,2.78883409889807e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANSC1,MANSC domain-containing protein 1,42186,0.0161466331796311,0.00290640601231949,0.0104500773954849,0.0218431889637773,2.82208757091293e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,42126,-0.0427487140799656,0.00772811618412485,-0.0578958218008503,-0.0276016063590809,3.23518337799961e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,42004,-0.0326197428070988,0.0059087328380673,-0.0442008591697107,-0.0210386264444869,3.44420497762182e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39577,-0.0278815932647248,0.00505576650837263,-0.0377908956211351,-0.0179722909083144,3.57519816530125e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NIT1,Deaminated glutathione amidase,39804,-0.0266999817041598,0.0048443159065831,-0.0361948408810627,-0.017205122527257,3.63879445590906e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDI2,Protein DDI1 homolog 2,39863,-0.0444760565272049,0.0080882636771907,-0.0603290533344986,-0.0286230597199111,3.91109679278057e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,42101,0.0277681523361149,0.00505640989836672,0.0178575889353161,0.0376787157369137,4.05674977181467e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPOCK1,Testican-1,42004,0.014601753149433,0.00266081438920425,0.00938655694659269,0.0198169493522734,4.14939368805947e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFAP,Glial fibrillary acidic protein,41841,0.0278231367290809,0.00507196192984007,0.0178820913465944,0.0377641821115675,4.19812411588673e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL3A1,Collagen alpha-1(III) chain,40097,-0.0131667322966844,0.0024039959028486,-0.0178785642662676,-0.00845490032710111,4.42149749312241e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,41985,-0.0132250977964907,0.00241658886197677,-0.0179616119659651,-0.00848858362701619,4.51754915502436e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,42004,-0.0330860028326977,0.00604994400892524,-0.0449438930901911,-0.0212281125752042,4.61560212699734e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,40021,-0.0430156733485527,0.00787065600208904,-0.0584421591126472,-0.0275891875844582,4.72307606816956e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBS,Cystathionine beta-synthase,39804,-0.0288302560591575,0.005279430265563,-0.0391779393796609,-0.018482572738654,4.84504999987741e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,42144,-0.0211525217814828,0.00387770471338081,-0.0287528230197092,-0.0135522205432564,4.9898154287503e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,42162,0.027793848115806,0.00509678569542943,0.0178041481527643,0.0377835480788477,5.03744546803009e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A14,Protein S100-A14,40054,-0.0306247115667741,0.00562579613096456,-0.0416512719834647,-0.0195981511500836,5.33435414732872e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,39804,-0.0292176563323907,0.00537369398299971,-0.0397500965390701,-0.0186852161257113,5.53354077996723e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEXIM1,Protein HEXIM1,42103,-0.0451603415186279,0.0083137802832448,-0.0614553508737877,-0.0288653321634681,5.67402184819771e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM4,Intercellular adhesion molecule 4,42103,0.0295469378951036,0.00544774807305093,0.0188693516719238,0.0402245241182834,5.94303846819326e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,42094,-0.0188023520468533,0.00346804117042813,-0.0255997127408924,-0.0120049913528142,6.01293138835334e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AXIN1,Axin-1,42103,-0.052866508598238,0.00975883063459695,-0.071993816642048,-0.033739200554428,6.15909973131243e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFPI,Tissue factor pathway inhibitor,42127,0.0173046320516063,0.00319745064327823,0.011037628790781,0.0235716353124316,6.34328001016496e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,42213,-0.0198213095898839,0.00366562696657671,-0.0270059384443743,-0.0126366807353936,6.50950724658646e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",42111,0.0320467999804641,0.00592694163449627,0.0204299943768514,0.0436636055840768,6.5239874133568e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,41861,-0.0292555920906553,0.00541372724977032,-0.0398664975002051,-0.0186446866811055,6.63637399507718e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP2B,DNA topoisomerase 2-beta,39784,-0.0441285102904581,0.00819119178315,-0.0601832461854321,-0.0280737743954841,7.30513218526999e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL5,Insulin-like peptide INSL5,40021,-0.0547343872220095,0.0101740350605062,-0.0746754959406017,-0.0347932785034174,7.61178160290537e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APLP1,Amyloid-like protein 1,42144,0.0286282940467142,0.00532358399661045,0.0181940694133577,0.0390625186800707,7.67813734972891e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL25,C-C motif chemokine 25,42256,-0.0266195938211407,0.00495376371745879,-0.03632897070736,-0.0169102169349215,7.85008338607727e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,40021,-0.0271362759168456,0.00505425810091982,-0.0370426217946484,-0.0172299300390427,8.08145336716432e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSTL3,Follistatin-related protein 3,42085,-0.0188258303049243,0.0035103049533279,-0.0257060280134469,-0.0119456325964016,8.32557227441459e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC4A1,Band 3 anion transport protein,40097,-0.0258879772538831,0.00482805482132966,-0.0353509647036893,-0.016424989804077,8.39917292327943e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD248,Endosialin,40097,0.0224993780903661,0.00420040276384948,0.0142665886732211,0.0307321675075111,8.65846703426286e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPIND1,Heparin cofactor 2,40092,-0.0154493108019628,0.00288817666334271,-0.0211101370621145,-0.00978848454181112,9.0153676087657e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,40054,-0.03337774631299,0.00623984290791277,-0.045607838412499,-0.0211476542134809,9.01722412154776e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RFC4,Replication factor C subunit 4,40020,-0.0116207296554114,0.00217321139009296,-0.0158802239799936,-0.00736123533082924,9.11122607945342e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN2,Dynactin subunit 2,42094,-0.0516722921481082,0.00966596906593623,-0.0706175915173432,-0.0327269927788731,9.15547194094244e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",42296,-0.0283032995555786,0.00530137435197223,-0.0386939932854442,-0.017912605825713,9.50934285340436e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,42103,-0.0384201118626072,0.00720403141938019,-0.0525400134445924,-0.024300210280622,9.81569797769982e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD6,Programmed cell death protein 6,42144,0.0389132381669429,0.00732220839971386,0.0245617097035037,0.0532647666303821,1.08776628792483e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALPP,"Alkaline phosphatase, placental type",42094,-0.0553785911203562,0.0104288601291699,-0.0758191569735292,-0.0349380252671831,1.11366179677446e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,41861,-0.0343925107840778,0.00648568728743853,-0.0471044578674573,-0.0216805637006983,1.15937181406679e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTSS2,Protein MTSS 2,40020,-0.0537040787671563,0.0101269543799769,-0.073552909351911,-0.0338552481824016,1.16106598276803e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST13,Hsc70-interacting protein,39863,-0.0307407139259651,0.00580504790101608,-0.0421186078119566,-0.0193628200399735,1.21041796987226e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK4,Dickkopf-related protein 4,41986,-0.0253093243155132,0.00478503418969194,-0.0346879913273094,-0.015930657303717,1.24831930946686e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC16A1,Monocarboxylate transporter 1,41829,-0.0312612936026216,0.00592585347503474,-0.0428759664136897,-0.0196466207915535,1.34649711476329e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAMBP,STAM-binding protein,41985,-0.034291614520134,0.00650253529793297,-0.0470365837040827,-0.0215466453361854,1.35971147553087e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTR,Transthyretin,40000,-0.0136521388033749,0.00259045446530944,-0.0187294295553814,-0.00857484805136841,1.38922333794786e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",40054,-0.0232824329173913,0.00443086825672,-0.0319669347005625,-0.0145979311342201,1.5115892975402e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGA,Fibrinogen alpha chain,39862,0.0167114528749788,0.00318270128588368,0.0104733583546468,0.0229495473953108,1.54425759712321e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,42148,-0.0216595523503203,0.0041373716412019,-0.029768800767076,-0.0135503039335646,1.67474624111733e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES2,Cocaine esterase,42094,-0.0295585352643927,0.0056647537816363,-0.0406614526763998,-0.0184556178523855,1.83695993241345e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTNB,Dystrobrevin beta,40001,-0.0229669254382208,0.00440577156962627,-0.0316022377146883,-0.0143316131617534,1.89324850955694e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,40021,-0.0157698127017048,0.00302639418333828,-0.0217015453010478,-0.00983808010236177,1.91528741244265e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMBP,Protein AMBP,42208,-0.0112734734154634,0.0021643357063594,-0.0155155713999278,-0.00703137543099895,1.93023643302827e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SARG,Specifically androgen-regulated gene protein,40026,-0.0580761508025514,0.0111572549841625,-0.0799443705715098,-0.0362079310335929,1.97297625854845e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAC1,Cartilage acidic protein 1,42296,0.0160926625506294,0.00309402704688991,0.0100283695387252,0.0221569555625336,2.00987489029401e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,39706,-0.039411859069468,0.00757897657070673,-0.0542666531480532,-0.0245570649908828,2.02865394952653e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',40054,-0.0230601962829458,0.00443931856270844,-0.0317612606658544,-0.0143591319000373,2.08950487952053e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPPK1,Epiplakin,39804,-0.0386305139403805,0.00745673749942857,-0.0532457194392605,-0.0240153084415005,2.25210488892832e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAB2,Stabilin-2,40097,-0.0148073769180637,0.00287042079526838,-0.0204334016767898,-0.00918135215933771,2.53162067725484e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIL1,Nucleotide exchange factor SIL1,39804,-0.0164361136593278,0.00318671665336813,-0.0226820782999294,-0.0101901490187263,2.54518425266003e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,42256,-0.0184903891234608,0.0035880279865831,-0.0255229239771637,-0.011457854269758,2.5959641235749e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGRN,Agrin,42184,-0.0193538996383687,0.00376634589652595,-0.0267359375955595,-0.0119718616811778,2.80746656988732e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,42103,-0.0222911790192353,0.00435056246916509,-0.0308182814587989,-0.0137640765796717,3.03846889989341e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,40020,-0.025268169038603,0.00493516840556559,-0.0349410991135116,-0.0155952389636944,3.10749507010779e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,39863,-0.0412038313662805,0.00804847488979657,-0.0569788421502818,-0.0254288205822792,3.11754896096177e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MLN,Promotilin,42103,-0.0468382674176275,0.00915167943880901,-0.0647755591176932,-0.0289009757175618,3.13235243201564e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,40102,0.0143657624064428,0.00281071441226133,0.00885676215841056,0.019874762654475,3.25761756725702e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",42076,-0.0402420939570761,0.00787723938464334,-0.0556814831509771,-0.0248027047631752,3.29100643211289e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXO3,Forkhead box protein O3,41861,-0.0499521974233686,0.00979930092762979,-0.069158827241523,-0.0307455676052142,3.4908241360617e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCN1,Ficolin-1,40085,-0.0292401463743958,0.00573618234067719,-0.0404830637621231,-0.0179972289866685,3.49960062027495e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN8,Septin-8,40041,-0.017090260280738,0.00335311437346252,-0.0236623644527245,-0.0105181561087514,3.51203698263778e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UROD,Uroporphyrinogen decarboxylase,39863,-0.0361353440659791,0.00709116817791465,-0.0500340336946918,-0.0222366544372664,3.53171519514902e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,41829,-0.0200680650532751,0.00394358209179635,-0.0277974859531959,-0.0123386441533543,3.65528614947325e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EEF1D,Elongation factor 1-delta,40080,-0.047645678703139,0.00938597943566554,-0.0660421983970435,-0.0292491590092346,3.9129604975455e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARF6,ADP-ribosylation factor 6,40021,-0.0559421397900898,0.0110330238078513,-0.0775668664534783,-0.0343174131267014,4.03490241079342e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARG1,Arginase-1,41999,-0.0270213769421085,0.00534674485943593,-0.0375009968666029,-0.016541757017614,4.39080727079149e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,42120,-0.0121644277297874,0.00240736303196487,-0.0168828592724385,-0.00744599618713621,4.40842112831608e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,40020,-0.0370312987218452,0.00734473016399877,-0.0514269698432828,-0.0226356276004076,4.68423994983126e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,42004,-0.0203753088814413,0.00405099895628423,-0.0283152668357584,-0.0124353509271242,4.97897726376901e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,41861,-0.023919786798182,0.00475862420537256,-0.0332466902407123,-0.0145928833556518,5.06022657469878e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D17,TBC1 domain family member 17,41829,-0.0234144927321591,0.00465983234332383,-0.0325477641250738,-0.0142812213392444,5.10980631815216e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD5,T-cell surface glycoprotein CD5,42208,-0.0187272911460913,0.00372857421174125,-0.0260352966011042,-0.0114192856910784,5.1640960826085e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSTL1,Follistatin-related protein 1,39804,-0.0116493575248181,0.00232010566389169,-0.0161967646260458,-0.00710195042359041,5.22260231525376e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,39804,-0.0302288358627329,0.00602354954127702,-0.0420349929636359,-0.01842267876183,5.29370294912761e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,40080,-0.032543682101605,0.00648588332700108,-0.0452560134225272,-0.0198313507806829,5.31425420160668e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",42094,0.0215657756630489,0.00430388596426607,0.0131301591730874,0.0300013921530104,5.49312326576189e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFA,Vascular endothelial growth factor A,42219,-0.0301783457692916,0.00604145737913402,-0.0420196022323943,-0.018337089306189,5.95336350841511e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX15,Sorting nexin-15,39863,-0.0279459868260287,0.0055959337363881,-0.0389140169493494,-0.016977956702708,6.00832707809654e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,40054,0.0161327343437372,0.00323263186017026,0.00979677589780346,0.0224686927896709,6.11290377107702e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R9B,Neurabin-2,42256,-0.0482156676776294,0.00966509913312219,-0.0671592619785489,-0.0292720733767099,6.15887519765449e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,40054,-0.0453243032161939,0.00908708326179258,-0.0631349864093074,-0.0275136200230804,6.20244146214707e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,40054,-0.0354228391318851,0.00710213892248676,-0.0493430314199592,-0.0215026468438111,6.20701259421941e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELENOP,Selenoprotein P,40113,0.0117786821306796,0.00236172914149459,0.00714969301335018,0.016407671248009,6.21665924735369e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFI,Complement factor I,40113,-0.0100070319518143,0.00200654435531532,-0.0139398588882323,-0.0060742050153963,6.22037938614e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,41876,0.0110381761754916,0.00221573815502252,0.00669532939164744,0.0153810229593357,6.38534661470506e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF2,Trefoil factor 2,42162,-0.0299060493696767,0.00601388176590228,-0.0416932576308451,-0.0181188411085082,6.68244984416665e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,42167,-0.026251549804666,0.00529051222497148,-0.0366209537656101,-0.0158821458437219,7.06538148312159e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAV,Integrin alpha-V,42223,0.00842338845767809,0.00169758181234015,0.0050961281054914,0.0117506488098648,7.06545979042256e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADA,Adenosine deaminase,42256,-0.0177766988332689,0.0035870992935846,-0.0248074134486948,-0.0107459842178431,7.29619596763096e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,42103,-0.0402496208707628,0.00812981438529653,-0.056184057065944,-0.0243151846755816,7.48174155793242e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,42213,-0.0264148372370944,0.00534715014492625,-0.0368952515211499,-0.015934422953039,7.9099255668029e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHPS,Deoxyhypusine synthase,40020,-0.0206060464935789,0.00417149651600596,-0.0287821796649506,-0.0124299133222073,7.94021444445501e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,39784,-0.0428920084243156,0.00869718516526235,-0.0599384913482298,-0.0258455255004014,8.27501526129057e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,39902,-0.0288975407851456,0.00586849674408334,-0.040399794403549,-0.0173952871667423,8.59791278532564e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,41861,-0.0277548179351838,0.00564563098975537,-0.0388202546751044,-0.0166893811952633,8.93647362244509e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA4,Apolipoprotein A-IV,40113,-0.0181070745549737,0.00368690824938417,-0.0253334147237667,-0.0108807343861807,9.18411823608352e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,40102,-0.0112107981428524,0.00228355730438732,-0.0156865704594515,-0.00673502582625321,9.26989879972023e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,40021,-0.0548061965051102,0.0111652208751466,-0.0766900294203975,-0.0329223635898229,9.30415232396422e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,42096,-0.0327099051467442,0.00666519145096418,-0.045773680390634,-0.0196461299028545,9.33375346072973e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,39881,-0.026676506392509,0.00543929386724284,-0.037337522372305,-0.0160154904127131,9.50905567864324e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F10,Coagulation factor X,40102,-0.0144135062222468,0.00294088903358015,-0.0201776487280639,-0.0086493637164297,9.66871236519405e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",42077,-0.053140589668158,0.0108512370975773,-0.0744090143794096,-0.0318721649569064,9.83957229530843e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERMAP,Erythroid membrane-associated protein,39784,-0.0225877719367883,0.00461516582642506,-0.0316334969565814,-0.0135420469169951,1.00136724541056e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,41861,-0.0554829867730058,0.011349084590674,-0.0777271925707269,-0.0332387809752848,1.02715701147862e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AZU1,Azurocidin,41742,-0.0385349416011601,0.00788680582618742,-0.0539930810204874,-0.0230768021818327,1.04175681851547e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRG2,Bone marrow proteoglycan,40097,0.0265560705028771,0.00543664083451138,0.0159002544672348,0.0372118865385194,1.05086798800909e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDA,Cytidine deaminase,40063,-0.0235710762704904,0.00482893947073107,-0.0330357976331233,-0.0141063549078575,1.06934841760396e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,40020,-0.0333766558847478,0.00684215300699241,-0.0467872757784529,-0.0199660359910427,1.0864174757357e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,40054,-0.0161884649199137,0.00332084718028542,-0.0226973253932731,-0.00967960444655428,1.10460743319085e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,41861,-0.030178479626611,0.00620564921751692,-0.0423415520929442,-0.0180154071602779,1.16970107639372e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL5,Fc receptor-like protein 5,42120,0.0297037459934016,0.00611580942888293,0.017716759512791,0.0416907324740121,1.20647420873758e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WIF1,Wnt inhibitory factor 1,42223,0.0172194782812507,0.00355512233149019,0.0102514385115299,0.0241875180509714,1.28994197034311e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,40020,-0.0564730716772798,0.0116587071532563,-0.0793241376976622,-0.0336220056568974,1.29109047548531e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,42213,-0.0323801341492459,0.00669769988431256,-0.0455076259224985,-0.0192526423759933,1.34995151227329e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP4,Bone morphogenetic protein 4,41984,-0.0233188437845523,0.00482555933710216,-0.0327769400852725,-0.0138607474838321,1.36489942387029e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA3,Carbonic anhydrase 3,42273,-0.0297030015014071,0.00615113563688234,-0.0417592273496965,-0.0176467756531177,1.38868197300107e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6L,Seizure 6-like protein,42186,0.0140178359003081,0.00291038459036406,0.00831348210319455,0.0197221896974217,1.47754817205821e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,40021,-0.0220105919517706,0.00457037166046194,-0.030968520406276,-0.0130526634972652,1.48500410405981e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100G,Protein S100-G,40054,0.0239095016675143,0.00496478553537018,0.0141785220181888,0.0336404813168399,1.48578091731202e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDGF,Hepatoma-derived growth factor,42202,-0.0461573011402832,0.00959592595748891,-0.0649653160169615,-0.027349286263605,1.52551272604962e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKD1,Polycystin-1,40080,-0.0132823486193648,0.00276264778742785,-0.0186971382827233,-0.00786755895600617,1.54617629832722e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LARP1,La-related protein 1,40020,-0.0302712179730479,0.0063173882933164,-0.042653299027948,-0.0178891369181478,1.67546425935828e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,40054,-0.0315732043718096,0.0065985251430729,-0.0445063136522325,-0.0186400950913867,1.73336133542e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD5L,CD5 antigen-like,40055,0.0235537711764979,0.00493302330738622,0.0138850454940209,0.0332224968589749,1.82314440673291e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLU,Clusterin,40113,0.0152221336564756,0.00319217640361397,0.00896546790539221,0.021478799407559,1.87931999222299e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6L2,Seizure 6-like protein 2,42094,0.0116271896885891,0.00244392852931028,0.006837089771141,0.0164172896060373,1.9804935293083e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",39793,-0.0387815966875268,0.00818166284270233,-0.0548176558592234,-0.0227455375158302,2.16432735901018e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANG,Angiogenin,42127,-0.0163842176794364,0.00346316462729916,-0.0231720203489427,-0.00959641500993001,2.2578453585676e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,42296,-0.0192284259896575,0.00406530399681002,-0.0271964218234051,-0.0112604301559099,2.26989093874506e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,39753,-0.0238278517700894,0.00504712158152986,-0.0337202100698879,-0.0139354934702908,2.37616605275737e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP43,Centrosomal protein 43,41779,-0.0336538186839373,0.00713415998101601,-0.0476367722467287,-0.0196708651211459,2.4159032946272e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,42149,-0.0240158833644566,0.00509469019753078,-0.0340014761516169,-0.0140302905772963,2.45545337256118e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,40036,-0.0387953421121674,0.00823170983886822,-0.0549294933963491,-0.0226611908279857,2.47237780731415e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL8,Interleukin-8,42006,-0.0340267628498587,0.00722279490207157,-0.0481834408579189,-0.0198700848417984,2.49064260373902e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,41887,-0.0329616846927859,0.007012028733616,-0.0467052610106732,-0.0192181083748985,2.61953548066104e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMG4,Proteasome assembly chaperone 4,39784,-0.0275981836072446,0.00587955264378338,-0.03912210678906,-0.0160742604254292,2.71373330022189e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPTC,Opticin,42094,0.0224813259057104,0.00479331059001128,0.0130864371492882,0.0318762146621325,2.75810617177364e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRPK2,SRSF protein kinase 2,42103,-0.0404118209500604,0.00861668329858823,-0.0573005202152933,-0.0235231216848274,2.76071252554311e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL13,C-X-C motif chemokine 13,42213,-0.0303017123413161,0.00646368653224414,-0.0429705379445146,-0.0176328867381176,2.78697443236341e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,40054,-0.0412294588781667,0.00880530360633004,-0.0584878539465736,-0.0239710638097599,2.87049198313153e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,42088,-0.0118283032789934,0.00253122098310323,-0.0167894964058757,-0.00686711015211107,2.99888318391244e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3BP1,SH3 domain-binding protein 1,40021,-0.0229073823761125,0.00490374886010211,-0.0325187301419127,-0.0132960346103124,3.02753381258551e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,39955,-0.0286169946321488,0.00612693990448212,-0.0406257968449337,-0.0166081924193638,3.03835125856137e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNA4,Ephrin-A4,41984,-0.0164405019171773,0.00352569009454402,-0.0233508545024836,-0.00953014933187101,3.14694909018242e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTA,Lymphotoxin-alpha,42103,-0.0196934571020711,0.00422404526422908,-0.0279725858199601,-0.0114143283841821,3.1593944898417e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP29,Synaptosomal-associated protein 29,42186,-0.0438187169741002,0.00940135629049203,-0.0622453753034646,-0.0253920586447359,3.17970155784028e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRCAM,Neuronal cell adhesion molecule,42144,-0.0140068951040976,0.00301133912842283,-0.0199091197958063,-0.00810467041238884,3.32977230557953e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXO1,Forkhead box protein O1,42103,-0.0406411493763346,0.00874756487295105,-0.0577863765273186,-0.0234959222253505,3.41784751278048e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATRN,"Attractin, Isoform 2",40113,-0.00802085173486638,0.00172642155173729,-0.0114046379762715,-0.0046370654934613,3.42488686888813e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",39804,-0.017641916572614,0.00380823714048096,-0.0251060613679567,-0.0101777717772713,3.65456209693945e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD93,Complement component C1q receptor,41662,0.0154986065815419,0.00334929291541648,0.00893399246732563,0.0220632206957582,3.73968682393174e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,42094,-0.0101560904505457,0.0021953813754897,-0.0144590379465055,-0.00585314295458589,3.76209914911401e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,40080,-0.036976703123629,0.00802339524436705,-0.0527025578025884,-0.0212508484446696,4.09977459532324e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNA4,Plexin-A4,42103,-0.0388602184101961,0.00844002738719602,-0.0554026720891003,-0.0223177647312919,4.17853556092009e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNCA,Alpha-synuclein,39863,-0.054437673455663,0.011852983162228,-0.0776695204536299,-0.0312058264576961,4.42471248526037e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",40053,-0.0187926619666969,0.00409273136982419,-0.0268144154515523,-0.0107709084818415,4.4455526006921e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,42296,-0.0312486718773741,0.00680638220726652,-0.0445891810036164,-0.0179081627511317,4.45051402342763e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,41861,-0.0247567940744986,0.00540374344184527,-0.0353481312205153,-0.0141654569284819,4.66247048359843e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPA33,Cell surface A33 antigen,42094,-0.0656478045501168,0.0143349807514803,-0.0937443668230182,-0.0375512422772154,4.70330507587278e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,39804,-0.0339889545372158,0.00742221274468496,-0.0485364915167983,-0.0194414175576333,4.71718862409407e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,39758,-0.0129982675202588,0.00283952424349517,-0.0185637350375094,-0.00743280000300831,4.75661301483015e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,39768,-0.0306452107181208,0.00669575061042145,-0.0437688819145468,-0.0175215395216947,4.77489844917327e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAP18,Chromatin complexes subunit BAP18,40054,-0.031808751267048,0.00695459619176567,-0.0454397598029087,-0.0181777427311873,4.84318137339408e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG1B,Lithostathine-1-beta,42296,-0.0276723419855135,0.00606994962141455,-0.0395694432434861,-0.015775240727541,5.18857985347752e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,42122,-0.0224220212168149,0.0049220485477142,-0.0320692363703348,-0.0127748060632951,5.27581374462613e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,42120,-0.021533153980095,0.00472901212565418,-0.0308020177463772,-0.0122642902138128,5.32641751586417e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCAN,Versican core protein,42213,0.0143442523148403,0.00315297878437909,0.00816441389745728,0.0205240907322233,5.42779364831541e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,40020,-0.0273808537107914,0.00603003551901649,-0.0391997233280637,-0.015561984093519,5.66610443498846e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC39A14,Zinc transporter ZIP14,41829,0.0162172830438073,0.0035785384558989,0.0092033476702454,0.0232312184173691,5.90149864286927e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OBP2B,Odorant-binding protein 2b,41971,0.0287023911997366,0.00634069300455591,0.016274632910807,0.0411301494886662,6.04542509912742e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP2B1,AP-2 complex subunit beta,39768,-0.0225779884894611,0.00499406416375847,-0.0323663542504277,-0.0127896227284945,6.22276537550625e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,41876,-0.0156401601698745,0.00346219137525868,-0.0224260552653815,-0.00885426507436753,6.31640540810416e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AZI2,5-azacytidine-induced protein 2,40054,-0.0255604676339868,0.00565879348379719,-0.0366517028622293,-0.0144692324057443,6.33994978625425e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP1,Interstitial collagenase,41651,-0.0427080357973879,0.0094655471960996,-0.0612605083017431,-0.0241555632930327,6.48234932588381e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,42256,-0.0193979878739886,0.00430702284476364,-0.0278397526497253,-0.0109562230982519,6.73261476534959e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XCL1,Lymphotactin,42223,-0.02615953733482,0.00581662270062181,-0.0375601178280388,-0.0147589568416013,6.93918412212932e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS22,Brain-specific serine protease 4,39784,-0.0170384007662816,0.00379428814854029,-0.0244752055374206,-0.00960159599514268,7.17944255229396e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UROS,Uroporphyrinogen-III synthase,39768,-0.0314032493557313,0.00699565855828415,-0.0451147401299682,-0.0176917585814944,7.2328008249167e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,41861,-0.0454953478605043,0.0101404289493715,-0.0653705886012725,-0.0256201071197361,7.30297534704315e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",42120,-0.0209594624374468,0.00467444835455788,-0.0301213812123802,-0.0117975436625133,7.39440263090903e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,39867,-0.0299745722678905,0.0066856241992297,-0.0430783956983807,-0.0168707488374003,7.42165783607565e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP2,Methionine aminopeptidase 2,42193,-0.0262583426480564,0.00586335531132702,-0.0377505190582574,-0.0147661662378554,7.58519567536288e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINI2,Serpin I2,40021,-0.0258504203432917,0.00577372323248756,-0.0371669178789674,-0.0145339228076161,7.63828831748305e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLN4,Cerebellin-4,42223,-0.0150509413271518,0.00336777337564146,-0.021651777143409,-0.0084501055108945,7.92091244133101e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,42144,0.0125375211892379,0.00280547419342347,0.00703879177012793,0.0180362506083479,7.92717956205271e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAM1,Neural cell adhesion molecule 1,42197,0.0139550098916074,0.00313142750450817,0.00781741198277142,0.0200926078004434,8.40296462374631e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,40054,-0.0221357345321188,0.00497537098191402,-0.0318874616566703,-0.0123840074075673,8.7104395854304e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD2,Sushi domain-containing protein 2,42120,0.0132687827724712,0.00298374798798099,0.00742063671602841,0.0191169288289139,8.77966114088084e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACYP1,Acylphosphatase-1,39830,-0.0300278045733771,0.00675233224363182,-0.0432623757708955,-0.0167932333758588,8.79501081729362e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CX3CL1,Fractalkine,42004,0.0158176363348512,0.0035629532068949,0.00883424804933722,0.0228010246203652,9.09333640023587e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,40054,-0.0184062609372353,0.0041489950601553,-0.0265382912551397,-0.0102742306193309,9.2411433769755e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MBL2,Mannose-binding protein C,39957,0.0498882621688079,0.0112454957516061,0.02784709049566,0.0719294338419559,9.24322138527701e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6AP2,Renin receptor,41861,-0.0185282500567258,0.00417771695471338,-0.026716575287964,-0.0103399248254876,9.28402189961167e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,41829,-0.027831045534028,0.00627811091692388,-0.0401361429311988,-0.0155259481368572,9.37019888501839e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,42184,-0.0180557540968682,0.0040761277630678,-0.0260449645124811,-0.0100665436812554,9.5164969520618e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD70,CD70 antigen,42103,0.0198903756841562,0.00449463070520438,0.0110808995019556,0.0286998518663568,9.7069198088612e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KAZN,Kazrin,40021,-0.0473079406909533,0.0107075023826546,-0.0682946453609562,-0.0263212360209503,1.00491310890743e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,39863,-0.0378321829206827,0.00859363817621394,-0.054675713746062,-0.0209886520953033,1.08127594054404e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RSPO1,R-spondin-1,42004,0.0154367199974186,0.00350760292050169,0.00856181827323531,0.0223116217216019,1.08658942947309e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD36,Platelet glycoprotein 4,39784,-0.0203257602666746,0.0046224945338355,-0.0293858495529922,-0.011265670980357,1.10756328336694e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPQ,Carboxypeptidase Q,40086,-0.0161128334271506,0.00366550864632879,-0.023297230373955,-0.00892843648034619,1.1141252099643e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,40097,0.00957602908899331,0.00218148578363281,0.00530031695307301,0.0138517412249136,1.1458521023085e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIMAP8,GTPase IMAP family member 8,39665,-0.0237917955026399,0.00542204217251558,-0.0344189981607705,-0.0131645928445094,1.15530020512589e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAM,Integrin alpha-M,42120,0.0143011714613674,0.00326125263902644,0.00790911628887554,0.0206932266338592,1.16807477135605e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARB2,Lysosome membrane protein 2,41824,-0.0158942240547567,0.00362963468094197,-0.023008308029403,-0.00878014008011044,1.2017649217692e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGFR,Opioid growth factor receptor,42094,-0.0147160055563189,0.00336105760532565,-0.0213036784627572,-0.00812833264988067,1.2050330414623e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRR3,Small proline-rich protein 3,40054,-0.0316357741895645,0.00723245102077663,-0.0458113781902867,-0.0174601701888423,1.2304726817503e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QDPR,Dihydropteridine reductase,42090,-0.0192104325152683,0.00439302855011281,-0.0278207684734894,-0.0106000965570472,1.23547742121827e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD5,Programmed cell death protein 5,42213,-0.0259336061062666,0.00593064529631271,-0.0375576708870395,-0.0143095413254937,1.23607847561553e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INHBB,Inhibin beta B chain,39863,0.0246032200768426,0.00562812033742108,0.0135721042154973,0.0356343359381879,1.2457534737634e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK3,Dickkopf-related protein 3,42296,0.0136207485884034,0.00312088795319278,0.00750380820014555,0.0197376889766612,1.284587066991e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,40097,-0.0132132059959223,0.00302834869086504,-0.0191487694300178,-0.00727764256182686,1.2936930096897e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,39784,-0.0197642011184345,0.00453456424224634,-0.0286519470332373,-0.0108764552036317,1.32151946368213e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,42094,-0.0177702472784418,0.00408160333434125,-0.0257701898137506,-0.00977030474313292,1.34864669412488e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,41829,-0.0348785905253496,0.00804022920119551,-0.0506374397596928,-0.0191197412910064,1.44894718044826e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",42071,-0.0315877463615613,0.00729286393520488,-0.0458817596745629,-0.0172937330485597,1.49338222230822e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGL1,Fibrinogen-like protein 1,40102,0.0292430707878415,0.0067528975591114,0.0160073915719832,0.0424787500036999,1.50135694204134e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NADK,NAD kinase,42144,-0.0244861957445344,0.00565661631143731,-0.0355731637149515,-0.0133992277741173,1.51069855612509e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,39804,-0.0329780080280766,0.00763218816850691,-0.0479370968383501,-0.018018919217803,1.56801359197186e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH2B3,SH2B adapter protein 3,41861,-0.0433819913782082,0.0100424166108492,-0.0630651279354728,-0.0236988548209437,1.57306351870249e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN4,CCN family member 4,42223,-0.0177723721537689,0.0041169998893288,-0.0258416919368534,-0.00970305237068446,1.59457859577475e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5E,5'-nucleotidase,42186,-0.0252282080496435,0.00584500565325246,-0.0366844191300183,-0.0137719969692687,1.59913864145775e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,42094,-0.0341381504858651,0.00791762136511003,-0.0496566883614808,-0.0186196126102495,1.63231106118386e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,42111,0.0134240672643298,0.00311423812645755,0.00732016053647296,0.0195279739921866,1.64058256407139e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FETUB,Fetuin-B,42172,-0.0142648508308141,0.00331626000692964,-0.0207647204443961,-0.00776498121723197,1.70896279034495e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,42094,-0.0374921698528387,0.0087201692374431,-0.0545837015582272,-0.0204006381474502,1.72458947353009e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATG16L1,Autophagy-related protein 16-1,40021,-0.0372368261459058,0.00868862795969123,-0.0542665369469006,-0.020207115344911,1.83742867815417e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPB6,Heat shock protein beta-6,42223,-0.0174744859062362,0.0040811045217377,-0.0254734507688421,-0.00947552104363033,1.86712166696874e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTD,Biotinidase,40113,-0.00900431859812442,0.00210722603048051,-0.0131344816178662,-0.00487415557838261,1.94437264561145e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,42213,0.0205846373480294,0.00482647598454628,0.0111247444183187,0.0300445302777401,2.01365790008007e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL3,C-C motif chemokine 3,42103,-0.0249928857653278,0.00586637154114876,-0.0364909739859794,-0.0134947975446763,2.05539754658022e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,39706,-0.0161082557038856,0.00379122145388855,-0.0235390497535071,-0.008677461654264,2.16742245211137e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,42126,-0.0119982088818375,0.00282584272439437,-0.0175368606216504,-0.0064595571420245,2.19251072068383e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNM1,Dynamin-1,40021,0.0497509499232962,0.0117205749964907,0.0267786229301745,0.072723276916418,2.20658642059127e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,39784,-0.0195913277161734,0.00461572888385266,-0.0286381563285246,-0.0105444991038222,2.20977111516824e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QL2,Complement C1q-like protein 2,39784,0.0192845413225729,0.00456156989581747,0.0103438643267707,0.0282252183183752,2.38168721353098e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TF,Serotransferrin,40113,-0.00925521196196454,0.00219803767909343,-0.0135633658129877,-0.00494705811094143,2.56655337893113e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,40080,-0.0116217129925809,0.00276647476690782,-0.0170440035357203,-0.00619942244944161,2.67962523444707e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,42296,-0.0136997930632767,0.00326271012792363,-0.020094704914007,-0.00730488121254637,2.69987006398738e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,39784,-0.0193701803429927,0.00461931331293582,-0.028424034436347,-0.0103163262496385,2.77158991343955e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIFR,Leukemia inhibitory factor receptor,42103,-0.0104718269078759,0.00249755906427391,-0.0153670426738527,-0.005576611141899,2.77339902311065e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,42103,-0.0168949900727275,0.00403564727205664,-0.0248048587259585,-0.00898512141949643,2.85244215663004e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL36A,Interleukin-36 alpha,39784,0.0249401780377154,0.00596411546946702,0.0132505117175601,0.0366298443578708,2.91659467531554e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPP1,Osteopontin,42274,0.0204075561728356,0.00489412026658766,0.0108150804503238,0.0300000318953474,3.06817243328914e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFLAM,Pikachurin,40021,-0.0133049968725073,0.00319629160908289,-0.0195697284263097,-0.0070402653187048,3.17030039188613e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1B,Interleukin-1 beta,41815,0.0243877482009117,0.00586509799190943,0.0128921561367692,0.0358833402650542,3.23006087346884e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP23,Synaptosomal-associated protein 23,42144,-0.037000777923554,0.00892557632276206,-0.0544949075161676,-0.0195066483309403,3.41264836472243e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,39625,-0.0140347951576573,0.0033859699090306,-0.0206712961793573,-0.00739829413595737,3.42521948782508e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,42256,-0.0417563505128664,0.0100936760556157,-0.0615399555818731,-0.0219727454438596,3.54261049818708e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL13,C-C motif chemokine 13,42237,-0.0294909806610779,0.00712990365127635,-0.0434655918175795,-0.0155163695045762,3.5525823095522e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,41861,-0.0216824463168824,0.00524472200225831,-0.0319621014413087,-0.0114027911924561,3.58571945863776e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POF1B,Protein POF1B,39784,-0.0198490874509102,0.00480447872557184,-0.029265865753031,-0.0104323091487894,3.63377513734424e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,42213,-0.0196754056428449,0.00476328020401454,-0.0290114348427134,-0.0103393764429763,3.64011200459494e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYTL4,Synaptotagmin-like protein 4,40080,-0.0314159082149174,0.00761136466508829,-0.0463341829584905,-0.0164976334713444,3.69461319700258e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C8B,Complement component C8 beta chain,40113,0.0129136992411532,0.00312916998928554,0.00678052606215352,0.0190468724201528,3.70453701777845e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN5,Contactin-5,42144,0.0162756821442948,0.00394580747806411,0.00854189948728917,0.0240094648013005,3.73368456172062e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EHBP1,EH domain-binding protein 1,40080,-0.0314795150397724,0.0076384394242623,-0.0464508563113265,-0.0165081737682183,3.79701224846333e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,41829,-0.017845063917309,0.00433214835954305,-0.0263360747020134,-0.00935405313260461,3.8258163904647e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,39754,-0.016666534034326,0.00405583740863303,-0.0246159753552468,-0.0087170927134053,3.999090470242e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,39784,-0.0147704470879356,0.00360156683350018,-0.0218295180815959,-0.00771137609427522,4.1423457136386e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMOX1,Heme oxygenase 1,42013,0.0204886473024807,0.00499657994789346,0.0106953506046095,0.0302819440003518,4.14740741505305e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,41813,-0.0242970384281169,0.00592706740308227,-0.0359140905381581,-0.0126799863180756,4.16932142885403e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB8,Serpin B8,42256,-0.0244790874304145,0.00597283687891637,-0.0361858477130906,-0.0127723271477384,4.18526113682131e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AK1,Adenylate kinase isoenzyme 1,42144,-0.0267384932236197,0.00652498264529679,-0.0395274592084014,-0.013949527238838,4.19520134601194e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,41635,-0.0159182566296574,0.00388714469211098,-0.023537060226195,-0.00829945303311991,4.24650852999392e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLC,Galectin-10,42121,0.0278638236891043,0.00681327618145734,0.0145098023734479,0.0412178450047607,4.34666453223696e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,42184,-0.0127484633793331,0.00311795590640084,-0.0188596569558788,-0.0066372698027875,4.36363454172768e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR2,TGF-beta receptor type-2,42186,-0.0152127192209415,0.00372662821658957,-0.0225169105254571,-0.00790852791642595,4.48847203588441e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,42223,-0.0340472262747449,0.00834457462339332,-0.0504025925365959,-0.017691860012894,4.52721682274085e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOLGA3,Golgin subfamily A member 3,40054,-0.0328600941377066,0.00805379404785499,-0.0486455304715024,-0.0170746578039108,4.53427701142617e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,42004,0.050257159405951,0.0123468860455309,0.0260572627567106,0.0744570560551915,4.7207791425972e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,40021,0.021464918534508,0.00528084323453515,0.0111144657948191,0.0318153712741969,4.84391420136284e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TALDO1,Transaldolase,40069,-0.0183303381952928,0.00451643798523545,-0.0271825566463543,-0.00947811974423128,4.9716848621836e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TADA3,Transcriptional adapter 3,40020,-0.0165596675311396,0.00408324043869742,-0.0245628187909865,-0.00855651627129267,5.03732579871555e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARA5,Scavenger receptor class A member 5,42213,-0.0129758668886597,0.0032027696287506,-0.0192532953610109,-0.00669843841630849,5.11962033729018e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,41861,-0.0182947531889862,0.00451749409986269,-0.027149041624717,-0.00944046475325531,5.15761981001448e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN3,Calsyntenin-3,40054,-0.0127791683110744,0.00315670874167706,-0.0189663174447614,-0.00659201917738736,5.19585308393887e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNMBP,Dynamin-binding protein,42004,-0.0250528299270926,0.00619278459905987,-0.03719068774125,-0.0129149721129353,5.25207085412529e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,39665,-0.0174199035752196,0.00431082611192318,-0.025869122754589,-0.00897068439585014,5.36119045959522e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",42162,-0.0354264094907258,0.008767882326753,-0.0526114588511617,-0.0182413601302899,5.36506529262836e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD302,CD302 antigen,42094,-0.013423401018399,0.00332322920746466,-0.0199369302650298,-0.00690987177176831,5.39296014257815e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,41876,-0.0176463914334295,0.00436881940503883,-0.0262092774673056,-0.00908350539955339,5.39572776996007e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,41887,-0.0179593096921391,0.00444852659963463,-0.026678421827423,-0.00924019755685527,5.44253481463911e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,39881,-0.0464791333258095,0.0115148629564365,-0.0690482647204251,-0.0239100019311939,5.46452452925368e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,42094,-0.0157778587693054,0.0039103376133457,-0.023442120491463,-0.00811359704714787,5.49383230933397e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRG3,Proteoglycan 3,40097,0.0207065178227739,0.00513441172966917,0.0106430708326223,0.0307699648129254,5.54704083691618e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL20,C-C motif chemokine 20,42256,-0.0382207478054928,0.0094858339660311,-0.0568129823789138,-0.0196285132320719,5.62732892827741e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA9,Carbonic anhydrase 9,42223,-0.0202331345591687,0.00502456389107726,-0.0300812797856801,-0.0103849893326573,5.68508502531141e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,40054,-0.0170822111775709,0.00424403194664474,-0.0254005137929946,-0.00876390856214719,5.73631157057827e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,42144,-0.028200414470615,0.0070319723911847,-0.041983080357337,-0.014417748583893,6.09784972594047e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,41985,-0.0458153321005366,0.0114414741270012,-0.0682406213894589,-0.0233900428116142,6.25473649608112e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,39768,-0.0282632036488047,0.00705925321703554,-0.0420993399541944,-0.0144270673434151,6.27829081060534e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,42094,-0.0564321048590419,0.0140965420051475,-0.084061327189131,-0.0288028825289529,6.2825584584932e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,41861,-0.0155477682146558,0.00388923208511137,-0.0231706631014741,-0.00792487332783753,6.43386012212995e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP20,Centrosomal protein 20,41861,-0.0307793390666975,0.00770736045711948,-0.0458857655626517,-0.0156729125707433,6.54729386662723e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,41770,0.0166573274467801,0.00417273896660875,0.00847875907222695,0.0248358958213332,6.59069425809223e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,42103,-0.0239774374137417,0.00601733879171847,-0.0357714214455099,-0.0121834533819735,6.79297175728366e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FST,Follistatin,42162,0.0201828605487231,0.00507138473743835,0.0102429464633439,0.0301227746341022,6.93623988530933e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMPR2,GMP reductase 2,39863,-0.0275029937072417,0.00691278400586154,-0.0410520503587303,-0.0139539370557531,6.97895455908748e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,40020,-0.0188252637477744,0.00473543523246171,-0.0281067168033994,-0.00954381069214949,7.07166554169037e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMCN2,Hemicentin-2,39849,-0.0240371353727191,0.00605079500580554,-0.0358966935840979,-0.0121775771613402,7.15729979704361e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,42097,0.0102400645925916,0.00258348023565092,0.00517644333071581,0.0153036858544674,7.42037997982133e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,40080,-0.0116092560143954,0.00293129126418421,-0.0173545868921964,-0.00586392513659435,7.52826369785059e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBIN,Erbin,42094,-0.0415803265124437,0.0105030792113304,-0.0621663617666513,-0.0209942912582361,7.57091998659987e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GASK1A,Golgi-associated kinase 1A,39706,-0.017661454823805,0.0044652099244722,-0.0264132662757705,-0.00890964337183944,7.69253306875891e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,42032,0.023613066336001,0.00597149959546149,0.0119089271288965,0.0353172055431056,7.71729269733775e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],41888,-0.0195469372089823,0.00494554294418875,-0.0292402013795922,-0.00985367303837233,7.7779144721535e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA2,Annexin A2,39640,-0.0293897879460073,0.00744706869633307,-0.0439860425908201,-0.0147935333011945,7.98244496021155e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,41861,-0.021666973386755,0.00549486911300631,-0.0324369168482473,-0.0108970299252626,8.08585033173516e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,42211,0.008243467705364,0.0020920320455106,0.00414308489616322,0.0123438505145648,8.17667608460567e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG6,Large proline-rich protein BAG6,41876,-0.0144814995868054,0.00367834601441879,-0.0216910577750662,-0.00727194139854453,8.29614957462136e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD80,T-lymphocyte activation antigen CD80,40080,-0.0140409332510397,0.00356927244376801,-0.021036707240825,-0.00704515926125442,8.41198321027211e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MATN2,Matrilin-2,42146,-0.0119959800700893,0.00305295248765015,-0.0179797669458836,-0.00601219319429503,8.56343830954927e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN1,Contactin-1,42296,0.0113112200778115,0.00287913437881558,0.00566811669533294,0.01695432346029,8.58489193848953e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,42120,0.0181871186767859,0.00463948289604751,0.00909373220053283,0.0272805051530391,8.8978221820456e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPEP1,Dipeptidase 1,41985,0.0202427814272665,0.0051647728432705,0.0101198266544563,0.0303657362000767,8.92342265629209e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G1B,Phospholipase A2,42284,0.0184413241255594,0.00471000550535591,0.00920971333506177,0.0276729349160569,9.07305562356093e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,40021,-0.0124839051019684,0.00319556172109035,-0.0187472060753055,-0.00622060412863134,9.41580461383495e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",40021,0.0409644847238779,0.010503509405032,0.0203776062900151,0.0615513631577407,9.67435622813987e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAS2,Growth arrest-specific protein 2,39881,-0.0212206000201202,0.00546072471048379,-0.0319236204526684,-0.010517579587572,0.000102507622807632
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA5,Integrin alpha-5,42120,-0.00999931681248627,0.00257878668456165,-0.0150537387142271,-0.00494489491074544,0.000106045631436518
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBXN1,UBX domain-containing protein 1,39863,-0.0273808999714887,0.00706540142422015,-0.0412290867629602,-0.0135327131800172,0.000107109139080664
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,42186,-0.0113036399735069,0.00291966791877308,-0.0170261890943021,-0.00558109085271167,0.000108674996996307
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEL1L,Protein sel-1 homolog 1,39804,-0.0130164763871724,0.003361862277286,-0.019605726450653,-0.00642722632369188,0.000108680280102221
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST5,Cystatin-D,41876,-0.0228116665011284,0.00589345240730802,-0.0343628332194521,-0.0112604997828047,0.000109076242700891
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,39706,-0.0150252172346778,0.00389761680783189,-0.0226645461780283,-0.00738588829132734,0.000116430586022163
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDN1,Endothelin-1,39804,-0.0120915231390104,0.00313741337012117,-0.0182408533444479,-0.00594219293357292,0.000116898982969443
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA6,Carbonic anhydrase 6,42091,0.0247544996141488,0.00645666841781449,0.0120994295152324,0.0374095697130652,0.000126704744972965
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP10,Stromelysin-2,42116,0.0232399464454302,0.00606496687520046,0.0113526113700373,0.0351272815208231,0.000127793720285072
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA4C,Semaphorin-4C,42094,0.0110450288632527,0.00288337478192437,0.0053936142906809,0.0166964434358244,0.000128441482433398
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RALY,RNA-binding protein Raly,40020,-0.0186383008140876,0.00486574497513381,-0.0281751609653499,-0.00910144066282533,0.000128598150358978
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12B,Interleukin-12 subunit beta,42256,-0.0224218858827169,0.00586031743302765,-0.0339081080514511,-0.0109356637139827,0.00013082060464567
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,39706,-0.0243625941351584,0.00636815395519079,-0.0368441758873324,-0.0118810123829844,0.000131160017453532
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,41861,-0.0247406543182495,0.00647090652089563,-0.0374236310992049,-0.012057677537294,0.000132271825259559
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,40054,-0.0157254461611162,0.0041175866461567,-0.0237959159875834,-0.00765497633464909,0.000134688639424953
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",42094,-0.0134433704529046,0.00352061980219395,-0.0203437852652048,-0.00654295564060445,0.000134912056147509
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",39980,-0.0426857349743175,0.011190556370619,-0.0646192254607308,-0.0207522444879042,0.000137251895938071
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNST,Consortin,42144,-0.0425879092005551,0.0111994906170583,-0.0645389108099893,-0.0206369075911209,0.000143804994954238
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP7,Dipeptidyl peptidase 2,42062,-0.0237687531605319,0.00625993942196918,-0.0360382344275915,-0.0114992718934723,0.000147152937661937
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASPN,Asporin,40080,0.0110540660603808,0.00291192196627513,0.00534669900648154,0.01676143311428,0.000147763507195924
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,39706,0.0152566972405824,0.00401904252104615,0.00737937389933195,0.0231340205818329,0.000147814801597359
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1,Integrin beta-1,42146,0.00838851319053349,0.00221003133574895,0.00405685177246555,0.0127201746086014,0.000147926141442512
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,42120,-0.0197594530590008,0.0052126946343436,-0.0299763345423143,-0.00954257157568736,0.000150941869224507
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,41861,-0.0329925586625125,0.00871953365453911,-0.0500828446254092,-0.0159022726996159,0.000155192768896385
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARSB,Arylsulfatase B,42094,-0.0214223179609464,0.00567586606507981,-0.0325470154485028,-0.01029762047339,0.000161188098597666
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ING1,Inhibitor of growth protein 1,41810,-0.018326395404761,0.00486048875608607,-0.0278529533666897,-0.00879983744283231,0.000163674668646194
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,41861,-0.0128924401804763,0.00342782472809699,-0.0196109766475464,-0.00617390371340616,0.000169919778790273
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,42091,-0.0105095147462782,0.00280223061821861,-0.0160018867579867,-0.00501714273456968,0.00017731772722681
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRLF1,Cytokine receptor-like factor 1,42184,-0.00972921656376706,0.00259743800708703,-0.0148201950576576,-0.00463823806987649,0.000180671020005805
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,42167,-0.0252617618747637,0.00674475884472745,-0.0384814892104295,-0.0120420345390979,0.00018089209913511
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,42162,0.0336949676110574,0.00900960986386863,0.0160361322778749,0.0513538029442399,0.0001848918795902
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP5,Microfibrillar-associated protein 5,42296,-0.0158852265161102,0.00425178762728008,-0.0242187302655792,-0.00755172276664123,0.000187668140142184
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,42120,-0.0218495475383548,0.00584907275792029,-0.0333137301438785,-0.010385364932831,0.000188105182761609
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,42296,0.00878680844464833,0.00235350292672948,0.00417394270825855,0.0133996741810381,0.000189634937176335
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,42227,-0.0324433991734053,0.0086955043353918,-0.0494865876707732,-0.0154002106760374,0.000191489596694796
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHAD,Chondroadherin,39863,0.0199916203255626,0.00536192581107476,0.0094822457358561,0.0305009949152692,0.000193665404565539
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,41887,-0.017741313007697,0.0047609731338668,-0.0270728203500759,-0.00840980566531803,0.000195073143434332
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDHD2,Phospholipase DDHD2,40054,-0.0250586422463428,0.00673556584285711,-0.0382603512983427,-0.0118569331943428,0.000199952227715435
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGA,Protein O-GlcNAcase,40021,-0.0267636782307425,0.00720513037993585,-0.0408857337754168,-0.0126416226860683,0.000204604566274104
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLSCR3,Phospholipid scramblase 3,40028,-0.0220239969978095,0.00594013565158036,-0.033666662874907,-0.010381331120712,0.00021022776147971
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR3,Toll-like receptor 3,42256,-0.0234198325182237,0.00631925169443091,-0.0358055658393083,-0.0110340991971391,0.000211337463874882
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN2,Nectin-2,42122,-0.0121307158167936,0.00327323100041097,-0.0185462485775991,-0.00571518305598809,0.0002114059193058
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,40002,-0.015716233754552,0.00424972538954651,-0.0240456955180632,-0.00738677199104086,0.00021822963133506
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,39804,-0.0121156708908998,0.0032794724047168,-0.0185434368041447,-0.00568790497765483,0.000221517629182538
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,39804,-0.0165098661556878,0.00447040131696014,-0.0252718527369297,-0.00774787957444593,0.000222604482875826
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,42168,0.0202165956254634,0.00547580175736952,0.00948402418101912,0.0309491670699077,0.000223419864813824
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,42262,-0.00733426291077877,0.00198985752293506,-0.0112343836557315,-0.00343414216582604,0.000228886550845327
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF6,SLAM family member 6,41861,-0.0147948512256509,0.00401527978627887,-0.0226647996067575,-0.00692490284454434,0.000229982629640034
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100P,Protein S100-P,41876,-0.0207563503065751,0.00563382027508524,-0.0317986380457422,-0.00971406256740805,0.000230339752394879
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNAS,Neuroendocrine secretory protein 55,40054,-0.0326205528842762,0.00887470139038938,-0.0500149676094394,-0.0152261381591131,0.000238360525925887
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,42091,0.0129284385816648,0.00351830734603291,0.0060325561834403,0.0198243209798893,0.000239169747405779
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSPN,Persephin,42103,-0.0353035656921481,0.00961563925672841,-0.0541502186353358,-0.0164569127489605,0.000242128929546072
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBPL,FK506-binding protein-like,40021,-0.0220748927535656,0.00601575668170523,-0.0338657758497078,-0.0102840096574234,0.00024418063002825
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDRKH,Tudor and KH domain-containing protein,41829,-0.0318558522955457,0.00873795067816018,-0.0489822356247397,-0.0147294689663517,0.000267746694648065
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PZP,Pregnancy zone protein,40113,0.0190583486188518,0.00523167118356241,0.00880427309906945,0.0293124241386341,0.000270853930442218
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,41861,-0.0149226974173143,0.00409722389768181,-0.0229532562567706,-0.0068921385778579,0.000271450841807341
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,41928,-0.0181414304670119,0.00498236091891681,-0.0279068578680888,-0.00837600306593495,0.000272518754693314
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEFTY2,Left-right determination factor 2,42193,-0.0186836844197974,0.00514298545593801,-0.0287639359134359,-0.00860343292615887,0.000281389507395288
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,39863,-0.0121841366576416,0.00335594483528665,-0.0187617885348034,-0.00560648478047975,0.000284072789203175
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,39784,-0.0362060512914257,0.00997373646073551,-0.0557545747544673,-0.0166575278283841,0.000284603961491711
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,42004,-0.0354471746045335,0.00976625326195322,-0.0545890309979619,-0.0163053182111052,0.000285013431800303
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,42004,-0.0108703742874179,0.00299663041951018,-0.0167437699096578,-0.00499697866517793,0.000287254709236559
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREML2,Trem-like transcript 2 protein,42120,0.0130398219231218,0.00360102045334855,0.00598182183455869,0.020097822011685,0.000294422675143811
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,42223,0.0127331885884825,0.00351678791050961,0.00584028428388363,0.0196260928930813,0.000294936356034151
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,42296,-0.010307056876631,0.00284685016246169,-0.0158868831950559,-0.00472723055820609,0.000295128925146461
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,42223,-0.0127819009243061,0.00354104241516322,-0.019722344058026,-0.00584145779058623,0.000307768012276786
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGKA,Diacylglycerol kinase alpha,39784,-0.0203389950036197,0.0056383822129924,-0.0313902241410848,-0.0092877658661546,0.000310896808163654
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,39724,-0.0159768660798002,0.00443057853171347,-0.0246608000019586,-0.00729293215764182,0.000312336876318053
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C7orf50,Uncharacterized protein C7orf50,40054,-0.00842343323821221,0.00233716118430564,-0.0130042691594513,-0.00384259731697316,0.000314601555752808
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNC5D,Netrin receptor UNC5D,39784,0.00973276531672187,0.00270895348688644,0.00442321648242445,0.0150423141510193,0.00032861006497925
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,42094,-0.0164380411791606,0.0045806585670562,-0.0254161319705908,-0.00745995038773046,0.000333721282763374
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRZB,Secreted frizzled-related protein 3,41963,0.00921616618381347,0.00256853646917427,0.0041818347042319,0.014250497663395,0.00033434276055768
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH9,Protocadherin-9,40021,-0.0127574101504021,0.00355774836766682,-0.0197305969510291,-0.00578422334977515,0.000337513160271311
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPARCL1,SPARC-like protein 1,42153,0.0102922557249756,0.00287290795217877,0.00466135613870524,0.015923155311246,0.000341540453890147
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,41861,-0.021919102011236,0.00612807126562308,-0.0339301216918572,-0.00990808233061477,0.000349075592801192
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,40020,-0.0290319142725894,0.00811942307033013,-0.0449459834904365,-0.0131178450547424,0.000350930764699751
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMMT,MICOS complex subunit MIC60,40020,-0.0165807328430243,0.00464452624043821,-0.0256840042742832,-0.00747746141176542,0.000358594064770764
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIAE,Sialate O-acetylesterase,42154,-0.0168973827308013,0.00473904879896107,-0.026185918376765,-0.00760884708483763,0.000364381651219718
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12A_IL12B,Interleukin-12,42094,-0.030079588632768,0.00847573523255559,-0.046692029688577,-0.0134671475769591,0.00038821009031772
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,42217,-0.0115580194165582,0.00325778982524473,-0.0179432874740379,-0.00517275135907851,0.000389814504008894
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,40021,-0.014576651934013,0.00410842522193495,-0.0226291653690055,-0.0065241384990205,0.000389825730400635
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",39804,-0.0249850669390141,0.00704611071957365,-0.0387954439493784,-0.0111746899286497,0.000392905251598782
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASET2,Ribonuclease T2,42255,-0.010124712495985,0.00286295299123863,-0.0157361003588128,-0.00451332463315733,0.000406936456906925
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,40054,0.0137344537312721,0.00388787018908965,0.00611422816065638,0.0213546793018878,0.000413137172617803
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,42120,-0.0109389190288741,0.0030967480246872,-0.017008545157261,-0.00486929290048717,0.000413258621171683
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP7,Matrilysin,41854,-0.018441547671504,0.00522519005973409,-0.0286829201885829,-0.00820017515442522,0.000418052909123545
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS1,Galectin-1,42144,0.0128335734840009,0.00364449670107803,0.00569035994988796,0.0199767870181138,0.000430821058949792
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,39706,-0.01664867508186,0.00473222201254594,-0.0259238302264501,-0.00737351993726996,0.000436399287101156
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,42126,-0.0106812763473552,0.00303753905849446,-0.0166348529020044,-0.00472769979270608,0.000438899878637513
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18,Interleukin-18,42078,-0.016825476165647,0.00479073605787651,-0.026215318839085,-0.00743563349220908,0.000446126345935944
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,41861,-0.0280722452034447,0.00799305128401501,-0.0437386257201141,-0.0124058646867753,0.000446160179862889
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,41876,-0.0126782701905584,0.0036104373919375,-0.0197547274787559,-0.00560181290236095,0.000447032052355393
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPE,Carboxypeptidase E,42093,0.0139765139610884,0.00398900848108947,0.00615805733815307,0.0217949705840238,0.000460299473159074
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH17,Protocadherin-17,42144,-0.0135163747323663,0.00386609465933207,-0.0210939202646571,-0.0059388292000754,0.00047363683271657
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",40054,0.032944694167262,0.00943370690160096,0.0144546286401241,0.0514347596943999,0.000480906712418728
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,42129,-0.021097494474383,0.00604794884280283,-0.0329514742062766,-0.00924351474248948,0.000487587304218238
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA1,Alpha-1-antitrypsin,39906,0.00293145350475076,0.000840544182076139,0.00128398690788153,0.00457892010161999,0.000489393666391604
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NIT2,Omega-amidase NIT2,40033,-0.026074549797803,0.00749527528444204,-0.0407652893553093,-0.0113838102402966,0.000505646022620788
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,40054,-0.0168880382894205,0.00486039156847917,-0.0264144057636397,-0.00736167081520135,0.000513564255024572
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAA80,N-alpha-acetyltransferase 80,39768,-0.0431318347218282,0.0124154008525066,-0.0674660203927412,-0.0187976490509153,0.000514701889654074
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFH,Complement factor H,39548,-0.00821552247841186,0.00236592369054294,-0.012852732911876,-0.00357831204494771,0.0005178610815361
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,39863,-0.0134924973068859,0.00389254962659592,-0.0211218945750139,-0.00586310003875785,0.000529876772907678
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST3,Cystatin-C,42168,-0.0108448107353966,0.00313080032947721,-0.0169811793811719,-0.00470844208962127,0.000534103329076749
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSTB,Cystatin-B,41949,-0.015240616590336,0.00440506431164552,-0.0238745426411612,-0.00660669053951077,0.000542355555203742
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP13,Collagenase 3,41829,0.0119007541739928,0.00344367576370076,0.00515114967713929,0.0186503586708463,0.000550406469361024
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD63,CD63 antigen,41984,-0.0181439268601074,0.0052541291489458,-0.0284420199920411,-0.00784583372817362,0.000555627402239868
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",39804,0.0246207535125981,0.00713130731241197,0.0106433911802706,0.0385981158449256,0.000557608492325314
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE4,Ribonuclease 4,39755,-0.0103798125476888,0.00301486588579785,-0.0162889496838526,-0.00447067541152503,0.000577792998971448
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAMR1,Inactive serine protease PAMR1,42120,-0.00948252204189902,0.00275448394189529,-0.0148813105680138,-0.00408373351578425,0.000578025303590547
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,42120,0.0186953016755499,0.0054308269254067,0.00805088090175273,0.029339722449347,0.000578314798786003
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM26,Tripartite motif-containing protein 26,39665,-0.0199723846744058,0.00581305100160922,-0.0313659646375599,-0.00857880471125173,0.000593136297774341
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,39752,-0.0198557999953645,0.00578121505846927,-0.0311869815099642,-0.00852461848076469,0.000595847740744443
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,42197,0.0128304218648993,0.00373623814941164,0.00550739509205248,0.0201534486377461,0.000596493180527356
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPCAM,Epithelial cell adhesion molecule,42125,-0.0350221318446403,0.0101992986227505,-0.0550127571452314,-0.0150315065440493,0.000597096849436072
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,40021,0.0249566883960771,0.00726955253439423,0.0107083654286644,0.0392050113634898,0.000599080589734689
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXJ3,Forkhead box protein J3,39784,-0.0153330301233749,0.0044897850633067,-0.024133008847456,-0.00653305139929379,0.00063999674065891
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,39863,-0.0203131716168695,0.00596056961523479,-0.0319958880627297,-0.00863045517100935,0.000657008996177927
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRAP,BRCA1-associated protein,39916,-0.0381857689261363,0.0112072374934384,-0.0601519544132757,-0.016219583438997,0.000658640825707369
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYTL1,Cytokine-like protein 1,40097,0.00899698646350218,0.00264139915145659,0.00381984412664726,0.0141741288003571,0.000661251631126031
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NLGN2,Neuroligin-2,39719,0.0168445085392046,0.00494759565115193,0.00714722106294676,0.0265417960154623,0.00066512082154778
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,40102,0.00946658022576992,0.00278471602942319,0.00400853680810047,0.0149246236434394,0.000677564614636607
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",39804,0.0266836587145178,0.00785019148265445,0.011297283408515,0.0420700340205205,0.000678545246598937
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,40010,0.00959628639434897,0.00282424175873291,0.00406077254723247,0.0151318002414655,0.00068168111572436
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,42213,-0.01831046275989,0.00539005372670477,-0.0288749680642314,-0.00774595745554869,0.000683119686401972
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,42256,-0.0234076763231183,0.00689178360482812,-0.0369155721885814,-0.00989978045765514,0.000684666569654328
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRK1,Protein BRICK1,41829,0.0158421067581788,0.00466656644051979,0.00669563653475999,0.0249885769815976,0.000688874447137246
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53,Cellular tumor antigen p53,41861,-0.01507530108384,0.00445027749313863,-0.0237978449703917,-0.00635275719728828,0.000707481776982515
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLL1,Delta-like protein 1,42186,0.0110499932281894,0.00326247263892216,0.00465554685590192,0.0174444396004768,0.000708710608571552
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",42178,-0.0250399026056987,0.00740365049448142,-0.0395510575748823,-0.0105287476365151,0.000721456831342896
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,42121,-0.0213232065000475,0.0063065077578559,-0.033683961705445,-0.00896245129464991,0.000723986468321718
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,40021,-0.0479972249865573,0.0142064001851956,-0.0758417693495407,-0.0201526806235739,0.000731225502993657
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEP1B,Meprin A subunit beta,42144,-0.0412571765870047,0.0122169149929825,-0.0652023299732504,-0.0173120232007589,0.000734823832868853
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD14,Monocyte differentiation antigen CD14,41927,0.0146094302420789,0.00432633429564096,0.00612981502262257,0.0230890454615351,0.000735374417855444
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,40021,-0.0287296757080558,0.00851742160838003,-0.0454238220604807,-0.012035529355631,0.000746014323443627
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",39706,0.0195157536295233,0.00583424320745803,0.00808063694290557,0.0309508703161411,0.000825598368043076
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELP,P-selectin,42197,-0.0193208729952435,0.00578138420471417,-0.0306523860364833,-0.00798935995400376,0.000834382155215785
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK4,Kallikrein-4,42223,0.0219776529680009,0.00657880719200829,0.00908319087166461,0.0348721150643371,0.000838099775404823
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP5,Platelet glycoprotein V,39863,0.0123140410679977,0.00370269270643899,0.00505676336337729,0.0195713187726181,0.000884948144244484
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,40054,-0.0123599455037739,0.00372353967697362,-0.0196580832706422,-0.00506180773690562,0.000905056903032037
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BSG,Basigin,42248,-0.00745952368046839,0.00225428930346529,-0.0118779307152604,-0.00304111664567642,0.000938713381408579
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOE,Apolipoprotein E,40113,-0.0245944163672747,0.00743707484032822,-0.039171083054318,-0.0100177496802314,0.000946049835810583
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,40021,-0.0349055373542667,0.0105715066442818,-0.0556256903770591,-0.0141853843314743,0.000963601784523278
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",40021,0.0298555601389828,0.00904346316396993,0.0121303723376018,0.0475807479403639,0.000965350983118195
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB44,Ras-related protein Rab-44,40020,-0.014259536009173,0.00432352877604834,-0.0227336524102277,-0.00578541960811827,0.000976468738429739
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,39863,0.00943790747020151,0.00286396584385717,0.00382453441624146,0.0150512805241616,0.000986029952411749
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,41876,-0.0184111817188466,0.00559461189337417,-0.02937662102986,-0.00744574240783324,0.00100148123265674
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,39863,-0.0224412990205372,0.00682229124955839,-0.0358129898696716,-0.00906960817140275,0.00100723735651945
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA7A,Semaphorin-7A,42262,-0.00965631306610122,0.0029379419722724,-0.0154146793317551,-0.00389794680044731,0.00101614092313835
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,42213,-0.0322496370175899,0.00981746841345234,-0.0514918751079565,-0.0130073989272233,0.00102279389912755
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,40054,0.0154437610720274,0.00470130948268399,0.0062291944859668,0.024658327658088,0.00102308552185731
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK11,Serine/threonine-protein kinase STK11,41876,-0.0245124537531672,0.00746922417029228,-0.0391521331269401,-0.00987277437939434,0.00103427750723314
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SATB1,DNA-binding protein SATB1,40054,-0.00989886695433587,0.00301763761545881,-0.0158134366806351,-0.00398429722803661,0.00104010038955011
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHCHD6,MICOS complex subunit MIC25,40020,-0.00976699152879087,0.00298296654422777,-0.0156136059554773,-0.00392037710210443,0.00106273748614374
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,39706,-0.00962429362016367,0.00294562427721517,-0.0153977172035054,-0.00385087003682194,0.00108919628509922
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,42177,0.00819349096178919,0.00250865442374437,0.00327652829125023,0.0131104536323281,0.00109326395525322
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,42103,0.0195126381790777,0.00597682656304338,0.00779805811551269,0.0312272182426427,0.00109859428630841
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,40054,-0.0178221695622671,0.00545952553584295,-0.0285228396125193,-0.0071214995120149,0.00110028956506247
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN2,Calsyntenin-2,42256,-0.0134295435335684,0.00411484018035255,-0.0214946302870594,-0.00536445678007745,0.0011025592900973
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,39804,-0.0140423892676508,0.00430260252116855,-0.0224754902091412,-0.00560928832616045,0.00110316934479947
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD5,Sushi domain-containing protein 5,39816,0.0117150613641842,0.00359419503222501,0.00467043910102314,0.0187596836273452,0.00111983822427538
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF7,SLAM family member 7,42103,0.0201114520425145,0.0061718942247143,0.00801453936207444,0.0322083647229545,0.00112271054620943
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CMIP,C-Maf-inducing protein,40020,-0.0277540063723236,0.00852657829208124,-0.0444660998248028,-0.0110419129198444,0.00113740940837993
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAT,Linker for activation of T-cells family member 1,42256,-0.0251922097220822,0.00774211217128385,-0.0403667495777985,-0.0100176698663658,0.00114113904226004
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,39768,-0.0162423809913196,0.0049954429907211,-0.0260334492531329,-0.00645131272950623,0.00115181824655102
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",42144,-0.0244677602695635,0.00755443857033249,-0.0392744598674152,-0.00966106067171183,0.00120311449709389
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB27B,Ras-related protein Rab-27B,40080,-0.0273258197239163,0.00844587629444597,-0.0438797372610304,-0.0107719021868022,0.0012183369710132
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RLN2,Prorelaxin H2,39838,-0.0166628485462892,0.00515600275657689,-0.02676861394918,-0.00655708314339853,0.00123414277538285
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRLB,Fc receptor-like B,41861,-0.0217185359315318,0.00673388400819302,-0.0349169485875901,-0.00852012327547344,0.00126177050190758
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",40054,-0.0139123746420149,0.0043150785246937,-0.0223699285504146,-0.00545482073361526,0.00126729481786096
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,39863,0.0176896245458791,0.00548691702762667,0.00693526717173079,0.0284439819200273,0.00126809516606178
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D5,TBC1 domain family member 5,42103,-0.0260849674520118,0.00809397919721455,-0.0419491666785523,-0.0102207682254713,0.00127276250353806
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFRP1,Secreted frizzled-related protein 1,41966,0.0147231319110402,0.00457078881522366,0.00576438583320182,0.0236818779888786,0.00128003381651545
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROCR,Endothelial protein C receptor,39706,0.0115832530417017,0.00359790666303314,0.00453135598215676,0.0186351501012467,0.00128830338835653
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,42296,-0.00782564138659653,0.00243448115335692,-0.0125972244471761,-0.00305405832601698,0.00130988201066522
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA4D,Semaphorin-4D,42213,0.0098938328028609,0.00308051407348312,0.00385602521883398,0.0159316403868878,0.00132251041148622
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,41876,-0.0306194165489887,0.00956358779488558,-0.0493640486269644,-0.0118747844710129,0.00136972208451743
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APRT,Adenine phosphoribosyltransferase,41989,-0.0155498071076195,0.00486817331224472,-0.0250914267996192,-0.00600818741561989,0.00140570001551862
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOLM2,Protein GOLM2,42213,-0.00762925216810407,0.00238934572541204,-0.0123123697899117,-0.00294613454629647,0.00141123316880645
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,42144,-0.0124113923166945,0.00389493855039749,-0.0200454718754736,-0.00477731275791545,0.00144325450450317
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,42024,0.0137118764748924,0.00430969412180579,0.005264875996153,0.0221588769536317,0.00146794802209767
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,41828,-0.0256513620219199,0.00806282144256156,-0.0414544920493406,-0.00984823199449928,0.00146900625782923
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG4,Regenerating islet-derived protein 4,42146,-0.0173697254800123,0.00546432918785537,-0.0280798106882088,-0.00665964027181578,0.00148260510727478
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERI1,3'-5' exoribonuclease 1,39881,-0.0113090643563655,0.00355843281221187,-0.0182835926683007,-0.0043345360444302,0.00148664614889564
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCT,Secretin,39768,-0.0164026074824263,0.0051673042313964,-0.0265305237759632,-0.00627469118888931,0.0015062553033716
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JAM3,Junctional adhesion molecule C,39863,-0.0166033061675563,0.00523299947992494,-0.0268599851482092,-0.00634662718690342,0.00151400141404857
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDHB15,Protocadherin beta-15,40020,-0.0132020507201282,0.0041659209154631,-0.0213672557144358,-0.00503684572582047,0.00153358725881003
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",42094,-0.0193858919089717,0.00612101454146789,-0.0313830804102487,-0.00738870340769462,0.00154323749661072
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAU,Urokinase-type plasminogen activator,42120,0.00966159211218908,0.00305704449520103,0.00366978490159506,0.0156533993227831,0.00157896894634051
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,39768,-0.0226649244196204,0.00717704383671343,-0.0367319303395787,-0.00859791849966208,0.00159316061336117
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX4,Syntaxin-4,42094,-0.0193633910809814,0.00614147555456731,-0.0314006831679333,-0.00732609899402948,0.00162033683518497
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDCP1,CUB domain-containing protein 1,42004,-0.017629718079832,0.00560472411453679,-0.0286149773443241,-0.00664445881533992,0.00166176600778884
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,39784,-0.0281312035788172,0.00894451482442897,-0.045662452634698,-0.0105999545229365,0.00166501455899734
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,40080,-0.0157821615733398,0.00502469838998281,-0.0256305704177061,-0.00593375272897348,0.00168870672378592
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK13,Kallikrein-13,41897,-0.0149785210569971,0.0047714606404756,-0.0243305839123293,-0.00562645820166497,0.00169803592252099
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR3,Folate receptor gamma,42137,0.0602647658214075,0.0192133563781252,0.0226065873202822,0.0979229443225328,0.00171297503797549
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",39804,-0.0310733569992014,0.00991804280334948,-0.0505127208937664,-0.0116339931046364,0.00173492812097111
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL3,C-X-C motif chemokine 3,42128,0.0300629910538728,0.00960495148170339,0.0112372861497342,0.0488886959580115,0.00175226716642087
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,39784,-0.015804695057534,0.00505628119684597,-0.0257150062033521,-0.00589438391171588,0.00177828994553668
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,39804,-0.0146951935386847,0.00470798691643112,-0.0239228478948897,-0.00546753918247969,0.00180517946171647
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBS4,Thrombospondin-4,42161,-0.014782416050575,0.00473859900217357,-0.0240700700948351,-0.00549476200631476,0.0018150906342439
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,40102,-0.00874152716218509,0.00280351641510716,-0.0142364193357951,-0.00324663498857506,0.00182520538488797
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,39881,-0.0210848684497833,0.00676679644800737,-0.0343477894878777,-0.00782194741168882,0.00183851121125024
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,41861,-0.0140939979917293,0.00454222631222028,-0.0229967615636811,-0.00519123441977757,0.00192066932484542
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AAMDC,Mth938 domain-containing protein,39804,-0.0168691574558054,0.00543987110578308,-0.0275313048231402,-0.00620701008847054,0.00193359854911618
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP6,Bone morphogenetic protein 6,41861,-0.0129495310998401,0.00419041009537169,-0.0211627348867686,-0.00473632731291159,0.00200402900141325
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TG,Thyroglobulin,40020,0.0367675421564474,0.0119125113687879,0.0134190198736232,0.0601160644392717,0.00203063708798794
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXN,Thioredoxin,39961,-0.0141881612773876,0.00459784209241128,-0.0231999317785137,-0.00517639077626148,0.00203499529048042
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MIA,Melanoma-derived growth regulatory protein,42186,0.0120354588372075,0.00390267876014103,0.00438620846733107,0.0196847092070839,0.00204736963378153
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,40054,-0.0212408915965615,0.0068915352436588,-0.0347483006741328,-0.00773348251899026,0.00206011276989968
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,41810,-0.0210946537150342,0.0068463693938864,-0.0345135377270515,-0.00767576970301682,0.00206650505064031
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,39942,-0.0108225328347818,0.00352123407563035,-0.0177241516230173,-0.00392091404654632,0.00212089569757176
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMOTL2,Angiomotin-like protein 2,39975,-0.0152837676456958,0.00498223766592164,-0.0250489534709022,-0.00551858182048936,0.00216283214726789
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,42004,0.0115119814766687,0.00376319545385176,0.00413611838711928,0.0188878445662182,0.00222463479336445
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ULBP2,UL16-binding protein 2,42004,-0.0126596704636976,0.00414343726486845,-0.0207808075028398,-0.00453853342455542,0.00225256719942979
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,39804,0.0125819667779872,0.00412603168343478,0.00449494467845506,0.0206689888775194,0.00229855726885568
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD84,SLAM family member 5,42103,0.00985600928193604,0.00323261949685197,0.00352007506810618,0.0161919434957659,0.00230128018631344
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF1,Trefoil factor 1,42067,-0.0260797257079826,0.00858011161210875,-0.0428967444677157,-0.00926270694824942,0.00237403181587969
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,40054,-0.0106100178800756,0.00349513816799816,-0.017460488689352,-0.00375954707079919,0.00240585974791335
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH12,Protocadherin-12,40054,-0.00806893657992006,0.00265811623903749,-0.0132788444084335,-0.00285902875140658,0.00240638544128197
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,40097,-0.0160267400104886,0.00529010999425649,-0.0263953555992313,-0.00565812442174591,0.00245478605077914
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,42162,0.0276376359594063,0.00912299930662679,0.00975655731841777,0.0455187146003948,0.00245484855792189
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBP1,Z-DNA-binding protein 1,39784,-0.0125101336268117,0.00413007879216517,-0.0206050880594555,-0.00441517919416798,0.00245931363511159
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIPF,Gastric triacylglycerol lipase,39804,-0.0194470986163464,0.00643260078110297,-0.0320549961473082,-0.00683920108538457,0.00250706573504606
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,39784,-0.0109361510339072,0.00362639910392494,-0.0180438932776001,-0.0038284087902143,0.00256990284664729
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,40080,-0.0330652847317946,0.010979342958855,-0.0545847969311503,-0.0115457725324389,0.00260479471922391
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,42103,-0.0220796579901633,0.00735068678820508,-0.0364870040950453,-0.00767231188528137,0.00267181721626869
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,42103,-0.0344272933452444,0.011464879808999,-0.0568984577708823,-0.0119561289196064,0.00267978041574498
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA1,Annexin A1,39816,-0.0128684149802444,0.00428962556926,-0.021276081095994,-0.00446074886449482,0.0027070140354896
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF16,Fibroblast growth factor 16,39784,-0.0146974653294425,0.00490278559634997,-0.0243069250982884,-0.00508800556059654,0.00272586252470695
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",40054,0.0126803704019032,0.00423055736817108,0.00438847796028787,0.0209722628435185,0.00272972894996211
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,40020,-0.010530755450231,0.00351502380071523,-0.0174202020996328,-0.0036413088008291,0.00274231349749117
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIT,Vitrin,40080,-0.0119450881922048,0.00398996753979278,-0.0197654245701986,-0.00412475181421093,0.00276162756266389
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,42186,0.00855727704352589,0.0028588043869353,0.0029540204451327,0.0141605336419191,0.00276491723640589
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,42116,0.00692425244985073,0.00231378253806086,0.00238923867525145,0.01145926622445,0.00277124135188632
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,39881,-0.0215459166403589,0.00720599940836877,-0.0356696754807617,-0.0074221577999561,0.00279615562018787
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",39804,0.0280141419126792,0.0094035381951693,0.00958320705014736,0.046445076775211,0.0028974467692464
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNA1,Ephrin-A1,42099,0.00937576737952298,0.00314916070234236,0.00320341240293196,0.015548122356114,0.0029140826693039
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,41861,-0.0174207329849444,0.00585636009792168,-0.0288991987768709,-0.00594226719301792,0.00293857883621721
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR158,Probable G-protein coupled receptor 158,40054,0.0110591262207513,0.00372000969062046,0.00376790722713515,0.0183503452143674,0.00295671448854717
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTDH,Protein LYRIC,39784,-0.0287999716817306,0.00968869816782938,-0.0477898200906762,-0.00981012327278501,0.00296018269470186
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,39986,-0.0132856658285852,0.004469727230299,-0.0220463311999712,-0.00452500045719913,0.00296166304799429
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARK7,Parkinson disease protein 7,42120,-0.0158588415818885,0.00534051936429873,-0.026326259535914,-0.005391423627863,0.00298801691528798
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",42296,0.00897322933456947,0.00302717769146119,0.00303996105930554,0.0149064976098334,0.00303994566129272
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,39784,-0.0102854204120199,0.0034718867506585,-0.0170903184433106,-0.00348052238072929,0.00305842525444784
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,40097,0.010069991916873,0.00340706641044935,0.00339214175239223,0.0167478420813537,0.0031270961238314
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,42111,-0.0106228669920179,0.00359585899485292,-0.0176707506219296,-0.00357498336210614,0.00314051588910948
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",39847,-0.0257951887354778,0.00875515587137143,-0.0429552942433658,-0.00863508322758978,0.0032231180729895
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JAM2,Junctional adhesion molecule B,42213,-0.00869890268623617,0.00295428065836945,-0.0144892927766403,-0.00290851259583204,0.00324040516742869
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,42128,-0.0172658806730694,0.00586631236128165,-0.0287638529011815,-0.00576790844495741,0.00325388677206711
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS5,Transmembrane protease serine 5,41948,0.0116046567816735,0.00394436924899708,0.00387369305363927,0.0193356205097078,0.00326600376956551
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,42096,0.0183862386491938,0.00625654075841012,0.00612341876270995,0.0306490585356776,0.00330151427057229
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,40054,0.021391945168788,0.00728170226056307,0.00711980873808443,0.0356640815994917,0.00331280101946596
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB33A,Ras-related protein Rab-33A,39706,-0.0198575224055186,0.00677257222047895,-0.0331317639576573,-0.00658328085337986,0.00337458212476506
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,39804,-0.0147553590750815,0.00503396188222386,-0.0246219243642403,-0.00488879378592273,0.00338416911262312
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DMD,Dystrophin,39804,-0.0156012315648056,0.00532550056233263,-0.0260392126669776,-0.00516325046263364,0.0034019425747231
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNR,Tenascin-R,42004,0.0128541351771518,0.00438850411701921,0.00425266710779413,0.0214556032465094,0.00340602174967781
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,39863,-0.0126776536691964,0.00433264398638224,-0.0211696358825056,-0.00418567145588721,0.00343988815907685
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN2L,Ataxin-2-like protein,40054,-0.0145587098423694,0.00497651368060815,-0.0243126766563614,-0.00480474302837747,0.00344633054603968
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,42142,0.0114050676283419,0.00390164764797404,0.00375783823831275,0.019052297018371,0.00347118965614833
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,42094,-0.0137602026595678,0.00470937764966643,-0.022990582852914,-0.00452982246622165,0.00348537105699428
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,42016,-0.00884392607256991,0.00302783203904101,-0.0147784768690903,-0.00290937527604953,0.00349655602161017
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,40054,-0.0291682726907048,0.0100004918706758,-0.0487692367572292,-0.0095673086241803,0.00354498529812366
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFD,Complement factor D,40113,0.00632739283603754,0.00217066099260138,0.00207289729053883,0.0105818883815363,0.00356455465418533
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,39804,-0.0096817977533305,0.00332927262587019,-0.0162071721000361,-0.00315642340662492,0.00364406946085296
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,41876,-0.0283137076089116,0.00974200838671943,-0.0474080440468817,-0.00921937117094153,0.00366302443822295
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD164,Sialomucin core protein 24,42120,-0.00822573171099236,0.00283640037614561,-0.0137850764482378,-0.00266638697374697,0.00373719588181168
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DENR,Density-regulated protein,39784,-0.0169928923350992,0.0058828037194125,-0.0285231876251477,-0.00546259704505074,0.00387781926852835
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH5,Cadherin-5,42296,0.00896474323691859,0.00310690847395601,0.00287520262796481,0.0150542838458724,0.00391526685219331
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBQLN3,Ubiquilin-3,39706,-0.0161494037243213,0.00560317969962675,-0.0271316359355898,-0.0051671715130529,0.00395727090997607
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FXN,"Frataxin, mitochondrial",42223,0.0217696253733989,0.00755813314276072,0.00695568441358786,0.0365835663332099,0.00397955612220241
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,39803,-0.0165378602489797,0.00574417162198476,-0.0277964366280698,-0.00527928386988953,0.00399649876106724
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,42223,0.0176923487187182,0.00614908838807885,0.00564013547808364,0.0297445619593527,0.00401833146475048
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",41829,-0.0152993854939149,0.00532347712147336,-0.0257334006520027,-0.00486537033582712,0.00406054438918098
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREML1,Trem-like transcript 1 protein,40102,0.0155316138810158,0.00540897792807764,0.00493001714198363,0.026133210620048,0.00409379333909375
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP1,DNA topoisomerase 1,40021,-0.0332707568292419,0.0115994373033439,-0.0560056539437959,-0.0105358597146878,0.00413471369246108
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",40054,-0.0233542160202479,0.00817119935346039,-0.0393697667530303,-0.00733866528746557,0.00426978398377351
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSC22D1,TSC22 domain family protein 1,40054,-0.0191841221084919,0.00671606879321741,-0.0323476169431981,-0.00602062727378581,0.00429219137408489
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,40102,-0.0120065495289014,0.00420569269689255,-0.0202497072148108,-0.00376339184299203,0.00431406930210896
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY6D,Lymphocyte antigen 6D,42059,0.012100781122266,0.00424243617697247,0.00378560621539997,0.0204159560291321,0.00434706999481516
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,42280,-0.00842918324726383,0.00296092141771867,-0.0142325892259924,-0.00262577726853524,0.00442282997062996
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F12,Coagulation factor XII,40113,-0.0121215447401102,0.00426155605424021,-0.020474194606421,-0.00376889487379942,0.00445787031980896
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,39804,-0.00982352466324203,0.00346161832997846,-0.0166082965899998,-0.00303875273648424,0.00455058888582903
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YTHDF3,YTH domain-containing family protein 3,41887,-0.0247978700414726,0.00873998852474808,-0.0419282475499789,-0.00766749253296637,0.00455705666203038
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO1,Roundabout homolog 1,42146,-0.00719176535256173,0.00254054005341776,-0.0121712238572605,-0.00221230684786292,0.00465030008059753
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIM,Vimentin,41876,-0.0336279428300226,0.0118868094253475,-0.0569260893037037,-0.0103297963563416,0.00467650298545598
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,39719,0.0174120283045393,0.00615922339962224,0.00533995044127971,0.0294841061677989,0.00470772593681707
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,39719,0.0180274697336071,0.006382081341785,0.00551859030370851,0.0305363491635057,0.00474138094394659
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB6,Integrin beta-6,41887,-0.0091159650404049,0.00322865625639696,-0.0154441313029429,-0.00278779877786687,0.00475830951201478
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,42296,-0.0110614342175778,0.0039438225269383,-0.0187913263703768,-0.00333154206477869,0.00504298535798173
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,39804,0.0101631747452868,0.00363414888322255,0.00304024293417055,0.017286106556403,0.00517401521190922
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNG,Interferon gamma,41887,-0.0326350088544485,0.0116749839549529,-0.0555179774061562,-0.00975204030274089,0.00519304520365274
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,40020,-0.025222274834884,0.00902871653552869,-0.0429185592445202,-0.00752599042524778,0.00522227000859115
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,41829,-0.0184004517684886,0.00658808300908213,-0.0313130944662896,-0.0054878090706876,0.00523018093123613
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,42184,-0.011651821656692,0.00417232830638292,-0.0198295851372025,-0.00347405817618144,0.0052355870920764
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,40054,-0.0109769241394995,0.00394178430396453,-0.01870282137527,-0.00325102690372902,0.0053660068850622
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNU13,NHP2-like protein 1,39706,-0.018262602208612,0.00657334200470614,-0.0311463525378361,-0.005378851879388,0.00547439909864268
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLIC5,Chloride intracellular channel protein 5,39768,0.00904952973217888,0.00326457725401204,0.00265095831431528,0.0154481011500425,0.00558041047407911
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOL1,Apolipoprotein L1,40102,0.0166047164421302,0.00599282007370372,0.00485878909767087,0.0283506437865894,0.00560188597377797
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL4,C-C motif chemokine 4,42150,-0.0194631815109948,0.00703438148761717,-0.0332505692267244,-0.0056757937952651,0.00566784992010272
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMA,Granzyme A,42256,-0.0101618238719196,0.00367699174983756,-0.0173687277016012,-0.00295492004223799,0.00572433662932916
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MST1,Hepatocyte growth factor-like protein,39944,0.0187192260195012,0.0067796609811028,0.00543109049653971,0.0320073615424627,0.00577072470646363
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,39804,-0.0215840505644701,0.00782975474154031,-0.0369303698578891,-0.00623773127105105,0.0058493014192871
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,42256,-0.0101833184136702,0.00369768207520208,-0.0174307752810663,-0.00293586154627411,0.00589579608943352
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,42004,0.014814160060328,0.00538156796551893,0.00426628684791085,0.0253620332727451,0.00591785704651838
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F13B,Coagulation factor XIII B chain,40055,-0.00732250047498141,0.00266109449991381,-0.0125382456948125,-0.00210675525515034,0.00593873910422924
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,39706,-0.0188649369960567,0.00686331452002134,-0.0323170334552986,-0.00541284053681488,0.00599410447330467
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,40054,-0.0186134502031119,0.00677225675668978,-0.0318870734462238,-0.00533982695999988,0.00599701466102002
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,42167,-0.0198348842804419,0.00721951926452378,-0.0339851420389085,-0.00568462652197527,0.00601533349775859
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,40020,-0.0147251580345711,0.00536794641512494,-0.025246333008216,-0.00420398306092625,0.0060950378022997
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPING1,Plasma protease C1 inhibitor,40092,0.00516721975919945,0.00188857458052441,0.00146561358137161,0.00886882593702729,0.00622837359960223
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FN1,Fibronectin,40113,-0.00749642852823913,0.00274170146487308,-0.0128701633993904,-0.00212269365708789,0.00626281197771921
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYT1,Synaptotagmin-1,40054,0.0119228108815466,0.00436111327773169,0.0033750288571925,0.0204705929059007,0.00626920632916987
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_A,,40054,0.00934964225392241,0.0034247144705624,0.00263720189162011,0.0160620826162247,0.00634267772586049
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLIT2,Slit homolog 2 protein,41829,-0.0147859811286975,0.00542090433804185,-0.0254109536312596,-0.00416100862613552,0.00638877949749277
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,39706,-0.0188573045547825,0.00692155891995269,-0.0324235600378897,-0.0052910490716752,0.00645190196167861
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCBP2,Poly(rC)-binding protein 2,40054,-0.0201041744455283,0.00739355242650684,-0.0345955372014817,-0.00561281168957488,0.00655540236583129
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPP,Lipoma-preferred partner,39706,-0.0184410240243508,0.00678197627315945,-0.0317336975197433,-0.00514835052895826,0.00655628250629589
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CETN2,Centrin-2,41829,-0.0188774304651367,0.0069458096417122,-0.0324912173628926,-0.00526364356738081,0.00658040254369762
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MICALL2,MICAL-like protein 2,39768,-0.0193315634216184,0.00712090589231943,-0.0332885389705645,-0.00537458787267236,0.00664310720723461
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,40021,-0.0221373020299468,0.00815634161219576,-0.0381237315898505,-0.0061508724700431,0.00665570102681181
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",40097,-0.0114157611136452,0.0042098969984055,-0.0196671592305199,-0.00316436299677038,0.00670544577404193
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,42080,-0.0514114305486925,0.0189674287412107,-0.0885875908814656,-0.0142352702159195,0.0067268496287838
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,40054,-0.0162275585521287,0.00599133104058888,-0.0279705673916829,-0.00448454971257454,0.00676927061948507
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,39719,0.00811718965799687,0.00300564573904292,0.00222612400947275,0.014008255306521,0.0069315370181164
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,42223,-0.0149348355153397,0.00553150803077519,-0.0257765912556591,-0.00409307977502034,0.00694379198896347
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,39700,-0.00958571155051312,0.00355020860279571,-0.0165441204119927,-0.00262730268903353,0.00694418100265722
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,41876,0.00990920713404485,0.00367575694030831,0.00270472353104057,0.0171136907370491,0.00703066235210378
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,42094,0.00741322588965974,0.00275109467711397,0.00202108032251635,0.0128053714568031,0.0070554726184479
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,39784,-0.0247062155259632,0.00916958226582558,-0.0426785967669813,-0.00673383428494502,0.00706337769604235
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,42126,-0.0105824172720483,0.00393277472022009,-0.0182906557236797,-0.00287417882041693,0.00713667021791022
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SWAP70,Switch-associated protein 70,40021,-0.0098916011486869,0.00367640176555922,-0.017097348609183,-0.00268585368819083,0.00714404173841757
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,40021,-0.0113405828002408,0.00421693664500191,-0.0196057786244446,-0.00307538697603708,0.0071713005851845
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP3,Stromelysin-1,42120,0.0140410908574825,0.0052255106320457,0.00379909001867289,0.0242830916962921,0.00721832412112474
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOC1,Apolipoprotein C-I,40092,0.0101492655010713,0.00377747423786352,0.00274541599485878,0.0175531150072838,0.00722525623635653
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,41861,-0.0110382427672903,0.00411586822290672,-0.0191053444841875,-0.00297114105039316,0.00733058010230853
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",39804,-0.0234445280410719,0.00874815093195416,-0.040590903867702,-0.00629815221444173,0.00737488381944718
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPO,Lactoperoxidase,41661,-0.0167318624606626,0.00625861357043994,-0.0289987450587249,-0.00446497986260033,0.00751814194358463
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNPEP,Aspartyl aminopeptidase,40054,-0.0157016204680978,0.00588591789937332,-0.0272380195508695,-0.00416522138532611,0.00764951303468673
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNMT,Histamine N-methyltransferase,41949,-0.0132395280424371,0.00496494415661213,-0.0229708185893969,-0.00350823749547734,0.00767191043358648
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNG,Uracil-DNA glycosylase,40020,0.00936509206288155,0.0035156257956128,0.00247446550348047,0.0162557186222826,0.00773669093317078
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP10,Caspase-10,41829,-0.0196363773328929,0.0073739281016637,-0.0340892764121537,-0.00518347825363205,0.0077557851705072
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPHN1,Oligophrenin-1,40054,-0.0291074041017618,0.0109814784487777,-0.0506311018613661,-0.00758370634215757,0.00804676846544004
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC51B,Organic solute transporter subunit beta,39706,-0.0209799248603633,0.00794281022409396,-0.0365478328995875,-0.00541201682113912,0.00826929227872711
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",42103,-0.0116128822587568,0.00439719082741183,-0.020231376280484,-0.0029943882370296,0.00827667448233688
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,39706,0.00566554132777188,0.00215329202629273,0.00144508895623813,0.00988599369930563,0.00852314737339858
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TK1,"Thymidine kinase, cytosolic",39881,-0.0123109242220019,0.00467972178091721,-0.0214831789125996,-0.00313866953140412,0.00853325178019949
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASC3,Protein CASC3,39768,-0.0113819130787089,0.00433259099445542,-0.0198737914278416,-0.0028900347295763,0.00862541111064574
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPL,Periplakin,39784,-0.0089314233631965,0.00340630014207067,-0.015607771641655,-0.00225507508473799,0.00875326281235931
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGRN,Neugrin,40054,-0.00627855776508368,0.00240172122696333,-0.0109859313699318,-0.00157118416023555,0.0089562505564208
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,40544,0.00857364283826014,0.00328033415192513,0.00214418790048688,0.0150030977760334,0.00896991780551766
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMT,Catechol O-methyltransferase,41741,-0.0223471948189049,0.00855969394797781,-0.0391241949569415,-0.00557019468086844,0.00904521477041877
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO1,Alpha-enolase,42095,0.0211801721833125,0.00812740154389503,0.0052504651572782,0.0371098792093467,0.00917063248406717
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAL,Galanin peptides,42184,0.0173373892086301,0.00665703015597377,0.00428961010292153,0.0303851683143387,0.00921473395715473
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A12,Protein S100-A12,41947,-0.0202062598014748,0.0077644726348575,-0.0354246261657955,-0.00498789343715413,0.00926810131372251
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MATN3,Matrilin-3,41984,0.00882921118195243,0.00339346710800961,0.0021780156502536,0.0154804067136513,0.00928357260516688
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,42093,0.00887047942832462,0.00341063733883066,0.00218563024421652,0.0155553286124327,0.00931053190145918
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,41861,-0.0243483928732209,0.00936650369038079,-0.0427067401063673,-0.00599004564007457,0.00934631239279073
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,42184,-0.0279244210162981,0.0107476572007216,-0.0489898291297124,-0.00685901290288378,0.00938233028079587
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,42144,-0.0179365878287923,0.00690430967021339,-0.0314690347824105,-0.00440414087517401,0.00939066660214045
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN2,Contactin-2,42223,-0.0119178337857896,0.00460009411587285,-0.0209340182529004,-0.00290164931867881,0.00958652652205117
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGA4,Pepsin A-4,40102,-0.0216556373861201,0.00837421103355658,-0.038069091011891,-0.00524218376034916,0.00972277500692292
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,42213,-0.00623690020025628,0.00241466911981227,-0.0109696516750883,-0.00150414872542423,0.00980757478036738
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,42103,0.00880893818311419,0.00341998908616266,0.00210575957423538,0.015512116791993,0.0100141471217081
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAFB2,Scaffold attachment factor B2,40054,-0.0072991096534115,0.00283534573386807,-0.0128563872917929,-0.00174183201503009,0.0100566293187765
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YJU2,Splicing factor YJU2,40020,-0.00862050824974954,0.00334987034299525,-0.0151862541220202,-0.00205476237747886,0.0100840778643482
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOBR,Apolipoprotein B receptor,39804,0.0112747030049332,0.00438212648950881,0.00268573508549598,0.0198636709243705,0.0100989656683852
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,42122,0.00865856360027678,0.00336610292560584,0.00206100186608934,0.0152561253344642,0.0101141363037357
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNL1,Thioredoxin-like protein 1,39707,-0.0262654772548192,0.0102128066143835,-0.0462825782190109,-0.00624837629062744,0.0101302239102961
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM13A,Protein FAM13A,40021,-0.0177809442368728,0.00691569223716501,-0.0313357010217162,-0.00422618745202939,0.0101508013481787
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD99,CD99 antigen,42120,0.00538758601112035,0.002096117019836,0.00127919665224179,0.00949597536999892,0.0101730325162987
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOK2,Docking protein 2,42144,-0.0319498694551276,0.0124310648373524,-0.0563147565363382,-0.00758498237391696,0.0101761280952141
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH1,Protocadherin-1,42226,-0.00577225861067505,0.00224642026607201,-0.0101752423321762,-0.0013692748891739,0.0101944865769181
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,39784,-0.0098546501111696,0.00384223161110908,-0.0173854240689434,-0.0023238761533958,0.0103364518641292
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,39863,-0.0187348720624045,0.00731787435540686,-0.033077905799002,-0.0043918383258071,0.0104762813714844
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,39784,0.0115177511101871,0.00450149217101383,0.00269482645500002,0.0203406757653742,0.0105216734239876
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,41968,-0.0078688956463753,0.00307915566594199,-0.0139040407516216,-0.001833750541129,0.0106138917125894
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYN,Tyrosine-protein kinase Lyn,42094,-0.0220754499329965,0.00864096951027323,-0.0390117501731321,-0.00513914969286102,0.0106380237183399
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,42240,0.0112596722209117,0.00441388662225132,0.00260845444129912,0.0199108900005243,0.0107538119347919
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTP1,Glutathione S-transferase P,41759,0.0185758149030475,0.00728258850584196,0.00430194143159727,0.0328496883744978,0.010761940789747
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,39706,0.00856619757222705,0.0033638950621712,0.00197296325037149,0.0151594318940826,0.0108946963837664
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,39768,-0.0112735627515422,0.00442770211494331,-0.0199518588968311,-0.00259526660625328,0.0109061153373022
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD101,Immunoglobulin superfamily member 2,40021,-0.0113916281750882,0.00449241930594059,-0.0201967700147318,-0.00258648633544466,0.011234794022919
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,40054,-0.0233783477232615,0.0092282287756346,-0.0414656761235053,-0.00529101932301765,0.0113117059808396
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRUNE2,Protein prune homolog 2,39881,-0.00786693512360332,0.00310555371786839,-0.0139538204106254,-0.00178004983658127,0.0113173776136429
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,42095,-0.00496488583982595,0.00196035833635127,-0.00880718817907443,-0.00112258350057746,0.0113324038714747
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,39784,-0.0148207723636959,0.0058677215887702,-0.0263215066776854,-0.00332003804970626,0.0115575238616311
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRIB,Protein scribble homolog,39804,-0.0236039663057221,0.0093484673058682,-0.0419269622252238,-0.00528097038622046,0.0115874993729171
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,40054,-0.0195043383633118,0.0077340873151969,-0.0346631495010978,-0.00434552722552592,0.0116875703395298
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COCH,Cochlin,40080,-0.0121187547296019,0.00483375187341937,-0.0215929084015038,-0.00264460105769992,0.0121866814145201
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA7,Carbonic anhydrase 7,39881,0.00913523867803066,0.00364510373243869,0.00199083536245082,0.0162796419936105,0.0122195342636097
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,39804,-0.0263186152502554,0.0105018533572566,-0.0469022478304785,-0.00573498267003242,0.0122222169450646
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB7,Integrin beta-7,42223,-0.0119079709223956,0.00475691815722347,-0.0212315305105536,-0.00258441133423756,0.0123164206918142
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,39719,0.00884849698962172,0.00353971234534417,0.00191066079274715,0.0157863331864963,0.0124421969998492
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L15,Bcl-2-like protein 15,39784,-0.0144791523149792,0.00580100141210822,-0.0258491150827113,-0.00310918954724705,0.0125762474310648
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,41829,0.0145434455859201,0.00583004943775204,0.00311654868792606,0.0259703424839141,0.0126237831040421
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,41829,-0.00988622996972541,0.00396588238739558,-0.0176593594490208,-0.00211310049043007,0.0126860183307785
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,42120,0.00913368038673078,0.00366429816888543,0.00195165597571533,0.0163157047977462,0.012693086542742
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSH,Pro-cathepsin H,41854,-0.0191460093086305,0.007685647620252,-0.0342098786443244,-0.00408213997293656,0.0127461698945828
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP8,Neutrophil collagenase,42186,0.0187119834459161,0.00752322820509781,0.00396645616392442,0.0334575107279078,0.0128867378004517
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RWDD1,RWD domain-containing protein 1,42213,-0.0161210201688502,0.00648260436453334,-0.0288269247233356,-0.00341511561436489,0.0129017702330424
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAP,Prolyl endopeptidase FAP,42296,-0.00703725024082206,0.00283029277826691,-0.0125846240862252,-0.00148987639541891,0.0129165109211756
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANSC4,MANSC domain-containing protein 4,39706,0.0183855562161957,0.00739666055385727,0.00388810153063548,0.032883010901756,0.0129466987039941
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YWHAQ,14-3-3 protein theta,39863,-0.0188461793088659,0.00758629219821347,-0.0337153120173643,-0.00397704660036753,0.0129980097433562
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,42103,-0.00983480616357711,0.00396264949605202,-0.0176015991758391,-0.00206801315131516,0.0130818843121197
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLA2,Src-like-adapter 2,40054,-0.0263515209196728,0.0106547623608439,-0.0472348551469268,-0.0054681866924188,0.0134055319374765
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYMP,Thymidine phosphorylase,42073,0.016662819730381,0.00674046857767299,0.00345150131814194,0.0298741381426201,0.0134466504130923
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTXR,Neuronal pentraxin receptor,42144,0.00872640680974775,0.00353689362454574,0.0017940953056381,0.0156587183138574,0.0136283004632606
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS2,"Nitric oxide synthase, inducible",39706,0.0101797835667678,0.00412740847444797,0.00209006295684975,0.0182695041766858,0.013664242692254
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,39706,-0.0114373574985694,0.00464221907318033,-0.0205361068820028,-0.00233860811513592,0.0137643443622166
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C7,Complement component C7,39833,-0.00838091563747409,0.00340413145636784,-0.0150530132919551,-0.00170881798299313,0.0138328416175194
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN4B,Sodium channel subunit beta-4,39804,-0.0111657447536746,0.00453702812017409,-0.0200583198692158,-0.00227316963813336,0.0138698322679412
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,P4HB,Protein disulfide-isomerase,42074,-0.00972401469178359,0.00395428703823784,-0.0174744172867298,-0.00197361209683743,0.0139413649330121
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,42223,-0.0100983967608012,0.00411152177930638,-0.0181569794482417,-0.00203981407336073,0.0140575246093255
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STC2,Stanniocalcin-2,42101,-0.0063281741519821,0.00257659572934334,-0.011378301781495,-0.00127804652246915,0.0140615604247283
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",40080,-0.0181723038539255,0.0074025082647127,-0.0326812200527624,-0.00366338765508857,0.0141085128508436
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,40093,0.00643077351887176,0.00262620137321655,0.00128341882736731,0.0115781282103762,0.0143530118403978
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,40021,-0.0160948217342636,0.00657882051390762,-0.0289893099415226,-0.0032003335270047,0.0144424720866022
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,40054,0.0112809620255702,0.00461956302233956,0.00222661850178471,0.0203353055493558,0.0146220825231306
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRP15,RRP15-like protein,39719,0.0231575041011477,0.00950110099812683,0.0045353461448191,0.0417796620574763,0.0148118162754532
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY75,Lymphocyte antigen 75,42103,-0.00980143352686556,0.00402437861971124,-0.0176892156214996,-0.00191365143223154,0.0148840588915465
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,41810,-0.0108465198650593,0.00445624777083614,-0.0195807654958982,-0.0021122742342205,0.0149466573537853
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,42066,-0.00824908564770393,0.00339151267665954,-0.0148964504939566,-0.00160172080145124,0.0150179193441897
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,42144,0.0290891666772655,0.0119779191963356,0.00561244505244767,0.0525658883020833,0.0151721896260108
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,42296,0.0039998148833221,0.001648423453498,0.000768904914466026,0.00723072485217818,0.0152608092414658
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAP,Cartilage-associated protein,39768,-0.0119885067894271,0.00496181285863152,-0.0217136599923448,-0.00226335358650928,0.0157022320645603
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,42184,-0.03081610923555,0.0127569594947207,-0.0558197498452026,-0.00581246862589742,0.0157216719270233
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBQ1,Hemoglobin subunit theta-1,42223,-0.0150107191486752,0.00621617284167006,-0.0271944179183485,-0.00282702037900183,0.0157581957006092
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,40054,-0.0166363314266607,0.00688987192220647,-0.0301404803941854,-0.003132182459136,0.0157686254199936
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,39784,-0.0224520381620219,0.00929900516272498,-0.0406780882809629,-0.00422598804308091,0.015775571391606
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHRL,Appetite-regulating hormone,42144,0.0213211594598272,0.00883094732705804,0.0040125026987935,0.038629816220861,0.015776293370535
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,40097,0.00985891010474338,0.0040858389178734,0.00185066582571151,0.0178671543837753,0.015840539164688
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,39706,0.00815034829230152,0.00337925813867184,0.00152700234050471,0.0147736942440983,0.0158877445705201
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,41861,-0.0144672025670631,0.00601380350793862,-0.0262542574426229,-0.00268014769150345,0.0161572568240764
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,40054,0.0594837668542425,0.0247340518955748,0.0110050251389159,0.107962508569569,0.0161920045154678
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSHB,Thyrotropin subunit beta,42144,0.0198197423718014,0.00824306375418739,0.00366333741359416,0.0359761473300087,0.0162123443797771
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,40080,-0.0184601730283193,0.00768757751297805,-0.0335278249537562,-0.00339252110288227,0.0163536398519616
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,39768,-0.0177936839404486,0.00741160651986029,-0.0323204327193748,-0.00326693516152247,0.0163770503197075
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTF2,Transcription termination factor 2,39768,-0.0121317046102609,0.00505548310099109,-0.0220404514882035,-0.0022229577323184,0.0164251550731289
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,41887,-0.008118758706284,0.003385303022131,-0.0147539526296608,-0.00148356478290723,0.0164885520876044
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,41861,0.00951570606616174,0.00396795211093503,0.00173851992872908,0.0172928922035944,0.0164929275719209
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REEP4,Receptor expression-enhancing protein 4,40054,-0.0152499168297452,0.00637358914237326,-0.0277421515487967,-0.00275768211069358,0.0167430120556408
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LACRT,Extracellular glycoprotein lacritin,39989,-0.0127827355904733,0.0053434734061398,-0.0232559434665073,-0.00230952771443931,0.0167640413771165
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA4,Annexin A4,42094,0.0176626860846182,0.0073869987590808,0.00318416851681984,0.0321412036524166,0.0168144931913909
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRD1,Natural killer cells antigen CD94,42256,-0.0115975164050529,0.0048672159252327,-0.021137259618509,-0.00205777319159681,0.0171965630197521
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP1,"Fatty acid-binding protein, liver",42126,-0.0232685318127241,0.00977096540905163,-0.0424196240144653,-0.0041174396109829,0.0172615724334649
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP5,Fatty acid-binding protein 5,42180,-0.016635766749195,0.00698642283342975,-0.0303291555027173,-0.00294237799567267,0.0172727014830341
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE6,Ribonuclease K6,40041,-0.00838442497085798,0.00352116928221748,-0.0152859167640042,-0.00148293317771172,0.0172759327701926
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNC79,Protein unc-79 homolog,39665,-0.0136389681365997,0.00572969182370253,-0.0248691641110567,-0.00240877216214275,0.017311560606699
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,42103,0.0147498191160436,0.006211286284189,0.00257569799903316,0.026923940233054,0.0175786855192098
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,40020,0.0109884334694943,0.00462968412935543,0.00191425257595761,0.0200626143630309,0.0176389996994249
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,42103,-0.00882497864666062,0.00371918564906555,-0.0161145825188291,-0.00153537477449213,0.0176671629497329
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK1,Dickkopf-related protein 1,42213,-0.0143320940228782,0.00604341034803092,-0.0261771783050188,-0.00248700974073755,0.0177293483714649
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXDC1,Plexin domain-containing protein 1,41861,-0.00778414719517022,0.00328451938655231,-0.0142218051928128,-0.00134648919752769,0.0178053776781942
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAL,Integrin alpha-L,39784,-0.0108759208738432,0.00460930750183366,-0.0199101635774372,-0.00184167817024926,0.0183148442049823
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,39881,-0.0131954486876889,0.00559569417280004,-0.024163009266377,-0.0022278881090008,0.0183845120284632
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300LF,CMRF35-like molecule 1,42223,0.0148795868574101,0.00631179280653026,0.00250847295661076,0.0272507007582094,0.0184168070794458
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDC,Nuclear migration protein nudC,42256,-0.0150442886339373,0.00638750101880846,-0.0275637906308019,-0.00252478663707271,0.0185239627895886
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICA1,Islet cell autoantigen 1,41887,-0.019092630013516,0.00810924570406445,-0.0349867515934823,-0.00319850843354966,0.0185664162136289
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,42004,-0.0189385000335192,0.00805292530623769,-0.0347222336337451,-0.00315476643329333,0.0187001807106007
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEK,Angiopoietin-1 receptor,42186,-0.00532981721801695,0.00226900851878573,-0.00977707391483698,-0.000882560521196917,0.0188406704705246
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,39706,0.00996003694566097,0.00424727505010417,0.00163537784745679,0.0182846960438651,0.0190434519647996
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUB1,NEDD8 ultimate buster 1,42103,-0.0200792685261281,0.00857351970641613,-0.0368833671507037,-0.0032751699015525,0.0191953209171316
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,42213,-0.0139275821766371,0.00594956770818934,-0.0255887348846882,-0.00226642946858595,0.0192502572660929
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6,Interleukin-6,42094,-0.0185797819897661,0.00794373602335373,-0.0341495045955395,-0.00301005938399283,0.0193546348385292
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYAP1,Synapse-associated protein 1,39863,-0.0138517838381284,0.00593279421617872,-0.0254800605018387,-0.00222350717441811,0.0195732381677484
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMA4,Laminin subunit alpha-4,42184,0.00799522762846499,0.00342674354651818,0.00127881027728936,0.0147116449796406,0.0196536042095824
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,40021,0.0271634261731207,0.0116533297796783,0.00432289980495115,0.0500039525412902,0.0197738196258466
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA13,Carbonic anhydrase 13,41998,0.0247516032613909,0.0106317798067832,0.00391331484009589,0.0455898916826859,0.0199235042030547
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD226,CD226 antigen,39784,-0.0101566855694857,0.0043655028570407,-0.0187130711692855,-0.00160029996968597,0.0200064719051941
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,42184,-0.00666342235797787,0.00286484547594144,-0.0122785194908231,-0.00104832522513266,0.0200377399183159
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE3,Eosinophil cationic protein,42088,-0.026460750264889,0.0113816482683373,-0.0487687808708301,-0.0041527196589478,0.0200948383710058
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RILPL2,RILP-like protein 2,40080,0.0231081509113935,0.00995448291833728,0.0035973643914524,0.0426189374313345,0.0202846401651569
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB2A2,Mammaglobin-A,39706,0.00763189392297712,0.00328856901145547,0.0011862986605244,0.0140774891854298,0.020320240876221
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,40021,-0.0111978080967567,0.00482534840056283,-0.0206554909618598,-0.00174012523165357,0.0203257561818392
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",41985,-0.0174092465612399,0.00750342796516753,-0.0321159653729682,-0.00270252774951149,0.0203472068674401
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS8,Galectin-8,42213,-0.0143183182345185,0.00618408819520633,-0.0264391310971229,-0.00219750537191408,0.0206093436836707
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RSPO3,R-spondin-3,42223,0.0071359007305987,0.0030839614664698,0.00109133625631789,0.0131804652048795,0.0206900715762813
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLG4,Disks large homolog 4,40054,-0.0166673716775512,0.00720368781874148,-0.0307865998022845,-0.00254814355281793,0.0207012427190258
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",39706,0.0103856010584347,0.00449468545554756,0.00157601756556144,0.0191951845513079,0.0208719946918059
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MITD1,MIT domain-containing protein 1,42004,-0.0227724085147971,0.00985783068482425,-0.0420937566570526,-0.00345106037254156,0.0208993658492136
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,41813,0.0134620766263066,0.00582989074242496,0.00203549077115372,0.0248886624814596,0.0209514783805702
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MKI67,Proliferation marker protein Ki-67,39784,-0.00921386394025522,0.00399250973744958,-0.0170391830256564,-0.00138854485485404,0.0210301408080204
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MARCO,Macrophage receptor MARCO,42144,0.00626039059291757,0.00271381798884442,0.000941307334782512,0.0115794738510526,0.0210784830821683
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEXN,Nexilin,40102,-0.0164509232339658,0.00713521333365613,-0.0304359413679318,-0.00246590509999975,0.0211518543268632
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",42120,0.00900897507760346,0.00390951133001885,0.00134633287076652,0.0166716172844404,0.0212174504112444
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL14,C-C motif chemokine 14,42127,-0.00963933754032245,0.00418655025778949,-0.0178449760455899,-0.00143369903505504,0.0213254087220596
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,41965,0.00731165172761698,0.00317589762534512,0.00108689238194055,0.0135364110732934,0.0213381230426208
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN5,CCN family member 5,42120,0.00918340553912587,0.0039901571618172,0.00136269750196416,0.0170041135762876,0.0213783795703082
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINH1,Serpin H1,39881,-0.030536860200389,0.0132685570426193,-0.0565432320039227,-0.00453048839685516,0.0213856098991709
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMI,N-myc-interactor,39991,0.0171639327473074,0.00745986355941391,0.00254260017085615,0.0317852653237587,0.0214197884387831
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO2,Roundabout homolog 2,42213,-0.00556205916000159,0.0024247416298379,-0.0103145527544839,-0.000809565565519299,0.0218134122008102
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSNK1D,Casein kinase I isoform delta,39784,-0.0148214389950892,0.00647166907335593,-0.0275059103788668,-0.00213696761131159,0.0220290903348566
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMS1,PMS1 protein homolog 1,39768,-0.0122272772456949,0.00534726581143287,-0.0227079182361034,-0.00174663625528653,0.0222364599698084
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KHDC3L,KH domain-containing protein 3,39665,0.0162319103517031,0.00711338409362412,0.00228967752819981,0.0301741431752063,0.0225162206415027
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,42213,0.016858563625872,0.00739260559489478,0.00236905665987825,0.0313480705918658,0.0225963308100621
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG4,Desmoglein-4,42051,0.0117777564278777,0.00517479053445016,0.00163516698035539,0.0219203458754,0.0228631546693627
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,42248,-0.0123255528677171,0.00542646537622332,-0.0229614250051148,-0.00168968073031941,0.0231403251822804
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYZL2,Lysozyme-like protein 2,39665,-0.00844951539297033,0.00372457310104938,-0.0157496786710271,-0.00114935211491354,0.0233137641730243
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX1,Peroxiredoxin-1,41787,0.0209328174354021,0.00925267750355176,0.00279756952844067,0.0390680653423636,0.0236926031487297
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRKL,Crk-like protein,42145,-0.0243709506165046,0.01077950063377,-0.0454987718586938,-0.00324312937431544,0.0237844003323889
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG1A,Lithostathine-1-alpha,42085,-0.0122555395400785,0.00542516765897256,-0.0228888681516647,-0.00162221092849228,0.0238990342966244
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARD3,Partitioning defective 3 homolog,39881,-0.0174046730034657,0.00772229148257714,-0.0325403643093168,-0.00226898169761446,0.0242275231416446
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,41829,-0.0146388342804359,0.00650030113558267,-0.0273794245061779,-0.00189824405469385,0.0243378519990016
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SULT1A1,Sulfotransferase 1A1,42213,0.0295545449456839,0.0131701808559688,0.00374099046798498,0.0553680994233827,0.0248459158194297
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSDE1,Cold shock domain-containing protein E1,39706,-0.0269975296415297,0.0120439124800503,-0.0506035981024282,-0.00339146118063113,0.0250085770312891
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EXOSC10,Exosome component 10,39706,0.0140265490068875,0.0062884204542548,0.00170124491654807,0.0263518530972269,0.0257328922012432
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSS,Cathepsin S,39477,-0.0056458295441981,0.00253536348564044,-0.0106151419760534,-0.000676517112342832,0.025980048323721
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,42103,0.0111664832889525,0.00502191365502891,0.00132353252509588,0.0210094340528092,0.0261958799878751
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX5,Syntaxin-5,39784,-0.00948899681567416,0.0042682654016426,-0.0178547970028937,-0.00112319662845466,0.0262266710729038
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROK1,Prokineticin-1,42103,0.0127188321074089,0.00572358745188568,0.00150060070171293,0.0239370635131048,0.0262885198984544
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMMD1,COMM domain-containing protein 1,39804,-0.0137639656128861,0.00619687232857962,-0.0259098353769021,-0.00161809584887001,0.0263642074583374
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,42162,-0.0118972008317446,0.00535778063997152,-0.0223984508860888,-0.00139595077740039,0.0263989105045189
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,39804,-0.00911393207875799,0.00410435662567379,-0.0171584710650786,-0.00106939309243735,0.0264024475679603
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCP2,Non-specific lipid-transfer protein,41861,-0.0169612826236159,0.00763910473160441,-0.0319339278975606,-0.00198863734967131,0.0264144539012767
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPMT,Thiopurine S-methyltransferase,41861,-0.0166876766572736,0.00751707618141283,-0.0314211459728427,-0.00195420734170442,0.0264385013306871
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,39706,-0.0125888740776353,0.0056729077656954,-0.0237077732983983,-0.00146997485687237,0.0264996981787588
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSL,Cathepsin L1,42144,-0.00570417623734675,0.00257075440891212,-0.0107428548788145,-0.000665497595878989,0.0265126688442696
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNRD2,Protein ZNRD2,40021,-0.0159205800720668,0.00718794016676536,-0.0300089427989269,-0.00183221734520673,0.0267875584383341
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPLAH,5-oxoprolinase,39804,-0.0154129980726287,0.00695881344354807,-0.0290522724219829,-0.00177372372327449,0.0267888595468173
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,42197,-0.0105422506290747,0.00477017804770646,-0.0198917996025793,-0.00119270165557,0.0271202285835356
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK11,Kallikrein-11,42057,-0.00750833566431266,0.00339983622615149,-0.0141720146675696,-0.000844656661055744,0.0272311578752681
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,39784,-0.00884494676679118,0.00401177177082852,-0.0167080194376151,-0.000981874095967271,0.02749318565454
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C5,Complement C5,40113,0.00341218768133719,0.00155343685100049,0.000367451453376222,0.00645692390929816,0.0280741907670408
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCK2,Cytoplasmic protein NCK2,42184,-0.0236444155201167,0.0107917096674144,-0.044796166468249,-0.00249266457198439,0.0284709716080561
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,39665,-0.0147558088402562,0.00673899642854288,-0.0279642418402003,-0.00154737584031219,0.0285741472044849
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USO1,General vesicular transport factor p115,42094,-0.0202940230449226,0.00927402003428237,-0.038471102312116,-0.00211694377772915,0.0286681017712679
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGS10,Regulator of G-protein signaling 10,40054,0.0133481628094663,0.00609986728502491,0.00139242293081747,0.0253039026881151,0.0286710962286755
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLGN,Calmegin,39768,-0.010457650533256,0.00478433684063519,-0.0198349507409009,-0.001080350325611,0.0288513770067444
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,40054,0.00877183996220189,0.00402667463861071,0.000879557670524906,0.0166641222538789,0.0293952656891934
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPART,Spartin,39863,-0.0171604594489863,0.00788857957409272,-0.0326220754142081,-0.00169884348376459,0.029625419862052
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN4,Contactin-4,42120,0.00540742619274852,0.00248603296627158,0.00053480157885622,0.0102800508066408,0.0296390033621475
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP3B1,AP-3 complex subunit beta-1,40021,-0.0171101173058084,0.00786774947338935,-0.0325309062736515,-0.00168932833796523,0.0296730120198459
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GM2A,Ganglioside GM2 activator,39851,0.00912572372197565,0.00419873798341469,0.000896197274482867,0.0173552501694684,0.0297688289154255
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOLA1,BolA-like protein 1,39719,-0.0121823406654913,0.00560608592538107,-0.0231702690792382,-0.00119441225174437,0.0297983049578765
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,40020,-0.00634167728410482,0.00291871605858737,-0.0120623607589361,-0.000620993809273583,0.0298198016719363
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD22,B-cell receptor CD22,42256,-0.00977457108128348,0.00450561327145749,-0.0186055730933402,-0.000943569069226801,0.0300687256853144
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBH,Dopamine beta-hydroxylase,40085,-0.0246289177327035,0.0113570298526495,-0.0468886962438965,-0.00236913922151049,0.0301342181223764
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB2,Integrin beta-2,42081,0.0064023474008894,0.0029571246850483,0.000606383018194739,0.0121983117835841,0.0304015120293129
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNM3,Dynamin-3,40054,-0.0122637804621379,0.00566808386493157,-0.0233732248374038,-0.00115433608687202,0.0305125395056003
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTB,Lymphotoxin-beta,40020,-0.00798086361690296,0.00369356324311669,-0.0152202475734117,-0.000741479660394249,0.0307365860748564
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,41829,-0.0146419202893245,0.00677708914490257,-0.0279250150133335,-0.00135882556531543,0.0307525020511948
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP6,Gastrotropin,41854,0.0131554680366246,0.00609018117892065,0.00121871292594013,0.0250922231473091,0.0307827763092684
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",39706,-0.0137926076493099,0.00639862251215731,-0.0263339077731382,-0.00125130752548157,0.0311407513435124
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFP,Alpha-fetoprotein,41968,0.014918157328069,0.00692110447324877,0.00135279256050139,0.0284835220956366,0.0311445499595393
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM3,Paralemmin-3,39706,-0.0158956419816746,0.0073958314305219,-0.0303914715854975,-0.00139981237785163,0.0316357248158171
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",40054,-0.0105733593020639,0.00492523074970764,-0.0202268115714909,-0.000919907032636931,0.0318333249300948
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASHC3,WASH complex subunit 3,40054,-0.0164926842870611,0.00768674974912422,-0.0315587137953445,-0.0014266547787776,0.0319270700816495
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL11,C-X-C motif chemokine 11,42213,0.0176919036898084,0.00824793245321129,0.00152595608151424,0.0338578512981025,0.0319704352005024
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,42262,-0.00741143639545813,0.00345990306459321,-0.0141928464020608,-0.000630026388855448,0.0322043730928521
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD200,OX-2 membrane glycoprotein,42103,0.00609310760090015,0.00284701754230765,0.000512953217977153,0.0116732619838231,0.0323595445856508
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB10,Ras-related protein Rab-10,40080,-0.0118028949638787,0.00551530736173762,-0.0226128973928844,-0.000992892534872962,0.0323749181131101
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,39804,0.00518745548040438,0.0024284233896289,0.000427745636731733,0.00994716532407702,0.0326907170666959
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAYN,Layilin,41985,-0.00835112085046435,0.00392229050849866,-0.0160388102471217,-0.000663431453806976,0.0332614039965391
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,40080,0.00732416903049536,0.00344122762865576,0.000579362878330068,0.0140689751826607,0.0333296949484279
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",42091,-0.014918714858969,0.00701092921960562,-0.028660136129396,-0.00117729358854201,0.0333624100125872
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CR2,Complement receptor type 2,42197,-0.0105197761717373,0.00494922934734773,-0.0202202656925389,-0.00081928665093578,0.0335605234136942
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCN2,Ficolin-2,42106,-0.00897893092395687,0.00423145166185777,-0.0172725761811981,-0.000685285666715638,0.0338608839521956
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,40054,-0.0104434058820925,0.00492540196331476,-0.0200971937301894,-0.000789618033995585,0.0340020600591783
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,41861,-0.0142280805199739,0.006714195386434,-0.0273879034773845,-0.00106825756256329,0.0341010544977919
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,42103,-0.0330403660649237,0.0156205775573411,-0.0636566980773122,-0.0024240340525352,0.034433534966104
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM25,Transmembrane protein 25,40054,-0.00994609514024502,0.00470668727846668,-0.0191712022060397,-0.000720988074450323,0.0346077918496912
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,41876,0.00673290531135506,0.00318655896969962,0.000487249730743804,0.0129785608919663,0.0346281454408631
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,39784,-0.0118347972538162,0.00560200990678228,-0.0228147366711094,-0.000854857836522897,0.0346584958005805
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,40054,-0.0202268070888838,0.00958174770600541,-0.0390070325926544,-0.00144658158511318,0.0347974580759939
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TUBB3,Tubulin beta-3 chain,39719,0.00614072845974869,0.00290948873633657,0.000438130536529013,0.0118433263829684,0.0348313714409938
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,40020,-0.00728815965626824,0.00345554345576594,-0.0140610248295695,-0.000515294482966989,0.03495703008537
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOH,Beta-2-glycoprotein 1,42120,0.0079551372855513,0.00377682282574759,0.000552564547086032,0.0153577100240166,0.0351971748477867
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRC1,Macrophage mannose receptor 1,40102,0.00634573080991391,0.00301523763489493,0.000435865045519857,0.012255596574308,0.0353529563666468
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA4,Ephrin type-A receptor 4,39863,-0.00630897520165933,0.00300683376608196,-0.01220236938318,-0.000415581020138681,0.0359098622858945
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCA,Tubulin-specific chaperone A,39863,-0.0182998886924774,0.00872581925491697,-0.0354024944321147,-0.00119728295284016,0.0359983299517649
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,42186,-0.020704909008438,0.00987424256006152,-0.0400584244261586,-0.00135139359071745,0.0360252108680807
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,39784,-0.00675415456954066,0.00322151260068589,-0.013068319266885,-0.00043998987219632,0.0360545528834
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,42197,-0.00525992018994053,0.00251137093744076,-0.0101822072273244,-0.000337633152556634,0.0362399512576962
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAP3,Cytosol aminopeptidase,41887,-0.0104690281594958,0.00499992690558585,-0.020268884894444,-0.000669171424547508,0.0362943581768211
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL22,Interleukin-22,40020,-0.0151428777963381,0.00723316084148276,-0.0293198730456443,-0.000965882547031923,0.0363245995348427
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",39706,0.0103259365143569,0.00493494914297328,0.000653436194129262,0.0199984368345845,0.0364257846198152
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL16,C-X-C motif chemokine 16,42280,-0.00516512415434987,0.00247167002491758,-0.0100095974031883,-0.000320650905511405,0.0366612778777094
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCND2,G1/S-specific cyclin-D2,39881,-0.00795268335875432,0.00381798410484251,-0.0154359322042456,-0.000469434513262987,0.0372791776321604
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,41887,0.0079747682976853,0.00383927368381834,0.000449791877401347,0.0154997447179693,0.0378072753427236
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA2,Ephrin type-A receptor 2,41650,-0.00724690204947916,0.00349287390936049,-0.0140929349118257,-0.000400869187132605,0.0380285509313353
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,39706,-0.0147798573439984,0.00713490941773507,-0.0287642798027592,-0.000795434885237697,0.038337837601932
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP3R1,Calcineurin subunit B type 1,42004,0.00856085504376668,0.00413602273359368,0.000454250485923067,0.0166674596016103,0.0384884653835777
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,42075,0.00831636119572728,0.00401819135109089,0.000440706147589145,0.0161920162438654,0.038502421841985
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFA,Protransforming growth factor alpha,42103,0.0101610924790482,0.00491192133364271,0.00053372666510846,0.0197884582929879,0.0385979173271976
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PVALB,Parvalbumin alpha,42158,0.0234841175307165,0.0113627368962741,0.00121315321401932,0.0457550818474137,0.0387760229496424
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",42186,-0.00750006003409297,0.00363066324776057,-0.0146161599997037,-0.00038396006848225,0.0388714191965692
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,40054,-0.0104685424909414,0.00507709371117097,-0.0204196461648366,-0.000517438817046344,0.0392394385849966
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,39804,0.00840133951923794,0.00407489095486564,0.00041455324770129,0.0163881257907746,0.0392574076434155
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABO,Histo-blood group ABO system transferase,40102,0.030871937777562,0.0150001136647858,0.00147171499458177,0.0602721605605423,0.039602934475112
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,42103,-0.0220029424398878,0.0106930019832535,-0.0429612263270646,-0.00104465855271101,0.0396394050427901
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LUZP2,Leucine zipper protein 2,40020,-0.00979750920058297,0.00476165034328364,-0.0191303438734189,-0.000464674527747042,0.0396537017281929
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKAP12,A-kinase anchor protein 12,39863,0.00462676580027178,0.00225007199855784,0.000216624683098421,0.00903690691744514,0.0397803290527679
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL19,Interleukin-19,41783,-0.015415889068668,0.00750217767611267,-0.0301201573138488,-0.000711620823487165,0.0399135802258989
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,42103,-0.0212540984588261,0.0103566085055645,-0.0415530511297325,-0.000955145787919703,0.0401678515542941
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,40054,0.00568888099963536,0.00277250530118076,0.000254770609321075,0.0111229913899496,0.0402040996624758
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,42103,-0.0184159922573574,0.00898022979928997,-0.0360172426639657,-0.000814741850749003,0.0403137660254344
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,42103,0.0101989780752516,0.0049734166692574,0.000451081403507102,0.0199468747469961,0.0403164631703182
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GKN1,Gastrokine-1,41542,-0.00595515247626071,0.00290796332763932,-0.0116547605984338,-0.000255544354087646,0.0405931172902154
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,39767,-0.0176621154141033,0.0086276017409397,-0.0345722148263451,-0.000752016001861509,0.0406666518523101
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA6,Corticosteroid-binding globulin,40113,0.00331674259370607,0.00162091631762365,0.000139746611163711,0.00649373857624843,0.0407591637448433
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL3,Fc receptor-like protein 3,41887,-0.0119200389434335,0.00584740528413808,-0.0233809533003441,-0.000459124586522865,0.0415188707033219
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINE2,Glia-derived nexin,40080,-0.0134546339410499,0.00660130582837599,-0.0263931933646669,-0.000516074517432968,0.0415562902445581
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RCC1,Regulator of chromosome condensation,40020,-0.0109550893999385,0.00537493986446627,-0.0214899715342924,-0.000420207265584636,0.0415562909864272
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,42126,-0.0625461616447804,0.0307434798548189,-0.122803382160225,-0.00228894112933523,0.0419263136324425
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,42223,0.0129144904989601,0.00635020757592366,0.00046808365014976,0.0253608973477705,0.0420009069334897
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD40LG,CD40 ligand,42256,0.0162259100731078,0.00799971770529649,0.000546463370726634,0.0319053567754889,0.04254883558473
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1RL,Complement C1r subcomponent-like protein,40093,0.00414774798569304,0.00205188836228582,0.000126046795612835,0.00816944917577325,0.0432597002332726
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,40080,0.00571181694517949,0.00282718206289561,0.000170540101904084,0.0112530937884549,0.0433744830707201
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",39665,-0.0193324702110054,0.00958861428050767,-0.0381261542008004,-0.000538786221210355,0.0438055770074578
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX6,Syntaxin-6,41861,-0.013796835530155,0.00685954712903067,-0.0272415479030551,-0.000352123157254917,0.044311405997893
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD46,Membrane cofactor protein,42091,0.00602455635569917,0.00300002169886375,0.000144513825926221,0.0119045988854721,0.0446459432965565
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMSB10,Thymosin beta-10,42120,0.0153310385053785,0.0076369936355611,0.00036253097967869,0.0302995460310782,0.0447203772286805
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,39784,-0.0112151120334957,0.00558857878319732,-0.0221687264485624,-0.000261497618428939,0.0447972461766756
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL21,C-C motif chemokine 21,42184,-0.0087898517687159,0.00438540774442133,-0.0173852509477817,-0.000194452589650085,0.0450542828492728
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANPEP,Aminopeptidase N,42176,0.00575780391948617,0.00287932979716478,0.000114317517043206,0.0114012903219291,0.0455531629739196
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,41876,-0.0128393769559331,0.00642414056385601,-0.0254306924610909,-0.000248061450775291,0.0456714475876577
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATOX1,Copper transport protein ATOX1,42186,-0.0143273525553042,0.00717019469568863,-0.0283809341588539,-0.000273770951754501,0.0457177594715073
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,42091,-0.00423539942669516,0.00212018856178542,-0.00839096900779459,-7.98298455957315e-05,0.0457753423084632
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",42103,-0.0196552345279735,0.00985206818205093,-0.0389652881647933,-0.000345180891153686,0.0460598965312858
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F3,Tissue factor,42141,0.005606768483054,0.00281631839343279,8.67844319257212e-05,0.0111267525341823,0.0465222307125174
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,40054,-0.00669924016455934,0.00336913511020115,-0.0133027449805536,-9.57353485650913e-05,0.0467908247557577
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,42094,0.013591069136242,0.00683858047389179,0.000187451407414095,0.0269946868650699,0.0468979948099194
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB5,Integrin beta-5,42186,0.0076604870631829,0.00386926674686373,7.6724239329984e-05,0.0152442498870358,0.0477437989283585
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEPD,Xaa-Pro dipeptidase,40102,0.00537382943593522,0.00273558202052226,1.20886757115912e-05,0.0107355701961588,0.0495068647562847
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR5,Cadherin-related family member 5,42144,-0.00787118405234674,0.00400733741775077,-0.0157255653911382,-1.68027135552355e-05,0.0495290710271146
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",39665,0.0104752611572081,0.00533586229248227,1.69710639428399e-05,0.0209335512504734,0.0496516251580466
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLKB1,Plasma kallikrein,39873,-0.00496962838141567,0.00253321059278937,-0.00993472114328284,-4.53561954849406e-06,0.0498128214253709
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,41876,0.00643208907176101,0.00328343324966767,-3.44009758762153e-06,0.0128676182411096,0.0501402548931614
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",40021,-0.0291896251691639,0.0149513522549158,-0.0584942755887988,0.00011502525047111,0.0509275395973133
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDK1,Cyclin-dependent kinase 1,39665,-0.00743491838130868,0.0038139001743737,-0.0149101627230811,4.03259604637692e-05,0.051271162725382
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR2,Complement factor H-related protein 2,40028,0.0116097617053889,0.00595815135694561,-6.82149542244864e-05,0.0232877383650023,0.0513748511465665
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC12A2,Solute carrier family 12 member 2,39706,0.00551295456930992,0.00282929194074003,-3.24576345405309e-05,0.0110583667731604,0.0513783887356278
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,39768,0.00764821405581996,0.0039254119976366,-4.5593459547774e-05,0.0153420215711877,0.0513953247200861
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUCB2,Nucleobindin-2,42185,-0.00743613586406508,0.00382183229958246,-0.0149269271712467,5.46554431165329e-05,0.05171242684422
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,41963,-0.00440158660917752,0.00226242883161403,-0.00883594711914102,3.27739007859769e-05,0.0517350805919327
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,39793,-0.0111195625110272,0.00571554650645067,-0.0223220336636705,8.29086416161157e-05,0.0517419310655763
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP1,Guanylate-binding protein 1,40038,-0.0130229438593356,0.00670029663878161,-0.0261555252713476,0.000109637552676341,0.0519650870677729
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX16,Syntaxin-16,41861,-0.0116428709590829,0.00601043337433459,-0.0234233203727787,0.00013757845461288,0.0527540966539845
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNPO1,Transportin-1,39881,0.00710716587798864,0.00367225599964169,-9.04558813090758e-05,0.0143047876372864,0.0529715298444312
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDS,Iduronate 2-sulfatase,42256,0.00175737313635425,0.000908946776923224,-2.41625464152719e-05,0.00353890881912377,0.053206432687113
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,42240,-0.00623821752688981,0.00323043203289022,-0.0125698643113546,9.34292575750202e-05,0.0534949963055111
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,42215,-0.00576900790041545,0.00299867606847068,-0.011646412994618,0.000108397193787082,0.0543949543371175
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,39768,-0.0101978630556282,0.00530445496703814,-0.0205945947910229,0.0001988686797666,0.0545685599849454
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRND,Prion-like protein doppel,40054,-0.010391238877354,0.00540658040169843,-0.0209881364646829,0.000205658709974911,0.0546367486313062
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,42004,-0.0156050400395967,0.00812952055661584,-0.0315389003305637,0.000328820251370382,0.0549366588689855
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRXN3,Neurexin-3,39768,-0.0070694527367237,0.00368430526930872,-0.0142906910645688,0.000151785591121395,0.0550362730805644
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESYT2,Extended synaptotagmin-2,40054,-0.0162018514057937,0.00846244848922923,-0.032788250444683,0.000384547633095637,0.0555750976968507
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",40054,0.014261074622546,0.00746407198844287,-0.00036850647480203,0.028890655719894,0.0560785417110982
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPI,Mannose-6-phosphate isomerase,42094,0.0166442920866125,0.0087177429030098,-0.000442484003286742,0.0337310681765117,0.0562528775267246
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB9,Serpin B9,42004,-0.00644188492596201,0.00337627815648812,-0.0130593901126787,0.000175620260754714,0.0564156097434457
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPON2,Spondin-2,42072,0.0070882308628515,0.00372011705127596,-0.000203198557649388,0.0143796602833524,0.0567531428633058
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,42256,-0.0107650393071316,0.00565500268340204,-0.0218488445665996,0.000318765952336396,0.0569801943419261
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK1,Kallikrein-1,42021,0.0255682743105133,0.0134501231264856,-0.000793967017398509,0.0519305156384251,0.0573283946668317
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,42223,-0.00686522622605096,0.00361482583197376,-0.0139502848567195,0.000219832404617604,0.0575621049192134
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,40054,-0.0208671240055475,0.011016396366677,-0.0424592608842344,0.000725012873139343,0.058226627346801
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,42103,-0.0069201757673389,0.0036557626054308,-0.0140854704739833,0.000245118939305469,0.0583868678655341
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],42094,0.0109480446279932,0.00578381470509621,-0.000388232193995423,0.0222843214499817,0.058396711390803
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,42285,-0.0115749200009375,0.00614740353263528,-0.0236238309249027,0.000473990923027617,0.0597366509539003
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,42200,-0.00805657351098287,0.00428159579717257,-0.0164485012734411,0.000335354251475361,0.0599024139391665
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,42168,0.0095900822601286,0.00510697239671565,-0.000419583637434074,0.0195997481576913,0.0604253292243718
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,41861,-0.0091887873110232,0.00492151110156901,-0.0188349490700985,0.000457374448052066,0.0619154173495838
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS53,Serine protease 53,40054,0.00719287355303713,0.00385278622238894,-0.0003585874428452,0.0147443345489195,0.0619386006101548
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARTN,Artemin,41887,0.00864561695904637,0.00463447546022361,-0.000437954942991906,0.0177291888610846,0.0621343141124642
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,42186,0.00844780086626752,0.00453683957028807,-0.000444404691497088,0.0173400064240321,0.0626192632668235
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPARC,SPARC,42186,-0.0134035212225588,0.00720734414759399,-0.027529915751843,0.000722873306725453,0.0629501101927068
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN4,Nectin-4,42186,0.00667386098052067,0.00358987341370205,-0.000362290910335336,0.0137100128713767,0.0630384275217988
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAT2,Signal transducer and activator of transcription 2,39784,-0.0145733717286391,0.00785031930886414,-0.0299599975740128,0.000813254116734588,0.0634236111881562
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPT1,Translationally-controlled tumor protein,41887,0.0124723046528891,0.00673199236748996,-0.000722400387391249,0.0256670096931694,0.0639497935806603
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYBB1,Beta-crystallin B1,40080,0.0121607878083579,0.00657347183943643,-0.000723216996937523,0.0250447926136533,0.0643435934274926
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,42144,0.00633954807811144,0.0034302745620013,-0.000383790063411109,0.013062886219634,0.0646082318992936
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,41876,0.00669830799422536,0.00363599399096542,-0.000428240228066854,0.0138248562165176,0.0654660195167861
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6,Seizure protein 6 homolog,39768,0.00597863841873116,0.00324634753990373,-0.000384202759480147,0.0123414795969425,0.0655542401160287
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FH,"Fumarate hydratase, mitochondrial",39719,-0.0163642875080469,0.00889089321694839,-0.0337904382132658,0.00106186319717191,0.0657131239142718
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOB,Apolipoprotein B-100,40102,0.00425030406858562,0.00231043371492796,-0.000278146012673173,0.00877875414984442,0.0658522211289934
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK24,Serine/threonine-protein kinase 24,41829,-0.0116671897143784,0.00634660258211054,-0.0241065307753151,0.000772151346558234,0.0660363289484375
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNNI3,"Troponin I, cardiac muscle",41876,-0.0159557403871554,0.00869745621757076,-0.0330027545735941,0.00109127379928327,0.0665988388927454
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASQ2,Calsequestrin-2,39706,0.00931680661243882,0.00507998087378068,-0.000639955900171321,0.019273569125049,0.0666786903480117
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,39804,0.0105304607891599,0.00574188494733116,-0.000723633707609176,0.021784555285929,0.0666860241599722
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX3,Syntaxin-3,40054,-0.00737725106581402,0.00402311456706578,-0.0152625556172629,0.000508053485634898,0.0667234568316242
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,39774,-0.00666190433422072,0.0036368556606937,-0.0137901414291804,0.000466332760738929,0.0670129226802836
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTN3,Myeloblastin,41797,0.00923196263802914,0.00504099703284665,-0.000648391546350298,0.0191123168224086,0.0670679843980717
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,40021,-0.00487058797085812,0.00265960864238026,-0.0100834209099234,0.00034224496820718,0.0670806234595871
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH22,Cadherin-22,39881,0.00532611500141573,0.00291015759586315,-0.000377793886476042,0.0110300238893075,0.0672507219240697
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGFAC,Hepatocyte growth factor activator,40000,0.00525525711256516,0.00287170080358688,-0.000373276462465121,0.0108837906875954,0.0672751466979607
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RETN,Resistin,42112,0.00817477987452825,0.00446949324218263,-0.000585426880149705,0.0169349866292062,0.0674200774645746
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMP,Cartilage oligomeric matrix protein,42022,0.00635152106357922,0.0034914158964449,-0.000491654093452793,0.0131946962206112,0.0689069649735677
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",42186,-0.0114010116630528,0.00627156150928675,-0.0236932722212548,0.000891248895149278,0.0691039011571592
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,42126,-0.00751638328118462,0.00414558864637771,-0.0156417370280849,0.000608970465715703,0.0698389586636514
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,39863,-0.0112057170657915,0.00618134906110297,-0.0233211612255534,0.00090972709397028,0.0698865855379688
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,39804,-0.012079137782778,0.00667461377583,-0.0251613807834048,0.00100310521784877,0.0703685328639589
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA5,Protein disulfide-isomerase A5,39665,-0.0113358372650075,0.00627800158564355,-0.0236407203728688,0.000969045842853867,0.0710026386571767
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMOX2,Heme oxygenase 2,41829,-0.00845971066710319,0.0046857794313026,-0.0176438383524563,0.00072441701824991,0.071035754775709
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JCHAIN,Immunoglobulin J chain,41887,0.0116240760042005,0.00644760085681777,-0.00101322167516237,0.0242613736835633,0.0714350259133245
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP6,Platelet glycoprotein VI,42099,0.0161332591410761,0.00895161182386343,-0.00141190003369627,0.0336784183158484,0.071525598429285
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMB,Granzyme B,42103,0.0123678819820846,0.00687761431852679,-0.00111224208222786,0.0258480060463971,0.0721558703495463
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSCA,Prostate stem cell antigen,40021,-0.0493573281921669,0.0274521002294094,-0.103163444641809,0.00444878825747552,0.0722137932248243
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GC,Vitamin D-binding protein,40113,0.00480005575998526,0.00267107392638,-0.000435249135719542,0.0100353606556901,0.0723551660291774
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,39804,-0.0168160816028266,0.00938071591838195,-0.0352022848028552,0.00157012159720204,0.0730617973897022
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCG3,Secretogranin-3,42146,0.00634934628416407,0.00354297034697703,-0.000594875595910906,0.013293568164239,0.073140773086338
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA6,Integrin alpha-6,42103,0.00942925325231316,0.00526252516920916,-0.000885296079336802,0.0197438025839631,0.0731926652076907
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAM,Basal cell adhesion molecule,42120,0.00456669692677777,0.00254907445058686,-0.000429488996372484,0.00956288284992803,0.0732345894271203
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,41829,-0.0123861918397682,0.0069146087003715,-0.0259388248924964,0.00116644121295992,0.0732678556414867
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRH,Corticoliberin,41840,0.0159081243335836,0.0089022289575238,-0.00154024442316301,0.0333564930903303,0.0739643155236901
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THTPA,Thiamine-triphosphatase,40005,-0.0161593568287262,0.00905530569613942,-0.0339077559931595,0.00158904233570705,0.0743675512989629
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1F,Protein phosphatase 1F,40080,0.009554476317752,0.0053641058966099,-0.000959171239603403,0.0200681238751074,0.0749097619980307
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAG,Myelin-associated glycoprotein,39768,0.0090549292627823,0.00508521925823079,-0.000912100483350053,0.0190219590089147,0.075000483579136
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,40021,0.0173651915931827,0.00975821198084226,-0.00176090388926818,0.0364912870756335,0.0751782579982862
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAG1,Dystroglycan,42184,-0.00841286497907426,0.00472795267390997,-0.0176796522199378,0.000853922261789273,0.0751994528744717
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,39719,0.0118710866556449,0.00667596131276037,-0.00121379751736538,0.0249559708286553,0.0754025248947479
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,39665,-0.0107933131283103,0.00607164668443578,-0.0226937406298045,0.00110711437318381,0.0754890085854528
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKN3,Serine/threonine-protein kinase N3,39881,-0.013716342530162,0.00771718353312497,-0.028842022255087,0.00140933719476293,0.0755347074902886
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,41861,-0.00697985489208747,0.00393024093214745,-0.0146831271190965,0.000723417334921522,0.075767528815677
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN1,Nectin-1,39784,-0.00599281589024107,0.00337893926830838,-0.0126155368561255,0.000629905075643348,0.0761615380494007
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN2,CCN family member 2,42132,-0.0100512218704495,0.00568253759233586,-0.0211889955514278,0.00108655181052883,0.0769523012207641
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,39651,-0.0159264923402435,0.00901816465687539,-0.0336020950677193,0.00174911038723227,0.0774173295876733
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",40054,-0.014026049911665,0.0079467633160159,-0.0296017060110561,0.00154960618772619,0.0775915993614419
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNLY,Granulysin,42120,0.00977810380701095,0.0055401133507976,-0.00108051836055235,0.0206367259745743,0.0775933296930879
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LHB,Lutropin subunit beta,41861,0.0153771757633301,0.00871774826149386,-0.00170961082919783,0.0324639623558581,0.0777740851190079
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1B,Protein phosphatase 1B,39784,-0.0111109254619643,0.00630065158805071,-0.0234602025745437,0.00123835165061508,0.0778523482861301
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,39706,0.007350157218529,0.00417323187557026,-0.000829377257588708,0.0155296916946467,0.0782230355873494
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA10,Annexin A10,41829,-0.015738941553011,0.00894232855666985,-0.0332659055240839,0.00178802241806187,0.0784235956918488
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,40097,-0.0114848867270853,0.00653314036276854,-0.0242898418381116,0.00132006838394107,0.0787853079336416
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,40080,-0.00729288479610976,0.00415328888320734,-0.0154333310071961,0.000847561414976617,0.0791284707340913
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,42120,0.00626451786473527,0.0035684837971898,-0.000729710377756736,0.0132587461072273,0.0791953712772921
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF20B,Kinesin-like protein KIF20B,39719,-0.0142134331405474,0.00809934847547556,-0.0300881561524795,0.00166128987138469,0.0793079051257179
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPS10,40S ribosomal protein S10,39706,0.00742811343456629,0.00423296310906364,-0.000868494259198441,0.015724721128331,0.0793182165065923
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,42068,-0.00637833320403727,0.00363981652365668,-0.0135123735904044,0.000755707182329829,0.0797326926111746
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,42144,-0.00317703808012455,0.00181310136574244,-0.00673071675697973,0.000376640596730637,0.0797515362041791
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,42004,-0.0168494746112118,0.00961756208878434,-0.0356998963052291,0.00200094708280554,0.0798065700579173
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,40097,-0.00417972987229213,0.00239192828611998,-0.00886790931308729,0.000508449568503025,0.0805907386862792
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,40002,0.0155534742668582,0.00890955396515545,-0.00190925150484644,0.0330162000385629,0.0808902233580301
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL2,Fc receptor-like protein 2,42186,-0.00947080852352419,0.00543519307254554,-0.0201237869457134,0.00118216989866506,0.0814451481647086
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DXO,Decapping and exoribonuclease protein,40054,-0.00815997568185956,0.0047014068194617,-0.0173747330480045,0.00105478168428537,0.0826548964963743
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,41887,-0.00657715796412025,0.00379820183125194,-0.0140216335533741,0.000867317625133561,0.083360111918351
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,41861,0.00849942634684982,0.00491682375920041,-0.00113754822118299,0.0181364009148826,0.0838976174269554
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,41984,-0.00723362772828038,0.00419116477051204,-0.015448310678484,0.000981055221923217,0.0843854154486545
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,42094,0.00699876938775768,0.00405585404316562,-0.000950704536846936,0.0149482433123623,0.0844438952139274
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,39719,0.0110335623442051,0.00640078467105015,-0.00151197561105315,0.0235791002994634,0.0847764321424398
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM132A,Transmembrane protein 132A,39804,-0.0111458511381367,0.00647344133875844,-0.0238337961621033,0.00154209388582981,0.0851382653097279
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MIF,Macrophage migration inhibitory factor,42096,-0.011982245082874,0.00696407217609374,-0.0256318265480177,0.00166733638226974,0.0853509958644373
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACE,Angiotensin-converting enzyme,40102,-0.00476563337222306,0.00277353357574856,-0.0102017591806902,0.000670492436244111,0.0857787910707489
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINC1,Antithrombin-III,40092,0.00260565619256642,0.00151685821319937,-0.000367385905304355,0.00557869829043719,0.0858618510905882
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX6,Peroxiredoxin-6,42223,-0.0107586877251407,0.00627782426422366,-0.0230632232830191,0.00154584783273766,0.0865964928636821
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXDC2,Plexin domain-containing protein 2,40054,-0.0048358864143066,0.00282217863112022,-0.0103673565313022,0.000695583702689025,0.0866437046334601
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,39706,0.00687683046092808,0.00402140534433757,-0.00100512401397357,0.0147587849358297,0.0872849300894185
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCC,Tubulin-specific chaperone C,42004,-0.0140979363054649,0.0082605196411114,-0.0302885548020432,0.00209268219111349,0.0879086502464291
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,40021,-0.0133086358532622,0.00780071678367791,-0.0285980407492709,0.00198076904274651,0.088022128741528
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHNAK2,Protein AHNAK2,39804,-0.00529732061841521,0.00310551596365908,-0.011384131907187,0.000789490670356589,0.0880787005142655
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSBP1,Heat shock factor-binding protein 1,39804,0.0165100475191035,0.00971486480488132,-0.00253108749846394,0.0355511825366708,0.0892614051836247
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRNN,Cornulin,41727,0.012143804966391,0.00715275303556084,-0.00187559098330825,0.0261632009160903,0.0895740139003789
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GTPBP2,GTP-binding protein 2,39768,-0.014106291371218,0.00830864760403166,-0.03039124067512,0.00217865793268407,0.0895779066033457
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOK1,Docking protein 1,40054,-0.0236297644951875,0.0139359529928232,-0.050944232361121,0.00368470337074599,0.0899908305371588
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD177,CD177 antigen,42105,0.0231310315183728,0.0136484641352101,-0.003619958186639,0.0498820212233845,0.0901428427864754
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDZD2,PDZ domain-containing protein 2,39706,-0.0105905265393227,0.00625723365527005,-0.022854704503652,0.00167365142500659,0.0905754860466185
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIAPIN1,Anamorsin,42186,-0.0108161795069315,0.00639803302817968,-0.0233563242421637,0.00172396522830068,0.0909472238070874
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA2,Protein disulfide-isomerase A2,39665,0.00730260540596378,0.0043301816669126,-0.00118455066118491,0.0157897614731125,0.0917402574273766
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR1,Cadherin-related family member 1,41829,-0.00747305478142691,0.00443177664340601,-0.0161593370025027,0.00121322743964886,0.0917735876688372
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA11,Serpin A11,42296,0.00712869126715309,0.00422880911515604,-0.00115977459855275,0.0154171571328589,0.0918688532077985
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,39768,-0.0139758526773121,0.00830466376731372,-0.030252993661247,0.00230128830662276,0.0924255118498256
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RCOR1,REST corepressor 1,41876,-0.00769091262788026,0.00458609489528573,-0.0166796586226403,0.00129783336687977,0.0935657839155769
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA7,Thyroxine-binding globulin,40113,0.00319025067157892,0.00190421146164385,-0.000542003793243024,0.00692250513640087,0.093891124682949
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARFIP1,Arfaptin-1,40054,0.0117969880290852,0.00704242827145751,-0.00200617138297156,0.0256001474411419,0.0939373744393782
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,42120,-0.00561396882749212,0.00335165518661676,-0.012183212993261,0.000955275338276742,0.0939615592358416
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL11,Interleukin-11,41887,0.0108902196096034,0.00650272393660795,-0.00185511930614815,0.023635558525355,0.0940144868358928
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,40021,-0.00473850821339397,0.00283958218396522,-0.0103040892939658,0.000827072867177855,0.0951989600382865
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMMR,Hyaluronan mediated motility receptor,39646,0.00862466103726889,0.0051689898329796,-0.00150655903537111,0.0187558811099089,0.0952387320332977
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,41887,-0.00915067100722136,0.00549640253983157,-0.0199236199852912,0.00162227797084851,0.0959679022299293
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",39863,-0.0177588766905085,0.0106702929930881,-0.0386726509569612,0.00315489757594406,0.0960760913297138
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL36G,Interleukin-36 gamma,39739,-0.0118305387147576,0.00710940498700226,-0.0257649724892821,0.00210389505976679,0.0961284021027304
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,39784,-0.00706973887836899,0.00425115080629283,-0.0154019944587029,0.00126251670196496,0.0963384914126684
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,42094,-0.00343147177504449,0.00206365093414378,-0.00747622760596631,0.000613284055877328,0.096373567934135
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,39863,-0.0144546227572398,0.0087038517122372,-0.0315141721132247,0.00260492659874511,0.0967999529897459
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,40021,-0.00786707952709804,0.00474493718558226,-0.0171671564108393,0.00143299735664319,0.0973475553589481
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCP1,Plastin-2,40097,0.00819494285515722,0.0049437267770274,-0.00149476162781648,0.0178846473381309,0.0974179556897553
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,41887,-0.00736191609099085,0.00444653579177931,-0.0160771262428783,0.00135329406089658,0.0978170234344877
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTKN2,Rhotekin-2,39706,0.00886880126388893,0.00536407172302548,-0.00164477931324102,0.0193823818410189,0.0982852172308888
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,39706,-0.00669209388602545,0.00405263622129326,-0.0146352608797602,0.00125107310770935,0.0987084265138026
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,40054,-0.0182221111255788,0.0110443771080196,-0.0398690902572971,0.0034248680061396,0.098992433558321
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,42197,-0.00737223933285411,0.00446927656606811,-0.0161320214023476,0.00138754273663939,0.099061720052376
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRDL1,Chordin-like protein 1,42162,0.00551974581704455,0.00334680085232684,-0.00103998385351606,0.0120794754876051,0.0991185376112173
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,41861,-0.0125950863129202,0.00763796360394168,-0.0275654949766459,0.00237532235080552,0.0991701701892861
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCAM1,Vascular cell adhesion protein 1,42172,0.00477531588505216,0.00289696365524514,-0.000902732879228318,0.0104533646493326,0.0992975825916873
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,42004,-0.0105326496346347,0.00639227019582198,-0.0230614992184457,0.00199619994917642,0.099435368007864
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAS6,Growth arrest-specific protein 6,42222,0.00431203904427872,0.00261927919994413,-0.000821748187611766,0.00944582627616921,0.0997324389531326
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACRV1,Acrosomal protein SP-10,39784,-0.0137124160677438,0.00833150340969267,-0.0300421627507414,0.00261733061525384,0.0998240440181055
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,40102,0.0122442379566126,0.00744485436767469,-0.00234767660402977,0.026836152517255,0.100069211004409
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP2,Guanylate-binding protein 2,41887,0.0102960979579211,0.00626322826894208,-0.00197982944920543,0.0225720253650475,0.100222384410234
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,42178,0.00592993932217937,0.00362070289835117,-0.00116663835858893,0.0130265170029477,0.101490413207839
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBLN2,Fibulin-2,40097,0.00549712366900849,0.00335928699835909,-0.00108707884777534,0.0120813261857923,0.101785606664195
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNPY2,Protein canopy homolog 2,41876,0.0104786329679038,0.00640434463925973,-0.00207388252504531,0.0230311484608529,0.101827638358668
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDM1,Nuclear protein MDM1,39768,-0.00528710121609114,0.00323169776202706,-0.0116212288296642,0.0010470263974819,0.101866520638763
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,39784,-0.0107837052506746,0.00659183433559732,-0.0237037005484454,0.0021362900470961,0.101886314799587
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,40021,-0.0151635375161949,0.00927376451947531,-0.0333401159743665,0.00301304094197666,0.102057039697627
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,42186,0.00406108404636419,0.00248500252504547,-0.000809520902724932,0.00893168899545331,0.102233242433955
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,40021,-0.00840183085774082,0.00514333212203506,-0.0184827618169295,0.0016791001014479,0.102384873699191
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,42004,-0.00616846900917192,0.00377966435570906,-0.0135766111463617,0.00123967312801783,0.102700901351491
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,42184,-0.00468532345540578,0.00288009196957678,-0.0103303037157763,0.000959656804964708,0.103804586084216
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,42256,0.0102581355193274,0.00630687095051184,-0.00210333154367579,0.0226196025823306,0.103867121156837
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,42103,-0.00636176976738927,0.0039124265239353,-0.0140301257543024,0.00130658621952392,0.103965134768714
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,42240,0.00582893163881538,0.00359379669876255,-0.00121490989075922,0.01287277316839,0.104839822621208
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,42146,0.00599509224772227,0.0036963733680219,-0.00124979955360066,0.0132399840490452,0.104852329556069
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYO6,Unconventional myosin-VI,40054,0.00606429794257429,0.00374757350756252,-0.00128094613224825,0.0134095420173968,0.10565000944015
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMCH,Pro-MCH,39706,0.0141075579441704,0.00872302731157565,-0.00298957558651789,0.0312046914748587,0.105848345323413
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,42296,0.00529918019850033,0.00328717815985748,-0.00114368899482033,0.011742049391821,0.106969542675932
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST1,Cystatin-SN,38671,-0.0183982493336784,0.0114148331326014,-0.0407713222735773,0.00397482360622039,0.107042175672638
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,42184,0.0195340805454214,0.0121439861107808,-0.00426813223170899,0.0433362933225518,0.107741388261199
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",39665,-0.00917368339203723,0.00570306339940597,-0.0203516876548729,0.00200432087079847,0.107744125693209
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,39784,-0.00583683836724237,0.00363640535529138,-0.0129641928636135,0.00129051612912875,0.108498946639955
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,40020,-0.00854612132157868,0.00533169482695513,-0.0189962431824107,0.00190400053925337,0.108988073441073
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTN,Neuroplastin,41861,0.01308798825297,0.00817745229711683,-0.00293981824937898,0.029115794755319,0.109513299324888
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,41887,-0.00998896309578737,0.00625168296623102,-0.0222422617096002,0.00226433551802543,0.110111529883911
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,39867,0.00832802093334278,0.00521356067375426,-0.00189055798721556,0.0185465998539011,0.110211341499026
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALB2,Calretinin,41829,-0.00530329956700062,0.00332324773016201,-0.0118168651181182,0.00121026598411693,0.110554374245808
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMS,Spermine synthase,39719,-0.0105483859123888,0.0066106480972087,-0.0235052561829179,0.00240848435814024,0.110593423717148
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,40041,0.00675880389154189,0.00424236096806421,-0.00155622360586397,0.0150738313889477,0.111151108272163
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EBI3_IL27,Interleukin-27,42193,0.00507613020404493,0.00319055074166544,-0.00117734924961933,0.0113296096577092,0.111636433795642
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRAS,Ras-related protein R-Ras,39768,-0.0212116470641,0.0133588596573006,-0.0473950119924093,0.00497171786420923,0.112353856237735
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,42094,0.00429356448153334,0.00270474145931927,-0.00100772877873242,0.0095948577417991,0.112441743636764
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,39719,0.0127630036552041,0.00804164610209037,-0.00299862270489298,0.0285246300153013,0.112517020756317
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",40054,0.00427490443722748,0.0026938940673356,-0.0010051279347503,0.00955493680920527,0.112567440191445
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,39881,0.00611795174527534,0.00385641723912529,-0.00144062604341022,0.0136765295339609,0.112670459259347
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA3,GDNF family receptor alpha-3,41983,-0.0047022355357023,0.00296592012227119,-0.0105154389753538,0.00111096790394923,0.112895169812101
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XG,Glycoprotein Xg,42237,0.00566256940252521,0.00357178720626891,-0.00133813352176186,0.0126632723268123,0.112908753244066
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,39998,-0.00493012350899962,0.00311044767062757,-0.0110266009434297,0.00116635392543042,0.112990929989932
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,42103,-0.0102080368279007,0.00644411463036272,-0.0228385015034116,0.00242242784761025,0.11319846699169
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,42128,-0.00807331847491026,0.00509827532042295,-0.0180659381029392,0.00191930115311872,0.113323083956702
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B4,Protein ATP1B4,39665,0.00691826403957508,0.00437521670461581,-0.00165716070147191,0.0154936887806221,0.113853565133542
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBX2,Chromobox protein homolog 2,39706,0.00659806217318865,0.00418085518528094,-0.001596413989962,0.0147925383363393,0.114558740199956
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,42067,0.00350861725300124,0.00222366601307949,-0.000849768132634563,0.00786700263863704,0.114624042246431
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOST,Sclerostin,42122,-0.00632990977339603,0.00403021028701562,-0.0142291219359466,0.00156930238915458,0.116296516065623
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIF,Leukemia inhibitory factor,41829,-0.00838066052178063,0.00534485916544212,-0.0188565844860472,0.00209526344248592,0.116909608322463
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,39784,-0.0134858601618159,0.00861164418556514,-0.0303646827655235,0.0033929624418918,0.117377806306248
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,42057,-0.00461917058959668,0.0029499427329448,-0.0104010583461685,0.00116271716697513,0.117408117489146
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP9,Matrix metalloproteinase-9,42103,0.00971958102276887,0.00621315362769356,-0.00245820008751051,0.0218973621330482,0.117758618171476
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACRBP,Acrosin-binding protein,40020,0.0063343568526333,0.00405751085315252,-0.00161836441954563,0.0142870781248122,0.118519116930991
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPO,Myeloperoxidase,42120,-0.00749888249426186,0.00480638099786365,-0.0169193892500746,0.0019216242615509,0.118738735758694
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,39784,-0.0128212062174354,0.00822132732089952,-0.0289350077663985,0.00329259533152763,0.118906635458878
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD274,Programmed cell death 1 ligand 1,42004,-0.00565268282199759,0.00362525884628312,-0.0127581901607125,0.00145282451671732,0.118962056793692
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN1,Tetraspanin-1,41876,-0.0110309699270505,0.00707530854396625,-0.0248985746732244,0.0028366348191233,0.119002470073608
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FADD,FAS-associated death domain protein,42144,0.0121762935357929,0.00781062306427607,-0.00313252767018816,0.027485114741774,0.119034993317179
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,42248,-0.00651472621310412,0.00418217470821857,-0.0147117886412125,0.00168233621500429,0.119319964877376
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPA1,Inositol monophosphatase 1,42004,0.00974097200337141,0.00625364675382626,-0.00251617563412805,0.0219981196408709,0.119341733919536
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMA1,Proteasome subunit alpha type-1,41861,-0.00744101522577406,0.00477917158149685,-0.0168081915255079,0.00192616107395977,0.11950316461684
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAX,Apoptosis regulator BAX,41813,0.0142896882457114,0.00918103980256612,-0.00370514976731816,0.032284526258741,0.119629854493893
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",41876,-0.0141034547875848,0.00906386132873046,-0.0318686229918965,0.00366171341672691,0.119730774513071
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VGF,Neurosecretory protein VGF,40054,0.00505733650769379,0.00325523313803612,-0.00132292044285701,0.0114375934582446,0.12030853657799
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,39881,-0.0138814563435398,0.00894004710231229,-0.0314039486640719,0.00364103597699227,0.120517877959924
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,42262,-0.00735448491610823,0.00474824360145739,-0.0166610423749647,0.00195207254274825,0.121433500712895
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX5,Sorting nexin-5,39804,-0.00465132459774847,0.00300600409824404,-0.0105430926303068,0.00124044343480984,0.121809966372188
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTX2,Neuronal pentraxin-2,40097,0.00524571080935991,0.00339069187400306,-0.00140004526368609,0.0118914668824059,0.121870190313804
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",40080,-0.00486225811530384,0.00314357684788622,-0.0110236687371608,0.00129915250655316,0.121957933575614
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD3,Extracellular superoxide dismutase,40102,0.00938562997239097,0.00606858637924308,-0.00250879933092547,0.0212800592757074,0.12199055766049
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,41476,-0.00701706830479851,0.00455175743605364,-0.0159385128794636,0.00190437626986661,0.123192365868142
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTF3,Neurotrophin-3,42103,-0.00572104153766944,0.00371209157242383,-0.0129967410196201,0.00155465794428127,0.123294856738058
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCN1,Transcobalamin-1,39916,0.00543447385451599,0.00352873780751196,-0.00148185224820745,0.0123507999572394,0.123574830743579
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN3B,Sodium channel subunit beta-3,39719,0.0077176688876374,0.00501243873944157,-0.00210671104166807,0.0175420488169429,0.123662733685989
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSC2,Desmocollin-2,42003,0.00565450598952286,0.00367591984547486,-0.00155029690760787,0.0128593088866536,0.124010718820555
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HCG22,Protein PBMUCL2,39706,0.00897231105873686,0.00583337846939914,-0.00246111074128545,0.0204057328587592,0.124054614577395
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE1,Ribonuclease pancreatic,40102,-0.0041865865448652,0.00272682567364685,-0.00953116486521303,0.00115799177548264,0.124730955874193
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,42144,0.0078285795197614,0.00509962990497624,-0.00216669509399203,0.0178238541335148,0.124777066762459
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PADI2,Protein-arginine deiminase type-2,41887,-0.00880382529784075,0.00574461220360442,-0.0200632652169054,0.00245561462122391,0.125415130694356
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,41999,-0.0159972483173086,0.0104661504215404,-0.0365109031435278,0.00451640650891057,0.126419368783006
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPC1,Glypican-1,42223,-0.00473275163618944,0.00309673877045623,-0.0108023596262836,0.00133685635390476,0.126461882728702
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STXBP1,Syntaxin-binding protein 1,40054,0.012025862060384,0.00786993265507451,-0.00339920594356203,0.0274509300643301,0.126522576954388
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,42094,-0.0138011637902324,0.00904160314149787,-0.0315227059475682,0.00392037836710346,0.126933121421449
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,39665,0.00914026118394312,0.00599271604101588,-0.002605462256448,0.0208859846243342,0.127232320654323
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH7B,Myosin-7B,39665,0.00706364348714675,0.00463452651387548,-0.00202002848004919,0.0161473154543427,0.127505222394875
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,41829,-0.0114149821327844,0.00750793636944547,-0.0261305374168976,0.0033005731513287,0.128438318271716
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD244,Natural killer cell receptor 2B4,42256,-0.00430035470552002,0.00283493093390571,-0.00985681933597521,0.00125610992493518,0.129311860533163
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1R,Complement C1r subcomponent,40113,0.00300398235824819,0.00198155191913869,-0.00087985940326364,0.00688782411976003,0.129554725293503
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,39804,0.00325950665006924,0.00215433879082501,-0.000962997379947772,0.00748201068008626,0.130310379921391
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,39768,0.0112504543642414,0.00743838830861595,-0.00332878672064585,0.0258296954491287,0.130440287096785
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYGD,Gamma-crystallin D,40054,-0.0151563034856165,0.0100211065890117,-0.0347976724000793,0.0044850654288464,0.130451544722571
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,41696,-0.0104328362105226,0.00691328520182551,-0.0239828752061006,0.00311720278505537,0.131298591885637
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPCAL1,Hippocalcin-like protein 1,42256,0.0112483243031358,0.00746663662686162,-0.00338628348551299,0.0258829320917846,0.131968675845364
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,42208,-0.00458183169679344,0.00304525505794818,-0.0105505316103719,0.001386868216785,0.132456203410849
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HK2,Hexokinase-2,41876,0.00431179237878674,0.00286698165881302,-0.00130749167248677,0.00993107643006026,0.132619563962497
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMM2,Phosphomannomutase 2,39706,0.00929392195846098,0.0061894535959815,-0.00283740708966275,0.0214252510065847,0.133237224659383
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",39706,0.00765113321926064,0.00510423909191518,-0.00235317540089311,0.0176554418394144,0.133909820047509
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR15L,Protein GPR15L,40021,-0.00939499924232508,0.00627364984316247,-0.0216913529349235,0.00290135445027335,0.134283711774205
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,39706,0.00586454585715464,0.00391898289490346,-0.00181666061685615,0.0135457523311654,0.134567519617984
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLG,Plasminogen,39864,0.00332705784324546,0.00222623410663616,-0.00103636100576142,0.00769047669225234,0.135080305578375
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,39719,0.00885403108741068,0.00592553148705749,-0.002760010627222,0.0204680728020434,0.135148835708998
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,40097,0.00431652993921391,0.0028924099773327,-0.00135259361635817,0.009985653494786,0.135632552420208
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,39719,0.0120256529949021,0.00806897092341601,-0.00378953001499324,0.0278408360047975,0.136160173211255
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,39863,0.00960398979054605,0.00645485758788555,-0.00304753108170963,0.0222555106628017,0.136814700616238
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F11,Coagulation factor XI,39959,0.00463568646099566,0.00311675513029896,-0.00147315359439029,0.0107445265163816,0.136953316990033
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD69,Early activation antigen CD69,42093,-0.0134278838269611,0.00903355984630902,-0.0311336611257268,0.00427789347180453,0.137186071980633
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB6A,Ras-related protein Rab-6A,42103,0.00705376785873818,0.0047546246903597,-0.00226529653436684,0.0163728322518432,0.137950277184277
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,39733,-0.00585204865619708,0.00395754620918539,-0.0136088392262004,0.00190474191380629,0.139248704193232
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,42296,0.00352014750296864,0.00239187962881254,-0.00116793656950393,0.00820823157544121,0.141123863735349
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RP2,Protein XRP2,42094,-0.00639469641820768,0.0043475764758014,-0.0149159463107784,0.00212655347436307,0.141352123643899
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2orf69,UPF0565 protein C2orf69,39768,-0.00929362401407705,0.00632642761207279,-0.0216934221337397,0.00310617410558563,0.141858171132785
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELAVL4,ELAV-like protein 4,39719,-0.0128450674177877,0.00875384228484039,-0.0300025982960749,0.00431246346049947,0.142307116473419
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NENF,Neudesin,40020,-0.0166855709925923,0.0113741643752509,-0.0389789331680841,0.00560779118289952,0.142412951246762
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFD,Vascular endothelial growth factor D,42237,0.00547959123500732,0.00373926209166311,-0.00184936246465237,0.012808544934667,0.142830339045262
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,39768,0.0107786088736892,0.00736660863028914,-0.00365994404167747,0.025217161789056,0.143450288840386
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTUD7B,OTU domain-containing protein 7B,40054,-0.0093119569732328,0.00636973268241272,-0.0217966330307617,0.00317271908429613,0.143795623578782
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBNL,Drebrin-like protein,42184,-0.0137493935703075,0.00944428390880519,-0.0322601900315657,0.00476140289095067,0.145460223347471
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",39847,-0.00953847526457643,0.00656340313675508,-0.0224027454126164,0.00332579488346353,0.146174944498102
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRC,Chymotrypsin-C,42135,0.00991099262572397,0.00683138638563262,-0.00347852469011596,0.0233005099415639,0.146859093828338
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,42146,-0.00478162883954432,0.00330060912981082,-0.0112508227339735,0.00168756505488489,0.147442508277997
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL31,Interleukin-31,39784,0.00848739606256814,0.00586249165584988,-0.00300308758289761,0.0199778797080339,0.147717835336328
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGCC,Regulator of cell cycle RGCC,40054,-0.0112139337254583,0.00775313410238528,-0.0264100765661335,0.00398220911521683,0.148101112418258
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,42296,0.00615816824434946,0.00426016090656768,-0.00219174713252319,0.0145080836212221,0.14833444958506
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH4,Myosin-4,39706,0.00679310486070552,0.00470307034977091,-0.00242491302484547,0.0160111227462565,0.148656889839596
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,H2AP,Huntingtin-interacting protein M,39665,0.00784249477434255,0.00545114684174215,-0.00284175303547206,0.0185267425841572,0.15026907760084
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,42109,-0.00718175871512089,0.00499431176469045,-0.0169706097739142,0.00260709234367238,0.150461783309201
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,39784,-0.0130099145078339,0.00905909450036346,-0.0307657397285463,0.00474591071287852,0.15099874981782
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY2B,Alpha-amylase 2B,41315,0.00742623895766119,0.00517997647720001,-0.00272651493765083,0.0175789928529732,0.151699853235122
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH7,Protocadherin-7,40021,-0.00538357471974088,0.00375976922168301,-0.0127527223942396,0.00198557295475781,0.15220426500162
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDRG1,Protein NDRG1,41829,-0.00958349830539768,0.00669804291204636,-0.0227116624130086,0.00354466580221319,0.152514905574718
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAD1,Glutamate decarboxylase 1,39665,0.00386200412190383,0.00270305747722352,-0.00143598853345427,0.00915999677726193,0.153104786230626
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRMD4B,FERM domain-containing protein 4B,39706,-0.010337607419557,0.00723691581144181,-0.024521962409983,0.00384674757086894,0.153190694540121
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAMDC2,MAM domain-containing protein 2,40080,0.00539060862269351,0.00377462361284408,-0.00200765365848088,0.0127888709038679,0.153286531843648
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1S,Complement C1s subcomponent,40113,0.00306180810112522,0.00214456793825282,-0.00114154505785031,0.00726516126010075,0.153405689296234
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRTN,Neurturin,41887,-0.00722367440509041,0.00506200652435158,-0.0171452071928195,0.00269785838263869,0.153593611628674
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,39719,0.00922138111419484,0.00646324142502712,-0.00344657207885832,0.021889334307248,0.153683798553824
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",41861,-0.00732016548856533,0.0051344042700486,-0.0173835978578606,0.00274326688072993,0.153977049074637
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCB,Tubulin-folding cofactor B,42004,-0.0145919194261621,0.0102352571830069,-0.0346530235048557,0.00546918465253148,0.153993055983395
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,39768,-0.0059055422342168,0.00414672690057665,-0.014033126959347,0.00222204249091343,0.154433881832459
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,41887,-0.00572405427897805,0.00402308303225689,-0.0136092970222015,0.00216118846424545,0.154817870583273
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THPO,Thrombopoietin,41876,0.0057071438069789,0.00401544338738757,-0.00216312523230073,0.0135774128462585,0.155254577553468
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,40054,0.0034823080253639,0.00245080034611105,-0.00132126065301376,0.00828587670374156,0.155378599884375
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASAH1,Acid ceramidase,39992,-0.00664662084116809,0.00468397812499639,-0.015827217966161,0.00253397628382484,0.155924401555883
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL1A1,Collagen alpha-1(I) chain,42296,0.0036646640908141,0.00258687402513604,-0.00140560899845254,0.00873493718008075,0.156612562435025
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,39784,-0.013289282592257,0.00938718104458613,-0.0316881574396459,0.00510959225513178,0.15689743483957
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,42162,-0.0110305462739704,0.00779854666655585,-0.0263156977404198,0.00425460519247909,0.15725789248506
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,39719,0.00935495812596228,0.0066345059484495,-0.00364867353299874,0.0223585897849233,0.15855567052503
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,39706,0.0108065360003645,0.0076659095576458,-0.00421864673262131,0.0258317187333502,0.158661595099585
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD27,CD27 antigen,42186,0.00646913056936852,0.00458955711297176,-0.00252640137205612,0.0154646625107932,0.158701663988838
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GH2,Growth hormone variant,41861,0.0243056926518353,0.0172485602736512,-0.00950148548452096,0.0581128707881916,0.158817355700462
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCN15,Lipocalin-15,40054,-0.00908220024763461,0.00645854436592353,-0.0217409472048447,0.00357654670957551,0.159684385556011
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF2,Fibroblast growth factor 2,42103,-0.00997200368910518,0.00710259973897405,-0.0238930991774943,0.00394909179928396,0.160344849282052
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDK2,Protein sidekick-2,39863,-0.00587846216702818,0.00419129313579525,-0.0140933967131869,0.0023364723791305,0.160782731656395
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,39881,-0.00969630116801774,0.00691749176771111,-0.0232545850327315,0.00386198269669603,0.161031605018896
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17C,Interleukin-17C,41887,-0.0108123119441591,0.00772185532299972,-0.0259471483772385,0.00432252448892033,0.161471282892211
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTX3,Pentraxin-related protein PTX3,42103,0.00706796874261999,0.00504903359463379,-0.00282813710286224,0.0169640745881022,0.161577582379081
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF8,SLAM family member 8,41861,0.00800944371583335,0.00572740848374292,-0.00321627691230278,0.0192351643439695,0.162005114022159
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP112,Centrosomal protein of 112 kDa,39706,-0.00644525230042999,0.00461304140657587,-0.0154868134573187,0.00259630885645871,0.162388736830875
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTN,Titin,39706,-0.00947086970007724,0.00678636301909016,-0.022772141217494,0.00383040181733947,0.162872386320086
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITM2A,Integral membrane protein 2A,42103,0.00892131761083515,0.00639949826421952,-0.0036216989870351,0.0214643342087054,0.16332192117633
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL23,C-C motif chemokine 23,42184,-0.0060295868208274,0.00432591029040193,-0.0145083709900152,0.00244919734836039,0.163392560577602
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,41861,-0.00826587563991169,0.005949528950249,-0.0199269523823997,0.00339520110257635,0.164755999027742
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,40021,-0.00836961126014867,0.00602455870822186,-0.0201777463282635,0.00343852380796616,0.164785662011763
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHGB,Secretogranin-1,42166,0.00618607464699982,0.00445708740696595,-0.00254981667065343,0.0149219659646531,0.165185661471633
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPON1,Spondin-1,42146,-0.00487046930667265,0.00350972212847935,-0.0117495246784922,0.00200858606514687,0.165249866261674
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,40054,-0.00698853173771207,0.0050414607803584,-0.0168697948672145,0.00289273139179039,0.165710740016722
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",39768,-0.00557590592045594,0.00402481485608202,-0.0134645430383767,0.00231273119746482,0.165964924167565
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPT1,Angiopoietin-1,42067,-0.011958552553884,0.00864029681385287,-0.0288935343090356,0.00497642920126759,0.166368920105831
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM1,Intercellular adhesion molecule 1,42104,-0.00417644541135742,0.00302117486776667,-0.0100979481521801,0.00174505732946525,0.166875544701141
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD83,CD83 antigen,42103,-0.0050672495886721,0.0036658326589018,-0.0122522816001196,0.00211778242277543,0.166906107779236
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CR1,Complement receptor type 1,40080,-0.00514832320432086,0.00372728691046729,-0.0124538055488368,0.00215715914019504,0.167229783718318
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCNE1,G1/S-specific cyclin-E1,39784,-0.0126660165074625,0.00917306239822265,-0.0306452188079788,0.00531318579305394,0.167374566483806
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFC,Vascular endothelial growth factor C,42186,-0.00788130116050575,0.0057156682990102,-0.0190840110265657,0.00332140870555424,0.167951153340605
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,39881,-0.0054490972410588,0.00395327037796729,-0.0131975071818747,0.00229931269975708,0.168115753115648
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,39784,0.00698706573701668,0.00506955318975709,-0.00294925851490722,0.0169233899889406,0.168158029098234
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF20,Fibroblast growth factor 20,39784,0.00644058836377369,0.00467399053204842,-0.00272043307904122,0.0156016098065886,0.168243671614905
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPI,Glucose-6-phosphate isomerase,40102,-0.00666811972097268,0.00483984232483,-0.0161542106776395,0.00281797123569412,0.168307032019239
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPN1,Epsin-1,39881,-0.00633686132450121,0.00460226345839659,-0.0153572977029585,0.00268357505395611,0.168571688069527
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,40020,0.00907455072498417,0.00659853731994986,-0.00385858242211755,0.0220076838720859,0.169086528781946
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REST,RE1-silencing transcription factor,39665,0.00487172986966464,0.00354635100293943,-0.00207911809609664,0.0118225778354259,0.16955483073784
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,39881,-0.0148454504451283,0.0108133326935624,-0.0360395825245106,0.00634868163425392,0.169817246095229
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",42120,-0.0108016980687213,0.00787194546058872,-0.0262307111714752,0.00462731503403255,0.17003233030679
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",40020,-0.00743956294897625,0.00542392831992411,-0.0180704624560275,0.00319133655807501,0.170210511868852
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,41876,-0.0106634032197984,0.00778548842195751,-0.0259229605268352,0.00459615408723828,0.170820072846574
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF12,Fibroblast growth factor 12,39784,0.00658729794702733,0.00481716563571508,-0.00285434669897423,0.0160289425930289,0.171509106369101
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEG1,Protein LEG1 homolog,39518,0.00983030710133356,0.00721974244225242,-0.00432038808548119,0.0239810022881483,0.173357987780584
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",40080,-0.0124698440556452,0.00918540077674031,-0.0304732295780562,0.00553354146676581,0.174627633807176
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL2A1,Collagen alpha-1(II) chain,39804,-0.0113152591558703,0.00833794279811924,-0.027657627040184,0.00502710872844341,0.174784518138935
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,39768,-0.0107013234238648,0.0078954993501834,-0.0261765021502243,0.00477385530249466,0.17532863371605
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINF2,Alpha-2-antiplasmin,39899,0.00188406341987664,0.00139053671081134,-0.000841388533313585,0.00460951537306687,0.175472229294292
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP3,"Fatty acid-binding protein, heart",40080,-0.00732709511420734,0.00541487420041441,-0.0179402485470196,0.0032860583186049,0.176038285931705
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRC1,Protein regulator of cytokinesis 1,40020,-0.00620278355314567,0.00460629350032497,-0.0152311188137826,0.00282555170749126,0.178140871476334
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,39881,0.00400138074746478,0.00297245159057567,-0.00182462437006354,0.0098273858649931,0.178281067571424
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BIN2,Bridging integrator 2,42120,-0.0125572737437366,0.00933098732930733,-0.0308460089091789,0.00573146142170579,0.178403386444499
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,41869,0.00764494394200541,0.00570107390837012,-0.00352916091840003,0.0188190488024109,0.179955654218237
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,42144,-0.00353726232831713,0.00263786342445524,-0.00870747464024941,0.00163294998361514,0.179957821948291
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,39719,0.0103015889585009,0.0076880630823674,-0.00476701468293916,0.025370192599941,0.180291846501016
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUCA2A,Guanylin,42072,-0.00505169402741115,0.00377141702896144,-0.0124436714041756,0.00234028334935326,0.180441864827478
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTNL10,Butyrophilin-like protein 10,39665,0.00592905985677349,0.00443002302885876,-0.00275378527978969,0.0146119049933367,0.180801240569891
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,39804,-0.00717390025558867,0.00536409131695325,-0.0176875192368171,0.0033397187256397,0.181122930605821
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,41861,-0.0116363885952337,0.00871701363753699,-0.0287217353248062,0.00544895813433882,0.18193130060262
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP6,Guanylate-binding protein 6,39706,-0.00626697295707746,0.00469602276142628,-0.015471177569473,0.00293723165531805,0.182059845156365
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,39768,-0.0142448794798509,0.0106741455822532,-0.0351662048210672,0.00667644586136531,0.182061658094317
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNW1,Interferon omega-1,39706,0.00508261755245222,0.00381301125850343,-0.0023908845142145,0.0125561196191189,0.182571575593254
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN7,Septin-7,39881,0.00755722221620912,0.00567384024773289,-0.00356350466934734,0.0186779491017656,0.182907878949563
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XRCC4,DNA repair protein XRCC4,41829,-0.00508032594482201,0.00381451385896925,-0.0125567731084017,0.00239612121875771,0.182936466797048
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR101,Probable G-protein coupled receptor 101,39719,0.00834921673477482,0.00627091945005854,-0.00394178538733992,0.0206402188568896,0.183080256250475
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,39719,0.00416352402521796,0.00312741718014741,-0.00196621364787096,0.0102932616983069,0.183119832641756
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR1,Toll-like receptor 1,39784,-0.00368442679702774,0.00277339123817149,-0.00912027362384385,0.00175142002978838,0.184044403108576
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,39784,-0.00549706423568641,0.00414255209381391,-0.0136164663395617,0.00262233786818886,0.184545468959073
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK4,Serine/threonine-protein kinase 4,42144,0.0117707227526053,0.00887311004687246,-0.00562057293926472,0.0291620184444753,0.184677298467745
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,39665,0.00341280598131821,0.00257905836411319,-0.00164214841234365,0.00846776037498007,0.185772510050083
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",42184,-0.00387242155176159,0.00292665998598843,-0.00960867512429891,0.00186383202077574,0.185807494871716
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,39784,-0.0138955622484261,0.0105084366649551,-0.034492098111738,0.00670097361488589,0.186088707489207
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRING1,SREBP regulating gene protein,39665,-0.00809093846480332,0.00612063796003855,-0.0200873888664789,0.00390551193687224,0.186226676411269
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEX33,Testis-expressed protein 33,39881,0.00525512816369615,0.00397732678872457,-0.00254043234220402,0.0130506886695963,0.186439170781254
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB116,Beta-defensin 116,39719,0.0104648193978694,0.00794547818898153,-0.00510831785253444,0.0260379566482732,0.187840948529597
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17F,Interleukin-17F,41887,0.0102987856887065,0.0078231853856714,-0.00503465766720949,0.0256322290446224,0.188048822913426
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",42103,0.0110772123451749,0.00842958351369873,-0.00544477134167462,0.0275991960320244,0.188840029455341
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL24,Interleukin-24,41887,0.00680924133835659,0.00518206625407892,-0.00334760851963809,0.0169660911963513,0.188869542769833
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,42079,-0.0119730504013479,0.00913594350480446,-0.0298794996707646,0.00593339886806889,0.190035433691322
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERVV_1,,39706,0.00592636297675056,0.00452612518248203,-0.00294484238091421,0.0147975683344153,0.190438381129669
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPM3,Tropomyosin alpha-3 chain,39706,0.00593885028637625,0.00453776751003048,-0.00295517403328349,0.014832874606036,0.190644145626492
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,42144,0.00383457176042638,0.00293676001461448,-0.00192147786821801,0.00959062138907077,0.191672671346156
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL5,Interleukin-5,41887,0.0188325896868446,0.0144267567363828,-0.00944385351646575,0.0471090328901549,0.191782664404907
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",40080,-0.00977792345785506,0.00749473001638141,-0.0244675942899626,0.00491174737425249,0.192043091115816
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,40054,-0.0156168036518083,0.0119897696608152,-0.0391167521870061,0.00788314488338951,0.192769472196515
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRY2,Protein sprouty homolog 2,41887,-0.0123447674421561,0.00948316644644251,-0.0309317736771834,0.00624223879287121,0.193023483187013
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRSF1,G-rich sequence factor 1,39601,-0.0108364427879334,0.00834214217887647,-0.0271870414585313,0.00551415588266447,0.193972703828712
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL34,Interleukin-34,41813,-0.00491115658959299,0.0037823678347335,-0.0123245975456706,0.00250228436648466,0.194161825737939
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,39881,-0.00591723025066762,0.00455733544730824,-0.0148496077273918,0.00301514722605652,0.194178998587009
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,39227,-0.00737915219400517,0.00568914322662922,-0.0185298729181984,0.0037715685301881,0.194640848010742
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,42094,-0.00336978434046788,0.00259812105346607,-0.00846210160526139,0.00172253292432562,0.194651558317345
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D23,TBC1 domain family member 23,42094,-0.0119794608050653,0.0092366299333309,-0.0300832554743938,0.00612433386426331,0.194671080217337
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNLR1,Interferon lambda receptor 1,42103,-0.00486899359623032,0.00375902991923838,-0.0122366922379375,0.0024987050454769,0.195247064530995
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD3,Bromodomain-containing protein 3,39706,0.00667453992014592,0.00515389040086972,-0.00342708526555873,0.0167761651058506,0.19533181435189
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RYR1,Ryanodine receptor 1,39706,0.00459893862913005,0.0035528399915554,-0.00236462775431853,0.0115625050125786,0.195541873645384
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPG,Macrophage-capping protein,41971,0.00780507235780621,0.00604403476918259,-0.00404123578979167,0.0196513805054041,0.196599504715078
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,40069,-0.00630640556570301,0.0048845838149588,-0.0158801898430223,0.00326737871161624,0.196702168496295
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL33,Interleukin-33,41887,-0.00515659628999836,0.00400713629232436,-0.0130105834229541,0.0026973908429574,0.198168916329589
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC1A4,Neutral amino acid transporter A,39768,-0.00692288184399965,0.0053797451874781,-0.0174671824114567,0.00362141872345742,0.198177548451838
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNIP4,Kv channel-interacting protein 4,41829,0.00660715802721633,0.00513659635378493,-0.00346057082620213,0.0166748868806348,0.198365066604018
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBN1,Drebrin,39784,-0.00662543945758735,0.00515232851399634,-0.0167240033450202,0.00347312442984547,0.198501999630553
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARF2,Scavenger receptor class F member 2,42213,0.00403209417090743,0.00313994065349333,-0.0021221895099395,0.0101863778517544,0.199119081127484
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,40021,0.00616031906396198,0.00480344574444383,-0.00325443459514793,0.0155750727230719,0.199702067266195
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,39768,-0.00654113908285567,0.0051013571867115,-0.0165397991688102,0.00345752100309887,0.199788307816013
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CERT,Ceramide transfer protein,41829,-0.00808491768982624,0.00631661146649031,-0.0204654761641472,0.00429564078449476,0.20058784433762
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,39651,0.00686858829234194,0.00536716262724428,-0.00365105045705684,0.0173882270417407,0.200663961104705
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,42161,0.0122967332698171,0.0096101405538261,-0.00653914221568206,0.0311326087553163,0.200723484609942
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,40021,-0.00579829626649533,0.00453784842003806,-0.0146924791697699,0.00309588663677928,0.201360286357832
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS1,"Nitric oxide synthase, brain",41829,-0.00716324955205971,0.00561393098631945,-0.0181665542852458,0.00384005518112642,0.201986932863874
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPE4,NXPE family member 4,39706,0.00444755632916265,0.00349184491665319,-0.00239645970747759,0.0112915723658029,0.202798582005226
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHD,SH2 domain-containing adapter protein D,39674,0.0114406543226796,0.00902832094369067,-0.00625485472695415,0.0291361633723133,0.205113288890998
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,39719,0.00544700069768249,0.0043025106097229,-0.0029859200973744,0.0138799214927394,0.205539250332472
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,39719,0.00929473364010082,0.00734543107484029,-0.00510231126658614,0.0236917785467878,0.205764515764672
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,41829,-0.0095067464861255,0.00753467549121151,-0.0242747104489001,0.00526121747664906,0.207068276169206
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTX1,Neuronal pentraxin-1,42120,-0.00522283076973256,0.00415182632346369,-0.0133604103637214,0.00291474882425627,0.208429005003801
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A13,Protein S100-A13,39784,0.00461577544516758,0.00367172754537782,-0.00258081054377294,0.0118123614341081,0.20874054164541
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",41968,-0.00540679034979056,0.00430695710095152,-0.0138484262676555,0.00303484556807442,0.209370335063624
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN6,Dynactin subunit 6,41829,-0.00932544952041936,0.00744290102121336,-0.0239135355219975,0.00526263648115882,0.21025360966717
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPT,Dermatopontin,42296,0.00326242579034515,0.00260582293002389,-0.00184498715250167,0.00836983873319197,0.210601235304444
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,39719,0.00653393215366204,0.00522070887403449,-0.00369865723944556,0.0167665215467696,0.210764913640581
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,40020,0.0117304854368814,0.00937365803902595,-0.0066418843196095,0.0301028551933722,0.210804344953571
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KDM3A,Lysine-specific demethylase 3A,39784,-0.0113440748281642,0.00906540556794372,-0.0291122697413339,0.00642412008500549,0.210831251519816
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,41935,0.0222301242826072,0.0177893523072982,-0.0126370062396972,0.0570972548049115,0.211457365374624
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN3,CCN family member 3,42282,-0.00460231663229954,0.00368662296707638,-0.0118280976477692,0.00262346438317016,0.211913242773904
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,39863,-0.00472800053841515,0.00378930450926712,-0.0121550373765787,0.00269903629974841,0.212160078933811
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,41861,0.0159233673188339,0.0127647708482139,-0.00909558354366543,0.0409423181813331,0.212256927408136
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,39784,-0.00315737627424008,0.00253109621383013,-0.00811832485334715,0.00180357230486698,0.212265875062883
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,40020,0.00626688631327041,0.00502670142697148,-0.00358544848359369,0.0161192211101345,0.212527366687081
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,39665,-0.00345807816728641,0.00277686027660607,-0.00890072430943431,0.0019845679748615,0.213042208333837
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A3,Protein S100-A3,40020,-0.00556757253203609,0.00447846296564005,-0.0143453599446906,0.00321021488061842,0.213825394081634
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAA4,Serum amyloid A-4 protein,40113,-0.00407396836385183,0.00328502611823426,-0.010512619555591,0.00236468282788732,0.214941701586373
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKCQ,Protein kinase C theta type,41887,-0.00558979017105124,0.00451156754352897,-0.014432462556368,0.00325288221426554,0.215371857037771
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRADD,Death domain-containing protein CRADD,41985,-0.00952797093281034,0.00770215364350172,-0.0246241920740737,0.00556825020845303,0.216090181934337
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,39784,-0.00263216175735371,0.00212927021408889,-0.00680553137696793,0.0015412078622605,0.216418992488977
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTNNA1,Catenin alpha-1,39719,0.00444361864983201,0.00361736428656594,-0.00264641535183724,0.0115336526515013,0.219319299166099
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENG,Endoglin,42296,-0.00221131396542612,0.00180036072139349,-0.00574002097935736,0.00131739304850512,0.21937083893537
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2,Complement C2,42172,0.00290645211948453,0.00236716830831024,-0.00173319776480354,0.00754610200377259,0.219537523858448
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD1,Programmed cell death protein 1,42192,0.00574081550974778,0.00467646345901965,-0.00342505286993072,0.0149066838894263,0.219620279141833
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,40080,-0.0114011192516959,0.00929368745870105,-0.02961674667075,0.00681450816735812,0.219939533861425
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFIC,Nuclear factor 1 C-type,40054,-0.0059987984426,0.00489433472156756,-0.0155916944968724,0.00359409761167242,0.220352600557587
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EREG,Proepiregulin,41985,-0.0101399420274049,0.00830130149131863,-0.0264104929503894,0.00613060889557965,0.221923733293651
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,40021,0.0122024358277731,0.00999597973159622,-0.0073896844461555,0.0317945561017017,0.222213201492717
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",40020,-0.00475065351153218,0.00389597266731791,-0.0123867599394753,0.00288545291641093,0.222728280709284
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,42184,0.00535528749897928,0.00439841281166431,-0.00326560161188277,0.0139761766098413,0.223417143269818
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,41887,0.00542977461312702,0.00446596234137112,-0.00332351157596038,0.0141830608022144,0.224078815774928
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC16,Mucin-16,42094,-0.0241777909134729,0.0198920369504225,-0.063166183336301,0.0148106015093553,0.22421647159427
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,40021,0.0146493652115552,0.0120629572997455,-0.008994031095946,0.0382927615190564,0.224618025292932
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD82,CD82 antigen,39881,0.00516141947774621,0.00425060423115362,-0.00316976481531488,0.0134926037708073,0.22466803096235
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,40054,-0.00670439267797442,0.00553541567481206,-0.0175538074006061,0.00414502204465722,0.225852232904343
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYO9B,Unconventional myosin-IXb,41887,-0.00825263383192586,0.00681532676714076,-0.0216106742955217,0.00510540663167002,0.225958828550196
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHH,Sonic hedgehog protein,39784,0.00531004102084038,0.00438540894914363,-0.00328536051948114,0.0139054425611619,0.225982665011416
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,39768,-0.00456507621841792,0.00377144605470632,-0.0119571104856423,0.00282695804880647,0.226140506757557
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,42296,-0.00407491292190665,0.00336666346449737,-0.0106735733123215,0.0025237474685082,0.22615827430855
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN10,Ataxin-10,41829,0.00903584166705252,0.00747625878958149,-0.0056176255605272,0.0236893088946322,0.226837359693392
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",42120,-0.00485547968464675,0.00402231784267589,-0.0127392226562915,0.003028263286998,0.22740233919359
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",39719,-0.00712320718660408,0.0059024546319553,-0.0186920182652365,0.00444560389202832,0.227528145357498
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,40054,-0.0143898664345602,0.0119405377973292,-0.0377933205173253,0.00901358764820497,0.228180474545157
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGMA,Repulsive guidance molecule A,42213,-0.00399087589933095,0.00331374197982191,-0.0104858101797819,0.00250405838111999,0.228479633670019
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",39768,-0.0104958253713648,0.00873041858042684,-0.0276074457890014,0.00661579504627186,0.229307817439728
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX9,Sorting nexin-9,42144,-0.00834021884197431,0.00694244237640518,-0.0219474058997285,0.00526696821577983,0.22964214178404
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP1,Retinol-binding protein 1,39768,-0.00851302337846474,0.00708840284341775,-0.0224062929515635,0.00538024619463405,0.229786225617257
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CADPS,Calcium-dependent secretion activator 1,39768,0.00533285905826476,0.0044515776153582,-0.00339223306783732,0.0140579511843668,0.230955318164319
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF3,Trefoil factor 3,42123,-0.00534735249744755,0.00446632838320213,-0.0141013561285237,0.00340665113362862,0.231227514215887
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLGAP5,Disks large-associated protein 5,40054,0.00625267983111991,0.00522327543543505,-0.00398494002233279,0.0164902996845726,0.231301409189469
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEBP1,Heme-binding protein 1,41876,0.00653832060426336,0.00547456797271497,-0.00419183262225798,0.0172684738307847,0.232379826515758
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDNRB,Endothelin receptor type B,39784,-0.00549341829422049,0.00460216431402837,-0.0145136603497161,0.00352682376127511,0.232637830563439
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FZD8,Frizzled-8,39719,0.00565730381141395,0.0047434553554333,-0.00363986868523532,0.0149544763080632,0.233031562657408
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,39706,0.0031934142690034,0.00267772673593822,-0.00205493013343551,0.00844175867144232,0.233059223460338
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAP1A,Ras-related protein Rap-1A,39784,0.00874867017766696,0.00733775518749224,-0.00563332998981783,0.0231306703451517,0.233177579064334
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,42223,-0.00328423097399061,0.00275644540280354,-0.00868686396348555,0.00211840201550432,0.233489553539639
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",40054,0.00888362607237843,0.00747560684677841,-0.00576856334730725,0.0235358154920641,0.234722129214802
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEFL,Neurofilament light polypeptide,41782,0.00569234247715954,0.00479556521521585,-0.00370696534466352,0.0150916502989826,0.23524948010611
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,39665,-0.00354568587968676,0.00298757109380722,-0.00940132522354892,0.0023099534641754,0.235328623020941
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAB2,Disabled homolog 2,42223,-0.0133461168825555,0.0112553080603838,-0.0354065206809078,0.00871428691579673,0.235737916425044
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F2,Prothrombin,40113,0.00182015542025061,0.00153640414206297,-0.0011911966981928,0.00483150753869402,0.236167677062067
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYB5A,Cytochrome b5,39665,-0.00894970738198284,0.00756031344143458,-0.0237679217271946,0.00586850696322895,0.236529152839916
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,42075,0.00370946291770094,0.00313665029928587,-0.00243837166889937,0.00985729750430124,0.236981921781555
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,40113,0.00228997859151147,0.00193713455705274,-0.0015068051403119,0.00608676232333484,0.237172959793606
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,39784,-0.00366921315235308,0.00310560530812352,-0.00975619955627519,0.00241777325156902,0.237438293447029
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD160,CD160 antigen,42256,0.00601201781361756,0.00509137831485462,-0.0039670836834975,0.0159911193107326,0.23769445248553
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP25,Synaptosomal-associated protein 25,39719,0.00576408606263658,0.00488464309139403,-0.00380981439649573,0.0153379865217689,0.238010012862803
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,40054,0.0120347914267064,0.0102037429182292,-0.00796454469302282,0.0320341275464356,0.238245385592092
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",39804,0.0030915567071964,0.00262925216767774,-0.00206177754145197,0.00824489095584478,0.239688722630923
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL7,Interleukin-7,42103,0.0077023288475638,0.00655829904446653,-0.0051519372795906,0.0205565949747182,0.240240488602266
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNB2,Ephrin-B2,39768,-0.00659379560823492,0.00562060200947511,-0.0176101755468061,0.00442258433033629,0.240763057243205
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,39768,0.00770225384417584,0.00656928980259972,-0.00517355416891961,0.0205780618572713,0.241037350385323
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,39719,0.00648848186673691,0.00553431887517481,-0.00435878312860571,0.0173357468620795,0.241059669287364
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPS,Calcyphosin,40054,-0.012483053310366,0.0106550215235302,-0.0333668954964851,0.00840078887575313,0.241397335635892
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD109,CD109 antigen,42120,0.00407719668379695,0.00348623747255819,-0.0027558287624171,0.010910222130011,0.242218959642821
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,42094,-0.00262707631128137,0.00224938060901225,-0.00703586230494538,0.00178170968238263,0.24286425955953
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,42075,-0.00316185903741633,0.00270807430044091,-0.00846968466628052,0.00214596659144786,0.243002952756657
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL7,C-C motif chemokine 7,42103,-0.00713061943913063,0.00611378333228266,-0.0191136347704046,0.00485239589214339,0.243507187560138
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNB3,Plexin-B3,42107,-0.0056347772078039,0.00484427542658455,-0.0151295570439096,0.00386000262830181,0.244776891483112
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,39706,-0.00549929206344191,0.00473742961190579,-0.0147846541027772,0.00378606997589343,0.245742410545597
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPH1,Neurexophilin-1,41829,0.00468350791003569,0.00403569185079897,-0.00322644811753029,0.0125934639376017,0.24585839633442
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP152,Centrosomal protein of 152 kDa,39665,0.00498037894342472,0.00429689876240841,-0.00344154263089576,0.0134023005177452,0.246456693416429
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,41876,-0.00696255865451712,0.00600912014026065,-0.018740434129428,0.00481531682039375,0.246614480330781
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,39881,-0.00803586004640098,0.00697066130762871,-0.0216983562093533,0.0056266361165513,0.249013457312659
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,41861,-0.00537814271728,0.00467532649672313,-0.0145417826508573,0.00378549721629734,0.250031950219533
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSLNL,Mesothelin-like protein,39768,0.00469073780074192,0.00407914767836148,-0.00330439164884657,0.0126858672503304,0.250198355653882
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20,Interleukin-20,41887,0.00580650722133739,0.0050506352199465,-0.00409273780975774,0.0157057522524325,0.250306091114151
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,41861,-0.00358097151028272,0.00311497385766024,-0.00968632027129679,0.00252437725073134,0.250330684994102
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,39719,0.00528926256045021,0.00460356139107064,-0.00373371776604824,0.0143122428869487,0.25060264538191
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,39768,0.00653669209419578,0.00570341881294352,-0.00464200877917353,0.0177153929675651,0.251779438180642
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,39881,0.00959540039014477,0.00837222179429556,-0.00681415432667453,0.0260049551069641,0.251779587710459
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LXN,Latexin,41974,-0.0080134582536905,0.00699327095146351,-0.021720269318559,0.00569335281117797,0.251865734439281
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRK5,G protein-coupled receptor kinase 5,41876,-0.00604125396021347,0.00527759852960155,-0.0163853470782325,0.00430283915780557,0.252356081164568
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,39764,-0.00453141524113959,0.00396047752899277,-0.0122939511979654,0.00323112071568625,0.252583692724981
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD72,B-cell differentiation antigen CD72,39863,-0.00522793098148343,0.00457274802462337,-0.0141905171097452,0.00373465514677838,0.252948043207537
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTF,Ciliary neurotrophic factor,39719,0.0040646667491506,0.00356067008708562,-0.00291424662153722,0.0110435801198384,0.2536689791824
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,42103,0.0140242220381916,0.0123119759533481,-0.0101072508303708,0.0381556949067539,0.254694432148211
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,39706,0.00571237862418659,0.00501750286111964,-0.00412192698360789,0.0155466842319811,0.254941728379717
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,41861,-0.00782325637520397,0.0068807987778998,-0.0213096219798876,0.00566310922947965,0.255572663227962
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,40020,0.00616011194636637,0.00542908750769136,-0.00448089956870871,0.0168011234614414,0.256547285757731
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",42256,0.00770188878260769,0.00679705395472506,-0.00562033696865343,0.0210241145338688,0.257183981532136
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFB2,BPI fold-containing family B member 2,40043,-0.00805481492059866,0.00711478569938128,-0.021999794891386,0.00589016505018865,0.257607606804766
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NID1,Nidogen-1,42161,0.00448129426702753,0.0039614551970857,-0.00328315791926045,0.0122457464533155,0.257981629568801
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD55,Complement decay-accelerating factor,41732,0.00319689684269233,0.00283114515610023,-0.00235214766326412,0.00874594134864879,0.258839884223583
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,39719,0.00601822017233318,0.00534305178023222,-0.00445416131692198,0.0164906016615883,0.260037238413006
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH4,Cadherin-4,39719,0.00575549356347228,0.00511988612265748,-0.00427948323693638,0.0157904703638809,0.260977223391082
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL9,Interleukin-9,39881,0.00652181256639796,0.0058032729388463,-0.00485260239374079,0.0178962275265367,0.261116219220267
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,42094,0.0107465508613386,0.00957903393779717,-0.00802835565674381,0.0295214573794211,0.261933269834989
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRG1,Scrapie-responsive protein 1,40080,-0.00330072836183546,0.00294358545141255,-0.00907015584660406,0.00246869912293313,0.262172488958568
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,39881,0.00805100041369407,0.00718463579777183,-0.00603088574993872,0.0221328865773269,0.262489418909372
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,39719,0.00816393337103738,0.00728659613779247,-0.00611779505903587,0.0224456618011106,0.262567094120942
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,40020,-0.00503142086522572,0.00449316084164483,-0.0138380161148496,0.00377517438439815,0.262825800116238
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINI1,Neuroserpin,39847,0.00350464128971085,0.00313186429385747,-0.0026338127262498,0.0096430953056715,0.263153771855413
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,40021,-0.00606451482992669,0.00542091944957868,-0.0166895169511009,0.00456048729124752,0.263282554335043
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLTA,Clathrin light chain A,41876,-0.00550972324576258,0.00492567881888907,-0.0151640537307851,0.00414460723925999,0.26334423509117
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,39706,-0.0061727067781079,0.00552797230951037,-0.0170075325047482,0.00466211894853242,0.264177535002148
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,39706,0.00588232202270123,0.00526823669417078,-0.00444342189787349,0.016208065943276,0.264206426957227
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,39863,-0.0034526456379458,0.00309635672849607,-0.0095215048257981,0.0026162135499065,0.264846768228392
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVPL,Envoplakin,39881,0.00403482467316772,0.00362258977587503,-0.00306545128754733,0.0111351006338828,0.265391919872844
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,42184,-0.00332016950842748,0.00299906141559963,-0.00919832988300275,0.0025579908661478,0.268284368300257
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DENND2B,DENN domain-containing protein 2B,39706,0.00570949634296373,0.00515831768224452,-0.00440080631423552,0.015819799000163,0.268383073289317
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN15,Tetraspanin-15,39706,0.00596663514457205,0.00540121770153882,-0.00461975155044403,0.0165530218395881,0.269322114232855
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGF,Beta-nerve growth factor,42004,-0.00137287990724604,0.00124403519883749,-0.00381118889696752,0.00106542908247544,0.269800446858524
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLPS,Colipase,42099,0.00828502328872778,0.00753766919997242,-0.00648880834321817,0.0230588549206737,0.271723484686721
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,40020,0.00449365846947692,0.00409916539688787,-0.00354070570842331,0.0125280226473771,0.272999275583649
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,42103,0.0135133212853906,0.0123293388636142,-0.0106521828872931,0.0376788254580744,0.273086234239073
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA10,Ephrin type-A receptor 10,41829,0.00758866451927292,0.00692391483586231,-0.00598220855901721,0.0211595375975631,0.273096259991859
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",39784,-0.00534191895438865,0.00487802439045103,-0.0149028467596727,0.00421900885089536,0.273498232655528
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSMB,Beta-microseminoprotein,42074,0.00816230003902674,0.00749447385724621,-0.00652686872117583,0.0228514687992293,0.276126133039411
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTN,Pleiotrophin,41876,0.00554770513223388,0.00511383898797679,-0.00447541928420063,0.0155708295486684,0.278012450961012
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB37,Ras-related protein Rab-37,41887,-0.00904691119132059,0.00834490644952452,-0.0254029278323886,0.00730910544974747,0.278330529785103
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,41861,0.00631591540050164,0.00583389495498021,-0.00511851871125958,0.0177503495122629,0.27899590419559
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",41887,0.00798210323341505,0.00737502352050711,-0.00647294286677889,0.022437149333609,0.279132863382729
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX2,Sorting nexin-2,40020,-0.00914599898885973,0.00846036699735943,-0.0257283183036842,0.00743632032596475,0.279703198966642
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,39706,0.00686212338378711,0.00634940827692331,-0.00558271683898258,0.0193069636065568,0.279833101592147
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD1,Bromodomain-containing protein 1,39881,0.00338369332423649,0.00313791452888219,-0.00276661915237261,0.00953400580084559,0.28091284877308
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOX9,Transcription factor SOX-9,39768,-0.00309124874030788,0.00287153415157257,-0.00871945567739011,0.00253695819677435,0.281721688057331
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,40020,-0.00910592395595813,0.00846255728270399,-0.025692536230058,0.0074806883181417,0.281940014303023
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,39665,0.00531125505472904,0.00494428346552013,-0.00437954053769041,0.0150020506471485,0.282748221215432
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FMR1,Synaptic functional regulator FMR1,41861,-0.00395177428762234,0.00368534652267396,-0.0111750534720633,0.00327150489681862,0.283608511638258
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNLZ,DNL-type zinc finger protein,39719,0.0100111284550048,0.00935014566883862,-0.00831515705591885,0.0283374139659285,0.284332382891024
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MESD,LRP chaperone MESD,42120,0.0132903056010039,0.0124142661362621,-0.0110416560260698,0.0376222672280776,0.284384086972176
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,41876,-0.008619752654819,0.00807577809200336,-0.0244482777151456,0.00720877240550759,0.285830171780349
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,42120,-0.00332932395532648,0.00312092026946389,-0.00944632768347571,0.00278767977282274,0.28609276129265
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMTN,Smoothelin,40031,-0.0100723775910968,0.00947764218686438,-0.0286485562773509,0.00850380109515742,0.287918381477764
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAEP,Glycodelin,42004,0.00992616215292737,0.00934138232681076,-0.00838294720762173,0.0282352715134765,0.287982966930523
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AOC3,Membrane primary amine oxidase,42197,0.00331950721668619,0.00312838315275717,-0.00281212376271786,0.00945113819609025,0.288667092062168
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBA,Lysosomal acid glucosylceramidase,39768,-0.00602711511053877,0.00568124036165676,-0.017162346219386,0.00510811599830848,0.288768602932771
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,42120,0.00403120170611679,0.00381067593250082,-0.00343772312158481,0.0115001265338184,0.290134248635797
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORN4,MORN repeat-containing protein 4,39665,0.00837488171782039,0.00792268313813611,-0.00715357723292639,0.0239033406685672,0.29050108743038
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRAL,GDNF family receptor alpha-like,39686,0.00686550110299384,0.00649608118355086,-0.00586681801676584,0.0195978202227535,0.290596113404893
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPAG1,Sperm-associated antigen 1,40054,-0.0062179929560236,0.00589752184363871,-0.0177771357695555,0.00534114985750827,0.29175075485114
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCUN1D2,DCN1-like protein 2,39665,0.00871458141067828,0.00826726096681303,-0.00748925008427525,0.0249184129056318,0.291858045942459
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2,Microtubule-associated protein 2,40054,-0.00505866396128865,0.00480251421611218,-0.0144715918248685,0.00435426390229122,0.292210188285396
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGKZ,Diacylglycerol kinase zeta,41887,-0.00379566558777638,0.00361123069848991,-0.0108736777568166,0.00328234658126384,0.293245263827163
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP4,Dipeptidyl peptidase 4,41959,0.00306610271346197,0.00292313529793511,-0.00266324247049084,0.00879544789741478,0.29423989413308
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPBGL,Trophoblast glycoprotein-like,39768,-0.00458471483597853,0.00437235382288279,-0.0131545283288288,0.00398509865687174,0.294400478542764
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,40021,-0.00936296290582356,0.00893720528728547,-0.0268798852689031,0.00815395945725596,0.294828446010537
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL3,Myosin light chain 3,39804,-0.0079220461611973,0.00756435017445902,-0.022748172503137,0.00690408018074239,0.294991052547616
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,39665,0.00339727092242762,0.00324510208717724,-0.00296312916843976,0.009757671013295,0.295173626577302
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,39706,0.00520297097195307,0.00497320432162841,-0.00454450949843861,0.0149504514423448,0.295492330310733
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLL4,Delta-like protein 4,39804,-0.00923748267448906,0.00885599488167556,-0.0265952326425732,0.00812026729359505,0.296936496717819
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_E,,42103,-0.0033263154671406,0.00319974927251671,-0.00959782404127335,0.00294519310699215,0.29856614650316
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSR,"Glutathione reductase, mitochondrial",40061,-0.00240913840906567,0.00232526393691579,-0.00696665572542062,0.00214837890728927,0.300192099073171
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,40080,0.00316587753087906,0.00306143851687471,-0.00283454196219538,0.0091662970239535,0.30110567599161
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEB,Nebulin,39706,-0.00406245426276403,0.00393358680560905,-0.0117722844017578,0.00364737587622971,0.301739611002783
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,40080,-0.00418168607959502,0.00406005352613853,-0.0121393909908265,0.0037760188316365,0.303052434695071
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB6B,Ras-related protein Rab-6B,41829,0.00525490243252756,0.00510240564660735,-0.00474581263482285,0.015255617499878,0.303082658535192
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,40020,-0.00573874835552109,0.00557699002276818,-0.0166696488001467,0.00519215208910455,0.303500504843251
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",39804,-0.0035405183561416,0.0034418579434665,-0.010286559925336,0.00320552321305274,0.303660632364641
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRAP2,GRB2-related adapter protein 2,42144,-0.0134778409265001,0.0131258405394108,-0.0392044883837453,0.0122488065307451,0.304525652226811
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",40021,-0.0110407916002693,0.0107523759417742,-0.0321154484461467,0.010033865245608,0.304526551600262
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,39665,-0.00846027494659515,0.00825118324273777,-0.0246325941023612,0.00771204420917089,0.305226090003211
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FZD10,Frizzled-10,39768,-0.00645099218184144,0.00630530011890675,-0.0188093804148987,0.00590739605121579,0.306281000993507
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS9,Galectin-9,42128,-0.00340980000702915,0.00333417509879597,-0.00994478320066925,0.00312518318661095,0.306477472606178
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,40020,-0.00432436413697584,0.00423709929028685,-0.0126290787459381,0.00398035047198638,0.307468965284774
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECE1,Endothelin-converting enzyme 1,41829,-0.00374966148147175,0.00367523629353728,-0.0109531246168048,0.00345380165386133,0.307629230851913
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,42144,-0.00829085391272812,0.00813806994838692,-0.0242414710115665,0.00765976318611024,0.308329313283101
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,39804,-0.00584939835776516,0.0057475755582832,-0.0171146464520002,0.00541584973646992,0.308836250346907
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,42004,-0.00320075589250393,0.00314696569435888,-0.00936880865344734,0.00296729686843947,0.309128532851348
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMOD4,Tropomodulin-4,39665,0.00432539476997867,0.0042600138764759,-0.00402423242791409,0.0126750219678714,0.309963632421614
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNL1,Interferon lambda-1,41829,-0.00478707729123156,0.00474605451566711,-0.0140893441419391,0.00451518955947599,0.313164927019913
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENAH,Protein enabled homolog,41887,-0.00489622064141288,0.00485515060316567,-0.0144123158236176,0.00461987454079184,0.313253353028268
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,42186,-0.00869627354284125,0.00862391136172442,-0.0255991398118211,0.00820659272613863,0.313285630631763
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS1BP3,HCLS1-binding protein 3,39804,-0.00914300451096682,0.00908187117990411,-0.0269434720235789,0.00865746300164524,0.314086846720575
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,39665,0.00360960486739986,0.0035878799830711,-0.00342263989941949,0.0106418496342192,0.314412324972731
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",41810,-0.00485264919882045,0.00482703335639868,-0.0143136345773619,0.00460833617972097,0.314768448304423
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKKL1,Dickkopf-like protein 1,42094,0.00911676527260075,0.00908065665558195,-0.00868132177233987,0.0269148523175414,0.315408804949901
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPSE,Heparanase,39984,-0.0096756775607982,0.00963760628158298,-0.0285653858727008,0.00921403075110444,0.315425091064126
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,42186,-0.00311554641517399,0.00310909689904329,-0.00920937633729885,0.00297828350695086,0.316326322924146
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMH,Granzyme H,41876,0.00807661133391735,0.00806341203564128,-0.00772767625593956,0.0238808989237743,0.316538085213562
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOP56,Nucleolar protein 56,39706,-0.0115883845661276,0.0115963394431803,-0.0343172098747609,0.0111404407425058,0.31766559890373
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,39881,-0.00704600388415368,0.00705537515734369,-0.0208745391925473,0.00678253142423996,0.31797633897933
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,39863,-0.00846626273650914,0.00849512918089453,-0.0251167159310624,0.00818419045804412,0.318980336601324
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,42184,-0.00291981248204864,0.00293254400071125,-0.00866759872344269,0.0028279737593454,0.319434626451087
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,42189,0.00280655913097237,0.00282064030501057,-0.00272189586684835,0.0083350141287931,0.319750992933333
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLNK,B-cell linker protein,39784,-0.00419063671937563,0.00423116263206317,-0.0124837154782194,0.00410244203946819,0.321990506400767
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP290,Centrosomal protein of 290 kDa,39881,-0.00556526229503351,0.00564055351993482,-0.0166207471941058,0.00549022260403873,0.32383570269193
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,40020,-0.0109256557990103,0.0110764210787703,-0.0326354411134,0.0107841295153794,0.323964487119019
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,39719,0.00328660639036502,0.00334607477733567,-0.00327170017321288,0.00984491295394293,0.326010400135245
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,39719,-0.00590641518455013,0.00601987181105576,-0.0177053639342194,0.00589253356511916,0.326539858206315
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK6,Kallikrein-6,42163,0.00322259836005666,0.00328823048650569,-0.00322233339349449,0.0096675301136078,0.327084512326188
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POMC,Pro-opiomelanocortin,39804,-0.00703379500790656,0.00720050536211284,-0.0211467855176477,0.00707919550183462,0.328666972601652
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,40021,-0.00635996027164926,0.00651649350085567,-0.0191322875333264,0.00641236699002785,0.329096717292148
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARG2,"Arginase-2, mitochondrial",40020,0.00425039499933624,0.00435862019008115,-0.00429250057322281,0.0127932905718953,0.329497803463921
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPGN,Epigen,40020,-0.00458672319231471,0.00470825125495552,-0.0138148956520275,0.00464144926739812,0.329984829053457
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,39706,0.00478947960573712,0.00491855246241224,-0.00485088322059086,0.0144298424320651,0.330199138277873
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,42296,-0.00348236459176192,0.00358037297340719,-0.01049989561964,0.00353516643611618,0.330757067459112
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WNT9A,Protein Wnt-9a,41887,0.00298441627270599,0.00307356393289743,-0.00303976903577297,0.00900860158118496,0.331569098761238
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,39784,-0.00624089104053017,0.00642801354596693,-0.0188397975906254,0.00635801550956501,0.331625467262969
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,42178,-0.00726629473933348,0.00748923875597716,-0.0219452027010487,0.00741261322238176,0.331949226482935
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,40020,-0.00552996301278654,0.0057104769094715,-0.0167224977553507,0.00566257172977761,0.33287176516556
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALLD,Palladin,39784,0.00390965171911618,0.00404071786861037,-0.00401015530336014,0.0118294587415925,0.333284435751468
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,41861,-0.00307268473021524,0.00317637392689044,-0.0092983776269205,0.00315300816649002,0.333384510996334
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD86,T-lymphocyte activation antigen CD86,40021,0.00302436942506409,0.00312752884151371,-0.00310558710430279,0.00915432595443096,0.333557795450119
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUGT1,Protein SGT1 homolog,41861,-0.00797477237971851,0.00826528510544023,-0.0241747311863814,0.00822518642694434,0.33463763743969
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCLN,Nicalin,41887,-0.00517410378103213,0.00536886504485984,-0.0156970792689574,0.00534887170689316,0.335202707424669
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300E,CMRF35-like molecule 2,42182,0.00430893405182833,0.00447662067510484,-0.00446524247137716,0.0130831105750338,0.335795489154398
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,39719,0.00378525249072462,0.00393323064301886,-0.00392387956959234,0.0114943845510416,0.335882144177173
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",39784,-0.00429404626132596,0.00446361304134256,-0.0130427278223574,0.00445463529970547,0.336065883916339
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,41829,0.00482825987811711,0.00502864538412602,-0.00502788507476989,0.0146844048310041,0.336997498336204
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JUN,Transcription factor AP-1,41887,-0.00475999884871262,0.00496292023265296,-0.0144873225047124,0.00496732480728719,0.337520340639618
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,39665,0.0082569379179383,0.00862176909929676,-0.00864172951668335,0.02515560535256,0.338243793391371
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,40021,0.00350882237427212,0.00367265682851961,-0.00368958500962631,0.0107072297581706,0.339401458782044
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDSN,Corneodesmosin,42213,0.0044189681814138,0.00462652269779665,-0.00464901630626763,0.0134869526690952,0.339525589120923
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,41887,0.00385315433117577,0.00405076832238736,-0.00408635158070345,0.011792660243055,0.341513013726928
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL3,Insulin-like 3,40054,0.00767437588030247,0.00807428830243071,-0.00815122919246173,0.0234999809530667,0.341894196605056
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL4,Early placenta insulin-like peptide,40020,-0.00477187607197779,0.00502162901300253,-0.0146142689374627,0.00507051679350717,0.341999056035344
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",41876,0.00904493842567617,0.00952396789149481,-0.00962203864165366,0.027711915493006,0.342281413222125
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPESP1,Sperm equatorial segment protein 1,40080,-0.00312263214633681,0.0032928686553577,-0.00957665471083789,0.00333139041816428,0.342997059386003
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",39881,0.00687903177769912,0.00728798197092437,-0.00740541288531263,0.0211634764407109,0.345248709762394
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTPN,Myotrophin,41876,0.00324816470674218,0.00345816521766706,-0.00352983911988526,0.0100261685333696,0.347607968157399
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWC2,Brorin,41965,0.00399861319953873,0.00426041864373578,-0.0043518073421834,0.0123490337412609,0.347979911462671
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPBP,Platelet basic protein,40048,-0.00810988340887018,0.00864272650405261,-0.0250496273568133,0.00882986053907295,0.348086581494263
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,42186,-0.00238394015995006,0.0025414546867939,-0.00736519134606611,0.00259731102616599,0.348250591633876
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,39665,-0.0139137274844874,0.0148544578445005,-0.0430284648597083,0.0152010098907335,0.348949849713783
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,41887,0.00635233189534523,0.00680941034522072,-0.00699411238128738,0.0196987761719778,0.350902011789804
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNGR1,Interferon gamma receptor 1,42184,0.00211734005249496,0.00226983919704673,-0.00233154477371664,0.00656622487870656,0.350932832072734
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300A,CMRF35-like molecule 8,39863,-0.0029920704422664,0.00322085628362284,-0.00930494875816717,0.00332080787363436,0.352927005145389
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAT1,Diamine acetyltransferase 1,39706,0.00493452048418995,0.00532466426230001,-0.00550182146991807,0.015370862438298,0.354088561889867
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCLRE1C,Protein artemis,39665,0.00297795085663226,0.00322780901867615,-0.003348554819973,0.00930445653323752,0.356241110951713
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,39706,-0.00798570769554873,0.00866875069270669,-0.0249764590532538,0.00900504366215638,0.356963873513759
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,39881,-0.00450807509752656,0.00489990133998915,-0.0141118817239053,0.00509573152885217,0.357575836052689
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHIT1,Chitotriosidase-1,42204,0.0146144471095312,0.0159251640766567,-0.0165988744807159,0.0458277686997784,0.358795457363974
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,42094,0.00367865029373545,0.00400964063417794,-0.0041802453492533,0.0115375459367242,0.358923316425671
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP9,Caspase-9,39784,-0.00594381124951761,0.0064838692433435,-0.0186521949664709,0.00676457246743564,0.359316835362599
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,42103,0.00854524517324057,0.00933626957298619,-0.00975384318981237,0.0268443335362935,0.360064880033064
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,40080,0.00348733106234439,0.00381763162191597,-0.00399522691661091,0.0109698890412997,0.361010250370582
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIF1,Allograft inflammatory factor 1,41861,-0.0049249130484617,0.00539388438006938,-0.0154969264333977,0.00564710033647429,0.361230998570352
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPXM1,Probable carboxypeptidase X1,42186,-0.00653978848030621,0.00716887779030281,-0.0205907889492997,0.0075112119886873,0.361655544340363
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIMAP7,GTPase IMAP family member 7,39863,0.00300982971544605,0.00330180512867252,-0.00346170833675208,0.00948136776764419,0.362015203843684
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,39706,0.00367394043168729,0.00403250698888344,-0.00422977326652425,0.0115776541298988,0.36227359672453
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,A1BG,Alpha-1B-glycoprotein,40113,-0.0015819784805434,0.0017499520959561,-0.00501188458861736,0.00184792762753057,0.366008744144322
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY2A,Pancreatic alpha-amylase,41633,0.00457673803079888,0.005071046450371,-0.00536251301192827,0.014515989073526,0.366796378148629
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHGA,Chromogranin-A,40097,-0.00912465611228677,0.0101172277693902,-0.0289544225402915,0.010705110315718,0.36713367441341
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGN,Cingulin,39768,-0.00384384863310476,0.00427063185438004,-0.0122142870676896,0.00452658980148013,0.368105862260458
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,39665,0.00242437686862299,0.00269489148457691,-0.00285761044114775,0.00770636417839373,0.368343476171054
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECM1,Extracellular matrix protein 1,39855,-0.00345939136918676,0.00384982878626437,-0.0110050557902649,0.00408627305189141,0.36889501822531
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,41861,0.00383407958824491,0.00427329955521506,-0.00454158753997662,0.0122097467164664,0.369619865128446
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,41861,-0.0117875450895405,0.0131527767596372,-0.0375669875384293,0.0139918973593484,0.370161908292458
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA12,Carbonic anhydrase 12,42094,0.00307534467195621,0.00343526557896345,-0.00365777586281216,0.00980846520672458,0.370682119542369
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,39881,0.00375977821778003,0.00420199500832806,-0.00447613199854296,0.011995688434103,0.370935399707128
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",40054,0.00341863713232838,0.00382443364140859,-0.00407725280483245,0.0109145270694892,0.371398578491606
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,40097,-0.0027700912700283,0.00310029973308859,-0.00884667874688195,0.00330649620682534,0.371613775682786
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRR1B,Cornifin-B,39881,-0.00769000689985005,0.00861232685496769,-0.0245701675355867,0.00919015373588663,0.371927085610085
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB1A1,Uteroglobin,42154,0.00511956654113876,0.00573682127105257,-0.00612460315012426,0.0163637362324018,0.372192596059833
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA8,Carbonic anhydrase-related protein,39784,-0.00258435313274184,0.00289720220503689,-0.00826286945461414,0.00309416318913045,0.37240417787079
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRR4,Proline-rich protein 4,39783,0.00641880039430014,0.00720704011452409,-0.00770699823016708,0.0205445990187674,0.373148361903044
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,39706,-0.00542388389268886,0.0060944615559973,-0.0173690285424436,0.00652126075706585,0.373502719114906
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHC1,SHC-transforming protein 1,39665,0.0108334968499233,0.0121851531090116,-0.0130494032437395,0.0347163969435861,0.373983998065007
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,42084,-0.00314833857308908,0.00354463827527417,-0.0100958295926265,0.0037991524464483,0.374451139269674
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",39719,-0.00408912219044414,0.00460545611016401,-0.0131158161663656,0.00493757178547732,0.374622110226349
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSR,Insulin receptor,39784,-0.00158790552265604,0.00178912659459763,-0.00509459364806739,0.0019187826027553,0.374813177625789
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF1C,Kinesin-like protein KIF1C,39706,-0.00326416537224297,0.00368384044993523,-0.010484492654116,0.00395616190963009,0.375596440107279
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2,Apoptosis regulator Bcl-2,40021,-0.00521670486400405,0.00589394764361157,-0.0167688422454827,0.00633543251747463,0.376124935026067
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,42094,0.00483552927075113,0.00546542872678519,-0.00587671103374785,0.0155477695752501,0.376308840158287
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17RA,Interleukin-17 receptor A,42120,-0.00402289051730775,0.00455168435999499,-0.0129441918628979,0.00489841082828243,0.376807353517975
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNL2,Interferon lambda-2,39719,0.00561118563284175,0.00635347847881827,-0.00684163218564206,0.0180640034513256,0.377165955920965
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,39768,0.00330320803528994,0.00374596089719792,-0.00403887532321798,0.0106452913937979,0.377902168882564
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESR1,Estrogen receptor,39784,-0.0050241993895312,0.00571642904565955,-0.0162284003190239,0.00618000153996151,0.379472603714705
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,40020,-0.00380620070144175,0.00433729890960963,-0.0123073065642766,0.00469490516139312,0.380206941047243
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PI16,Peptidase inhibitor 16,40102,0.00227125839316474,0.00259296021335046,-0.00281094362500216,0.00735346041133164,0.381085961371264
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGN,Mimecan,42120,0.00402987912034612,0.00460238075110011,-0.00499078715181009,0.0130505453925023,0.381259714973576
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM171A2,Protein FAM171A2,40054,0.0143752736983241,0.0164731082585808,-0.0179120184884942,0.0466625658851425,0.382872649708795
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,42213,-0.00415841380875146,0.00477240856186067,-0.0135123345899984,0.00519550697249545,0.383581934674162
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,40021,-0.00460463611614137,0.00528564651497824,-0.0149645032854987,0.00575523105321598,0.38368690816373
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNN,Tenascin-N,40097,-0.00393034738143707,0.00452045512917753,-0.012790439434625,0.00492974467175089,0.38461562852497
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPB1,Heat shock protein beta-1,41963,-0.00606047809914947,0.00698176722580065,-0.0197447418617188,0.0076237856634198,0.385386798275263
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEPACAM2,HEPACAM family member 2,40054,-0.00378509640116323,0.00436122510622931,-0.0123330976093727,0.00476290480704621,0.385469620643771
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,42197,0.00249350493389824,0.00287356908518287,-0.00313869047306019,0.00812570034085667,0.385553821518429
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROS1,Vitamin K-dependent protein S,40113,-0.00232061613632254,0.00269006054930982,-0.00759313481296979,0.0029519025403247,0.388341638939779
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA2,Integrin alpha-2,39863,0.00311729786583012,0.00361399592309002,-0.00396613414342631,0.0102007298750866,0.388397366353154
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLMH,Bleomycin hydrolase,42296,0.00279534482809963,0.00324500010047678,-0.00356485536883486,0.00915554502503412,0.389016278598262
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL5,C-C motif chemokine 5,42197,-0.00883381390991835,0.0102584887783252,-0.0289404519154357,0.011272824095599,0.389186542045689
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM17,Splicing factor 45,40054,0.00674428939147285,0.00785815698866592,-0.00865769830631235,0.022146277089258,0.390771535727777
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD7,T-cell antigen CD7,39752,-0.00396058384845201,0.00461621019536579,-0.013008355831369,0.00508718813446494,0.390926831845455
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,39719,0.0106858338473121,0.0124584177633205,-0.013732664968796,0.0351043326634202,0.391066634595326
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGLON5,IgLON family member 5,39665,0.00838867792062507,0.00978916629089593,-0.0107980880095309,0.0275754438507811,0.391500492728068
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESPL1,Separin,39665,0.00510662302991841,0.00595979623682227,-0.00657457759425324,0.0167878236540901,0.391550029242129
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF5,Fibroblast growth factor 5,41887,-0.00293253831269944,0.00342304856395874,-0.00964171349805857,0.0037766368726597,0.391624840590994
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB118,Beta-defensin 118,39719,0.00505034986901087,0.00590087238686453,-0.0065153600092436,0.0166160597472653,0.392091965938853
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSAP,Gamma-secretase-activating protein,41861,0.00759694792438087,0.00887863910402006,-0.00980518471949845,0.0249990805682602,0.392211304428087
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMOD1,Leiomodin-1,40054,0.00313587722949688,0.00366933501480181,-0.00405601939951467,0.0103277738585084,0.392781891906529
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,39665,0.00398678739078295,0.00468651469514489,-0.00519878141170105,0.0131723561932669,0.394959110474094
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,41953,-0.00524179986207848,0.00616900428215024,-0.017333048255093,0.00684944853093599,0.395508118909032
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPEP,Glutamyl aminopeptidase,39706,-0.00421165679042227,0.00496077368400535,-0.0139347732110728,0.00551145963022823,0.395905119586452
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEC31A,Protein transport protein Sec31A,39804,-0.00667508588448016,0.00786437050312458,-0.0220892520706043,0.00873908030164402,0.396025312290229
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST6,Cystatin-M,41853,0.00445405144107391,0.0052517886025935,-0.00583945422000935,0.0147475571021572,0.396397306756584
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,40020,0.00439381020384506,0.00518363567182545,-0.00576611571293282,0.0145537361206229,0.396662252092444
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM171B,Protein FAM171B,40020,0.00230261792843217,0.00272420288786388,-0.00303681973178103,0.00764205558864536,0.39799293478081
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGMB,RGM domain family member B,42213,0.00249596802602634,0.00295401574486373,-0.00329390283390657,0.00828583888595925,0.398159495731315
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RELB,Transcription factor RelB,39784,-0.00433397337146942,0.00514125351464415,-0.014410830260172,0.00574288351723311,0.399258724199274
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,42120,-0.00269454109375948,0.00320004237047397,-0.00896662413988847,0.00357754195236951,0.399785092628925
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,39768,0.00445317013452712,0.00528997452755689,-0.00591517993948437,0.0148215202085386,0.399911586512442
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,42184,-0.00243563274068654,0.00290768742111051,-0.00813470008606313,0.00326343460469006,0.402241096154183
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBD,Thrombomodulin,42144,0.00262138357833388,0.00313593492009093,-0.00352504886504435,0.00876781602171212,0.403216614006467
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC13A1,Solute carrier family 13 member 1,40020,-0.00535139580056783,0.00640965391580325,-0.0179143174755422,0.00721152587440654,0.403794568792319
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL9,C-X-C motif chemokine 9,42184,0.00586160992556585,0.00702136019514022,-0.00790025605690898,0.0196234759080407,0.403831367795359
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,39665,0.0049678349203377,0.00595936418593955,-0.00671251888410382,0.0166481887247792,0.404515136647876
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSLP,Thymic stromal lymphopoietin,41876,0.00524582383331894,0.00630405928454231,-0.00711013236438398,0.0176017800310219,0.405348823039832
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLASP1,CLIP-associating protein 1,39665,-0.0062232565789909,0.00750812774460244,-0.0209391869584117,0.00849267380042987,0.407197262744015
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA11,Carbonic anhydrase-related protein 11,41861,-0.00279944470547381,0.00338073879490696,-0.00942569274349145,0.00382680333254383,0.407653773487692
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,42161,-0.00304080670991638,0.00368095353024746,-0.0102554756292014,0.00417386220936864,0.408767035542607
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,41861,0.00311135617409194,0.00377317441762965,-0.00428406568446218,0.0105067780326461,0.4096147678533
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEF,Thyrotroph embryonic factor,39706,0.00370333463499602,0.00449171074020865,-0.00510041841581294,0.012507087685805,0.409684448853799
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,41829,0.00658449559194096,0.0079988659007733,-0.00909328157357471,0.0222622727574566,0.410421947155457
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,41887,0.003075703658947,0.00374196768397071,-0.00425855300163559,0.0104099603195296,0.411121809211929
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,39706,0.00322074477944527,0.0039208334679377,-0.00446408881771262,0.0109055783766032,0.411412089339819
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,42120,0.00459489686233836,0.00560718198560739,-0.00639517982945213,0.0155849735541289,0.412535511415389
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,42144,-0.00294806290348119,0.00360605074540554,-0.010015922364476,0.00411979655751366,0.413639347978709
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PITHD1,PITH domain-containing protein 1,39651,-0.00678512395696701,0.00831681719778047,-0.0230860856646167,0.0095158377506827,0.414614924341389
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,42186,-0.00603767204507245,0.00740617773441382,-0.0205537804045235,0.00847843631437863,0.414960730398721
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZPR1,Zinc finger protein ZPR1,39719,0.00820968962282575,0.0100718169270715,-0.0115310715542344,0.0279504507998859,0.415024897930956
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,42120,0.0032380638338969,0.00398021751238169,-0.0045631624903712,0.011039290158165,0.415923841694064
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBZ,Hemoglobin subunit zeta,40080,-0.00891681779492818,0.0109685114676618,-0.0304151002715453,0.0125814646816889,0.41626626081796
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",40054,0.00879761575575271,0.0108369644740055,-0.0124428346132981,0.0300380661248036,0.416915298409906
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",42094,0.00576317392509979,0.00710157720052134,-0.00815591738792202,0.0196822652381216,0.417073841148643
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,42120,-0.00360753943028743,0.00446331797170132,-0.012355642654822,0.00514056379424716,0.418953471756448
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,39706,0.00334368987240149,0.00413696910535408,-0.00476476957409251,0.0114521493188955,0.41896711320064
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,39881,-0.00374112741648164,0.00463174632078516,-0.0128193502052206,0.00533709537225727,0.419273086676665
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,42157,0.00178541515939157,0.00221190061701076,-0.00254991004994953,0.00612074036873266,0.419574153759644
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,40102,0.00227760333560153,0.00282239529228098,-0.0032542914372692,0.00780949810847226,0.419698298661645
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,39706,0.00596318971296185,0.00740938348077397,-0.00855920190935514,0.0204855813352788,0.420944120704285
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",41829,0.0042446303553768,0.00527569528412455,-0.00609573240150731,0.0145849931122609,0.421086915091022
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MINK1,Misshapen-like kinase 1,40054,-0.00765819105746199,0.009519397744706,-0.0263162106370858,0.0109998285221618,0.421135851311608
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,41887,-0.00548671778543,0.00683983927019361,-0.0188928027550095,0.00791936718414947,0.422469314091128
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",41829,-0.0044195544404171,0.00551570449425069,-0.0152303352491484,0.00639122636831425,0.422991901547662
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TJP3,Tight junction protein ZO-3,39719,0.00345395602497835,0.00432035683201422,-0.00501394336576952,0.0119218554157262,0.424041296656733
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",39804,0.0039863967195376,0.00499324761591304,-0.00580036860765196,0.0137731620467271,0.424680923687635
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,42144,-0.00239318536769736,0.00299929128347236,-0.00827179628330319,0.00348542554790847,0.424933314498227
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF174,Zinc finger protein 174,39784,0.00308288626153832,0.00386482607731855,-0.00449217285000604,0.0106579453730827,0.425075330293778
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH3,Cadherin-3,42213,-0.00309440450121357,0.00388477423370095,-0.0107085619992674,0.00451975299684028,0.425728807374914
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,39768,-0.00296770222613332,0.00373317631795771,-0.0102847278093304,0.0043493233570638,0.426658293396565
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCN2,Transcobalamin-2,42274,0.00253053178765639,0.00318326824651418,-0.00370867397551141,0.00876973755082419,0.426658346504356
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,40020,-0.00363791188999929,0.00458392229104321,-0.012622399580444,0.00534657580044539,0.427431604608158
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,39665,0.00281629659915705,0.00354878304073302,-0.00413931816067967,0.00977191135899378,0.427449206965922
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,42079,0.00705975981126648,0.00894921115931306,-0.0104806940609871,0.0246002136835201,0.43020279276791
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGES2,Prostaglandin E synthase 2,39690,-0.00443607136746796,0.00562684479735056,-0.0154646871702751,0.00659254443533913,0.430494404795946
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,40080,-0.00266342437045415,0.00338156318985707,-0.009291288222574,0.00396443948166571,0.430929660316607
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",39881,-0.00399718627533249,0.0050772305045863,-0.0139485580643216,0.00595418551365666,0.431137250005453
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18BP,Interleukin-18-binding protein,42197,-0.00263644473941844,0.0033493229639905,-0.00920111774883982,0.00392822827000294,0.431204011200146
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,39706,-0.0081057213345667,0.0103271171570184,-0.0283468709623229,0.0121354282931895,0.432531759396963
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,39768,-0.00684091967578262,0.00872210777702176,-0.0239362509187453,0.01025441156718,0.432870198464639
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,39768,0.00634821416887024,0.00811453939719567,-0.00955628304963327,0.0222527113873738,0.434040599882708
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,39706,0.00547322449698667,0.00700559677829526,-0.00825774518847204,0.0192041941824454,0.434664502776894
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF22,Kinesin-like protein KIF22,39706,-0.0100624414170723,0.0128972483770011,-0.0353410482359945,0.0152161654018498,0.435290353366296
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,39768,0.00371009909177435,0.00476297142718452,-0.00562532490550732,0.013045523089056,0.436028764873082
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",39784,-0.00229217439380504,0.0029432187511735,-0.00806088314610511,0.00347653435849502,0.436115813788261
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",41829,0.00329616280090415,0.00424371803668415,-0.00502152455099679,0.0116138501528051,0.437341009928766
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,39719,0.00254741522303511,0.00328159295774318,-0.00388450697414154,0.00897933742021175,0.437604677203109
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDC1,Syndecan-1,42144,0.00327543870045335,0.00422419825352334,-0.0050039898764524,0.0115548672773591,0.438118140784046
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,39784,-0.00490813767547838,0.00633470302086748,-0.0173241555963786,0.00750788024542187,0.438474236108077
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APP,Amyloid-beta precursor protein,42101,-0.00528433597098374,0.00684808772292984,-0.0187065879079262,0.00813791596595875,0.440335093503707
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARF1,Scavenger receptor class F member 1,42296,0.0033343809676973,0.00432973385352517,-0.00515189738521203,0.0118206593206066,0.441247210254217
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PENK,Proenkephalin-A,39863,-0.0026154851276837,0.00339708239501785,-0.00927376662191869,0.00404279636655128,0.441363793092403
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COLEC12,Collectin-12,42126,-0.00223467174962848,0.00290603806573977,-0.00793050635847844,0.00346116285922148,0.4419219648526
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTR,Methionine synthase,39706,-0.00530198395218117,0.00689606386045929,-0.0188182691186814,0.00821430121431904,0.442004348962902
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,40054,-0.00256742993774152,0.00335114940927394,-0.00913568277991844,0.0040008229044354,0.443613148488076
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,39665,0.00463205611487285,0.00604664097503262,-0.0072193601961911,0.0164834724259368,0.443661183436786
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,41829,0.00401105254041639,0.00523685792084178,-0.00625318898443351,0.0142752940652663,0.443733858355714
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",40054,-0.00373152660046355,0.00487447067874502,-0.0132854891308038,0.0058224359298767,0.443975935189339
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BST2,Bone marrow stromal antigen 2,42213,-0.00404427398584562,0.00528405146379439,-0.0144010148548826,0.00631246688319138,0.444062927380399
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX1B,Syntaxin-1B,39768,-0.00318768631751687,0.0041818856533766,-0.011384182198135,0.00500880956310127,0.445921536413813
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPPB,Natriuretic peptides B,41876,0.0111520178646954,0.0146771004713774,-0.0176150990592043,0.039919134788595,0.447373728465789
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYM,Ketimine reductase mu-crystallin,39719,-0.0058936996017344,0.00777204602622843,-0.0211269098131421,0.00933951060967332,0.448276288827913
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,40054,0.00977246416204602,0.0129197359853552,-0.0155502183692501,0.0350951466933421,0.449426935391045
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD59,CD59 glycoprotein,41664,0.00196543745298383,0.00259997793347636,-0.00313051929662984,0.0070613942025975,0.449697112441296
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF830,Zinc finger protein 830,40020,-0.00605267327266076,0.00801723331200632,-0.0217664505641931,0.00966110401887162,0.450290692454938
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHISA5,Protein shisa-5,40097,-0.00216862365921628,0.00287444030143176,-0.00780252665002254,0.00346527933158998,0.45059489823188
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBR1,T-box brain protein 1,39768,0.00380868141603993,0.00505509304616973,-0.00609930095445274,0.0137166637865326,0.451205642867875
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,42004,-0.00538554212129315,0.00715105267383824,-0.0194016053620161,0.00863052111942979,0.45139657680481
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,39768,0.00526272224558544,0.00698798630774299,-0.00843373091759083,0.0189591754087617,0.451400592973832
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN1,Calsyntenin-1,41829,0.00414279897475418,0.00550740692029918,-0.00665171858903222,0.0149373165385406,0.451930887594477
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,40020,0.00593942372007183,0.00790716330818902,-0.00955861636397865,0.0214374638041223,0.452581910650188
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,39706,0.00375401295245348,0.00501802002795896,-0.00608130630234607,0.013589332207253,0.454412711456736
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN9,Septin-9,42094,-0.00219884165501852,0.00294632073641074,-0.00797363029838357,0.00357594698834652,0.455499300972338
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP4,Caspase-4,39881,0.0133008476309778,0.0178511919531331,-0.0216874885971631,0.0482891838591187,0.456230210743661
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A16,Protein S100-A16,41813,-0.00466344795376723,0.00627182390886948,-0.0169562228151514,0.00762932690761694,0.457159393348647
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17D,Interleukin-17D,41887,0.00260530245801393,0.00351148365430502,-0.0042772055044239,0.00948781042045176,0.458138750048026
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDAC8,Histone deacetylase 8,39784,-0.00451417903496041,0.00609313681579556,-0.0164567271939197,0.00742836912399888,0.458792996410302
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17A,Interleukin-17A,41865,-0.00329692750462877,0.00445744684691149,-0.0120335233245753,0.00543966831531776,0.459529236189372
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TWF2,Twinfilin-2,40097,-0.00630129093608449,0.00852553763492895,-0.0230113447005452,0.0104087628283762,0.459857482459423
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL6B,Myosin light chain 6B,39768,-0.00694339639345397,0.00942899093906853,-0.0254242186340283,0.0115374258471204,0.461510901856412
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,39784,-0.00415375510748825,0.00566728187206824,-0.015261627576742,0.0069541173617655,0.4636136658073
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX7,Syntaxin-7,39784,0.00376427344362704,0.00514397351491341,-0.00631791464560324,0.0138464615328573,0.464317092440349
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,39665,0.00320861575845817,0.00438959541242372,-0.00539499124989231,0.0118122227668087,0.464820345330456
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,42144,0.00240463460305894,0.00329478058003647,-0.00405313533381255,0.00886240453993042,0.46550639759898
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",40054,0.00453106093064777,0.00621026483244377,-0.00764105814094201,0.0167031800022376,0.465645367083479
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,42144,-0.00439196537836747,0.00604267933369229,-0.0162356168724044,0.00745168611566942,0.467346813774314
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM25,RNA-binding protein 25,39665,0.00356841895704879,0.00491046329982548,-0.00605608911060915,0.0131929270247067,0.467427835301993
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,39881,-0.0057102253393125,0.00785820495969714,-0.0211123070603189,0.0096918563816939,0.467451572177228
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFA2,BPI fold-containing family A member 2,39432,0.00849656218683416,0.0116998105728721,-0.0144350665359952,0.0314281909096635,0.467724404425166
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13,Interleukin-13,41887,0.00356146553000523,0.0049354492278304,-0.00611201495654235,0.0132349460165528,0.47054807800874
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,42103,0.00605048567604797,0.00842206968725936,-0.0104567709109804,0.0225577422630763,0.472518506085181
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,39706,0.00359903817538074,0.00502368571212382,-0.00624738582038194,0.0134454621711434,0.473751741749568
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFL4,Insulin growth factor-like family member 4,39784,0.00545985766638745,0.00762884886654321,-0.00949268611203725,0.0204124014448121,0.474201252187598
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYDGF,Myeloid-derived growth factor,40080,-0.00721888627680252,0.010087029723159,-0.0269894645341941,0.0125516919805891,0.474216506658257
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,40021,-0.0109751201609018,0.0153402147646394,-0.0410419410995951,0.0190917007777915,0.47434792343088
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDF2,Growth/differentiation factor 2,42144,-0.00263340269762238,0.00370999136812135,-0.00990498577914022,0.00463818038389546,0.477832453006491
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,41813,0.00414177647218565,0.00586410804789768,-0.00735187530169379,0.0156354282460651,0.480019196718979
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,41702,-0.00628207237376279,0.00889656288550816,-0.0237193356293588,0.0111551908818332,0.480124472902037
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,42223,0.00302085470748033,0.00427834026806922,-0.00536469221793533,0.011406401632896,0.480150401410334
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,41829,0.00625198451289716,0.00885613443856759,-0.0111060389866953,0.0236100080124896,0.480232500146773
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",42111,0.0079141998408991,0.0112468364626168,-0.0141295996258297,0.0299579993076279,0.481643324434671
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,39665,-0.00566732753903418,0.00808478854478984,-0.0215135130868223,0.0101788580087539,0.48332702373316
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,41887,-0.00418664271510036,0.00598972049247601,-0.0159264948803533,0.00755320945015262,0.484582774316169
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMNB1,Lamin-B1,40007,-0.00430521143955667,0.00617420956055105,-0.0164066621782367,0.0077962392991234,0.48563663501311
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTA2,"Actin, aortic smooth muscle",41876,-0.00316702641835825,0.00454559011603507,-0.012076383045787,0.00574233020907048,0.485987660243184
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG3,Desmoglein-3,42155,-0.0025342986475208,0.00364287268212332,-0.00967432910448251,0.00460573180944091,0.486637431329351
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NID2,Nidogen-2,42120,-0.00530686589806497,0.00762946109713175,-0.0202606096484432,0.00964687785231326,0.486707244783663
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,40097,0.00193322745352343,0.00279476534791525,-0.00354451262839047,0.00741096753543733,0.489120639416418
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,42004,0.00411042612853986,0.00594586557692612,-0.00754347040223534,0.0157643226593151,0.489384354624255
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN2B,Sodium channel subunit beta-2,39768,0.00208762378660996,0.00302014170862134,-0.00383185396228787,0.00800710153550779,0.489433851484434
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA6C,Semaphorin-6C,39784,-0.00187053153415437,0.00270896045970543,-0.00718009403517702,0.00343903096686827,0.489896257121402
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL19,C-C motif chemokine 19,42213,-0.00931527725594003,0.0135329935402886,-0.0358399445949057,0.0172093900830256,0.49125205672538
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IKZF2,Zinc finger protein Helios,41861,-0.0062424947697766,0.0091328966473929,-0.0241429721986667,0.0116579826591135,0.494292392227803
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,41887,-0.00270253925761474,0.00395989338396664,-0.0104639302901893,0.00505885177495987,0.494949340850945
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,41861,-0.0053138502766122,0.00780104392350501,-0.020603896366682,0.00997619581345763,0.495775310831995
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPHS2,Podocin,39784,0.00735824179668215,0.0108206744905795,-0.0138502802048537,0.028566763798218,0.496508608786061
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,39881,0.00379494753961903,0.00561542724686516,-0.00721128986423669,0.0148011849434747,0.49917753040547
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,39665,-0.00440460767034055,0.00653369675813372,-0.0172106533162827,0.00840143797560155,0.50023900841332
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",41887,-0.00790908952339532,0.0117589053829953,-0.0309565440740661,0.0151383650272755,0.501211352526925
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP3,Caspase-3,42296,-0.00599728537066844,0.00895252034817849,-0.0235442252530983,0.0115496545117614,0.502933916000113
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,39881,0.0025546000140858,0.00381754181398481,-0.00492778194132443,0.010036981969496,0.503398896696904
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,39706,-0.00415411914548839,0.00622169512734487,-0.0163486415950843,0.00804040330410756,0.504350716009839
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCARE,Photoreceptor cilium actin regulator,39719,0.00582582337094161,0.00873472256786206,-0.011294232862068,0.0229458796039512,0.504804055588485
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRR5,Proline-rich protein 5,39784,-0.00330848169412688,0.00496211420754975,-0.0130342255409244,0.00641726215267063,0.504947385019263
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,39706,0.00230443631368923,0.00347168723386767,-0.00450007066469141,0.00910894329206986,0.506845729322524
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,40021,-0.00147829075884871,0.00222726284481925,-0.00584372593469445,0.00288714441699703,0.50688025894714
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",39863,0.00604936636465744,0.00911816832996496,-0.0118222435620739,0.0239209762913888,0.507062513638021
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANK2,Ankyrin-2,39706,-0.00501727430692466,0.00756541771679379,-0.0198454930318405,0.00981094441799117,0.507226385616997
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RALB,Ras-related protein Ral-B,39784,0.00205002077128229,0.00309696809591873,-0.00402003669671843,0.00812007823928301,0.508021241310737
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOX2,Transcription factor SOX-2,40035,0.00163997431567609,0.00247754718383813,-0.00321601816464665,0.00649596679599883,0.508027176830475
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39532,0.00726615115934985,0.0109824628360709,-0.0142594759993492,0.0287917783180489,0.50823337906558
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM2,Myomesin-2,39706,0.00344519307431428,0.00520861260344501,-0.00676368762843793,0.0136540737770665,0.508343649863053
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLINT1,Clathrin interactor 1,39665,-0.003170789366063,0.00479419596783083,-0.0125674134630114,0.00622583473088543,0.508382661265701
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,41829,0.00272418929431365,0.00412014354803017,-0.00535129205982548,0.0107996706484528,0.508503839564207
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,39881,0.00299140024588853,0.00453601925879317,-0.00589919750134608,0.0118819979931231,0.509603738997332
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,41834,-0.00198467458564832,0.00301033525174465,-0.00788493167906782,0.00391558250777119,0.509723565796436
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED8,Protein TMED8,40021,-0.00688311428914921,0.0104965386622162,-0.0274563300670931,0.0136901014887946,0.511998370304906
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP8,Caspase-8,42178,-0.00415419668454355,0.00633581680747744,-0.0165723976271993,0.00826400425811224,0.512048937960401
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,39804,0.00409944277219563,0.00625362996271758,-0.00815767195473082,0.0163565574991221,0.51214071639929
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXK,Tyrosine-protein kinase TXK,39881,0.00511378984064629,0.00780151140820887,-0.0101771725194431,0.0204047522007357,0.512168319314467
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACYBP,Calcyclin-binding protein,39847,-0.00688088545618232,0.0105072281247268,-0.0274750525806469,0.0137132816682823,0.512564555787368
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,40021,-0.0118268871643481,0.0181156647066828,-0.0473335899894463,0.0236798156607501,0.513864161735319
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP2,Caspase-2,42103,-0.00454539806738201,0.00696266411676819,-0.0181922197362477,0.00910142360148363,0.51388102025548
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN2,Ataxin-2,39719,0.00740440682368192,0.0113503209619901,-0.0148422222618187,0.0296510359091825,0.514188240818232
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSAB1,Tryptase alpha/beta-1,42243,-0.00353839572183039,0.00543108821846416,-0.0141833286300202,0.00710653718635936,0.514730290236766
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGA,Glycoprotein hormones alpha chain,42120,0.00423858362543587,0.00651620044237917,-0.0085331692416273,0.017010336492499,0.515401154300476
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCL2,Phosducin-like protein 2,39665,0.00357332246993235,0.00549684186879892,-0.00720048759291354,0.0143471325327782,0.515662386900609
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,40020,0.00629399366198729,0.00969075096854234,-0.0126998782363557,0.0252878655603303,0.516038966719013
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,39784,0.0027918223408519,0.00431421638888423,-0.00566404178136118,0.011247686463065,0.517567313637713
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,41810,0.00323418932427992,0.00501301136324804,-0.00659131294768623,0.0130596915962461,0.518835894211502
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPB2,Carboxypeptidase B2,40092,0.00147949098935548,0.00229331979665641,-0.00301541581209108,0.00597439779080203,0.518856075835487
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DRAXIN,Draxin,42004,0.00292628071942453,0.00453764478397655,-0.00596750305716951,0.0118200644960186,0.519010167621153
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,39706,0.0024975975278686,0.00387844190725045,-0.00510414861034228,0.0100993436660795,0.519609390178616
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,40020,-0.00225845169593545,0.00354512501904693,-0.00920689673326743,0.00468999334139654,0.52410027071827
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,39804,-0.00185259192276544,0.00290807324974688,-0.00755241549226933,0.00384723164673846,0.524105156079348
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",39784,-0.00185369399845783,0.00291252950167075,-0.00756225182173251,0.00385486382481685,0.524493650424961
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP164,Centrosomal protein of 164 kDa,41887,-0.00434572407563433,0.00683297319806279,-0.0177383515438374,0.00904690339256875,0.524792360602173
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,40097,-0.00242498484544222,0.0038161551868409,-0.00990464901165037,0.00505467932076594,0.525146759894214
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,40054,-0.00193393111377706,0.00305288429196861,-0.00791758432603553,0.00404972209848142,0.526435721861635
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLI2,Zinc finger protein GLI2,39784,0.0020866571843108,0.00329415194929653,-0.0043698806363104,0.008543195004932,0.526458133017889
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL6,Fc receptor-like protein 6,42103,-0.00459156060129233,0.00727104872847124,-0.018842816109096,0.00965969490651131,0.527734420171963
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPC5,Glypican-5,42004,0.00367255825948317,0.0058170516086108,-0.007728862893394,0.0150739794123603,0.527827154646904
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY96,Lymphocyte antigen 96,42004,0.00233582950693403,0.00370357178866469,-0.00492317119884876,0.00959483021271682,0.528250284910774
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD4,Sushi domain-containing protein 4,40020,0.00273533617256445,0.00433955370581024,-0.00577018909082363,0.0112408614359525,0.528494221178141
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGMN,Legumain,42184,0.00231321819179601,0.00368103273693522,-0.00490160597259703,0.00952804235618904,0.529742805162169
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL8,C-C motif chemokine 8,42208,0.0039177530461581,0.0062444524989092,-0.00832137385170393,0.0161568799440201,0.530409801521532
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNXB,Tenascin-X,42120,-0.00167388486724395,0.00266928358274596,-0.00690568068942603,0.00355791095493812,0.530610378242132
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,41829,-0.00546653542752576,0.00874940385653287,-0.0226153669863302,0.0116822961312787,0.532120522669846
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,42103,-0.00315430831373099,0.00505543819934302,-0.0130629671844433,0.00675435055698133,0.532675650115156
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,39719,-0.0039314682728289,0.00630646014702763,-0.0162921301610031,0.00842919361534525,0.533033017308021
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CENPJ,Centromere protein J,39881,0.00457383505994875,0.00733818336067441,-0.0098090043269731,0.0189566744468706,0.533105590215921
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BDNF,Brain-derived neurotrophic factor,40097,0.00535627484310035,0.00859504217779457,-0.011490007825377,0.0222025575115777,0.533178019808529
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,L1CAM,Neural cell adhesion molecule L1,42186,0.00188663473207336,0.00302942352712528,-0.0040510353810922,0.00782430484523891,0.533446466604418
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QA,Complement C1q subcomponent subunit A,42207,-0.0014190882255,0.00228282859247989,-0.00589343226676059,0.00305525581576059,0.534192193676122
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL10,C-X-C motif chemokine 10,42184,-0.0043281281164612,0.00700205195486761,-0.0180521499480017,0.00939589371507932,0.536505216135268
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,41876,-0.00382492927526679,0.00618957502240946,-0.0159564963191893,0.00830663776865575,0.536610726824312
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERC2,ERC protein 2,39768,0.00486242120472471,0.00787899387162619,-0.0105804067836626,0.020305249193112,0.537157439093329
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,40054,-0.00528455426131366,0.00859683980707042,-0.0221343602831717,0.0115652517605443,0.538759835143839
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GJA8,Gap junction alpha-8 protein,39665,0.00416140623247046,0.00677112599792048,-0.00911000072345368,0.0174328131883946,0.538844736509466
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC2,Mucin-2,40097,0.00586615200344411,0.00956125785250079,-0.0128739133874574,0.0246062173943457,0.539536437534869
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPN3,Calpain-3,40020,-0.00241509329738375,0.0039465662595753,-0.0101503631661513,0.00532017657138384,0.540585018853894
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMOD2,Leiomodin-2,39719,0.00392261989061704,0.00643523605448949,-0.00869044277618236,0.0165356825574164,0.542170859920043
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPLX2,Complexin-2,39665,0.00197305805865153,0.00323790928746058,-0.00437324414477121,0.00831936026207428,0.54229790876949
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF6,Fibroblast growth factor 6,39784,0.00259394945697725,0.00426508268271823,-0.00576561260115049,0.010953511515105,0.543079357186025
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF75D,Zinc finger protein 75D,39881,0.00387543589986134,0.00637565026301613,-0.00862083861565027,0.016371710415373,0.543300204032513
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,39665,-0.00317083419858068,0.00522288699339797,-0.0134076927056407,0.00706602430847935,0.543795235769128
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,39881,-0.00395864648394885,0.00652196013145769,-0.0167416883416059,0.00882439537370821,0.543882460004486
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,39881,-0.0032950549797564,0.00543757313141143,-0.0139526983173228,0.00736258835781001,0.544541586160579
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,42197,-0.00198404004535502,0.00327698009828066,-0.00840692103798511,0.00443884094727507,0.544892135533458
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBN2,Fibrillin-2,39768,-0.00380722773806328,0.00629522920103503,-0.0161458769720919,0.00853142149596538,0.545338264695841
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUK1,Guanylate kinase,39706,-0.00239687474167759,0.00396858483259723,-0.0101753010135682,0.00538155153021299,0.545881887960866
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,40113,0.00123083037232213,0.00204082133706583,-0.0027691794483269,0.00523084019297115,0.546451099690109
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,39665,0.00190834636512912,0.00317180184375646,-0.00430838524863355,0.00812507797889178,0.547413492674271
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM3,Myomesin-3,39863,0.00575521053543327,0.00957455532383409,-0.0130109178992816,0.0245213389701481,0.547789956271988
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COPB2,Coatomer subunit beta',39706,0.00269919944618265,0.00449383966992814,-0.0061087263068765,0.0115071251992418,0.548089835665573
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDHB,Succinate dehydrogenase,40021,0.00408560109228659,0.00682964390622847,-0.00930050096392121,0.0174717031484944,0.549708444019322
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRELP,Prolargin,42126,0.00150779506475782,0.00252816316531932,-0.00344740473926804,0.00646299486878369,0.55091886200045
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,41876,-0.00170848812182503,0.00286833867686416,-0.00733043192847878,0.00391345568482872,0.55142850425763
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCIN,Adseverin,39719,-0.00449504834586092,0.00755283679859615,-0.0192986084711094,0.0103085117793875,0.551757992999963
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,42213,-0.00409359162440192,0.00691672723391041,-0.0176503770028663,0.00946319375406248,0.553968420620437
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,39665,-0.00224140530638729,0.00379451203919802,-0.00967864890321541,0.00519583829044083,0.554736484764347
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",42004,-0.00358133583868938,0.00607111313661278,-0.0154807175864504,0.00831804590907167,0.555269622729378
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,39665,0.0052906009059057,0.00897262590217735,-0.0122957458623619,0.0228769476741733,0.555446113231833
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,42094,-0.00342353403611767,0.00580930910764614,-0.0148097798871041,0.00796271181486876,0.555657875424396
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC3B,Tetranectin,39847,0.0012810822555517,0.0021758033451808,-0.00298349230100267,0.00554565681210607,0.556017412445032
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,39706,0.00220680429287808,0.00376148662781895,-0.00516570949764707,0.00957931808340322,0.557428505252821
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,41967,0.00210302140242758,0.00359543985952347,-0.00494404072223843,0.00915008352709358,0.55861619562306
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,39706,-0.00404322184218132,0.00692043685881268,-0.0176072780854542,0.00952083440109154,0.559068881480819
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,39804,-0.00436894183423878,0.00750038590351485,-0.0190696982051279,0.0103318145366503,0.560245278163722
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,41876,-0.00292180739737371,0.00501943051316966,-0.0127598912031862,0.00691627640843883,0.560510089191853
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTF4,Neurotrophin-4,41861,0.00232964317418236,0.00401409269627904,-0.00553797851052456,0.0101972648588893,0.56167810960942
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMFG,Glia maturation factor gamma,40080,0.00425958761316093,0.00734075517606215,-0.0101282925319209,0.0186474677582427,0.561747540481838
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",41486,0.00175796993127674,0.00303013352999803,-0.00418109178751941,0.00769703165007289,0.561815654400446
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",39804,0.00260277539454605,0.0044965672201929,-0.00621049635703203,0.0114160471461241,0.562712063151216
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LACTB2,Endoribonuclease LACTB2,42144,-0.00389547724820489,0.00673315560295051,-0.0170924622299879,0.00930150773357811,0.562901902046731
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA2,GDNF family receptor alpha-2,42094,-0.0012762214745481,0.00220761868027957,-0.00560315408789605,0.00305071113879985,0.563207580223671
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,40080,0.00168408868433191,0.00291817552111816,-0.0040355353370597,0.00740371270572351,0.563881618168033
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL18,C-C motif chemokine 18,41991,-0.00414938114936565,0.00719888078075072,-0.0182591874796371,0.00996042518090577,0.564360025625884
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP10,Bone morphogenetic protein 10,39863,0.0017103139029937,0.00296891393985599,-0.00410875741912404,0.00752938522511144,0.56457736730383
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLMP,CXADR-like membrane protein,42223,-0.00130928187784138,0.00227966345276162,-0.00577742224525416,0.0031588584895714,0.565753605929005
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PI3,Elafin,41959,-0.00337353799065827,0.00590919025748454,-0.014955550895328,0.00820847491401142,0.568079629128776
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,39881,-0.0041565811055255,0.00728094969916526,-0.0184272425158894,0.0101140803048384,0.568089962763264
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPK3A,Uroplakin-3a,39719,0.00300483009186396,0.00527248853577357,-0.00732924743825224,0.0133389076219802,0.568752687703237
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",40097,0.00371433176285041,0.00653148438601674,-0.0090873776337424,0.0165160411594432,0.569584285200621
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOS,Proto-oncogene c-Fos,39651,-0.00210738443254525,0.00370640216895227,-0.00937193268369169,0.00515716381860119,0.569653724199367
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1A,Protein phosphatase 1A,41861,-0.00187413091522871,0.00329731493537275,-0.00833686818855929,0.00458860635810187,0.5697864149468
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BGLAP,Osteocalcin,40097,0.00525695001406249,0.00928624872279858,-0.0129440974826227,0.0234579975107477,0.57133711662437
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,39665,0.00386040069362907,0.00683837776608086,-0.00954281972788942,0.0172636211151476,0.572412417146476
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,39881,0.00412872429787983,0.00731477244685007,-0.0102082296979463,0.018465678293706,0.572468974223318
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRG,Histidine-rich glycoprotein,40055,-0.00179071275392675,0.00317587214133396,-0.00801542215094131,0.00443399664308781,0.572868452257925
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PREB,Prolactin regulatory element-binding protein,41887,-0.00171135942730911,0.00303539992130991,-0.00766074327307653,0.00423802441845832,0.572899998968307
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PYDC1,Pyrin domain-containing protein 1,39804,-0.00247308702795976,0.00438899534405375,-0.0110755179023051,0.00612934384638558,0.57312371638461
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMNB2,Lamin-B2,40054,-0.00166916760242168,0.0029667869076762,-0.00748406994146703,0.00414573473662368,0.573706671813582
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIP1,Huntingtin-interacting protein 1,39706,0.00192115130460544,0.00342962055473769,-0.00480090498268044,0.00864320759189132,0.575379250957814
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,42094,-0.00660834504273297,0.011897353513957,-0.0299271579300887,0.0167104678446227,0.57859882998238
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,39768,-0.00357239298499843,0.00644552137433912,-0.0162056148787031,0.00906082890870625,0.579423438135917
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHODH,Dihydroorotate dehydrogenase,39706,-0.00277821431401095,0.00501854314069815,-0.0126145588697793,0.00705813024175743,0.579871379475381
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,39784,-0.00278039513029747,0.00502424026015363,-0.0126279060401986,0.00706711577960365,0.580003868980143
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSHB,Follitropin subunit beta,39804,0.00306762903632588,0.00554858356859842,-0.00780759475812702,0.0139428528307788,0.580366098248749
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BGN,Biglycan,41843,-0.00685601413624494,0.0124103712973293,-0.0311803418790104,0.0174683136065205,0.580655113549659
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD58,Lymphocyte function-associated antigen 3,42109,-0.00101258496730546,0.00183323066281385,-0.00460571706642059,0.00258054713180968,0.580718134551846
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA3,Annexin A3,42186,-0.00393506302027438,0.00715322997368766,-0.0179553937687022,0.0100852677281534,0.582253415934425
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BEX3,Protein BEX3,39665,-0.00270751932522998,0.00493123565596965,-0.0123727412109305,0.00695770256047053,0.582979450790865
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NME1,Nucleoside diphosphate kinase A,39784,0.00124074306087066,0.0022624391777944,-0.00319363772760637,0.00567512384934768,0.583422338604926
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,40054,-0.002260582496446,0.00412953604375518,-0.0103544731422062,0.00583330814931415,0.584102818615535
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFHD1,EF-hand domain-containing protein D1,40054,0.00204305691886799,0.00373903067035559,-0.00528544319502897,0.00937155703276495,0.5847929422555
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,39863,-0.00151121018657,0.00276759954270482,-0.00693570529027144,0.00391328491713144,0.58505230967338
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",42094,0.00198799155160299,0.0036478367735895,-0.00516176852463242,0.0091377516278384,0.585777926162939
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA11,Annexin A11,42079,-0.00371795497991819,0.00685745410892489,-0.017158565033411,0.0097226550735746,0.58770584536171
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMIGO2,Amphoterin-induced protein 2,42094,-0.00131454566167837,0.00242475108005672,-0.00606705777858953,0.0034379664552328,0.587733954430881
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL5,C-X-C motif chemokine 5,42115,-0.00631903002332466,0.0116847637267509,-0.0292211669277564,0.0165831068811071,0.588660086378135
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS3,Galectin-3,42175,0.00166965371098598,0.00309353412959652,-0.00439367318302319,0.00773298060499516,0.58939684546888
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,40054,-0.00292386248523985,0.0054252416087797,-0.0135573360384481,0.00770961106796836,0.589941494063785
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTLA,B- and T-lymphocyte attenuator,39665,-0.00486410871615338,0.00903739481632641,-0.0225774025561531,0.0128491851238464,0.590436455237995
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",39706,0.0021816919998565,0.00406496034939561,-0.00578563028495889,0.0101490142846719,0.591481492826733
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRDT,Bromodomain testis-specific protein,39706,-0.00206509468381699,0.00385125428917274,-0.00961355309059555,0.00548336372296157,0.591822325016505
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,39804,-0.0149821465256678,0.0279529812185596,-0.0697699897140447,0.0398056966627091,0.591985891771212
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F2R,Proteinase-activated receptor 1,42162,0.00308724198629207,0.00577399371290056,-0.00822978569099303,0.0144042696635772,0.59287995777238
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,42144,0.00220028030359839,0.00412907728024509,-0.00589271116568198,0.0102932717728788,0.594129549449982
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA4,Protein disulfide-isomerase A4,40097,0.00328258746831081,0.00616248695546129,-0.00879588696439332,0.0153610619010149,0.594271145998382
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,41861,-0.00443570424200293,0.00833787794537554,-0.020777945014939,0.0119065365309331,0.594739215151941
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,39881,-0.00288351790680086,0.0054203008517456,-0.0135073075762222,0.00774027176262051,0.594747550497317
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSD1,Tryptase delta,40054,0.00210805135152213,0.00397119891441225,-0.00567549852072587,0.00989160122377013,0.595543983073316
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPHS1,Nephrin,39784,-0.00183977782092139,0.0034667456799722,-0.0086345993536669,0.00495504371182411,0.595642634756424
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,41984,-0.00146471679020039,0.00277516353772646,-0.00690403732414426,0.00397460374374348,0.597650946183737
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAA10,N-alpha-acetyltransferase 10,39706,-0.00279510916974405,0.00530665477501963,-0.0131961525287825,0.00760593418929442,0.598400733461112
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,41876,0.00168774567021876,0.00320569868571798,-0.00459542375378848,0.00797091509422601,0.598561909306879
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MILR1,Allergin-1,41887,-0.00279312074500777,0.00532098513497383,-0.0132222516095565,0.00763601011954095,0.59964415465799
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,39768,-0.00585140232339146,0.0111571383833118,-0.0277193935546826,0.0160165889078997,0.599974019937762
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,39784,-0.00217308076510218,0.00415837294232292,-0.0103234917320551,0.00597733020185075,0.601277788930218
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",41985,-0.00514067101821273,0.00986869719423867,-0.0244833175189205,0.0142019754824951,0.60244074763615
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,41984,0.00184028316172816,0.00355531639064294,-0.00512813696393201,0.00880870328738833,0.604736245309255
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICOSLG,ICOS ligand,42094,0.00103218058126818,0.00199971177801217,-0.00288725450363567,0.00495161566617202,0.605748246659081
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN4,Prefoldin subunit 4,39665,0.00277486873669594,0.00540564195950322,-0.00782018950393037,0.0133699269773223,0.607732555039123
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,40054,-0.00144249735168614,0.00281805774370954,-0.00696589052935684,0.00408089582598456,0.608747899714224
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,41829,0.00325794417659074,0.00637005924201154,-0.00922737193775187,0.0157432602909334,0.609047414876244
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,42126,0.00136197664661347,0.00266583400799046,-0.00386305800904782,0.00658701130227477,0.609429263613103
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,39706,-0.00275945821265987,0.00543443565868488,-0.0134109521036822,0.00789203567836248,0.611623392060698
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAP1,Antigen peptide transporter 1,39881,-0.00322996695484786,0.00638198273435778,-0.0157386531141891,0.00927871920449338,0.612791886143864
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL14,C-X-C motif chemokine 14,41887,0.00291070744059079,0.00576036455857753,-0.00837960709422116,0.0142010219754027,0.613357497932761
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,42095,-0.00219069567555054,0.00435091965605573,-0.0107184982014198,0.00633710685031869,0.614620144605166
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP7,Caspase-7,40054,-0.00432272814156483,0.00859421490544108,-0.0211673893562293,0.0125219330730997,0.614987721609413
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",39706,-0.00362591729548048,0.00721441506940996,-0.017766170831524,0.010514336240563,0.615260709051701
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,39665,-0.00287287539832663,0.00571673752025324,-0.014077680938023,0.00833193014136972,0.615299997912287
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,40020,0.00190340639916917,0.00378809228570017,-0.00552125448080315,0.0093280672791415,0.615346489245452
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,39881,-0.00377066634529744,0.00752728310151766,-0.0185241412242721,0.0109828085336772,0.61642842161653
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP7,Retinoid-binding protein 7,40021,-0.00308042298293213,0.00618598853486486,-0.0152049605112673,0.00904411454540299,0.618516865582945
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM1,Myomesin-1,39719,-0.00247394436877963,0.00496858945055044,-0.0122123796918585,0.00726449095429924,0.618553058947047
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YAP1,Transcriptional coactivator YAP1,40054,-0.00147707417493359,0.00297341137865335,-0.00730496047709416,0.00435081212722697,0.619367806265969
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,39881,0.00377093475391484,0.00761398869290911,-0.011152483084187,0.0186943525920167,0.62042393795796
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,42186,-0.00500434153486257,0.010111245739161,-0.0248223831836181,0.014813700113893,0.620659111945759
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,40021,-0.00285645166359804,0.00578668907760591,-0.0141983622557056,0.00848545892850955,0.621581387885473
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROC,Vitamin K-dependent protein C,42172,-0.00127559112024574,0.00259507610282078,-0.00636194028177448,0.003810758041283,0.623050861304518
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS7_LGALS7B,Galectin-7,42030,0.00219794499831011,0.00448370519661194,-0.00659011718704928,0.0109860071836695,0.623995597454874
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR1,Folate receptor alpha,42109,-0.00154373488849641,0.00315122228033746,-0.00772013055795784,0.00463266078096502,0.624223966946803
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",42184,-0.00550984572623248,0.0113104150985146,-0.027678259319321,0.0166585678668561,0.626161695789978
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHB6,Ephrin type-B receptor 6,41985,0.00169414703710927,0.00347768486607227,-0.00512211530039239,0.00851040937461092,0.626161839327208
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,39784,-0.00146352077800936,0.00301274326958843,-0.00736849758640269,0.00444145603038397,0.627135476953907
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",39646,0.00131945333822278,0.00274593423487449,-0.00406257776213121,0.00670148443857677,0.630873691503096
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYTH3,Cytohesin-3,39665,-0.00371700869090828,0.00775169738841991,-0.0189103355722113,0.0114763181903947,0.631586579156026
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF7,Fibroblast growth factor 7,39665,0.00392414374062656,0.00819283352216237,-0.0121338099628117,0.0199820974440648,0.631968039124641
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,39719,0.00372311852021306,0.00781013520132819,-0.0115847464743902,0.0190309835148163,0.633583191047935
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,40021,-0.00213051434483066,0.00447130432930132,-0.0108942708302613,0.00663324214059993,0.633737725979786
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDK,Midkine,42146,0.00251022440268645,0.00527566522976559,-0.0078300794476541,0.012850528253027,0.634216401871168
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,39768,0.00156647100695601,0.00329250344397943,-0.00488683574324367,0.00801977775715569,0.63424879987141
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPH3,Neurexophilin-3,39784,0.00150202880960485,0.00316786870985958,-0.00470699386171993,0.00771105148092964,0.635406353879483
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK8,Kallikrein-8,41683,-0.00183788176024012,0.00387701520175793,-0.00943683155568567,0.00576106803520542,0.635475720897649
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,40054,-0.00138286774653975,0.00291730195267754,-0.00710077957378772,0.00433504408070822,0.635493152248759
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNPY4,Protein canopy homolog 4,42094,0.00361205584628726,0.00762622841401481,-0.0113353518451818,0.0185594635377563,0.635767558754222
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL1,Fc receptor-like protein 1,42144,0.00230071763399089,0.0048793105074314,-0.00726273096057464,0.0118641662285564,0.637273705485543
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NLGN1,Neuroligin-1,39768,0.00340075678784847,0.00721659636779916,-0.0107437720930379,0.0175452856687348,0.637478295819585
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,42094,-0.00155336892278633,0.00330164280072797,-0.00802458881221315,0.00491785096664048,0.638017474309474
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PODXL,Podocalyxin,42094,0.000738226621215978,0.00157654181079139,-0.00235179532793515,0.00382824857036711,0.639608779341568
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP1,Caspase-1,41829,-0.00334402992347625,0.00716608567693683,-0.0173895578502724,0.0107014980033199,0.640760745959919
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,42184,-0.00626860341440255,0.013435343461065,-0.0326018765980899,0.0200646697692848,0.640811373113481
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS27,Serine protease 27,42111,0.00194139224613408,0.00417087503726445,-0.00623352282690425,0.0101163073191724,0.641607047227982
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSB,Lupus La protein,41829,-0.00280947542353596,0.00605847213944774,-0.0146840808168535,0.00906512996978161,0.64285153812154
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,39881,-0.00182728765416485,0.00394548720323671,-0.0095604425725088,0.00590586726417911,0.643278044839907
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,39864,0.00255960783372206,0.00553265664373181,-0.00828439918799228,0.0134036148554364,0.643634514296584
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFAP1,Actin filament-associated protein 1,39863,0.00398184817298261,0.00862471493914509,-0.0129225931077418,0.020886289453707,0.644321078229073
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",41829,0.00143255200937062,0.00311884686377781,-0.00468038784363389,0.00754549186237513,0.646011537315522
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADA2,Adenosine deaminase 2,42083,-0.0021030680447949,0.00459622348929329,-0.0111116660838097,0.00690552999421994,0.64727316849629
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,39719,0.0023544939877052,0.00514701771154461,-0.00773366072692222,0.0124426487023326,0.647358368601711
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,39768,0.00193883137788617,0.00424014243053393,-0.00637184778596032,0.0102495105417327,0.647496308067276
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABHD14B,Protein ABHD14B,41969,-0.00267782017823375,0.00587289767672666,-0.014188699624618,0.00883305926815051,0.648424808782388
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,40080,-0.00424906802547719,0.00932522163691088,-0.0225265024338225,0.0140283663828681,0.648648396114071
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTN2,Alpha-actinin-2,39706,0.00279380731922063,0.00613698352405234,-0.00923468038792197,0.0148222950263632,0.648945175026397
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,41861,-0.00241140815092177,0.0053352895885587,-0.0128685757444968,0.00804575944265327,0.651295995574143
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCUN1D1,DCN1-like protein 1,39719,-0.00349468009982059,0.00774314274362738,-0.0186712398773303,0.0116818796776891,0.651764050863075
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALB1,Calbindin,42094,-0.00211996001437749,0.0047282076264864,-0.0113872469622908,0.00714732693353586,0.653897754429086
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,39719,-0.00280517521605641,0.00626286446681449,-0.0150803895710128,0.0094700391389,0.654230182687295
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN3,Neuronal-specific septin-3,40054,0.00344775253973613,0.00773493551806044,-0.0117127210756623,0.0186082261551346,0.655795598144858
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TERF1,Telomeric repeat-binding factor 1,39784,0.0013484931490115,0.00303352003600362,-0.00459720612155559,0.0072941924195786,0.656667935568229
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGCR6,Protein DGCR6,39719,-0.00201628549788235,0.00455331947737822,-0.0109407916735437,0.00690822067777896,0.657907488057802
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL1,Growth-regulated alpha protein,42116,0.00433692115025965,0.00988005477885695,-0.0150279862163,0.0237018285168193,0.660699890545542
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COPE,Coatomer subunit epsilon,41829,0.00214559025769731,0.00489690424712465,-0.00745234206666702,0.0117435225820616,0.661283315293167
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN7,Tetraspanin-7,39719,0.00425543784175271,0.0097206708036857,-0.0147970769334713,0.0233079526169767,0.661560527890005
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH23,Cadherin-23,40054,0.00117451415998524,0.00268910479461293,-0.0040961312374561,0.00644515955742659,0.662288497665958
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",40054,0.00201475555801703,0.00462376677401146,-0.00704782731904543,0.0110773384350795,0.66303475919705
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,42171,-0.00534473239483877,0.0122667837753741,-0.0293876285945719,0.0186981638048944,0.663056050651846
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM2,Intercellular adhesion molecule 2,42296,0.00145014242094501,0.0033504967439905,-0.00511683119727636,0.00801711603916639,0.665156912372354
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,39665,0.00211254325282034,0.00489152828374055,-0.00747485218331113,0.0116999386889518,0.665839007179812
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CETN3,Centrin-3,40021,-0.00334223858754632,0.00779898816651529,-0.0186282553939163,0.0119437782188237,0.668260924916776
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAD2,Glutamate decarboxylase 2,39784,0.00206010461442199,0.0048148647610469,-0.00737703031722994,0.0114972395460739,0.668759244228314
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK3,Prostate-specific antigen,40097,0.00429547092921582,0.0101108422765404,-0.0155217799328033,0.024112721791235,0.670963091380396
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLN1,Cerebellin-1,39719,0.00418420607105651,0.00986349750320911,-0.0151482490352333,0.0235166611773464,0.671420466554491
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALMS1,Alstrom syndrome protein 1,39881,0.00194221514911593,0.00461194668754639,-0.007097200358475,0.0109816306567069,0.673670835064409
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,39706,0.00213130189038295,0.00506833224950967,-0.007802629318656,0.0120652330994219,0.674119000180678
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,40021,-0.00129104642283371,0.00307575302342298,-0.00731952234874274,0.00473742950307532,0.674676639133648
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,39804,0.00226745305533431,0.00543464471103929,-0.00838445057830269,0.0129193566889713,0.676524514126707
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,41861,0.0024864368569148,0.00599213208937409,-0.0092581420382584,0.014231015752088,0.678185332501391
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD48,CD48 antigen,42162,-0.00132384429768423,0.00321349355278619,-0.00762229166114517,0.00497460306577671,0.680372473177405
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX8,Syntaxin-8,42103,-0.00202930482474511,0.00494395940477269,-0.0117194652580996,0.00766085560860938,0.681474277360441
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCC,Netrin receptor DCC,39768,-0.000989208324518231,0.00241008053218474,-0.00571296616760033,0.00373454951856387,0.681486999536436
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,42296,-0.00303268554197743,0.00739376801606835,-0.0175244708534714,0.0114590997695165,0.681689568260825
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDAN1,Codanin-1,40054,-0.00095209998998946,0.0023405739633385,-0.00553962495813292,0.003635424978154,0.684177181458193
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRN1,Secernin-1,42103,-0.00230061688929615,0.0057220261260891,-0.0135157880964308,0.00891455431783847,0.687644074374082
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGS8,Regulator of G-protein signaling 8,41887,-0.00268227741167341,0.00667311132399062,-0.015761575606695,0.0103970207833482,0.6877253514197
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C3,Complement C3,39575,0.00194781509698098,0.00484906586594295,-0.0075563540002672,0.0114519841942292,0.687921390556607
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,42004,0.00188792193457202,0.00470395057896095,-0.00733182120019145,0.0111076650693355,0.688170501422314
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA3,Protein disulfide-isomerase A3,39863,-0.00102519378587424,0.00255894034152286,-0.00604071685525905,0.00399032928351057,0.68869898952179
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YY1,Transcriptional repressor protein YY1,39784,-0.00116402289207378,0.0029157769072754,-0.00687894563033355,0.004550899846186,0.689742585493271
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EHD3,EH domain-containing protein 3,39804,0.00479717027755482,0.0120333356256241,-0.0187881675486685,0.0283825081037781,0.69015417435596
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,40054,0.00464121510134541,0.0116468040116612,-0.0181865207615105,0.0274689509642013,0.690271789307146
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,39768,-0.00229227644974826,0.00576327387958211,-0.0135882932537292,0.00900374035423267,0.690830914543349
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOSB,Protein fosB,41829,-0.00158191001734418,0.00398382644760761,-0.00939020985465509,0.00622638981996674,0.691312914524169
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SF3B4,Splicing factor 3B subunit 4,42094,-0.00298225589394005,0.00751976432505999,-0.0177209939710576,0.0117564821831775,0.691677117774532
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL21R,Interleukin-21 receptor,39784,0.00228331711500771,0.00580637272095245,-0.0090971734180591,0.0136638076480745,0.694147714653668
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,40021,-0.00224612685663906,0.00572588792521403,-0.0134688671900586,0.00897661347678043,0.694862216879619
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,39881,0.00298378693293807,0.00761123118797585,-0.0119342261954946,0.0179018000613707,0.695048138954117
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGH,Gamma-glutamyl hydrolase,41953,0.00138521143155056,0.00353981460402068,-0.00555282519232997,0.00832324805543109,0.695564917553561
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,39706,0.00195142000150131,0.00499064892786908,-0.00783025189712209,0.0117330919001247,0.695793863902128
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC1,Sialoadhesin,42184,-0.00174671284605708,0.00447564735330928,-0.0105189816585433,0.0070255559664291,0.69634298100592
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",41829,-0.00114078510885312,0.00292336441379827,-0.00687057935989774,0.00458900914219149,0.696372902882977
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STXBP3,Syntaxin-binding protein 3,41861,-0.00174358661679373,0.00449540976156844,-0.0105545897494679,0.00706741651588041,0.698126654172472
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,41876,0.0043635134554973,0.0112896084007542,-0.0177641190099808,0.0264911459209754,0.69912765257764
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAGLN3,Transgelin-3,39665,-0.00244156159854977,0.00631979011920306,-0.0148283502321878,0.00994522703508823,0.699255789880237
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD276,CD276 antigen,42126,-0.00146553770385556,0.00379466492186487,-0.0089030809507107,0.00597200554299959,0.699347469868445
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRL,Prolactin,42213,0.00299568282563655,0.0077853073066967,-0.012263519495489,0.0182548851467621,0.700401727832695
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP9,Fatty acid-binding protein 9,42103,0.00225721147289458,0.0058747702500085,-0.00925733821712208,0.0137717611629112,0.700820810351674
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,42296,0.00108572166132783,0.00283724071568762,-0.0044752701414199,0.00664671346407556,0.701972038746323
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD2,Bromodomain-containing protein 2,39719,0.00140828702464239,0.00371517119984182,-0.00587344852704759,0.00869002257633236,0.704648111466254
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTF1,Cardiotrophin-1,41876,-0.0032679523733465,0.00864849642918079,-0.0202190053745408,0.0136831006278478,0.705538215513862
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,40080,-0.00271439876706707,0.00722438178105274,-0.0168741870579304,0.0114453895237963,0.707126826674819
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PF4,Platelet factor 4,40040,-0.00377226568036909,0.0100689475382623,-0.0235074028553632,0.015962871494625,0.707932946613166
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,39665,0.00119093811965464,0.00318432875938329,-0.0050503462487366,0.00743222248804588,0.708412084122969
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,39881,0.00349363524189644,0.00936411243551372,-0.0148600251317105,0.0218472956155033,0.709090566700889
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,39768,0.0014290439374625,0.0038561175343181,-0.00612894642980097,0.00898703430472598,0.710949323017987
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMBN,Ameloblastin,41887,0.00109516581599539,0.00297161481056661,-0.00472919921271516,0.00691953084470595,0.712475041862651
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,39768,0.00163300886323694,0.00444984807731393,-0.00708869336829836,0.0103547110947722,0.713640673897691
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSLN,Mesothelin,42061,-0.0022601106883895,0.00617684087118473,-0.0143667187959116,0.00984649741913257,0.714445154290946
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,39719,0.00212465641662587,0.00581187875476784,-0.0092666259427191,0.0135159387759709,0.714692296347137
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTBDN,Retbindin,42094,-0.00112904101858966,0.00309310302258098,-0.00719152294284838,0.00493344090566905,0.715103292737295
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVI2B,Protein EVI2B,39665,-0.00152677124559849,0.00420829257137798,-0.00977502468549933,0.00672148219430235,0.716761135201136
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,39706,0.0041164158139672,0.0114189516783535,-0.0182647294756056,0.02649756110354,0.718488112554127
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTOA,Otoancorin,39719,0.0020211569175252,0.00564060763349349,-0.00903443404412204,0.0130767478791724,0.720109129938213
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",39706,0.00145490536414056,0.00409767103156475,-0.00657652985772636,0.00948634058600747,0.722554272281369
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300C,CMRF35-like molecule 6,42213,-0.00131318630945125,0.0037234460068833,-0.00861114048294253,0.00598476786404003,0.724333787887959
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAPPA,Pappalysin-1,41887,-0.00170246308663528,0.00482791264987218,-0.0111651718803848,0.00776024570711419,0.724372281415619
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHCY,Adenosylhomocysteinase,42144,0.00244075091953096,0.00695127578757787,-0.0111837496241217,0.0160652514631836,0.725501989401967
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAGED1,Melanoma-associated antigen D1,41861,-0.00174992022935684,0.00501105983596872,-0.0115715975078555,0.00807175704914186,0.726936261993134
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRN1,Neuritin,40054,-0.0013060059737556,0.0037782812331459,-0.00871143719072156,0.00609942524321037,0.729603893004834
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYBB2,Beta-crystallin B2,40054,0.00290309832989791,0.00841213119161806,-0.0135846788056735,0.0193908754654693,0.730019455542513
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP15,Matrix metalloproteinase-15,40080,0.00173703809012451,0.00503566618455344,-0.00813286763160024,0.0116069438118493,0.730140858004823
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B2M,Beta-2-microglobulin,40113,-0.00110978157222126,0.0032328730271607,-0.00744621270545623,0.00522664956101371,0.731394220378101
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,42126,-0.00185805367836027,0.00542082958330472,-0.0124828796616375,0.00876677230491697,0.731783185332829
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSAP,Prosaposin,40013,-0.00100641095920733,0.00297598595088445,-0.00683934342294085,0.00482652150452619,0.735236126394535
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,42213,0.00164120650655504,0.00489201981168562,-0.00794715232434877,0.0112295653374589,0.73726354752363
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,39706,-0.00118231851747296,0.00352566279389396,-0.00809261759350512,0.0057279805585592,0.737370446649338
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA3G,Semaphorin-3G,39863,0.00154912449959704,0.0046397266456936,-0.00754473972596242,0.0106429887251565,0.738474630363621
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,40020,0.00161593419374696,0.00484450945124658,-0.00787930433069634,0.0111111727181903,0.738718125507196
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,40097,-0.00489485224232984,0.0146774911461039,-0.0336627348886935,0.0238730304040338,0.738767984601167
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGM2,Phosphoglucomutase-2,39768,-0.00204736950181168,0.0061771549446427,-0.0141545931933114,0.010059854189688,0.740317101282316
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX18,Sorting nexin-18,40021,-0.0014743163146432,0.00452077362440326,-0.0103350326184736,0.00738639998918719,0.744339597502493
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,42186,-0.00151295614981137,0.00464084907949949,-0.0106090203456304,0.00758310804600763,0.744423190637944
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,39719,-0.00376516989321839,0.0115601841236165,-0.0264231307755068,0.01889279098907,0.74465664577743
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBI,Acyl-CoA-binding protein,42073,-0.00254240656726673,0.00787961384532139,-0.0179864497040966,0.0129016365695632,0.746960834867948
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSC1,Hamartin,39784,0.00245389160052287,0.00760652686156396,-0.0124549010481425,0.0173626842491882,0.747001969900069
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CABP2,Calcium-binding protein 2,39768,0.00215031258562231,0.00666986942895168,-0.010922631495123,0.0152232566663676,0.747162113161997
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEDD9,Enhancer of filamentation 1,39784,0.00111341943109563,0.00346123742648369,-0.0056706059248124,0.00789744478700367,0.747699602573566
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMVK,Phosphomevalonate kinase,41821,0.0035620809913607,0.0111171512391019,-0.0182275354372789,0.0253516974200003,0.748660491393051
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,41876,0.00110062782466516,0.003442200977669,-0.00564608609156608,0.0078473417408964,0.749166630661467
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,40054,0.00153771166682648,0.0048536654962849,-0.00797547270589193,0.0110508960395449,0.751390441519666
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB6,Serpin B6,42182,-0.00188945788946724,0.00597786020604214,-0.0136060638933098,0.00982714811437536,0.751949934068748
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,39719,0.0017687526082888,0.00560556699131465,-0.00921815869468792,0.0127556639112655,0.752361733404885
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF3,Granulocyte colony-stimulating factor,41887,0.00158995127312587,0.00504253620201929,-0.00829341968283194,0.0114733222290837,0.752533105087873
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,40054,-0.00273783452410623,0.00871619345863268,-0.0198215737030263,0.0143459046548138,0.753444312672523
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,40102,-0.0012207306949462,0.00389785722958082,-0.00886053086492462,0.00641906947503221,0.754149945329428
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSPN,Claspin,41810,0.00112489976076747,0.00361246428749934,-0.00595553024273123,0.00820532976426617,0.755506247954609
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,42186,0.00080861652486003,0.00260191664657417,-0.00429114010242534,0.0059083731521454,0.755974944129509
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",39784,0.00113365243605177,0.00366464999281755,-0.00604906154987063,0.00831636642197418,0.757062847449349
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSG1,Tryptase gamma,39784,0.00084538687116086,0.00273787076615368,-0.00452083983050035,0.00621161357282207,0.757498532165471
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,42174,0.00354803650905173,0.0114922414089384,-0.0189767566524675,0.026072829670571,0.757529438678066
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",39804,-0.00274500289049424,0.00891629340785247,-0.0202209379698851,0.0147309321888966,0.758192107516844
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL3,Interleukin-3,39665,0.00196348457373971,0.00640696000819787,-0.0105941570423281,0.0145211261898075,0.759259620078578
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRN,Progranulin,42063,-0.000775698906369845,0.0025458795334325,-0.00576562279189754,0.00421422497915785,0.760608727972191
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB5,Serpin B5,41876,0.00152671330302477,0.00504535307560002,-0.00836217872515127,0.0114156053312008,0.762201269068962
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC25A,M-phase inducer phosphatase 1,39665,0.0012149830439637,0.00402286406267063,-0.00666983051887074,0.00909979660679813,0.762643262169524
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,42103,-0.00129800236041524,0.00430141991921245,-0.00972878540207164,0.00713278068124117,0.76283884336912
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR1,TGF-beta receptor type-1,39784,-0.000675597570782448,0.00223912318089209,-0.00506427900533095,0.00371308386376605,0.762868270354763
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THY1,Thy-1 membrane glycoprotein,42213,-0.000942542021852409,0.00312876419357908,-0.00707491984126741,0.00518983579756259,0.763228235449501
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1R1,Interleukin-1 receptor type 1,42099,-0.000734595638066569,0.00244379060894854,-0.00552442523160571,0.00405523395547257,0.763726813826363
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTTG1,Securin,39881,0.00127307266041486,0.00423592397940119,-0.00702933833921146,0.00957548366004118,0.763769683731809
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,39706,-0.00297770201204528,0.0099202421138754,-0.0224213765552411,0.0164659725311505,0.764057809884588
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEX101,Testis-expressed protein 101,39768,-0.00164816264510455,0.00549254591699725,-0.0124135526424192,0.00911722735221007,0.764127661927817
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,41829,0.00207566819405054,0.00692353758599652,-0.0114944654745026,0.0156458018626037,0.764335569621118
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,41861,-0.000992189756622798,0.00331090367460183,-0.00748156095884239,0.00549718144559679,0.764431208378409
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDAC9,Histone deacetylase 9,39719,-0.00202562589241137,0.00681430334986472,-0.0153816604581462,0.0113304086733235,0.76627320294225
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,39768,0.00159993703737571,0.00538607141376404,-0.00895676293360181,0.0121566370083532,0.766433530075448
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA4,Carboxypeptidase A4,39653,0.00135044812023151,0.00456629616567323,-0.00759949236448801,0.010300388604951,0.767432562753569
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAGEA3,Melanoma-associated antigen 3,39881,0.00261976436563287,0.00886635721486744,-0.0147582957755073,0.0199978245067731,0.76763872868038
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,41953,-0.00350375476175779,0.0118760475690758,-0.0267808079971464,0.0197732984736308,0.767978049598931
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,39706,0.00305146232881743,0.0103467365118723,-0.0172281412344524,0.0233310658920872,0.768060610908182
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APPL2,DCC-interacting protein 13-beta,39863,0.00336077233879569,0.0114379619698627,-0.0190576331221351,0.0257791777997265,0.768896466747448
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRMD7,FERM domain-containing protein 7,39768,-0.0010170559483895,0.00347310473107995,-0.00782434122130621,0.00579022932452721,0.769651968073823
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH6,Cadherin-6,42144,-0.00117476707366742,0.00401476648947482,-0.00904370939303807,0.00669417524570323,0.769823766951511
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGR,Progesterone receptor,39784,-0.00296417450704323,0.0101354432933666,-0.0228296433620418,0.0169012943479553,0.769943477124394
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HYAL1,Hyaluronidase-1,42059,0.000700876353149219,0.0024008888736445,-0.004004865839194,0.00540661854549244,0.770349672644501
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,39768,0.00127048041616609,0.004365393508966,-0.00728569086140728,0.00982665169373945,0.771030589595689
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPB41L5,Band 4.1-like protein 5,39768,0.00184190057670258,0.00635561485930238,-0.0106151045475301,0.0142989057009352,0.771969707016024
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1A,Interleukin-1 alpha,41887,-0.00173714789293983,0.0060018031682633,-0.0135006821027359,0.0100263863168562,0.772251202866692
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,40054,-0.00114879211060421,0.00397406761517798,-0.00893796463635306,0.00664038041514464,0.772531713665893
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,40080,-0.000821081146083894,0.00285630617051424,-0.00641944124029181,0.00477727894812403,0.773763620548931
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",39719,-0.000964885747695985,0.00335766938649244,-0.00754591774522117,0.0056161462498292,0.773836443456093
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL4,Interleukin-4,41887,0.00278912717806087,0.00971977029702689,-0.0162616226041118,0.0218398769602336,0.774152209460243
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASA1,Ras GTPase-activating protein 1,41829,-0.000958526574082746,0.00335106646301625,-0.0075266168415946,0.0056095636934291,0.774855026278219
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,39881,-0.00167373518844887,0.00587917379963878,-0.0131969158357409,0.00984944545884315,0.775888055020646
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSV,Cathepsin L2,42179,-0.00123095809477384,0.00433581339051438,-0.00972915234018202,0.00726723615063434,0.776487889014722
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,40054,0.00110476748094792,0.00391141956922142,-0.00656161487472607,0.0087711498366219,0.777606406638047
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,39665,0.00187365012522056,0.00663378893811066,-0.0111285761934763,0.0148758764439175,0.777611408788213
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NINJ1,Ninjurin-1,41861,0.00157413540910675,0.00560339059558285,-0.00940851015823564,0.0125567809764491,0.778772115679044
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,39881,0.00114554851506453,0.00407928589348298,-0.00684985183616211,0.00914094886629116,0.778853250181697
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,41861,-0.0013382874951209,0.00479748911451564,-0.0107413661595716,0.00806479116932976,0.780283286170592
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BID,BH3-interacting domain death agonist,42103,-0.00192872937684433,0.00692592090076186,-0.0155035343423376,0.0116460755886489,0.78064849536971
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAPK2,Death-associated protein kinase 2,39784,-0.00155153106622393,0.00558557926309776,-0.0124992664218955,0.00939620428944768,0.78119094746724
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOC,Brother of CDO,41876,0.000670460993455514,0.00241951103668786,-0.0040717806384527,0.00541270262536373,0.781703241317843
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,40002,0.00196883024004294,0.00711561307533881,-0.0119777713876211,0.015915431867707,0.782022227074476
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKD2,Polycystin-2,39706,-0.0016639754379628,0.00601472865956974,-0.0134528436107195,0.0101248927347939,0.782054210838167
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTO1,Protein LTO1 homolog,41887,-0.00120786240695504,0.00438117317215037,-0.00979496182436976,0.00737923701045968,0.782787723786981
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,42184,0.00245538041656082,0.00895474167870219,-0.0150959132736955,0.0200066741068171,0.783936124987552
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTC,Probetacellulin,41861,0.00212887793862847,0.00777017924527447,-0.0131006733821095,0.0173584292593664,0.784104040626933
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,39881,0.00186087989543055,0.00683535157764143,-0.0115364091967466,0.0152581689876077,0.785440071654496
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWF,von Willebrand factor,42296,0.00201668526185983,0.00742591620441125,-0.0125381104987862,0.0165714810225059,0.785953924391562
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,39881,-0.00176742456790108,0.00651895798005071,-0.0145445822088005,0.0110097330729983,0.786303423813088
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,42146,-0.000976818407959491,0.00360364425345206,-0.00803996114472553,0.00608632432880655,0.786346089973507
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,39719,0.00274328348801609,0.0101801887824229,-0.0172098865255327,0.0226964535015649,0.787571190170081
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,42105,-0.000897681152950763,0.00337022980058159,-0.00750333156209068,0.00570796925618915,0.789969250650743
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR4,Toll-like receptor 4,39784,-0.000809823019640962,0.00304258744056766,-0.00677329440315357,0.00515364836387164,0.790119157869072
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,42101,-0.00120366100819367,0.00455120691407295,-0.0101240265597766,0.00771670454338932,0.791421440120147
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMA1,Laminin subunit alpha-1,39706,0.00145196646695534,0.00557161011599136,-0.00946838936038772,0.0123723222942984,0.79440541996
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,41861,0.00129210573898015,0.00502661227551864,-0.00856005432103639,0.0111442657989967,0.797142038309533
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,39881,-0.00166232856694023,0.00649680414211088,-0.0143960646854776,0.0110714075515971,0.798057179792708
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHP1,Calcineurin B homologous protein 1,39719,0.0019456559940481,0.00765071630444838,-0.0130497479626707,0.0169410599507669,0.799260807590217
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",39768,-0.00207479439846341,0.00818642730228527,-0.0181201919109425,0.0139706031140157,0.799930669277062
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A11,Protein S100-A11,42043,0.00119506678404727,0.00472527522010535,-0.00806647264735921,0.0104566062154537,0.800342228197964
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QSOX1,Sulfhydryl oxidase 1,39922,-0.00111824123292055,0.00442292215381355,-0.00978716865439511,0.007550686188554,0.800405507064233
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSTN,Osteocrin,39768,0.00108212347668964,0.00430198269911819,-0.007349762613582,0.00951400956696129,0.801401034831525
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IST1,IST1 homolog,39948,-0.00253486906049079,0.0101485336519513,-0.0224259950183154,0.0173562568973338,0.802764671932837
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGF,Pro-epidermal growth factor,42107,-0.00264370577343393,0.0105898920497055,-0.0233998941908566,0.0181124826439888,0.802866437761026
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,41829,0.0010446081745951,0.00418926824362379,-0.00716635758290754,0.00925557393209773,0.803091501017926
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPA2,Replication protein A 32 kDa subunit,39784,-0.000819647412258504,0.00330460587798728,-0.00729667493311358,0.00565738010859657,0.804114595631176
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,40020,-0.00140423384965446,0.00569968092467991,-0.0125756084620271,0.00976714076271817,0.805400028209906
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,42181,-0.00145872028298557,0.00594867013681504,-0.0131181137511431,0.0102006731851719,0.806291606855893
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOC,Myocilin,42120,0.00112438484373494,0.00462517908053983,-0.00794096615412312,0.010189735841593,0.807931150675266
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP170,Centrosomal protein of 170 kDa,39804,-0.00191086476888923,0.0079285954069727,-0.0174509117665557,0.0136291822287773,0.809552610516146
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",40080,-0.00130491566196875,0.00542341710508284,-0.0119348131879311,0.00932498186399361,0.809863748948157
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,39881,0.00200814558512584,0.00836231536643935,-0.0143819925330953,0.018398283703347,0.81022455429038
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,39706,-0.00166761907909801,0.00707193413773574,-0.0155286099890601,0.012193371830864,0.813586206311073
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,39768,-0.00188513213070132,0.00800006481057031,-0.0175652591594191,0.0137949948980165,0.813716899998922
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAND5,DAN domain family member 5,39784,0.00135373563402176,0.00574742878223195,-0.00991122477915287,0.0126186960471964,0.813796046429456
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFB,Vascular endothelial growth factor B,39784,-0.000719868432361892,0.00306516109410004,-0.00672758417679797,0.00528784731207418,0.8143258121976
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10,Interleukin-10,41887,-0.00201578779930362,0.00876798504566228,-0.0192010384888017,0.0151694628901944,0.818170696136055
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TET2,Methylcytosine dioxygenase TET2,39865,-0.00240049176989786,0.0105620512548204,-0.0231021122293458,0.0183011286895501,0.820214149835011
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUOX2,Dual oxidase 2,41876,-0.00167850658712062,0.00740986092679054,-0.0162018340036301,0.0128448208293888,0.820798044285804
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,40054,0.00175241083664775,0.00779031126076076,-0.0135165992344433,0.0170214209077388,0.822024369273722
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLIN3,Perilipin-3,42144,-0.000981787245502842,0.00437031226123072,-0.00954759927751506,0.00758402478650938,0.82225571484018
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGT,Angiotensinogen,40102,-0.000553408244448055,0.00247847445429149,-0.00541121817485937,0.00430440168596326,0.823317230156739
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,42094,0.00103740683552067,0.00469974960207289,-0.00817410238454219,0.0102489160555835,0.82530101046347
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,40054,-0.000777707605545776,0.00353226664469273,-0.00770095022914352,0.00614553501805197,0.825741033507342
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL28,C-C motif chemokine 28,42049,0.00132532984981413,0.00608854664610893,-0.0106082215765594,0.0132588812761876,0.827685099994929
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,41887,-0.00088954724964872,0.00409416708349886,-0.00891411473330649,0.00713502023400905,0.827999987011658
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L1,Bcl-2-like protein 1,40054,-0.00219286421606888,0.0101828419963324,-0.0221512345288804,0.0177655060967426,0.829499320994799
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,39835,0.00107606955084696,0.00500425847991634,-0.00873227706978907,0.010884416171483,0.829747449995793
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM19,Probable RNA-binding protein 19,39706,-0.00106438159702018,0.00500715044033169,-0.0108783964600703,0.00874963326602993,0.831664683381136
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM,Paralemmin-1,39959,0.00069146082011167,0.00326367107738025,-0.00570533449155362,0.00708825613177696,0.832215615245234
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EXTL1,Exostosin-like 1,39706,-0.00103793101195311,0.00490457962421605,-0.0106509070754166,0.00857504505151034,0.832403810021449
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,42256,-0.000798395171215,0.00377524571904333,-0.00819787678053993,0.00660108643810993,0.832514753613471
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,41829,0.0032526318758177,0.0154694754271086,-0.0270675399613152,0.0335728037129506,0.833467135552521
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK7,Kallikrein-7,39606,-0.000850321251288741,0.00404669511126308,-0.00878184366936438,0.00708120116678689,0.833572404501345
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,39719,-0.00194248306266191,0.00936644147222286,-0.0203007083482187,0.0164157422228949,0.835711241008181
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC123,Cell division cycle protein 123 homolog,39665,-0.0013170215060047,0.00651937785668024,-0.014095002105098,0.0114609590930886,0.839907796328841
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL17,C-C motif chemokine 17,42112,-0.00190185358268356,0.00944178787152925,-0.0204077578108809,0.0166040506455138,0.840366006825448
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",39706,0.00106827893674562,0.00537506581305496,-0.00946685005684211,0.0116034079303333,0.842464393773174
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD2,T-cell surface antigen CD2,39706,-0.000791340408938894,0.00399335075669775,-0.00861830789206648,0.0070356270741887,0.842920183117375
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,41861,-0.00098194920023369,0.004960116587472,-0.0107037777116788,0.00873987931121142,0.843072513865677
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,42213,-0.000583900078845084,0.00295184230405807,-0.0063695109947989,0.00520171083710873,0.843197829963611
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,39784,0.000584650439935799,0.00299546856316952,-0.00528646794387646,0.00645576882374806,0.845257116522374
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",39784,-0.00129644781693028,0.00665838795481885,-0.0143468882083752,0.0117539925745147,0.845624529416286
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,40080,0.000643132682953015,0.00331784679070666,-0.00585984702683204,0.00714611239273807,0.846304484576465
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RLN1,Prorelaxin H1,40054,0.000962173221608247,0.00499413167330822,-0.00882632485807587,0.0107506713012924,0.847228256335566
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,39804,0.000785044233016308,0.00409231553140027,-0.00723589420852822,0.00880598267456084,0.84787610456469
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP4,Guanylate-binding protein 4,41829,-0.000966897093740243,0.00512543371746635,-0.0110127471799743,0.00907895299249381,0.850372615090973
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNF,Tumor necrosis factor,41859,-0.000750965724343298,0.00399175272954898,-0.0085748010742593,0.00707286962557271,0.850778291874145
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,39784,0.00175312095954292,0.00936892553194339,-0.0166099730830661,0.020116215002152,0.851569494827251
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK15,Kallikrein-15,39999,-0.00102914566660802,0.00552490734526712,-0.0118579640633316,0.00979967273011553,0.852233523671288
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD33,Myeloid cell surface antigen CD33,42186,0.00154310295234576,0.00831463575068991,-0.0147535831190065,0.017839789023698,0.852770164580861
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",39706,0.0011453543662404,0.00618006848666285,-0.0109675798676188,0.0132582886000996,0.852973496014905
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,42103,0.0018853325085849,0.0102179631931525,-0.018141875349994,0.0219125403671638,0.853615043842945
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",40054,0.00102759094967357,0.00562668282200796,-0.010000707381462,0.0120558892808092,0.855093165843827
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STEAP4,Metalloreductase STEAP4,39719,-0.00133731514716413,0.00750747158876772,-0.0160519594611489,0.0133773291668206,0.858623344582126
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,42193,0.00126278918456093,0.00709023936059443,-0.0126340799622042,0.015159658331326,0.858645272965052
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,39706,-0.0010467146345877,0.00593449473479333,-0.0126783243147826,0.0105848950456072,0.860000342195723
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCB,Calcitonin gene-related peptide 2,40054,0.000739490374324614,0.00421796996906231,-0.00752773076503752,0.00900671151368674,0.860832233503741
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PXDNL,Peroxidasin-like protein,40020,-0.00100714871365606,0.00575084395977703,-0.012278802874819,0.0102645054475069,0.86098029503171
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MN1,Transcriptional activator MN1,39768,-0.00107608005241262,0.00615710324705542,-0.0131440024166412,0.010991842311816,0.861263310195246
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",39768,-0.000898871226781671,0.00517714018434067,-0.0110460659880894,0.00924832353452604,0.862164985064218
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,39999,0.000697575585588002,0.00407039115548031,-0.00728039107915341,0.00867554225032941,0.86392974411956
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,39768,0.000640098233980874,0.00385462318820755,-0.00691496321490593,0.00819515968286767,0.868113007856836
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEO1,Neogenin,40054,-0.00037955112566559,0.00230483169833404,-0.0048970212544003,0.00413791900306912,0.86920184740856
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENSA,Alpha-endosulfine,40020,0.000900040221272086,0.00547265683079219,-0.0098263671670806,0.0116264476096248,0.869371085472443
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB39B,Ras-related protein Rab-39B,39706,-0.00157709660042489,0.00960029347519005,-0.0203936718117974,0.0172394786109476,0.86951713189811
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC44A4,Choline transporter-like protein 4,39768,-0.00119881420293325,0.00730320845706233,-0.0155131027787754,0.0131154743729089,0.869617003376389
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENOPH1,Enolase-phosphatase E1,40020,0.000934609543249017,0.0056971151753407,-0.0102317362004187,0.0121009552869168,0.869695149286729
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMP,Olfactory marker protein,39719,-0.000849246459934314,0.00519521073336649,-0.0110318594973326,0.009333366577464,0.87015374889383
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,41887,0.000754499093431128,0.00463830557959501,-0.0083365798425751,0.00984557802943735,0.870783247707355
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,41876,-0.000932507576073152,0.00575008226835798,-0.0122026688220548,0.0103376536699085,0.871172275441787
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAG,S-arrestin,39719,0.000877923134428745,0.00541404490074109,-0.0097336048710238,0.0114894511398813,0.871185645302053
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD1,Sushi domain-containing protein 1,41876,0.000820783387723344,0.00508068909554215,-0.00913736723953927,0.010778934014986,0.871663107665654
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CORO1A,Coronin-1A,41866,0.00144512311664604,0.00920397491079468,-0.0165946677085115,0.0194849139418036,0.875238867643398
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMMD9,COMM domain-containing protein 9,40020,0.000636619350050957,0.00412051938468314,-0.007439598643928,0.00871283734402992,0.877218562471158
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM106A,Transmembrane protein 106A,40020,-0.00110049020063177,0.00721418125891225,-0.0152402854680998,0.0130393050668362,0.878759624353362
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,39862,0.000857904114029322,0.00562774816967401,-0.0101724822985317,0.0118882905265904,0.878841366115423
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BSND,Barttin,39665,-0.000536919515454077,0.00353033526570153,-0.00745637663622908,0.00638253760532093,0.879120931241394
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,42184,0.00133784740165556,0.00879925394498779,-0.0159086903305205,0.0185843851338316,0.879156956492106
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,41716,0.00189145384715881,0.0125002941970689,-0.0226091227790962,0.0263920304734139,0.879731452248021
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP350,Centrosome-associated protein 350,39665,-0.000595814396395262,0.00393969182190075,-0.00831761036732073,0.00712598157453021,0.879794235480653
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHPK,Sedoheptulokinase,39881,0.000636694786964046,0.00421463115866287,-0.00762398228401518,0.00889737185794327,0.879925134604847
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,40054,-0.000590915552091397,0.00391713462286257,-0.00826849941290203,0.00708666830871923,0.880093664257126
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",39804,0.00099371172022067,0.00663396085274505,-0.0120088515511596,0.013996274991601,0.880931870918347
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,39863,-0.00108102476225755,0.00728591495204731,-0.0153614180682703,0.0131993685437552,0.882052109747119
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",40054,-0.00147572865309591,0.00998568626234477,-0.0210476737272917,0.0180962164210998,0.882515664680755
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR2,Toll-like receptor 2,39881,0.000357374557499737,0.00242168327647446,-0.0043891246643902,0.00510387377938967,0.882682714306359
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAM,Signal transducing adapter molecule 1,40020,-0.000563847397068242,0.00386877176262421,-0.00814664005181169,0.0070189452576752,0.884126785214342
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2,Interleukin-2,41887,0.00048178657489152,0.00331687735494413,-0.00601929304079898,0.00698286619058202,0.884513383130848
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,41876,0.000725245747037361,0.00505768882972109,-0.00918782435921598,0.0106383158532907,0.885980750691865
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA5,Annexin A5,41783,-0.000446441608380702,0.00317958864942046,-0.0066784353612448,0.00578555214448339,0.88833940533179
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM5,Intercellular adhesion molecule 5,42144,-0.000661329820615917,0.00474412848140596,-0.0099598216441716,0.00863716200293977,0.889136521526824
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],41887,-0.000817759526195229,0.00589100652563683,-0.0123641323164434,0.010728613264053,0.889598615702431
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF9,Fibroblast growth factor 9,39651,-0.000588649585098059,0.00425991605188099,-0.00893808504678479,0.00776078587658867,0.890098153093292
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",39784,0.000609259527306171,0.0044143132930939,-0.00804279452715788,0.00926131358177022,0.890227950147862
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EP300,Histone acetyltransferase p300,39784,0.000434269903373217,0.00320575470828496,-0.0058490093248653,0.00671754913161174,0.892246232224288
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL26,C-C motif chemokine 26,42103,0.00129860481396555,0.00965755117332373,-0.017630195485749,0.02022740511368,0.893036802189163
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,39881,0.000482712648428672,0.00360289895193682,-0.0065789692973675,0.00754439459422484,0.893421736062493
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",39665,-0.000802278574956993,0.00599067823500512,-0.012544007915567,0.010939450765653,0.89346749192494
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,42296,0.00090386535435002,0.00678932921112152,-0.0124032198994481,0.0142109506081482,0.894092386393404
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP73,Tumor protein p73,39768,-0.000475219845072824,0.00357560839273159,-0.00748341229482673,0.00653297260468108,0.894270242721914
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,39706,0.00081619798769593,0.00615555220041485,-0.0112486843251172,0.012881080300509,0.89451589796936
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF3,Fibroblast growth factor 3,39784,0.00039744700473828,0.00300586971514633,-0.00549405763694852,0.00628895164642508,0.89480992325061
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,39804,-0.00136777021220702,0.0104516193596107,-0.021852944157044,0.0191174037326299,0.895883142087763
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARB1,Scavenger receptor class B member 1,41829,0.000785690037072498,0.00602834849122749,-0.0110298730057334,0.0126012530798784,0.896305402560216
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,42226,0.000383295629254611,0.00294468692954213,-0.00538829075264797,0.00615488201115719,0.896437771624473
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,40054,0.000877974738158277,0.00684389330619172,-0.0125360561419775,0.014292005618294,0.897925130186592
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,42076,0.000575070747345364,0.00448430885781636,-0.00821417461397471,0.00936431610866543,0.897960522030697
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,40020,-0.000855569710862512,0.0068179398358802,-0.0142187317891877,0.0125075923674627,0.900139545750235
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,39863,-0.000485355451586738,0.00389088209420013,-0.00811148435621899,0.00714077345304551,0.900730351864577
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APCS,Serum amyloid P-component,39995,0.000436368643708412,0.00349863914243897,-0.00642096407547196,0.00729370136288878,0.900743387513814
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,39719,0.00074916684557241,0.00602353118210433,-0.0110569542713521,0.0125552879624969,0.901022035936699
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFP,Properdin,40113,-0.000285945151538148,0.00230112159444392,-0.00479614347664823,0.00422425317357194,0.901109026902441
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFRC,Transferrin receptor protein 1,42180,0.000488285461219288,0.00393002071077983,-0.00721455513190917,0.00819112605434775,0.901123208742827
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,39768,-0.000778430150149997,0.00627282365010493,-0.0130731645043556,0.0115163042040557,0.901241898331578
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL24,C-C motif chemokine 24,42162,0.00105934713096596,0.00857409497026121,-0.015745879010746,0.0178645732726779,0.901671863686463
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD99L2,CD99 antigen-like protein 2,42120,0.000305730027466454,0.00250513605051822,-0.00460433663154926,0.00521579668648217,0.902868217582871
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,39784,0.000727842052016155,0.00606314186829768,-0.0111559160098473,0.0126116001138796,0.90445079889572
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL25,Interleukin-25,39622,0.000426715486694981,0.00362331588868758,-0.00667498365513267,0.00752841462852263,0.906252699221824
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MELTF,Melanotransferrin,40080,-0.00036215112634001,0.00311737366389956,-0.00647220350758314,0.00574790125490312,0.907518473579511
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST7,Cystatin-F,42150,0.00109846911753043,0.00971452458374311,-0.0179419990666061,0.0201389373016669,0.90997290806609
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,42144,0.000961736331648205,0.00856183668123623,-0.0158194635635748,0.0177429362268712,0.910564865729054
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIFBP,KIF-binding protein,42094,-0.000931270677791304,0.00839923753600695,-0.0173937762483649,0.0155312348927823,0.911716702883175
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,42004,-0.00120558686381875,0.011113346133009,-0.0229877452845163,0.0205765715568788,0.913615853130994
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP2BP,LRP2-binding protein,39768,0.000956677986747522,0.00895323556012928,-0.0165916637111059,0.0185050196846009,0.914907812708516
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRAS,GTPase Hras,39865,-0.00108382611319374,0.0103018180147697,-0.0212753894221423,0.0191077371957548,0.916213322292039
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSP90B1,Endoplasmin,41770,0.000716000682881219,0.00690978071000543,-0.0128271695087294,0.0142591708744919,0.917471510389777
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,39768,0.00031052946140327,0.00311069902139386,-0.00578644062052869,0.00640749954333523,0.92048414906697
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,40020,-0.000992930999842546,0.0099867572297434,-0.0205669751701396,0.0185811131704545,0.920802860711482
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,42296,0.000716288607217284,0.00726835363464039,-0.0135296845166779,0.0149622617311124,0.921497913467382
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAX,Protein max,41829,0.00105775023127531,0.0108266325921889,-0.0201624496494149,0.0222779501119655,0.922172928738705
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,39719,-0.000437141396990649,0.00448661387350573,-0.00923090458906189,0.00835662179508059,0.922384899296061
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMIGO1,Amphoterin-induced protein 1,39768,-0.000509902935395272,0.0052377950062794,-0.0107759811477029,0.00975617527691235,0.922449750820891
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,39881,-0.00043217023081497,0.00448838118799595,-0.00922939735928703,0.00836505689765709,0.923294888460211
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,39706,0.000682557904087714,0.00711953581549941,-0.0132717322942911,0.0146368481024666,0.923624755769342
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,42120,0.00033006854639174,0.00345864645738967,-0.00644887851009202,0.0071090156028755,0.923972490681191
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",39706,0.000859469668172969,0.00909937410798674,-0.016975303583481,0.018694242919827,0.924750550106332
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCN,Decorin,41876,0.000233198855907331,0.00248371683507789,-0.00463488614084533,0.00510128385265999,0.925197162947822
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCNA,Proliferating cell nuclear antigen,39665,-0.000606754861429783,0.00647703185565794,-0.0133017372985194,0.0120882275756598,0.925366804027116
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,39804,0.00024695699814184,0.00264812251844157,-0.00494336313800364,0.00543727713428732,0.92570084207895
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,39706,0.00038484648931544,0.00417410097596576,-0.00779639142357744,0.00856608440220832,0.926541964776296
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,39719,-0.000506772687089673,0.00553799738255912,-0.0113612475569056,0.0103477021827262,0.927090458500051
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,41861,0.000492169869945821,0.00542110124673008,-0.0101331885736451,0.0111175283135368,0.927662637631372
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCP11,T-complex protein 11 homolog,39881,0.000552138399999576,0.00610660979442424,-0.0114168167970719,0.0125210935970711,0.927957924706232
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,41887,-0.000278546261404265,0.00308229429690325,-0.00631984308333464,0.0057627505605261,0.927994795386022
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLHL41,Kelch-like protein 41,40054,-0.000446980867487066,0.00495329930169734,-0.0101554474988138,0.00926148576383971,0.928098942641177
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,40097,0.000231116876307974,0.00261213325947235,-0.00488866431225783,0.00535089806487378,0.929498226930661
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN2,Prefoldin subunit 2,41829,0.000504818856494406,0.00570784248080658,-0.0106825524058865,0.0116921901188753,0.929525967755606
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTD,Deoxycytidylate deaminase,39863,0.000854725590657914,0.00969828047763481,-0.0181539041455063,0.0198633553268221,0.929773684609146
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUMF1,Formylglycine-generating enzyme,39784,-0.000572637473071159,0.00660097140815053,-0.0135105414330462,0.0123652664869039,0.930871486290643
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",39706,-0.000357190138066611,0.00421678004958985,-0.00862207903526271,0.00790769875912949,0.932496066327489
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP12,Macrophage metalloelastase,42098,-0.000486286891093012,0.00579790648322559,-0.0118501835982152,0.0108776098160291,0.933158833893861
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,39719,-0.000439184939122074,0.00533165843047056,-0.0108892354628444,0.0100108655846002,0.934351636662664
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_DRA,,42059,-0.000313319133884816,0.00383587539295855,-0.00783163490408358,0.00720499663631394,0.934901451857909
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MLLT1,Protein ENL,39665,-0.000559305549263109,0.00689088028912798,-0.0140654309159539,0.0129468198174277,0.935311448081477
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CORO6,Coronin-6,39719,0.000307636643830356,0.00384941276583881,-0.00723721237721372,0.00785248566487443,0.93630414301434
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,40080,0.000499916260031148,0.00625942982717182,-0.0117685662012256,0.0127683987212879,0.936345218556755
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,42094,0.000276012005731366,0.0035087367972437,-0.00660111211686629,0.00715313612832902,0.937300934193573
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,39863,-0.00100252268449163,0.012831028688174,-0.0261513389133127,0.0241462935443295,0.937723975372014
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53BP1,TP53-binding protein 1,39784,0.000649252531537882,0.0089738908307054,-0.0169395734966447,0.0182380785597205,0.942325492084122
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TST,Thiosulfate sulfurtransferase,41796,-0.000552579248667545,0.00769939535766529,-0.0156433941496915,0.0145382356523564,0.942786743659049
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3GL3,Endophilin-A3,39831,-0.000631606364821427,0.00881261641991496,-0.0179043345478548,0.0166411218182119,0.942865323685724
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,42056,0.000206669679800483,0.00291120766779577,-0.00549929734907922,0.00591263670868019,0.943405984850806
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,39719,-0.000521290377104956,0.00757239813074067,-0.0153631907133567,0.0143206099591468,0.945117603747935
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,40021,0.000621795408497797,0.00914239057532935,-0.0172972901191477,0.0185408809361433,0.945777064219995
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RUVBL1,RuvB-like 1,41861,0.000732582203456364,0.0109422943776706,-0.020714314776778,0.0221794791836907,0.946622885166441
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,39706,0.000297866601266588,0.00454919747778721,-0.00861856045519633,0.00921429365772951,0.947795673835669
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISM2,Isthmin-2,40097,-0.000286574004026853,0.00445358727279352,-0.00901560505870215,0.00844245705064844,0.948695284559081
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPD52L2,Tumor protein D54,39863,-0.000701874880872628,0.0110185759395128,-0.0222982837223177,0.0208945339605725,0.949210905586913
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,39863,-0.000561879281063464,0.00888964671269587,-0.0179855868379474,0.0168618282758204,0.94960362681678
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,39706,-0.000389820785208091,0.00631671355511925,-0.0127705793532418,0.0119909377828256,0.950792882988951
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MB,Myoglobin,42296,-0.000333580648663675,0.00550326429312431,-0.0111199786631873,0.01045281736586,0.95166671070031
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",39719,0.000346250475477154,0.00571231728837701,-0.0108498914097418,0.0115423923606961,0.951667206314363
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,40102,0.000176565044958555,0.00294737601181441,-0.00560029193819768,0.0059534220281148,0.952231723551197
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,39706,-0.000428367293404593,0.00720726118245294,-0.0145545992110124,0.0136978646242032,0.952606354495643
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MGLL,Monoglyceride lipase,42162,-0.000516267141458017,0.00885151574758617,-0.0178652380067269,0.0168327037238109,0.953490429285596
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,39768,-0.000222019519751675,0.00382594748224622,-0.00772087658495426,0.00727683754545091,0.953725873030872
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSM,Oncostatin-M,42044,-0.000409856567729907,0.00722546395365094,-0.0145717659168857,0.0137520527814259,0.954766009105292
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,42256,-0.000271205141207592,0.00494666611272849,-0.00996667072215544,0.00942426043974025,0.956278049876612
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,42120,0.000659318393651929,0.0122897394505463,-0.0234285709294187,0.0247472077167226,0.957216542523558
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUP50,Nuclear pore complex protein Nup50,39706,-0.000181495308813794,0.0036211929379361,-0.00727903346716856,0.00691604284954097,0.960027468116801
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39439,0.00024649903328819,0.00535505064875384,-0.0102494002382693,0.0107423983048457,0.963286335107847
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,39768,-0.000254677075601477,0.00564292925939996,-0.0113148184240254,0.0108054642728224,0.964002891922303
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN6,Prefoldin subunit 6,39768,0.000297541150903375,0.00669337442107974,-0.0128214727144129,0.0134165550162197,0.964544086069672
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRX,Cone-rod homeobox protein,41876,0.000480948221182426,0.0109777651024985,-0.0210354713797147,0.0219973678220795,0.965055650180284
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKIV2L,Helicase SKI2W,39706,-0.000177594192607917,0.00407678146619994,-0.00816808586635979,0.00781289748114396,0.965254088682598
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,39719,0.000145406496304155,0.00343887794665352,-0.00659479427913674,0.00688560727174505,0.966273801880727
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",39706,-0.000169522192688749,0.00402179386771738,-0.00805223817341481,0.00771319378803731,0.966379212024929
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,39881,-0.000280330531268949,0.00669015835629595,-0.013393040909609,0.0128323798470711,0.966577662493216
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB2B,Ras-related protein Rab-2B,40020,0.000258709081501043,0.00624540999594772,-0.0119822945105565,0.0124997126735586,0.966958743711064
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL22,C-C motif chemokine 22,42021,-0.000222894372604113,0.00545977779029853,-0.0109240588415892,0.010478270096381,0.967436198383622
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,42186,0.000138246793851146,0.00340112636326632,-0.00652796087815084,0.00680445446585313,0.967577655340626
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,42094,0.000139630759422407,0.00345933231836435,-0.00664066058457171,0.00691992210341653,0.967803954079959
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRGN,Neurogranin,40102,-0.000376634340526708,0.00935736522042936,-0.0187170701725683,0.0179638014915148,0.967894519030588
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP1,Methionine aminopeptidase 1,41829,-0.000121737992279314,0.00303458239746871,-0.00606951949131798,0.00582604350675935,0.968000574395558
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFB,Complement factor B,39922,0.000133297930643295,0.00333401704844166,-0.00640137548430236,0.00666797134558895,0.968108875672334
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,39863,-0.000479084789419911,0.0122031994940661,-0.0243973557977894,0.0234391862189496,0.968684669687636
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",41861,-0.000310070171134378,0.00804415315684701,-0.0160766103585545,0.0154564700162858,0.969252939320415
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FIS1,Mitochondrial fission 1 protein,42133,-0.000299065675674898,0.00779131397306812,-0.0155700410628884,0.0149719097115386,0.969381712847242
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPT,Microtubule-associated protein tau,41829,-0.00020210909644653,0.0055193155850069,-0.0110199676430601,0.010615749450167,0.970789765449919
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,41829,-0.000168825176823519,0.00472245779900245,-0.00942484246286831,0.00908719210922127,0.971482720626594
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PER3,Period circadian protein homolog 3,39784,-0.000445915027019939,0.0127632931096906,-0.0254619695220136,0.0245701394679737,0.972130394458941
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHB4,Ephrin type-B receptor 4,42296,9.07489079999706e-05,0.0027403239510287,-0.00528028603601628,0.00546178385201622,0.973582489087639
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK12,Kallikrein-12,41861,-0.000448719162202886,0.0144549932721714,-0.0287805059756588,0.0278830676512531,0.975236133107594
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",39665,0.000150788023443935,0.00505992355120287,-0.00976666213691369,0.0100682381838016,0.976226763933394
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUCL3,Mucin-like protein 3,39665,0.000124724102841303,0.00439195678672611,-0.00848351119914187,0.00873295940482448,0.977345021903869
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,39719,0.000112333755867592,0.00419851242077589,-0.00811675058885316,0.00834141810058834,0.978655166827759
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAX,Integrin alpha-X,39881,0.000148658982183584,0.00564003588817821,-0.0109058113586457,0.0112031293230129,0.978972439038134
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDF1,Endothelial differentiation-related factor 1,40054,0.000171830708857401,0.0069128003672945,-0.0133772580110398,0.0137209194287546,0.980169571182397
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALCAM,CD166 antigen,42296,4.99012690056797e-05,0.00202952479890092,-0.00392796733684013,0.00402776987485149,0.980384235370236
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,40031,-9.30784374062961e-05,0.00389697919914804,-0.00773115766773646,0.00754500079292387,0.980944965312586
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,40054,-0.000192861361367167,0.00828756729510167,-0.0164364932597664,0.0160507705370321,0.981434398541956
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP29,Dual specificity phosphatase 29,39768,-0.000160901844439096,0.00700718792427642,-0.0138949901760209,0.0135731864871427,0.981680699626964
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,39881,-0.000165423651421703,0.00826188156666303,-0.0163587115220813,0.0160278642192378,0.984025785210105
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,40057,-4.00487732608512e-05,0.00205599923620108,-0.00406980727621497,0.00398970972969327,0.984459361097168
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO4,Roundabout homolog 4,39804,3.53347796429136e-05,0.00187435452603516,-0.00363840009138601,0.00370906965067184,0.984959760540713
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,41829,0.000213717215127014,0.0114185020590162,-0.0221665468205448,0.0225939812507989,0.985067363886943
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,42200,-0.000108572846462034,0.00677711962911926,-0.0133917273195358,0.0131745816266117,0.987218282721439
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAGE2A,G antigen 2A,39665,-9.88700411398847e-05,0.00691247659472012,-0.0136473241667913,0.0134495840845116,0.988588416184979
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,39665,-0.000131451610147756,0.00994836439289208,-0.0196302458202162,0.0193673425999207,0.989457799307209
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,39904,-6.77794666150797e-05,0.00575194106849659,-0.0113415839608684,0.0112060250276382,0.990598360567863
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,40080,-0.000115798024077677,0.0100037250387717,-0.0197230991000703,0.0194915030519149,0.990764513221117
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,39665,6.68409098572378e-05,0.00596708180057571,-0.0116286394192712,0.0117623212389856,0.991062810410028
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELOB,Elongin-B,39706,-3.30461538837293e-05,0.00416476202903389,-0.00819597973079015,0.00812988742302269,0.993669239193257
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO2,Gamma-enolase,42213,4.43801592895792e-05,0.00666943002381693,-0.0130277026873916,0.0131164630059708,0.994690805290065
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK10,Kallikrein-10,42144,-2.58315334462918e-05,0.00421249396491494,-0.00828231970467957,0.00823065663778699,0.995107398412915
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTN4,Alpha-actinin-4,41887,1.80398033338771e-05,0.00338431365183977,-0.00661521495427206,0.00665129456093982,0.995747046408444
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,39804,4.83910239846298e-06,0.00511839285090646,-0.0100272108853782,0.0100368890901751,0.999245670730321
